data_6sy2_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6sy2 _Structure_validation_residue.Date_analyzed 2020-01-17 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 18.0 mt . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.676 0.274 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.77 150.81 39.9 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.586 2.191 . . . . 0.0 112.368 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.4 t -118.83 128.53 75.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.106 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 618' ' ' LYS . . . . . 0.405 ' HG3' ' N ' ' A' ' 630' ' ' GLY . 0.0 OUTLIER -66.35 170.47 5.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.857 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 16.2 m -157.79 157.26 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.149 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . 0.407 ' CD1' ' CG1' ' A' ' 627' ' ' ILE . 3.9 tp -124.59 127.64 73.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.724 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 621' ' ' HIS . . . . . 0.516 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 18.0 t-160 -91.01 132.91 35.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.552 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 23.4 t -87.4 -34.07 7.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.811 0.339 . . . . 0.0 111.231 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -33.82 74.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.348 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 44.2 t -111.51 -23.45 10.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.521 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 80.45 -0.58 84.68 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.508 -0.854 . . . . 0.0 112.828 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 7.2 tptp -76.59 149.2 36.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.819 0.343 . . . . 0.0 111.026 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 627' ' ' ILE . . . . . 0.407 ' CG1' ' CD1' ' A' ' 620' ' ' ILE . 5.7 mt -116.87 114.87 47.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.977 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 628' ' ' LEU . . . . . 0.451 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 41.2 mt -84.71 128.39 34.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.808 0.337 . . . . 0.0 111.01 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.72 166.2 16.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.206 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 630' ' ' GLY . . . . . 0.405 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -50.63 -21.18 4.54 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.873 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 19.2 p -71.17 -43.66 67.05 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -98.3 -29.34 13.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.759 0.314 . . . . 0.0 111.56 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.36 156.36 52.07 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.286 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.464 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 71.2 Cg_endo -73.37 163.6 37.35 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.727 2.285 . . . . 0.0 112.326 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -73.05 164.39 26.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.314 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -62.76 -31.57 72.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.85 0.357 . . . . 0.0 111.309 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.71 -36.23 48.75 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.371 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -104.01 3.33 33.27 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 639' ' ' LEU . . . . . . . . . . . . . 13.6 tp -58.36 -46.95 85.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.779 0.323 . . . . 0.0 111.121 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.17 -44.81 68.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.975 0.417 . . . . 0.0 111.132 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.79 -36.92 76.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.196 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 642' ' ' TRP . . . . . 0.464 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 47.6 t90 -66.67 -44.92 80.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 44.9 mt -65.91 -40.86 91.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.525 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.65 -40.87 96.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.647 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.1 -38.1 52.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.805 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -107.13 82.27 1.12 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.745 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.4 150.43 75.83 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.551 2.167 . . . . 0.0 112.447 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.45 -12.96 51.29 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.808 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.516 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 18.0 m-85 -90.03 160.94 16.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.829 0.347 . . . . 0.0 110.977 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -149.87 145.95 26.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.715 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.204 -179.897 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 16.1 mt . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.656 0.265 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -74.21 155.96 46.69 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.597 2.198 . . . . 0.0 112.25 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.4 t -117.47 133.33 64.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.131 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 618' ' ' LYS . . . . . 0.402 ' HG3' ' N ' ' A' ' 630' ' ' GLY . 0.0 OUTLIER -66.85 169.97 7.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.945 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 619' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 650' ' ' GLU . 26.8 m -157.14 162.88 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.82 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.21 128.04 12.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.987 0.422 . . . . 0.0 111.619 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 621' ' ' HIS . . . . . 0.494 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 3.6 t-160 -83.17 133.46 35.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.458 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.5 t -85.82 -23.67 6.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.754 0.311 . . . . 0.0 111.38 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -68.54 -37.41 79.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.494 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 49.0 m -117.17 -23.47 7.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.585 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 87.72 8.98 72.44 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.952 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.56 142.9 40.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.758 0.313 . . . . 0.0 110.807 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 1.9 mt -119.53 120.86 64.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.32 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 628' ' ' LEU . . . . . 0.414 HD13 ' CE1' ' A' ' 649' ' ' TYR . 23.3 mt -90.43 138.18 31.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.752 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.61 165.89 16.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.554 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 630' ' ' GLY . . . . . 0.402 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -55.94 -18.63 19.33 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.766 -0.73 . . . . 0.0 113.068 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 2.5 m -71.75 -43.54 65.62 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.793 0.297 . . . . 0.0 111.524 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -98.18 -22.79 16.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.429 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.55 156.26 54.46 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.169 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.461 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 71.7 Cg_endo -75.39 156.54 41.3 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.624 2.216 . . . . 0.0 112.313 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -73.95 168.02 20.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.487 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -62.86 -29.91 71.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.827 0.346 . . . . 0.0 111.249 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.64 -36.36 48.72 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.346 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.99 4.42 29.39 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 639' ' ' LEU . . . . . . . . . . . . . 16.4 tp -57.16 -52.32 65.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.697 0.284 . . . . 0.0 111.093 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -52.78 -43.7 66.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.969 0.414 . . . . 0.0 111.078 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.26 -36.25 76.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.924 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 642' ' ' TRP . . . . . 0.461 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 53.5 t90 -66.78 -49.64 65.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.68 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 82.1 mt -60.82 -42.11 97.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.488 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -61.06 -40.9 95.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.59 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.73 -25.68 49.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.993 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -121.87 78.98 40.82 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.773 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.1 144.12 86.3 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.717 2.278 . . . . 0.0 112.482 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.53 -7.58 46.58 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.841 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.494 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 12.2 m-85 -96.36 151.57 19.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.016 0.436 . . . . 0.0 111.105 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 650' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 619' ' ' VAL . 19.2 pt-20 -146.4 145.79 30.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.119 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 C--N 1.331 -0.237 0 CA-C-O 120.802 0.334 . . . . 0.0 111.487 -179.523 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 87.2 mt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.715 0.293 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.35 143.55 39.35 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.59 2.193 . . . . 0.0 112.446 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.89 115.32 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.007 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 618' ' ' LYS . . . . . 0.405 ' CB ' ' HA ' ' A' ' 629' ' ' THR . 0.0 OUTLIER -63.88 144.24 57.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.649 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 7.3 m -118.75 162.98 16.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.099 0.476 . . . . 0.0 111.544 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . 0.421 ' CD1' HG12 ' A' ' 627' ' ' ILE . 4.9 tp -124.31 127.69 73.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.454 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 621' ' ' HIS . . . . . 0.495 ' HB2' ' CE1' ' A' ' 649' ' ' TYR . 6.3 t-160 -96.78 119.29 34.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.661 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.3 t -88.39 -33.62 6.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.281 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.42 -34.92 76.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.172 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 3.6 m -110.85 -23.39 11.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.336 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 85.76 -6.04 81.91 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.85 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.29 155.47 40.36 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.823 0.344 . . . . 0.0 110.788 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 627' ' ' ILE . . . . . 0.421 HG12 ' CD1' ' A' ' 620' ' ' ILE . 12.1 mt -126.75 121.27 58.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.293 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 628' ' ' LEU . . . . . 0.465 ' CD1' ' CE1' ' A' ' 649' ' ' TYR . 16.4 mt -103.06 124.93 49.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.425 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 629' ' ' THR . . . . . 0.405 ' HA ' ' CB ' ' A' ' 618' ' ' LYS . 0.4 OUTLIER -85.45 166.08 16.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.187 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . -46.84 -25.14 2.19 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.963 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 14.0 p -65.45 -43.96 88.76 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.616 0.246 . . . . 0.0 111.625 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -98.55 -24.24 15.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.874 0.369 . . . . 0.0 111.58 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.54 156.27 54.29 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.451 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.433 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 72.7 Cg_endo -75.25 163.95 33.82 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.82 2.347 . . . . 0.0 112.303 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -72.96 176.43 5.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.471 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -58.95 -48.92 79.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.405 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.67 -36.19 49.08 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.037 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -81.5 -9.8 59.62 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.645 0.239 . . . . 0.0 111.645 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 639' ' ' LEU . . . . . . . . . . . . . 13.1 tp -58.88 -53.35 59.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.713 0.292 . . . . 0.0 111.162 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -52.19 -49.33 64.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.944 0.402 . . . . 0.0 111.068 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -66.78 -35.88 81.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.891 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 642' ' ' TRP . . . . . 0.433 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 27.9 t90 -66.85 -38.77 87.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.661 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 12.0 mt -68.33 -42.12 79.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.467 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.65 -41.01 96.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.469 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 3.3 tpp -77.73 -33.23 53.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.797 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 646' ' ' ASN . . . . . 0.422 ' HB2' ' CZ3' ' A' ' 642' ' ' TRP . 10.4 m-80 -115.28 79.28 6.59 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.755 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.46 148.59 73.48 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.569 2.179 . . . . 0.0 112.47 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.41 -8.77 48.55 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.789 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.495 ' CE1' ' HB2' ' A' ' 621' ' ' HIS . 17.7 m-85 -94.91 161.74 14.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.96 0.409 . . . . 0.0 111.168 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -149.86 168.09 24.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.753 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 29.2 t . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.975 179.955 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 5.6 mt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.719 0.295 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.18 140.92 31.65 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.525 2.15 . . . . 0.0 112.317 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.5 t -111.42 119.61 60.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.098 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 618' ' ' LYS . . . . . 0.401 ' HG3' ' N ' ' A' ' 630' ' ' GLY . 0.0 OUTLIER -58.85 174.49 0.34 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 16.2 m -157.87 155.85 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.135 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 4.9 tp -124.5 127.61 73.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.771 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 621' ' ' HIS . . . . . 0.51 ' CG ' ' CE1' ' A' ' 649' ' ' TYR . 6.4 t-160 -89.91 133.28 34.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.723 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 26.1 t -87.12 -29.45 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.366 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 623' ' ' GLU . . . . . 0.438 ' HB3' ' CE1' ' A' ' 621' ' ' HIS . 32.4 tt0 -68.46 -37.16 79.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.374 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.18 -23.32 10.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.427 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 82.45 3.31 90.58 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.697 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -76.7 151.14 36.21 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.81 0.338 . . . . 0.0 111.027 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 7.1 mt -117.08 111.05 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.019 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 628' ' ' LEU . . . . . 0.445 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 75.4 mt -81.41 133.59 35.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.848 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.74 166.05 16.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.196 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 630' ' ' GLY . . . . . 0.401 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -50.27 -21.34 4.16 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.771 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 1.1 m -69.79 -43.48 72.02 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.06 -30.73 12.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.819 0.342 . . . . 0.0 111.465 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.41 156.35 52.59 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.187 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.445 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 73.0 Cg_endo -75.18 162.92 35.91 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.713 2.275 . . . . 0.0 112.451 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 43.0 mttm -85.44 157.04 20.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.571 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -53.04 -26.87 17.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.499 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -73.97 -36.29 52.34 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.395 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -116.02 14.23 16.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.025 0.413 . . . . 0.0 111.872 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 639' ' ' LEU . . . . . . . . . . . . . 10.9 tp -59.59 -51.61 69.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.796 0.331 . . . . 0.0 111.108 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -52.98 -43.28 66.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.99 0.424 . . . . 0.0 111.106 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.94 -38.93 76.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.806 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 642' ' ' TRP . . . . . 0.445 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 37.7 t90 -64.69 -42.46 95.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.699 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 90.4 mt -66.61 -40.97 89.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.35 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -60.11 -41.04 91.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.494 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 18.4 ttt -77.47 -36.25 53.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.562 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 646' ' ' ASN . . . . . 0.424 ' HB2' ' CZ3' ' A' ' 642' ' ' TRP . 20.9 m-80 -112.38 78.01 2.45 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.584 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.81 149.03 83.43 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.609 2.206 . . . . 0.0 112.451 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.46 -18.89 43.78 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.615 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.51 ' CE1' ' CG ' ' A' ' 621' ' ' HIS . 21.3 m-85 -83.41 157.97 22.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.837 0.351 . . . . 0.0 111.005 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -148.61 145.9 27.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.563 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 2.7 m . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.407 -179.838 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 10.8 mt . . . . . 0 CA--C 1.528 0.11 0 CA-C-O 120.726 0.298 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.26 153.13 31.33 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.597 2.198 . . . . 0.0 112.425 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.7 t -118.85 122.63 69.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.065 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.63 176.42 0.88 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.874 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 5.9 m -159.23 158.02 2.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.246 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 5.0 tp -124.57 127.55 72.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.686 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 621' ' ' HIS . . . . . 0.519 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 7.6 t-160 -89.82 127.46 35.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.734 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.6 t -88.47 -39.27 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 0.0 111.05 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -68.5 -29.97 68.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.388 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 1.7 t -112.83 -23.44 10.13 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.573 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 79.4 -0.0 82.08 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.825 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -76.44 156.83 32.77 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.812 0.339 . . . . 0.0 110.887 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 2.8 mt -128.39 126.58 65.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.238 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 628' ' ' LEU . . . . . 0.462 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 11.5 mt -103.45 130.71 50.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.654 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.69 166.08 16.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.254 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . -53.59 -19.05 8.58 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.031 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 23.0 m -71.78 -43.81 65.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.681 0.277 . . . . 0.0 111.693 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -98.26 -23.18 15.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.857 0.361 . . . . 0.0 111.518 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.41 156.36 52.56 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.353 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.455 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 61.0 Cg_endo -71.68 163.96 37.25 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.764 2.31 . . . . 0.0 112.188 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -72.88 176.45 5.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.448 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -59.79 -49.01 79.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.792 0.33 . . . . 0.0 111.383 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.72 -36.22 48.71 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.01 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -81.16 -10.52 59.62 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 639' ' ' LEU . . . . . . . . . . . . . 10.9 tp -59.24 -50.71 72.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.774 0.321 . . . . 0.0 111.181 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -53.1 -45.63 68.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.299 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.77 -37.19 76.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.921 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 642' ' ' TRP . . . . . 0.455 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 51.8 t90 -64.28 -54.6 30.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.794 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 67.7 mt -58.53 -43.09 89.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.615 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -59.57 -38.13 80.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.614 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.03 -25.55 37.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.955 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -122.15 78.08 42.83 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.93 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.56 151.7 78.32 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.711 2.274 . . . . 0.0 112.313 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.41 -17.1 47.77 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.823 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.519 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 23.6 m-85 -89.54 152.25 21.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.907 0.384 . . . . 0.0 111.049 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -144.04 153.49 42.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.636 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.251 -179.902 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 25.4 mt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.764 0.316 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 616' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 635' ' ' LYS . 70.3 Cg_endo -74.69 148.1 36.33 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.604 2.203 . . . . 0.0 112.627 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.4 t -118.97 115.29 47.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.811 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.66 143.36 57.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.953 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 2.5 m -127.05 165.72 25.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.336 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.26 127.46 69.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.669 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 621' ' ' HIS . . . . . 0.462 ' ND1' ' CE2' ' A' ' 649' ' ' TYR . 5.9 t-160 -91.87 125.87 36.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.941 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 26.1 t -86.82 -31.1 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.264 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -68.12 -37.3 80.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.106 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 21.1 t -105.75 -23.58 12.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.219 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 88.21 -15.37 56.39 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.922 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 10.0 mtpp -70.25 156.83 38.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.687 0.279 . . . . 0.0 110.918 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 2.0 mp -128.55 115.39 37.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.061 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 628' ' ' LEU . . . . . 0.447 ' CD1' ' CE1' ' A' ' 649' ' ' TYR . 15.8 mt -85.06 130.18 34.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.906 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.7 166.05 16.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.184 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . -48.49 -24.05 3.58 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.838 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 8.5 p -65.34 -43.98 89.21 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.51 -34.11 10.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.902 0.382 . . . . 0.0 111.642 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.38 156.12 53.72 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.712 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.488 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 89.5 Cg_endo -75.32 163.76 34.04 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.957 2.438 . . . . 0.0 112.556 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 635' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 616' ' ' PRO . 0.0 OUTLIER -92.06 166.1 12.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.511 179.362 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -52.94 -26.89 16.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.588 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -67.17 -36.25 89.82 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.416 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.33 17.57 7.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 117.014 0.407 . . . . 0.0 111.854 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 639' ' ' LEU . . . . . . . . . . . . . 13.9 tp -64.71 -54.58 29.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.779 0.323 . . . . 0.0 111.23 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -52.26 -43.42 64.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.182 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -67.97 -37.53 81.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.848 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 642' ' ' TRP . . . . . 0.488 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 28.0 t90 -66.81 -48.79 67.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.864 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 36.1 mt -60.18 -41.19 92.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.591 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.15 -40.98 99.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.581 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 28.8 ttp -79.49 -18.74 51.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.175 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 646' ' ' ASN . . . . . 0.415 ' HB2' ' CZ3' ' A' ' 642' ' ' TRP . 27.7 m-80 -129.56 68.36 80.3 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.866 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -56.84 154.33 32.7 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.539 2.16 . . . . 0.0 112.328 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.29 -16.77 48.79 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.706 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.462 ' CE2' ' ND1' ' A' ' 621' ' ' HIS . 25.0 m-85 -88.13 161.17 17.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.819 0.343 . . . . 0.0 111.125 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -149.74 157.85 43.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.788 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.158 179.983 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 16.3 mt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.683 0.277 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.94 151.12 39.43 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.597 2.198 . . . . 0.0 112.374 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.93 119.13 60.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.155 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.92 146.04 54.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.762 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 4.1 m -122.68 164.51 19.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.392 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . 0.426 ' CD1' ' CG1' ' A' ' 627' ' ' ILE . 5.9 tp -124.46 127.64 73.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.573 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 621' ' ' HIS . . . . . 0.499 ' CD2' ' CD2' ' A' ' 649' ' ' TYR . 5.5 t-160 -95.5 118.82 32.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.78 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 19.2 t -89.18 -28.19 5.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.227 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -61.72 -37.37 83.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.108 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 61.3 m -119.17 -23.39 6.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.412 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 95.29 -3.29 66.25 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.837 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.33 147.07 51.61 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.811 0.339 . . . . 0.0 110.745 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 627' ' ' ILE . . . . . 0.426 ' CG1' ' CD1' ' A' ' 620' ' ' ILE . 1.6 mp -120.84 118.91 57.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.323 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 628' ' ' LEU . . . . . 0.454 ' CD1' ' CE1' ' A' ' 649' ' ' TYR . 27.2 mt -97.56 127.29 43.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.476 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.5 166.04 16.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.251 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . -49.2 -22.15 3.17 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.074 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 1.2 m -68.55 -43.98 75.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -98.42 -25.99 14.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.907 0.384 . . . . 0.0 111.47 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.49 156.59 51.93 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.389 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.44 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 58.0 Cg_endo -69.45 163.85 36.45 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.884 2.389 . . . . 0.0 112.189 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 25.4 mttp -72.92 174.19 8.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.454 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -60.37 -48.94 79.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.381 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.83 -36.24 48.16 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.0 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -82.38 -9.62 59.38 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 639' ' ' LEU . . . . . . . . . . . . . 11.4 tp -57.35 -45.66 84.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.774 0.321 . . . . 0.0 111.197 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.27 -49.77 68.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.995 0.426 . . . . 0.0 111.309 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -68.92 -34.48 75.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.176 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 642' ' ' TRP . . . . . 0.44 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 49.7 t90 -67.03 -44.43 80.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.826 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 83.2 mt -65.47 -44.4 87.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.387 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -60.78 -37.19 81.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.523 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 6.3 mtt -80.97 -26.27 36.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.008 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -122.34 78.3 44.74 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.976 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -64.28 150.14 88.87 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.72 2.28 . . . . 0.0 112.388 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.38 -15.85 49.64 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.789 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.499 ' CD2' ' CD2' ' A' ' 621' ' ' HIS . 22.5 m-85 -88.55 161.77 16.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.918 0.39 . . . . 0.0 111.116 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -148.64 145.91 27.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.765 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.226 179.989 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 19.7 mt . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.775 0.321 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.53 152.4 65.28 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.609 2.206 . . . . 0.0 112.319 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.81 131.47 71.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.13 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.16 172.8 7.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.88 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 6.2 m -159.17 162.97 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.171 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . 0.405 HD13 ' CG1' ' A' ' 627' ' ' ILE . 4.7 tp -129.13 127.51 65.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.744 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 621' ' ' HIS . . . . . 0.51 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 8.1 t-160 -91.19 134.35 34.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.72 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 25.5 t -87.39 -31.12 5.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.895 0.379 . . . . 0.0 111.108 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -68.6 -36.9 79.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.353 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 1.3 m -111.36 -23.27 10.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.645 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 81.43 1.69 90.19 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.817 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.69 153.62 34.96 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.863 0.364 . . . . 0.0 110.958 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 627' ' ' ILE . . . . . 0.405 ' CG1' HD13 ' A' ' 620' ' ' ILE . 3.9 mt -120.67 109.26 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.096 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 628' ' ' LEU . . . . . 0.451 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 30.4 mt -78.33 129.86 35.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.817 0.341 . . . . 0.0 110.66 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.7 166.06 16.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.193 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . -52.38 -19.04 5.58 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.9 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 35.7 m -72.96 -43.61 62.08 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -98.03 -29.0 13.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.786 0.327 . . . . 0.0 111.604 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.38 156.29 52.67 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.082 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.45 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 72.8 Cg_endo -75.28 157.85 41.38 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.672 2.248 . . . . 0.0 112.425 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 29.1 mttp -74.0 155.36 38.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.571 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -53.14 -26.98 18.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.503 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.37 -36.37 50.12 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.308 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -111.34 11.06 21.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.819 0.31 . . . . 0.0 111.733 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 639' ' ' LEU . . . . . . . . . . . . . 12.6 tp -63.63 -48.1 78.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.763 0.316 . . . . 0.0 111.103 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -52.83 -43.77 66.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.961 0.41 . . . . 0.0 111.095 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.87 -38.46 76.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.975 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 642' ' ' TRP . . . . . 0.45 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 30.5 t90 -67.68 -36.62 81.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.678 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 14.1 mt -69.3 -43.39 73.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.341 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.52 -40.96 96.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.456 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -75.68 -39.26 57.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.718 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -106.22 80.06 0.64 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.727 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.12 147.59 73.51 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.573 2.182 . . . . 0.0 112.448 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.43 -15.23 50.24 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.702 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.51 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 19.4 m-85 -86.66 153.08 22.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.806 0.336 . . . . 0.0 111.014 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -143.6 145.83 32.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.634 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 31.0 t . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.236 -179.983 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 10.0 mt . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.753 0.311 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.38 152.17 38.72 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.569 2.179 . . . . 0.0 112.365 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 26.5 t -118.87 129.36 75.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.025 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.41 173.54 4.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 12.0 m -158.58 160.67 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.21 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . 0.405 ' CD1' ' CG1' ' A' ' 627' ' ' ILE . 5.5 tp -124.3 127.65 73.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.636 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 621' ' ' HIS . . . . . 0.508 ' CG ' ' CE1' ' A' ' 649' ' ' TYR . 7.3 t-160 -93.23 127.97 39.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.79 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.4 t -88.68 -27.32 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.309 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 623' ' ' GLU . . . . . 0.412 ' HB3' ' CE1' ' A' ' 621' ' ' HIS . 13.2 tt0 -68.35 -37.22 80.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.149 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 12.4 p -113.51 -23.21 9.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.398 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 87.51 -5.72 84.57 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.886 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 29.1 tttt -69.39 156.8 38.23 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.856 0.36 . . . . 0.0 110.966 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 627' ' ' ILE . . . . . 0.405 ' CG1' ' CD1' ' A' ' 620' ' ' ILE . 2.6 mt -124.35 114.54 41.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.972 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 628' ' ' LEU . . . . . 0.442 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 45.1 mt -87.13 127.91 35.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.825 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.66 166.22 16.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.133 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . -49.58 -21.74 3.47 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.864 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 29.0 p -70.08 -43.69 70.62 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -98.38 -27.59 14.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.827 0.346 . . . . 0.0 111.628 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.41 156.36 52.61 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.298 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.459 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 71.5 Cg_endo -72.9 163.82 37.31 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.767 2.312 . . . . 0.0 112.314 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -73.04 172.54 10.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.4 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -61.01 -43.94 98.14 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.796 0.331 . . . . 0.0 111.433 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.54 -36.32 49.36 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.841 -0.695 . . . . 0.0 113.114 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -88.02 -6.05 58.18 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 639' ' ' LEU . . . . . . . . . . . . . 16.3 tp -58.49 -51.28 70.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.665 0.269 . . . . 0.0 111.229 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -50.67 -50.51 54.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.005 0.431 . . . . 0.0 111.122 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -66.55 -35.41 80.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.986 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 642' ' ' TRP . . . . . 0.459 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 36.4 t90 -67.63 -37.75 82.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.679 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.88 -46.03 72.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.291 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.27 -36.78 80.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.423 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 3.6 ttm -80.83 -24.33 38.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.894 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -125.8 75.46 70.84 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.872 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.84 149.59 90.34 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.682 2.254 . . . . 0.0 112.401 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.51 -18.29 44.89 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.735 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.508 ' CE1' ' CG ' ' A' ' 621' ' ' HIS . 20.7 m-85 -83.39 161.63 21.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.872 0.368 . . . . 0.0 111.075 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -149.64 145.98 27.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.75 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.159 -179.916 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 50.9 mt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.745 0.307 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.79 151.35 57.25 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.632 2.221 . . . . 0.0 112.324 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.3 t -118.83 128.92 75.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.143 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.39 176.72 1.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.813 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 10.1 m -158.95 158.84 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.257 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 5.3 tp -124.36 127.55 73.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.533 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 621' ' ' HIS . . . . . 0.487 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 7.8 t-160 -93.12 128.79 39.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.659 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.4 t -88.24 -34.65 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.216 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -68.46 -33.97 75.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.334 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 1.7 m -111.5 -23.4 10.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.558 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 82.39 -4.0 79.38 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.826 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.56 156.89 36.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.839 0.352 . . . . 0.0 110.935 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 1.6 mt -125.85 119.13 53.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.102 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 628' ' ' LEU . . . . . 0.458 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 17.6 mt -90.36 130.36 36.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.877 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.69 165.98 16.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.181 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . -50.73 -21.26 4.74 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.966 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 22.1 p -69.83 -43.63 71.59 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -98.31 -30.18 12.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.785 0.326 . . . . 0.0 111.516 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.36 156.25 52.79 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.182 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.451 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 72.4 Cg_endo -75.26 163.64 34.38 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.755 2.304 . . . . 0.0 112.444 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -80.52 157.08 26.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.546 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -53.08 -26.96 17.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.501 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.49 -36.3 49.68 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.81 -0.709 . . . . 0.0 113.39 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -113.51 12.6 18.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.964 0.382 . . . . 0.0 111.806 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 639' ' ' LEU . . . . . . . . . . . . . 11.9 tp -62.99 -49.69 73.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.775 0.321 . . . . 0.0 111.089 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -53.34 -41.73 66.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.211 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.74 -38.75 76.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.893 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 642' ' ' TRP . . . . . 0.451 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 47.3 t90 -66.14 -46.37 77.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.706 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 15.3 mt -61.92 -44.34 96.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.589 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.65 -39.62 89.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.547 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.2 -24.53 47.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.982 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -124.05 77.12 59.26 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.939 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -61.88 149.9 88.28 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.577 2.184 . . . . 0.0 112.224 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.43 -13.31 51.26 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.816 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.487 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 24.5 m-85 -94.05 156.15 16.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.861 0.363 . . . . 0.0 111.014 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -149.98 151.82 33.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.783 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.08 -179.926 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 73.2 mt . . . . . 0 CA--C 1.527 0.078 0 CA-C-O 120.782 0.325 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.75 148.72 36.9 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.532 2.154 . . . . 0.0 112.364 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.8 t -118.83 115.38 47.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.963 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.47 174.85 0.87 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.951 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 4.6 m -159.15 157.62 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.199 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.37 127.64 73.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.805 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 621' ' ' HIS . . . . . 0.517 ' CD2' ' CD1' ' A' ' 649' ' ' TYR . 5.4 t-160 -87.59 124.73 33.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.794 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 25.8 t -88.28 -29.48 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.311 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 623' ' ' GLU . . . . . 0.428 ' HB3' ' CE1' ' A' ' 621' ' ' HIS . 7.2 tp10 -68.38 -37.27 80.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.245 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 3.4 t -112.24 -23.33 10.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.281 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 89.26 -10.85 71.6 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.791 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -69.25 145.47 53.1 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.874 0.368 . . . . 0.0 110.854 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 10.1 mt -120.91 131.09 73.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.046 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 628' ' ' LEU . . . . . 0.455 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 11.1 mt -103.36 136.02 43.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.857 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.72 166.09 16.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.32 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . -51.39 -22.81 7.94 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.78 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 19.8 p -65.91 -43.84 86.99 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.719 0.295 . . . . 0.0 111.459 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -98.36 -21.56 16.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.341 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.48 156.24 53.92 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.352 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.456 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 73.3 Cg_endo -74.29 163.86 35.45 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.696 2.264 . . . . 0.0 112.174 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 31.5 mttt -72.98 175.62 6.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.475 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -60.54 -48.73 80.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.43 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.52 -36.25 49.63 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.943 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.07 -10.11 59.32 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 639' ' ' LEU . . . . . . . . . . . . . 10.6 tp -56.34 -50.62 70.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.73 0.3 . . . . 0.0 111.218 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -54.12 -47.63 71.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.989 0.423 . . . . 0.0 111.186 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -67.89 -36.59 80.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.754 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 642' ' ' TRP . . . . . 0.456 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 42.2 t90 -65.49 -43.77 89.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.723 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 2.6 mt -63.55 -45.11 92.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.319 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -60.2 -37.44 80.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.378 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.14 -23.3 41.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.951 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -127.34 73.11 77.54 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.928 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -61.17 148.87 91.68 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.606 2.204 . . . . 0.0 112.391 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.36 -20.53 39.74 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.771 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.517 ' CD1' ' CD2' ' A' ' 621' ' ' HIS . 21.1 m-85 -81.68 150.58 27.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.874 0.369 . . . . 0.0 110.895 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -137.33 145.93 43.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.724 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.235 -179.95 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 7.8 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.76 0.314 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.67 150.69 35.68 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.646 2.231 . . . . 0.0 112.466 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 27.9 t -118.8 127.35 75.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.053 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.39 167.96 7.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.953 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 619' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 650' ' ' GLU . 5.2 m -159.24 161.45 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.003 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 12.8 tt -134.98 128.14 49.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.926 0.394 . . . . 0.0 111.528 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 621' ' ' HIS . . . . . 0.48 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 13.8 t-160 -80.51 137.93 36.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.33 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 20.8 t -85.18 -22.16 7.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.779 0.323 . . . . 0.0 111.482 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 623' ' ' GLU . . . . . 0.42 ' HB3' ' CE1' ' A' ' 621' ' ' HIS . 26.1 tt0 -68.46 -37.4 80.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.499 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 32.0 t -120.12 -23.39 6.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.705 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 86.69 10.41 73.02 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.754 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 7.3 tppt? -76.58 146.92 37.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.785 0.326 . . . . 0.0 110.754 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 3.4 mp -119.97 123.55 71.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.335 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 628' ' ' LEU . . . . . 0.448 ' CD1' ' CE1' ' A' ' 649' ' ' TYR . 15.0 mt -92.35 140.03 30.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.636 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.77 165.88 16.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.389 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . -56.04 -18.46 19.56 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.841 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 6.0 m -70.94 -43.7 67.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.648 0.261 . . . . 0.0 111.484 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.11 -24.22 15.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.797 0.332 . . . . 0.0 111.374 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.52 156.2 54.54 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.161 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.438 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 73.0 Cg_endo -74.75 163.77 35.03 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.689 2.259 . . . . 0.0 112.327 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 21.7 mttp -72.99 175.77 6.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.433 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -61.39 -48.97 78.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.774 0.321 . . . . 0.0 111.205 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.71 -36.26 48.64 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.832 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.94 -11.31 59.59 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.619 0.229 . . . . 0.0 111.619 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 639' ' ' LEU . . . . . . . . . . . . . 10.9 tp -55.98 -47.52 77.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.726 0.298 . . . . 0.0 111.211 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -54.85 -47.75 73.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.997 0.427 . . . . 0.0 111.105 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -67.89 -36.92 81.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.701 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 642' ' ' TRP . . . . . 0.438 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 39.7 t90 -66.59 -38.6 87.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.491 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 8.3 mt -66.26 -44.72 82.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.077 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -59.5 -40.03 85.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.201 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 2.7 ttm -79.26 -21.02 46.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.83 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 646' ' ' ASN . . . . . 0.425 ' HB2' ' CZ3' ' A' ' 642' ' ' TRP . 23.9 m-80 -133.4 65.67 72.78 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.842 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -59.65 149.79 80.44 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.57 2.18 . . . . 0.0 112.444 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.46 -13.55 51.05 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.852 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.48 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 13.2 m-85 -85.01 142.31 29.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 0.0 111.053 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 650' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 619' ' ' VAL . 1.4 mm-40 -130.74 146.18 52.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.509 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 27.2 t . . . . . 0 C--N 1.33 -0.258 0 CA-C-O 120.835 0.35 . . . . 0.0 111.297 -179.794 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 71.2 mt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.755 0.312 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.41 144.3 28.79 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.584 2.189 . . . . 0.0 112.309 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.81 115.66 48.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.145 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 618' ' ' LYS . . . . . 0.405 ' HG3' ' N ' ' A' ' 630' ' ' GLY . 0.3 OUTLIER -65.46 175.66 1.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.813 179.912 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 11.2 m -158.33 157.07 3.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.158 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . 0.402 ' CD1' ' CG1' ' A' ' 627' ' ' ILE . 5.6 tp -124.35 127.6 73.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.922 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 621' ' ' HIS . . . . . 0.505 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 7.1 t-160 -89.51 127.98 35.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.692 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.6 t -88.35 -38.03 11.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.071 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -68.52 -30.59 69.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.413 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 8.9 t -112.5 -23.36 10.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.543 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 79.27 1.88 86.55 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.746 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.67 156.79 32.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.825 0.345 . . . . 0.0 110.888 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 627' ' ' ILE . . . . . 0.402 ' CG1' ' CD1' ' A' ' 620' ' ' ILE . 1.9 mt -126.65 124.46 65.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.103 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 628' ' ' LEU . . . . . 0.451 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 19.1 mt -102.25 129.89 48.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.842 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.6 166.09 16.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.221 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 630' ' ' GLY . . . . . 0.405 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -50.2 -22.23 4.78 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.832 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 8.1 p -68.5 -43.79 76.09 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -98.43 -25.05 14.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.524 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.48 154.7 63.01 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.262 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.463 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 72.0 Cg_endo -75.44 161.72 37.07 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.625 2.216 . . . . 0.0 112.382 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -81.66 158.85 24.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.411 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -53.1 -27.09 18.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.787 0.327 . . . . 0.0 111.417 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.68 -36.34 48.57 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.831 -0.699 . . . . 0.0 113.397 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -111.96 11.63 20.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.875 0.337 . . . . 0.0 111.908 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 639' ' ' LEU . . . . . . . . . . . . . 10.4 tp -62.18 -52.19 64.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.799 0.333 . . . . 0.0 111.084 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -53.24 -42.34 66.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.125 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.98 -39.06 76.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.883 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 642' ' ' TRP . . . . . 0.463 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 34.7 t90 -64.59 -46.91 80.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.677 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 11.7 mt -63.83 -40.53 96.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.509 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -60.63 -41.01 94.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.568 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 1.2 ttt -78.03 -35.75 49.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.845 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 646' ' ' ASN . . . . . 0.417 ' HB2' ' CZ3' ' A' ' 642' ' ' TRP . 24.5 m-80 -109.88 81.32 1.99 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.79 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.45 147.85 71.98 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.563 2.176 . . . . 0.0 112.392 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.46 -14.15 50.8 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.738 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.505 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 17.1 m-85 -88.39 149.41 23.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.85 0.357 . . . . 0.0 111.009 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -136.22 145.76 46.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.641 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.234 -179.899 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 80.1 mt . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.842 0.353 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.31 145.68 24.24 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.71 2.274 . . . . 0.0 112.402 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.3 t -118.84 119.88 62.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.086 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 618' ' ' LYS . . . . . 0.413 ' HG3' ' N ' ' A' ' 630' ' ' GLY . 0.0 OUTLIER -61.41 169.58 2.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.911 0.386 . . . . 0.0 110.985 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 619' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 650' ' ' GLU . 32.9 m -155.83 143.35 11.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.858 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.37 127.58 73.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.888 0.375 . . . . 0.0 111.132 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 621' ' ' HIS . . . . . 0.494 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 3.6 t-160 -86.69 131.09 34.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.62 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.6 t -86.43 -29.69 6.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.851 0.357 . . . . 0.0 111.054 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -68.55 -37.38 79.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.49 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 8.7 p -111.96 -23.48 10.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.456 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 87.21 -10.52 68.5 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.921 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.4 141.99 53.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.797 0.332 . . . . 0.0 110.89 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 1.9 mt -121.08 129.39 75.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.307 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 12.5 mt -95.68 139.64 31.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.777 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.84 165.91 16.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.497 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 630' ' ' GLY . . . . . 0.413 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -57.2 -18.38 27.77 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.92 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.63 -43.73 68.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.753 0.311 . . . . 0.0 111.446 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -98.19 -22.49 16.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.358 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.46 156.33 53.19 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.291 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.451 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 64.1 Cg_endo -72.42 163.82 37.45 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.735 2.29 . . . . 0.0 112.247 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -72.9 176.45 5.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.525 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -59.43 -48.49 81.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.46 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.47 -36.19 50.03 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.049 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -81.73 -9.85 59.53 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 639' ' ' LEU . . . . . . . . . . . . . 12.0 tp -62.18 -50.11 73.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.654 0.264 . . . . 0.0 111.077 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -52.41 -46.25 66.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.001 0.429 . . . . 0.0 111.17 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.48 -37.61 77.32 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.919 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 642' ' ' TRP . . . . . 0.451 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 44.2 t90 -65.31 -40.81 94.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.747 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 86.0 mt -67.59 -42.58 82.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.319 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.64 -40.45 87.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.414 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.22 -37.09 54.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.623 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -110.92 80.25 2.16 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.648 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.43 147.65 71.73 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.462 2.108 . . . . 0.0 112.454 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.45 -7.74 47.07 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.836 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.494 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 12.5 m-85 -93.47 157.55 16.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.897 0.379 . . . . 0.0 111.026 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 650' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' A' ' 619' ' ' VAL . 18.7 mm-40 -149.4 151.67 34.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.26 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 28.5 t . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 120.821 0.344 . . . . 0.0 111.259 -179.748 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 39.3 mt . . . . . 0 CA--C 1.527 0.094 0 CA-C-O 120.67 0.272 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.05 155.99 47.45 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.604 2.203 . . . . 0.0 112.323 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 27.9 t -118.69 121.06 66.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.06 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.53 134.97 39.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.965 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 2.6 m -124.0 176.89 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.189 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 3.4 tt -143.0 133.12 22.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.509 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 621' ' ' HIS . . . . . 0.482 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 3.3 t-160 -84.65 136.89 33.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.055 179.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 27.0 t -84.65 -36.55 11.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.826 0.346 . . . . 0.0 111.21 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -68.56 -33.0 73.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.41 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.17 -23.24 12.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.55 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 77.36 4.55 84.4 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.683 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 9.0 tttt -76.57 148.38 37.06 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.76 0.314 . . . . 0.0 110.836 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 10.7 mt -122.28 105.54 16.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.363 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 628' ' ' LEU . . . . . 0.452 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 13.6 mt -80.1 130.99 35.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.322 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.53 166.03 16.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.384 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . -50.51 -22.59 5.59 Favored Glycine 0 CA--C 1.517 0.193 0 C-N-CA 120.81 -0.71 . . . . 0.0 113.005 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.16 -43.89 81.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.675 0.274 . . . . 0.0 111.586 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -98.18 -23.72 15.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.911 0.386 . . . . 0.0 111.489 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.62 156.41 54.22 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.302 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.46 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 71.7 Cg_endo -75.11 163.79 34.41 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.878 2.385 . . . . 0.0 112.222 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -72.97 174.73 7.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.495 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -60.99 -44.21 97.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.852 0.358 . . . . 0.0 111.461 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.67 -36.22 49.0 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.214 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 6.1 mm100 -87.19 -7.36 58.02 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 639' ' ' LEU . . . . . . . . . . . . . 14.3 tp -59.62 -49.6 77.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.759 0.314 . . . . 0.0 111.197 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -52.42 -50.39 62.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.943 0.402 . . . . 0.0 111.281 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -66.58 -34.53 78.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.096 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 642' ' ' TRP . . . . . 0.46 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 49.5 t90 -66.73 -46.12 76.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.875 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 35.9 mt -62.76 -43.8 97.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.479 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.17 -38.83 87.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.562 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 6.8 tmm? -78.88 -24.85 43.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.005 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -123.39 77.8 53.84 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.826 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -64.81 144.68 84.28 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.705 2.27 . . . . 0.0 112.395 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.48 -3.41 43.04 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.965 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.482 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 7.7 m-85 -96.25 152.53 18.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.894 0.378 . . . . 0.0 110.976 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -147.81 147.2 29.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.847 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.126 -179.929 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 28.5 mt . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.722 0.296 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.19 136.87 20.57 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.548 2.166 . . . . 0.0 112.365 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.5 t -112.65 115.44 49.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.06 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 618' ' ' LYS . . . . . 0.411 ' HG3' ' N ' ' A' ' 630' ' ' GLY . 0.3 OUTLIER -60.76 173.2 0.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.967 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 5.7 m -157.81 159.31 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.237 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.72 127.71 72.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.696 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 621' ' ' HIS . . . . . 0.522 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 5.6 t-160 -88.77 127.59 35.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.746 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 26.9 t -88.36 -28.53 5.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.167 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 623' ' ' GLU . . . . . 0.421 ' HB3' ' CE1' ' A' ' 621' ' ' HIS . 2.4 tm-20 -68.52 -37.29 79.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.232 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 1.6 t -114.52 -23.38 9.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.542 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 90.57 -12.61 67.91 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.74 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.31 143.61 53.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.844 0.355 . . . . 0.0 110.922 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 2.0 mt -120.36 127.09 75.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.21 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 628' ' ' LEU . . . . . 0.463 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 5.6 mt -93.75 133.77 36.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.814 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.85 166.28 16.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.327 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 630' ' ' GLY . . . . . 0.411 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -50.08 -23.59 5.78 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.977 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 5.8 t -65.72 -43.4 89.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.703 0.287 . . . . 0.0 111.305 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.35 -20.58 17.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.359 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.53 150.7 80.17 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.318 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.442 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 72.9 Cg_endo -75.27 163.81 34.05 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.753 2.302 . . . . 0.0 112.353 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 35.5 mttp -73.03 172.0 11.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.425 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -62.39 -38.09 88.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.862 0.363 . . . . 0.0 111.425 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.7 -36.22 48.83 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.237 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -94.38 -3.34 50.47 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 639' ' ' LEU . . . . . . . . . . . . . 13.6 tp -59.64 -50.54 73.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.728 0.299 . . . . 0.0 111.194 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -52.9 -44.52 67.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.219 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.82 -36.81 75.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.003 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 642' ' ' TRP . . . . . 0.442 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 35.1 t90 -67.23 -41.27 85.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.789 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 16.4 mt -67.13 -43.56 82.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.479 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -60.78 -40.49 92.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.541 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.35 -37.28 57.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.797 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -107.84 81.76 1.26 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.818 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -68.39 147.43 71.48 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.616 2.211 . . . . 0.0 112.442 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.34 -20.59 39.63 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.578 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.522 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 23.8 m-85 -81.57 149.97 28.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.876 0.37 . . . . 0.0 111.115 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -142.49 155.62 45.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.62 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.18 179.998 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 13.4 mt . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.675 0.274 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.36 140.0 24.01 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.606 2.204 . . . . 0.0 112.32 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 26.2 t -116.45 115.41 48.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.055 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 618' ' ' LYS . . . . . 0.45 ' HG3' ' N ' ' A' ' 630' ' ' GLY . 0.0 OUTLIER -61.51 170.79 1.71 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.923 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 619' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 650' ' ' GLU . 27.7 m -157.42 146.06 10.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.995 179.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.43 127.63 73.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.943 0.402 . . . . 0.0 111.265 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 621' ' ' HIS . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 4.4 t-160 -83.96 131.79 34.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.675 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.5 t -87.8 -29.77 5.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.897 0.38 . . . . 0.0 111.051 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -68.43 -37.3 80.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.198 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 1.5 m -110.85 -23.48 10.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.405 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 85.58 -7.62 75.69 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.906 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -69.4 152.39 44.98 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.791 0.329 . . . . 0.0 110.824 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 2.0 mt -127.64 138.66 54.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.213 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 26.4 mt -105.46 139.2 40.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.768 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.83 165.96 16.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.483 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 630' ' ' GLY . . . . . 0.45 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -56.48 -18.94 24.52 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.005 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 10.0 t -71.17 -43.55 67.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.685 0.278 . . . . 0.0 111.554 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.2 -21.39 16.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.342 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.53 156.22 54.53 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.247 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.444 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 71.6 Cg_endo -73.88 163.79 36.15 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.631 2.221 . . . . 0.0 112.287 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 4.3 mtpp -73.04 176.4 5.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.595 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -60.7 -48.96 79.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.802 0.334 . . . . 0.0 111.286 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.72 -36.32 48.46 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.877 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.11 -11.84 59.72 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 639' ' ' LEU . . . . . . . . . . . . . 10.5 tp -57.71 -49.65 75.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.758 0.313 . . . . 0.0 111.143 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.73 -45.59 70.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.111 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.74 -37.72 76.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.872 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 642' ' ' TRP . . . . . 0.444 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 34.9 t90 -64.83 -42.67 94.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.682 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 65.6 mt -66.33 -42.4 88.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.417 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.17 -41.1 87.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.459 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 4.1 mmt -77.55 -35.17 53.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.645 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 646' ' ' ASN . . . . . 0.435 ' HB2' ' CZ3' ' A' ' 642' ' ' TRP . 23.5 m-80 -113.17 79.75 3.87 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.779 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.33 145.96 67.44 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.608 2.205 . . . . 0.0 112.404 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.44 -6.24 45.43 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.832 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.508 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 11.4 m-85 -95.51 149.5 21.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.911 0.386 . . . . 0.0 111.021 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 650' ' ' GLU . . . . . 0.533 ' O ' ' HA ' ' A' ' 619' ' ' VAL . 69.1 mt-10 -136.5 145.46 45.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.17 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 2.4 m . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 120.9 0.381 . . . . 0.0 111.491 -179.594 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 16.2 mt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.707 0.289 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.31 142.62 21.46 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.698 2.265 . . . . 0.0 112.442 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.92 122.72 70.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.122 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 618' ' ' LYS . . . . . 0.4 ' HG3' ' N ' ' A' ' 630' ' ' GLY . 0.8 OUTLIER -65.11 171.17 3.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.759 179.883 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 619' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 650' ' ' GLU . 27.2 m -156.71 152.43 7.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.308 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . 0.406 ' CD1' ' CG1' ' A' ' 627' ' ' ILE . 3.6 tp -124.88 127.45 72.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.647 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 621' ' ' HIS . . . . . 0.529 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 4.1 t-160 -89.26 135.83 33.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.633 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 25.8 t -87.12 -35.77 8.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.819 0.343 . . . . 0.0 111.287 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 623' ' ' GLU . . . . . 0.432 ' HB2' ' CE1' ' A' ' 621' ' ' HIS . 30.2 mt-10 -68.59 -32.99 73.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.536 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 3.3 t -112.2 -23.36 10.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.592 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 78.97 0.29 81.55 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.906 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -76.68 150.56 36.32 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.757 0.313 . . . . 0.0 110.929 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 627' ' ' ILE . . . . . 0.406 ' CG1' ' CD1' ' A' ' 620' ' ' ILE . 6.2 mt -119.32 119.38 60.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.199 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 628' ' ' LEU . . . . . 0.415 HD12 ' CE2' ' A' ' 649' ' ' TYR . 37.2 mt -87.13 135.82 33.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.745 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.52 166.03 16.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.407 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 630' ' ' GLY . . . . . 0.4 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -56.37 -17.73 19.54 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.646 -0.788 . . . . 0.0 113.004 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.55 -43.6 59.5 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.75 0.275 . . . . 0.0 111.681 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.15 -24.08 15.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.702 0.287 . . . . 0.0 111.461 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.44 154.3 64.77 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.171 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.442 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 72.7 Cg_endo -75.26 156.83 41.87 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.598 2.199 . . . . 0.0 112.414 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? -73.22 165.59 24.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.42 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -62.79 -29.14 70.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.81 0.338 . . . . 0.0 111.302 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.57 -36.35 49.11 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.308 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -106.69 4.72 28.1 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 639' ' ' LEU . . . . . . . . . . . . . 13.5 tp -57.26 -50.13 73.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.749 0.309 . . . . 0.0 111.079 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -52.88 -42.12 65.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.987 0.422 . . . . 0.0 110.961 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.85 -39.7 76.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.775 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 642' ' ' TRP . . . . . 0.442 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 33.3 t90 -66.32 -36.53 83.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.554 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 46.7 mt -69.4 -41.76 76.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.296 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -61.24 -41.16 96.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.328 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 73.7 mtp -77.83 -32.06 51.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.623 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 646' ' ' ASN . . . . . 0.419 ' HB2' ' CZ3' ' A' ' 642' ' ' TRP . 28.2 m-80 -118.93 75.45 13.76 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.682 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.19 149.79 76.45 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.562 2.175 . . . . 0.0 112.442 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.39 -12.3 51.26 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.779 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.529 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 16.0 m-85 -87.8 159.3 18.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.89 0.376 . . . . 0.0 111.032 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 650' ' ' GLU . . . . . 0.52 ' O ' ' HA ' ' A' ' 619' ' ' VAL . 30.1 mt-10 -149.96 147.22 27.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.232 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 31.3 t . . . . . 0 C--N 1.33 -0.273 0 CA-C-O 120.777 0.323 . . . . 0.0 111.272 -179.601 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 8.9 mt . . . . . 0 CA--C 1.529 0.161 0 CA-C-O 120.613 0.244 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.29 149.48 27.94 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.612 2.208 . . . . 0.0 112.444 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.4 t -118.87 130.54 73.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.112 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 618' ' ' LYS . . . . . 0.406 ' HG3' ' N ' ' A' ' 630' ' ' GLY . 0.0 OUTLIER -67.43 164.83 17.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.992 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 619' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 650' ' ' GLU . 33.5 m -156.19 144.07 11.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.97 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.24 127.66 73.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.889 0.376 . . . . 0.0 111.285 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 621' ' ' HIS . . . . . 0.489 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 2.5 t-160 -85.46 133.52 34.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.601 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 20.5 t -86.62 -29.52 5.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.77 0.319 . . . . 0.0 111.133 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.53 -37.34 79.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.357 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 1.8 m -110.1 -23.36 11.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.355 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 82.5 5.83 89.16 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.006 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.63 151.99 36.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.755 0.312 . . . . 0.0 110.895 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 3.5 mt -127.4 114.47 36.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.221 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 628' ' ' LEU . . . . . 0.417 HD11 ' CE1' ' A' ' 649' ' ' TYR . 19.1 mt -86.76 134.46 33.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.808 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.81 166.09 16.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.496 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 630' ' ' GLY . . . . . 0.406 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -58.46 -15.36 24.18 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.176 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.51 -43.68 38.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.899 0.35 . . . . 0.0 111.742 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.94 -26.1 14.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.873 0.368 . . . . 0.0 111.371 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.51 156.03 55.54 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.215 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.437 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 52.2 Cg_endo -68.69 163.81 35.64 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.594 2.196 . . . . 0.0 112.195 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 26.9 mttp -72.85 171.47 12.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.473 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -62.63 -40.21 96.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.426 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.58 -36.25 49.34 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.099 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -91.21 -5.25 55.14 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 639' ' ' LEU . . . . . . . . . . . . . 15.3 tp -57.78 -50.76 72.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.714 0.292 . . . . 0.0 111.271 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.08 -44.0 61.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.913 0.387 . . . . 0.0 111.111 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -68.17 -39.16 82.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.977 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 642' ' ' TRP . . . . . 0.437 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 18.4 t90 -68.98 -34.0 74.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.851 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 17.4 mt -69.05 -47.5 65.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.481 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -61.31 -41.07 96.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.486 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 15.9 tpt -74.17 -33.87 63.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.583 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 646' ' ' ASN . . . . . 0.436 ' ND2' ' CD2' ' A' ' 642' ' ' TRP . 35.6 m-80 -114.47 74.23 3.02 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.647 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.81 147.09 89.41 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.613 2.208 . . . . 0.0 112.51 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.44 -4.12 43.61 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.893 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.489 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 8.9 m-85 -94.88 156.59 16.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.966 0.412 . . . . 0.0 111.109 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 650' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 619' ' ' VAL . 14.7 mm-40 -144.27 145.75 32.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.281 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 24.3 t . . . . . 0 C--N 1.33 -0.262 0 CA-C-O 120.811 0.338 . . . . 0.0 111.32 -179.654 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 62.3 mt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.766 0.317 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.82 149.08 53.39 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.562 2.175 . . . . 0.0 112.294 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.2 t -118.81 119.92 62.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.984 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 618' ' ' LYS . . . . . 0.409 ' HG3' ' N ' ' A' ' 630' ' ' GLY . 0.0 OUTLIER -55.41 172.01 0.16 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.924 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 12.1 m -158.13 160.02 2.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.248 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . 0.403 HD13 ' CG1' ' A' ' 627' ' ' ILE . 6.4 tp -124.41 127.67 73.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.784 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 621' ' ' HIS . . . . . 0.491 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 7.2 t-160 -92.31 128.63 38.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.723 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.4 t -87.74 -28.61 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.859 0.361 . . . . 0.0 111.256 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.57 -37.15 79.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.388 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 70.1 m -113.99 -23.35 9.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.615 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 84.8 4.95 86.89 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.748 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.58 156.84 32.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.863 0.363 . . . . 0.0 111.079 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 627' ' ' ILE . . . . . 0.403 ' CG1' HD13 ' A' ' 620' ' ' ILE . 2.4 mt -125.35 115.29 43.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.054 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 628' ' ' LEU . . . . . 0.451 ' CD1' ' CE1' ' A' ' 649' ' ' TYR . 28.4 mt -90.04 130.33 36.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.822 0.344 . . . . 0.0 110.875 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.78 166.22 16.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.12 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 630' ' ' GLY . . . . . 0.409 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -50.67 -21.25 4.65 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.87 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 4.3 m -69.85 -43.65 71.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.648 0.261 . . . . 0.0 111.658 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -98.34 -23.47 15.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.778 0.323 . . . . 0.0 111.528 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.44 156.24 53.59 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.244 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.427 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 73.0 Cg_endo -75.18 163.72 34.4 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.735 2.29 . . . . 0.0 112.325 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 26.9 mttt -73.01 176.37 5.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.535 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -61.55 -48.94 78.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.849 0.357 . . . . 0.0 111.234 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.69 -36.22 48.89 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.745 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.0 -12.49 59.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.563 0.22 . . . . 0.0 111.55 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 639' ' ' LEU . . . . . . . . . . . . . 11.6 tp -56.16 -47.85 77.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.786 0.327 . . . . 0.0 111.154 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -53.49 -51.32 63.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.978 0.418 . . . . 0.0 111.038 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -67.82 -34.52 76.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.012 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 642' ' ' TRP . . . . . 0.427 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 30.0 t90 -67.65 -38.56 84.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.744 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.46 -43.34 73.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.433 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -61.1 -39.49 90.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.521 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 2.4 ttp -78.73 -35.71 44.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.806 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -110.49 78.34 1.45 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.943 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.39 146.65 69.42 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.531 2.154 . . . . 0.0 112.355 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.34 -12.53 51.5 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.783 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.491 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 15.9 m-85 -88.37 161.71 16.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.899 0.381 . . . . 0.0 111.042 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -148.4 145.81 28.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.698 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.282 -179.945 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.8 0.333 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -103.42 159.13 15.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.869 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 3.5 mtt -57.99 -30.9 66.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.034 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 613' ' ' SER . . . . . . . . . . . . . 1.4 m -63.31 -24.65 67.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.986 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.22 -27.83 19.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.088 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 18.0 mt -81.45 147.09 58.98 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.966 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.77 150.81 39.9 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.586 2.191 . . . . 0.0 112.368 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.4 t -118.83 128.53 75.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.106 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 618' ' ' LYS . . . . . 0.405 ' HG3' ' N ' ' A' ' 630' ' ' GLY . 0.0 OUTLIER -66.35 170.47 5.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.857 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 16.2 m -157.79 157.26 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.149 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . 0.407 ' CD1' ' CG1' ' A' ' 627' ' ' ILE . 3.9 tp -124.59 127.64 73.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.724 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 621' ' ' HIS . . . . . 0.516 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 18.0 t-160 -91.01 132.91 35.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.552 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 23.4 t -87.4 -34.07 7.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.811 0.339 . . . . 0.0 111.231 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -33.82 74.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.348 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 44.2 t -111.51 -23.45 10.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.521 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 80.45 -0.58 84.68 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.508 -0.854 . . . . 0.0 112.828 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 7.2 tptp -76.59 149.2 36.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.819 0.343 . . . . 0.0 111.026 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 627' ' ' ILE . . . . . 0.407 ' CG1' ' CD1' ' A' ' 620' ' ' ILE . 5.7 mt -116.87 114.87 47.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.977 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 628' ' ' LEU . . . . . 0.451 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 41.2 mt -84.71 128.39 34.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.808 0.337 . . . . 0.0 111.01 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.72 166.2 16.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.206 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 630' ' ' GLY . . . . . 0.405 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -50.63 -21.18 4.54 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.873 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 19.2 p -71.17 -43.66 67.05 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -98.3 -29.34 13.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.759 0.314 . . . . 0.0 111.56 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.36 156.36 52.07 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.286 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.464 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 71.2 Cg_endo -73.37 163.6 37.35 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.727 2.285 . . . . 0.0 112.326 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -73.05 164.39 26.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.314 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -62.76 -31.57 72.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.85 0.357 . . . . 0.0 111.309 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.71 -36.23 48.75 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.371 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -104.01 3.33 33.27 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 639' ' ' LEU . . . . . . . . . . . . . 13.6 tp -58.36 -46.95 85.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.779 0.323 . . . . 0.0 111.121 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.17 -44.81 68.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.975 0.417 . . . . 0.0 111.132 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.79 -36.92 76.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.196 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 642' ' ' TRP . . . . . 0.464 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 47.6 t90 -66.67 -44.92 80.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 44.9 mt -65.91 -40.86 91.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.525 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.65 -40.87 96.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.647 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.1 -38.1 52.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.805 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -107.13 82.27 1.12 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.745 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.4 150.43 75.83 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.551 2.167 . . . . 0.0 112.447 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.45 -12.96 51.29 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.808 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.516 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 18.0 m-85 -90.03 160.94 16.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.829 0.347 . . . . 0.0 110.977 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -149.87 145.95 26.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.715 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.4 t -56.2 126.91 14.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.204 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 652' ' ' ALA . . . . . . . . . . . . . . . -86.86 156.88 55.22 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.1 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.41 157.41 61.18 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.536 2.157 . . . . 0.0 112.37 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -83.8 -173.26 4.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.924 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 1.1 m -118.53 31.8 6.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.921 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -80.66 -72.36 0.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.909 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 74.7 m 60.39 167.59 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.904 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.787 0.327 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -103.84 121.44 43.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 16.5 ptm -69.22 -41.47 77.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.924 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 613' ' ' SER . . . . . . . . . . . . . 91.0 p -58.46 -25.17 61.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.997 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.99 -27.91 43.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.014 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 16.1 mt -71.46 146.32 91.48 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.945 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -74.21 155.96 46.69 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.597 2.198 . . . . 0.0 112.25 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.4 t -117.47 133.33 64.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.131 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 618' ' ' LYS . . . . . 0.402 ' HG3' ' N ' ' A' ' 630' ' ' GLY . 0.0 OUTLIER -66.85 169.97 7.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.945 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 619' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 650' ' ' GLU . 26.8 m -157.14 162.88 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.82 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.21 128.04 12.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.987 0.422 . . . . 0.0 111.619 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 621' ' ' HIS . . . . . 0.494 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 3.6 t-160 -83.17 133.46 35.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.458 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.5 t -85.82 -23.67 6.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.754 0.311 . . . . 0.0 111.38 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -68.54 -37.41 79.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.494 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 49.0 m -117.17 -23.47 7.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.585 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 87.72 8.98 72.44 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.952 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.56 142.9 40.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.758 0.313 . . . . 0.0 110.807 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 1.9 mt -119.53 120.86 64.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.32 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 628' ' ' LEU . . . . . 0.414 HD13 ' CE1' ' A' ' 649' ' ' TYR . 23.3 mt -90.43 138.18 31.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.752 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.61 165.89 16.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.554 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 630' ' ' GLY . . . . . 0.402 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -55.94 -18.63 19.33 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.766 -0.73 . . . . 0.0 113.068 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 2.5 m -71.75 -43.54 65.62 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.793 0.297 . . . . 0.0 111.524 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -98.18 -22.79 16.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.429 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.55 156.26 54.46 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.169 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.461 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 71.7 Cg_endo -75.39 156.54 41.3 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.624 2.216 . . . . 0.0 112.313 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -73.95 168.02 20.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.487 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -62.86 -29.91 71.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.827 0.346 . . . . 0.0 111.249 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.64 -36.36 48.72 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.346 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.99 4.42 29.39 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 639' ' ' LEU . . . . . . . . . . . . . 16.4 tp -57.16 -52.32 65.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.697 0.284 . . . . 0.0 111.093 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -52.78 -43.7 66.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.969 0.414 . . . . 0.0 111.078 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.26 -36.25 76.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.924 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 642' ' ' TRP . . . . . 0.461 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 53.5 t90 -66.78 -49.64 65.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.68 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 82.1 mt -60.82 -42.11 97.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.488 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -61.06 -40.9 95.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.59 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.73 -25.68 49.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.993 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -121.87 78.98 40.82 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.773 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.1 144.12 86.3 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.717 2.278 . . . . 0.0 112.482 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.53 -7.58 46.58 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.841 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.494 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 12.2 m-85 -96.36 151.57 19.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.016 0.436 . . . . 0.0 111.105 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 650' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 619' ' ' VAL . 19.2 pt-20 -146.4 145.79 30.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.119 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 2.8 m -54.34 130.84 16.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.802 0.334 . . . . 0.0 111.487 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 652' ' ' ALA . . . . . . . . . . . . . . . -93.11 104.65 12.52 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.1 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -68.88 158.97 55.75 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.468 2.112 . . . . 0.0 112.3 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -134.26 138.9 45.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.86 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 4.9 m -100.79 34.9 2.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.916 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -136.09 142.83 44.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.932 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 45.6 m -153.59 -51.55 0.1 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.867 179.977 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 3.7 t . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.793 0.33 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -72.69 -45.51 58.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.87 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -84.94 -26.73 27.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.07 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 613' ' ' SER . . . . . . . . . . . . . 64.7 m -56.29 -27.15 54.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.195 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.05 17.9 11.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.2 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 87.2 mt -105.42 153.23 39.88 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.868 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.35 143.55 39.35 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.59 2.193 . . . . 0.0 112.446 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.89 115.32 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.007 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 618' ' ' LYS . . . . . 0.405 ' CB ' ' HA ' ' A' ' 629' ' ' THR . 0.0 OUTLIER -63.88 144.24 57.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.649 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 7.3 m -118.75 162.98 16.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.099 0.476 . . . . 0.0 111.544 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . 0.421 ' CD1' HG12 ' A' ' 627' ' ' ILE . 4.9 tp -124.31 127.69 73.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.454 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 621' ' ' HIS . . . . . 0.495 ' HB2' ' CE1' ' A' ' 649' ' ' TYR . 6.3 t-160 -96.78 119.29 34.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.661 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.3 t -88.39 -33.62 6.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.281 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.42 -34.92 76.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.172 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 3.6 m -110.85 -23.39 11.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.336 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 85.76 -6.04 81.91 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.85 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.29 155.47 40.36 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.823 0.344 . . . . 0.0 110.788 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 627' ' ' ILE . . . . . 0.421 HG12 ' CD1' ' A' ' 620' ' ' ILE . 12.1 mt -126.75 121.27 58.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.293 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 628' ' ' LEU . . . . . 0.465 ' CD1' ' CE1' ' A' ' 649' ' ' TYR . 16.4 mt -103.06 124.93 49.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.425 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 629' ' ' THR . . . . . 0.405 ' HA ' ' CB ' ' A' ' 618' ' ' LYS . 0.4 OUTLIER -85.45 166.08 16.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.187 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . -46.84 -25.14 2.19 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.963 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 14.0 p -65.45 -43.96 88.76 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.616 0.246 . . . . 0.0 111.625 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -98.55 -24.24 15.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.874 0.369 . . . . 0.0 111.58 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.54 156.27 54.29 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.451 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.433 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 72.7 Cg_endo -75.25 163.95 33.82 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.82 2.347 . . . . 0.0 112.303 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -72.96 176.43 5.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.471 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -58.95 -48.92 79.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.405 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.67 -36.19 49.08 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.037 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -81.5 -9.8 59.62 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.645 0.239 . . . . 0.0 111.645 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 639' ' ' LEU . . . . . . . . . . . . . 13.1 tp -58.88 -53.35 59.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.713 0.292 . . . . 0.0 111.162 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -52.19 -49.33 64.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.944 0.402 . . . . 0.0 111.068 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -66.78 -35.88 81.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.891 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 642' ' ' TRP . . . . . 0.433 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 27.9 t90 -66.85 -38.77 87.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.661 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 12.0 mt -68.33 -42.12 79.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.467 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.65 -41.01 96.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.469 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 3.3 tpp -77.73 -33.23 53.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.797 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 646' ' ' ASN . . . . . 0.422 ' HB2' ' CZ3' ' A' ' 642' ' ' TRP . 10.4 m-80 -115.28 79.28 6.59 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.755 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.46 148.59 73.48 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.569 2.179 . . . . 0.0 112.47 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.41 -8.77 48.55 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.789 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.495 ' CE1' ' HB2' ' A' ' 621' ' ' HIS . 17.7 m-85 -94.91 161.74 14.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.96 0.409 . . . . 0.0 111.168 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -149.86 168.09 24.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.753 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 29.2 t -74.53 118.21 19.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.975 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 652' ' ' ALA . . . . . . . . . . . . . . . -81.53 139.72 47.86 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.086 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.66 159.01 39.38 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.548 2.165 . . . . 0.0 112.353 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -63.13 129.44 40.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.837 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.03 -32.39 10.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.933 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.59 -31.46 26.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.855 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 20.9 m -75.91 129.03 36.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.886 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.883 -179.988 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.839 0.352 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -163.33 164.69 24.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.897 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 22.4 mtt -82.25 -31.65 30.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.922 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 613' ' ' SER . . . . . . . . . . . . . 1.3 m -67.97 -27.24 66.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.012 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.94 -27.85 55.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.097 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 5.6 mt -79.62 148.15 68.89 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.897 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.18 140.92 31.65 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.525 2.15 . . . . 0.0 112.317 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.5 t -111.42 119.61 60.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.098 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 618' ' ' LYS . . . . . 0.401 ' HG3' ' N ' ' A' ' 630' ' ' GLY . 0.0 OUTLIER -58.85 174.49 0.34 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 16.2 m -157.87 155.85 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.135 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 4.9 tp -124.5 127.61 73.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.771 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 621' ' ' HIS . . . . . 0.51 ' CG ' ' CE1' ' A' ' 649' ' ' TYR . 6.4 t-160 -89.91 133.28 34.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.723 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 26.1 t -87.12 -29.45 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.366 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . 0.438 ' HB3' ' CE1' ' A' ' 621' ' ' HIS . 32.4 tt0 -68.46 -37.16 79.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.374 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.18 -23.32 10.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.427 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 82.45 3.31 90.58 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.697 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -76.7 151.14 36.21 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.81 0.338 . . . . 0.0 111.027 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 7.1 mt -117.08 111.05 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.019 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 628' ' ' LEU . . . . . 0.445 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 75.4 mt -81.41 133.59 35.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.848 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.74 166.05 16.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.196 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 630' ' ' GLY . . . . . 0.401 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -50.27 -21.34 4.16 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.771 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 1.1 m -69.79 -43.48 72.02 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.06 -30.73 12.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.819 0.342 . . . . 0.0 111.465 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.41 156.35 52.59 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.187 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.445 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 73.0 Cg_endo -75.18 162.92 35.91 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.713 2.275 . . . . 0.0 112.451 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 43.0 mttm -85.44 157.04 20.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.571 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -53.04 -26.87 17.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.499 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -73.97 -36.29 52.34 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.395 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -116.02 14.23 16.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.025 0.413 . . . . 0.0 111.872 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 639' ' ' LEU . . . . . . . . . . . . . 10.9 tp -59.59 -51.61 69.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.796 0.331 . . . . 0.0 111.108 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -52.98 -43.28 66.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.99 0.424 . . . . 0.0 111.106 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.94 -38.93 76.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.806 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 642' ' ' TRP . . . . . 0.445 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 37.7 t90 -64.69 -42.46 95.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.699 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 90.4 mt -66.61 -40.97 89.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.35 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -60.11 -41.04 91.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.494 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 18.4 ttt -77.47 -36.25 53.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.562 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 646' ' ' ASN . . . . . 0.424 ' HB2' ' CZ3' ' A' ' 642' ' ' TRP . 20.9 m-80 -112.38 78.01 2.45 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.584 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.81 149.03 83.43 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.609 2.206 . . . . 0.0 112.451 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.46 -18.89 43.78 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.615 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.51 ' CE1' ' CG ' ' A' ' 621' ' ' HIS . 21.3 m-85 -83.41 157.97 22.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.837 0.351 . . . . 0.0 111.005 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -148.61 145.9 27.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.563 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 2.7 m -54.51 126.66 11.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.407 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 652' ' ' ALA . . . . . . . . . . . . . . . -77.34 155.51 81.79 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.094 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.42 158.93 52.99 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.556 2.171 . . . . 0.0 112.309 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -83.53 171.92 12.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.924 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 10.3 t -99.15 31.58 3.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.917 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 13.2 p30 -114.73 -178.3 3.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.903 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.09 124.89 0.53 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.873 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.822 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 59.2 p . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.796 0.331 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -74.22 133.4 42.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.803 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.97 -32.96 39.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.969 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 613' ' ' SER . . . . . . . . . . . . . 13.2 m -59.88 -27.68 66.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.034 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -77.01 -26.97 54.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.065 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 10.8 mt -73.72 144.99 83.85 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.935 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.26 153.13 31.33 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.597 2.198 . . . . 0.0 112.425 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.7 t -118.85 122.63 69.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.065 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.63 176.42 0.88 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.874 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 5.9 m -159.23 158.02 2.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.246 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 5.0 tp -124.57 127.55 72.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.686 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 621' ' ' HIS . . . . . 0.519 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 7.6 t-160 -89.82 127.46 35.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.734 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.6 t -88.47 -39.27 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 0.0 111.05 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -68.5 -29.97 68.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.388 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 1.7 t -112.83 -23.44 10.13 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.573 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 79.4 -0.0 82.08 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.825 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -76.44 156.83 32.77 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.812 0.339 . . . . 0.0 110.887 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 2.8 mt -128.39 126.58 65.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.238 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 628' ' ' LEU . . . . . 0.462 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 11.5 mt -103.45 130.71 50.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.654 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.69 166.08 16.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.254 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . -53.59 -19.05 8.58 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.031 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 23.0 m -71.78 -43.81 65.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.681 0.277 . . . . 0.0 111.693 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -98.26 -23.18 15.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.857 0.361 . . . . 0.0 111.518 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.41 156.36 52.56 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.353 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.455 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 61.0 Cg_endo -71.68 163.96 37.25 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.764 2.31 . . . . 0.0 112.188 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -72.88 176.45 5.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.448 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -59.79 -49.01 79.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.792 0.33 . . . . 0.0 111.383 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.72 -36.22 48.71 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.01 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -81.16 -10.52 59.62 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 639' ' ' LEU . . . . . . . . . . . . . 10.9 tp -59.24 -50.71 72.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.774 0.321 . . . . 0.0 111.181 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -53.1 -45.63 68.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.299 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.77 -37.19 76.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.921 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 642' ' ' TRP . . . . . 0.455 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 51.8 t90 -64.28 -54.6 30.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.794 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 67.7 mt -58.53 -43.09 89.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.615 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -59.57 -38.13 80.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.614 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.03 -25.55 37.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.955 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -122.15 78.08 42.83 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.93 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.56 151.7 78.32 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.711 2.274 . . . . 0.0 112.313 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.41 -17.1 47.77 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.823 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.519 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 23.6 m-85 -89.54 152.25 21.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.907 0.384 . . . . 0.0 111.049 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -144.04 153.49 42.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.636 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.6 t -54.57 125.93 10.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.251 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 652' ' ' ALA . . . . . . . . . . . . . . . -75.99 118.59 72.26 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.182 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.81 159.02 7.56 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.425 2.083 . . . . 0.0 112.263 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 -91.69 137.18 32.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.851 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 47.7 m -98.46 31.32 2.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.905 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -152.68 -175.0 5.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.51 -50.8 0.37 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.871 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.952 179.965 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.849 0.357 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -157.32 30.58 0.29 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -77.38 -38.36 50.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.956 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 613' ' ' SER . . . . . . . . . . . . . 92.8 p -64.38 -21.53 66.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.001 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -86.0 -27.91 24.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.016 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 25.4 mt -79.31 156.05 76.43 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.949 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 635' ' ' LYS . 70.3 Cg_endo -74.69 148.1 36.33 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.604 2.203 . . . . 0.0 112.627 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.4 t -118.97 115.29 47.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.811 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.66 143.36 57.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.953 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 2.5 m -127.05 165.72 25.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.336 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.26 127.46 69.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.669 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 621' ' ' HIS . . . . . 0.462 ' ND1' ' CE2' ' A' ' 649' ' ' TYR . 5.9 t-160 -91.87 125.87 36.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.941 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 26.1 t -86.82 -31.1 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.264 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -68.12 -37.3 80.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.106 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 21.1 t -105.75 -23.58 12.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.219 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 88.21 -15.37 56.39 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.922 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 10.0 mtpp -70.25 156.83 38.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.687 0.279 . . . . 0.0 110.918 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 2.0 mp -128.55 115.39 37.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.061 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 628' ' ' LEU . . . . . 0.447 ' CD1' ' CE1' ' A' ' 649' ' ' TYR . 15.8 mt -85.06 130.18 34.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.906 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.7 166.05 16.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.184 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . -48.49 -24.05 3.58 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.838 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 8.5 p -65.34 -43.98 89.21 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.51 -34.11 10.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.902 0.382 . . . . 0.0 111.642 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.38 156.12 53.72 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.712 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.488 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 89.5 Cg_endo -75.32 163.76 34.04 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.957 2.438 . . . . 0.0 112.556 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 635' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 616' ' ' PRO . 0.0 OUTLIER -92.06 166.1 12.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.511 179.362 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -52.94 -26.89 16.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.588 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -67.17 -36.25 89.82 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.416 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.33 17.57 7.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 117.014 0.407 . . . . 0.0 111.854 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 639' ' ' LEU . . . . . . . . . . . . . 13.9 tp -64.71 -54.58 29.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.779 0.323 . . . . 0.0 111.23 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -52.26 -43.42 64.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.182 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -67.97 -37.53 81.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.848 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 642' ' ' TRP . . . . . 0.488 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 28.0 t90 -66.81 -48.79 67.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.864 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 36.1 mt -60.18 -41.19 92.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.591 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.15 -40.98 99.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.581 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 28.8 ttp -79.49 -18.74 51.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.175 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 646' ' ' ASN . . . . . 0.415 ' HB2' ' CZ3' ' A' ' 642' ' ' TRP . 27.7 m-80 -129.56 68.36 80.3 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.866 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -56.84 154.33 32.7 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.539 2.16 . . . . 0.0 112.328 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.29 -16.77 48.79 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.706 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.462 ' CE2' ' ND1' ' A' ' 621' ' ' HIS . 25.0 m-85 -88.13 161.17 17.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.819 0.343 . . . . 0.0 111.125 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -149.74 157.85 43.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.788 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.4 t -59.47 123.07 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.158 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 652' ' ' ALA . . . . . . . . . . . . . . . -96.89 116.17 65.97 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.0 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.59 158.97 54.31 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.432 2.088 . . . . 0.0 112.3 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.17 133.53 48.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.934 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.08 -33.55 17.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.814 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.78 86.8 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.978 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.98 -65.14 0.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.909 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.916 179.995 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.805 0.335 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.81 136.74 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.922 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -60.22 -24.85 65.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.075 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 613' ' ' SER . . . . . . . . . . . . . 17.3 p -54.91 -26.41 35.79 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.158 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -93.33 -27.89 16.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.997 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 16.3 mt -76.61 146.44 76.84 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.895 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.94 151.12 39.43 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.597 2.198 . . . . 0.0 112.374 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.93 119.13 60.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.155 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.92 146.04 54.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.762 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 4.1 m -122.68 164.51 19.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.392 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . 0.426 ' CD1' ' CG1' ' A' ' 627' ' ' ILE . 5.9 tp -124.46 127.64 73.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.573 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 621' ' ' HIS . . . . . 0.499 ' CD2' ' CD2' ' A' ' 649' ' ' TYR . 5.5 t-160 -95.5 118.82 32.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.78 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 19.2 t -89.18 -28.19 5.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.227 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -61.72 -37.37 83.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.108 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 61.3 m -119.17 -23.39 6.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.412 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 95.29 -3.29 66.25 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.837 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.33 147.07 51.61 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.811 0.339 . . . . 0.0 110.745 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 627' ' ' ILE . . . . . 0.426 ' CG1' ' CD1' ' A' ' 620' ' ' ILE . 1.6 mp -120.84 118.91 57.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.323 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 628' ' ' LEU . . . . . 0.454 ' CD1' ' CE1' ' A' ' 649' ' ' TYR . 27.2 mt -97.56 127.29 43.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.476 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.5 166.04 16.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.251 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . -49.2 -22.15 3.17 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.074 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 1.2 m -68.55 -43.98 75.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -98.42 -25.99 14.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.907 0.384 . . . . 0.0 111.47 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.49 156.59 51.93 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.389 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.44 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 58.0 Cg_endo -69.45 163.85 36.45 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.884 2.389 . . . . 0.0 112.189 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 25.4 mttp -72.92 174.19 8.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.454 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -60.37 -48.94 79.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.381 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.83 -36.24 48.16 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.0 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -82.38 -9.62 59.38 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 639' ' ' LEU . . . . . . . . . . . . . 11.4 tp -57.35 -45.66 84.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.774 0.321 . . . . 0.0 111.197 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.27 -49.77 68.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.995 0.426 . . . . 0.0 111.309 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -68.92 -34.48 75.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.176 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 642' ' ' TRP . . . . . 0.44 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 49.7 t90 -67.03 -44.43 80.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.826 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 83.2 mt -65.47 -44.4 87.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.387 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -60.78 -37.19 81.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.523 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 6.3 mtt -80.97 -26.27 36.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.008 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -122.34 78.3 44.74 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.976 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -64.28 150.14 88.87 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.72 2.28 . . . . 0.0 112.388 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.38 -15.85 49.64 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.789 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.499 ' CD2' ' CD2' ' A' ' 621' ' ' HIS . 22.5 m-85 -88.55 161.77 16.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.918 0.39 . . . . 0.0 111.116 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -148.64 145.91 27.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.765 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.4 t -60.17 124.06 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.226 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 652' ' ' ALA . . . . . . . . . . . . . . . -98.83 114.23 65.24 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.009 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -51.98 158.52 4.76 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.47 2.113 . . . . 0.0 112.305 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.01 -179.44 0.74 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.964 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 24.3 m -107.6 -32.77 7.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.979 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -134.7 109.69 8.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.882 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 37.8 t -137.17 177.01 8.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.915 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.852 179.984 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 62.8 m . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.833 0.349 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -157.38 31.77 0.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 2.8 mtt -73.73 -40.34 63.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.935 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 613' ' ' SER . . . . . . . . . . . . . 8.6 t -64.26 -29.19 70.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.957 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.49 -27.88 41.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.043 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 19.7 mt -88.83 152.68 49.07 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.005 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.53 152.4 65.28 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.609 2.206 . . . . 0.0 112.319 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.81 131.47 71.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.13 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.16 172.8 7.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.88 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 6.2 m -159.17 162.97 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.171 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . 0.405 HD13 ' CG1' ' A' ' 627' ' ' ILE . 4.7 tp -129.13 127.51 65.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.744 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 621' ' ' HIS . . . . . 0.51 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 8.1 t-160 -91.19 134.35 34.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.72 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 25.5 t -87.39 -31.12 5.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.895 0.379 . . . . 0.0 111.108 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -68.6 -36.9 79.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.353 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 1.3 m -111.36 -23.27 10.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.645 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 81.43 1.69 90.19 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.817 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.69 153.62 34.96 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.863 0.364 . . . . 0.0 110.958 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 627' ' ' ILE . . . . . 0.405 ' CG1' HD13 ' A' ' 620' ' ' ILE . 3.9 mt -120.67 109.26 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.096 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 628' ' ' LEU . . . . . 0.451 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 30.4 mt -78.33 129.86 35.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.817 0.341 . . . . 0.0 110.66 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.7 166.06 16.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.193 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . -52.38 -19.04 5.58 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.9 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 35.7 m -72.96 -43.61 62.08 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -98.03 -29.0 13.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.786 0.327 . . . . 0.0 111.604 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.38 156.29 52.67 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.082 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.45 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 72.8 Cg_endo -75.28 157.85 41.38 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.672 2.248 . . . . 0.0 112.425 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 29.1 mttp -74.0 155.36 38.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.571 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -53.14 -26.98 18.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.503 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.37 -36.37 50.12 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.308 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -111.34 11.06 21.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.819 0.31 . . . . 0.0 111.733 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 639' ' ' LEU . . . . . . . . . . . . . 12.6 tp -63.63 -48.1 78.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.763 0.316 . . . . 0.0 111.103 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -52.83 -43.77 66.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.961 0.41 . . . . 0.0 111.095 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.87 -38.46 76.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.975 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 642' ' ' TRP . . . . . 0.45 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 30.5 t90 -67.68 -36.62 81.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.678 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 14.1 mt -69.3 -43.39 73.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.341 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.52 -40.96 96.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.456 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -75.68 -39.26 57.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.718 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -106.22 80.06 0.64 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.727 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.12 147.59 73.51 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.573 2.182 . . . . 0.0 112.448 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.43 -15.23 50.24 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.702 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.51 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 19.4 m-85 -86.66 153.08 22.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.806 0.336 . . . . 0.0 111.014 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -143.6 145.83 32.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.634 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 31.0 t -55.12 128.7 15.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.236 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 652' ' ' ALA . . . . . . . . . . . . . . . -77.55 129.34 77.38 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.099 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.94 158.71 8.37 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.461 2.108 . . . . 0.0 112.281 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 52.6 mmm-85 58.89 105.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.944 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 6.4 m -114.79 31.5 6.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -124.15 -44.35 2.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.67 163.64 32.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.854 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.97 179.956 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 28.6 t . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.84 0.352 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -124.69 140.9 52.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.812 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 6.0 ttt -59.39 -29.52 67.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.956 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 613' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.76 -28.01 69.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.001 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.79 -27.88 26.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.1 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 10.0 mt -84.48 146.17 46.67 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.899 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.38 152.17 38.72 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.569 2.179 . . . . 0.0 112.365 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 26.5 t -118.87 129.36 75.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.025 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.41 173.54 4.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 12.0 m -158.58 160.67 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.21 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . 0.405 ' CD1' ' CG1' ' A' ' 627' ' ' ILE . 5.5 tp -124.3 127.65 73.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.636 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 621' ' ' HIS . . . . . 0.508 ' CG ' ' CE1' ' A' ' 649' ' ' TYR . 7.3 t-160 -93.23 127.97 39.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.79 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.4 t -88.68 -27.32 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.309 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . 0.412 ' HB3' ' CE1' ' A' ' 621' ' ' HIS . 13.2 tt0 -68.35 -37.22 80.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.149 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 12.4 p -113.51 -23.21 9.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.398 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 87.51 -5.72 84.57 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.886 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 29.1 tttt -69.39 156.8 38.23 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.856 0.36 . . . . 0.0 110.966 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 627' ' ' ILE . . . . . 0.405 ' CG1' ' CD1' ' A' ' 620' ' ' ILE . 2.6 mt -124.35 114.54 41.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.972 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 628' ' ' LEU . . . . . 0.442 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 45.1 mt -87.13 127.91 35.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.825 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.66 166.22 16.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.133 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . -49.58 -21.74 3.47 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.864 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 29.0 p -70.08 -43.69 70.62 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -98.38 -27.59 14.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.827 0.346 . . . . 0.0 111.628 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.41 156.36 52.61 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.298 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.459 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 71.5 Cg_endo -72.9 163.82 37.31 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.767 2.312 . . . . 0.0 112.314 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -73.04 172.54 10.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.4 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -61.01 -43.94 98.14 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.796 0.331 . . . . 0.0 111.433 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.54 -36.32 49.36 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.841 -0.695 . . . . 0.0 113.114 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -88.02 -6.05 58.18 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 639' ' ' LEU . . . . . . . . . . . . . 16.3 tp -58.49 -51.28 70.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.665 0.269 . . . . 0.0 111.229 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -50.67 -50.51 54.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.005 0.431 . . . . 0.0 111.122 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -66.55 -35.41 80.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.986 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 642' ' ' TRP . . . . . 0.459 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 36.4 t90 -67.63 -37.75 82.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.679 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.88 -46.03 72.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.291 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.27 -36.78 80.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.423 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 3.6 ttm -80.83 -24.33 38.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.894 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -125.8 75.46 70.84 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.872 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.84 149.59 90.34 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.682 2.254 . . . . 0.0 112.401 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.51 -18.29 44.89 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.735 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.508 ' CE1' ' CG ' ' A' ' 621' ' ' HIS . 20.7 m-85 -83.39 161.63 21.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.872 0.368 . . . . 0.0 111.075 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -149.64 145.98 27.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.75 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.3 t -56.31 128.88 17.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.159 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 652' ' ' ALA . . . . . . . . . . . . . . . -81.86 132.13 55.19 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.096 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -73.28 158.8 48.13 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.468 2.112 . . . . 0.0 112.324 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.15 148.42 51.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.935 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 1.5 p -137.44 58.73 1.69 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.858 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.5 -67.37 0.28 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.868 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 1.3 m -94.0 -55.12 3.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.808 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.872 179.98 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 72.1 p . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.825 0.345 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -77.23 90.31 3.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.93 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 6.1 ptt? -70.07 -44.99 67.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.87 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 613' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.36 -25.45 62.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.005 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.15 -24.78 51.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.04 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 50.9 mt -58.63 149.78 60.65 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.889 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.79 151.35 57.25 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.632 2.221 . . . . 0.0 112.324 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.3 t -118.83 128.92 75.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.143 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.39 176.72 1.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.813 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 10.1 m -158.95 158.84 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.257 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 5.3 tp -124.36 127.55 73.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.533 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 621' ' ' HIS . . . . . 0.487 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 7.8 t-160 -93.12 128.79 39.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.659 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.4 t -88.24 -34.65 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.216 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -68.46 -33.97 75.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.334 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 1.7 m -111.5 -23.4 10.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.558 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 82.39 -4.0 79.38 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.826 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.56 156.89 36.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.839 0.352 . . . . 0.0 110.935 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 1.6 mt -125.85 119.13 53.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.102 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 628' ' ' LEU . . . . . 0.458 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 17.6 mt -90.36 130.36 36.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.877 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.69 165.98 16.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.181 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . -50.73 -21.26 4.74 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.966 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 22.1 p -69.83 -43.63 71.59 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -98.31 -30.18 12.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.785 0.326 . . . . 0.0 111.516 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.36 156.25 52.79 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.182 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.451 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 72.4 Cg_endo -75.26 163.64 34.38 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.755 2.304 . . . . 0.0 112.444 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -80.52 157.08 26.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.546 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -53.08 -26.96 17.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.501 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.49 -36.3 49.68 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.81 -0.709 . . . . 0.0 113.39 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -113.51 12.6 18.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.964 0.382 . . . . 0.0 111.806 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 639' ' ' LEU . . . . . . . . . . . . . 11.9 tp -62.99 -49.69 73.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.775 0.321 . . . . 0.0 111.089 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -53.34 -41.73 66.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.211 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.74 -38.75 76.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.893 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 642' ' ' TRP . . . . . 0.451 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 47.3 t90 -66.14 -46.37 77.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.706 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 15.3 mt -61.92 -44.34 96.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.589 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.65 -39.62 89.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.547 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.2 -24.53 47.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.982 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -124.05 77.12 59.26 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.939 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -61.88 149.9 88.28 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.577 2.184 . . . . 0.0 112.224 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.43 -13.31 51.26 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.816 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.487 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 24.5 m-85 -94.05 156.15 16.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.861 0.363 . . . . 0.0 111.014 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -149.98 151.82 33.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.783 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.6 t -54.6 125.6 9.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.08 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 652' ' ' ALA . . . . . . . . . . . . . . . -87.23 138.21 32.47 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.174 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.99 159.12 10.04 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.47 2.113 . . . . 0.0 112.302 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 61.64 154.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.98 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.2 -31.72 11.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.92 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -113.45 160.27 18.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.9 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.62 -68.31 0.9 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.92 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.864 179.98 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.728 0.299 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -115.58 -56.0 2.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.955 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 54.8 mtt -59.76 -28.75 67.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.94 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 613' ' ' SER . . . . . . . . . . . . . 5.9 m -57.71 -24.91 59.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.147 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -100.15 -27.96 13.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.017 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 73.2 mt -64.12 154.81 81.28 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.95 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.75 148.72 36.9 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.532 2.154 . . . . 0.0 112.364 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.8 t -118.83 115.38 47.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.963 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.47 174.85 0.87 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.951 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 4.6 m -159.15 157.62 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.199 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.37 127.64 73.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.805 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 621' ' ' HIS . . . . . 0.517 ' CD2' ' CD1' ' A' ' 649' ' ' TYR . 5.4 t-160 -87.59 124.73 33.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.794 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 25.8 t -88.28 -29.48 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.311 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . 0.428 ' HB3' ' CE1' ' A' ' 621' ' ' HIS . 7.2 tp10 -68.38 -37.27 80.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.245 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 3.4 t -112.24 -23.33 10.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.281 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 89.26 -10.85 71.6 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.791 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -69.25 145.47 53.1 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.874 0.368 . . . . 0.0 110.854 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 10.1 mt -120.91 131.09 73.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.046 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 628' ' ' LEU . . . . . 0.455 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 11.1 mt -103.36 136.02 43.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.857 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.72 166.09 16.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.32 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . -51.39 -22.81 7.94 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.78 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 19.8 p -65.91 -43.84 86.99 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.719 0.295 . . . . 0.0 111.459 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -98.36 -21.56 16.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.341 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.48 156.24 53.92 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.352 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.456 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 73.3 Cg_endo -74.29 163.86 35.45 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.696 2.264 . . . . 0.0 112.174 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 31.5 mttt -72.98 175.62 6.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.475 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -60.54 -48.73 80.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.43 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.52 -36.25 49.63 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.943 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.07 -10.11 59.32 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 639' ' ' LEU . . . . . . . . . . . . . 10.6 tp -56.34 -50.62 70.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.73 0.3 . . . . 0.0 111.218 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -54.12 -47.63 71.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.989 0.423 . . . . 0.0 111.186 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -67.89 -36.59 80.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.754 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 642' ' ' TRP . . . . . 0.456 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 42.2 t90 -65.49 -43.77 89.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.723 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 2.6 mt -63.55 -45.11 92.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.319 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -60.2 -37.44 80.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.378 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.14 -23.3 41.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.951 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -127.34 73.11 77.54 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.928 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -61.17 148.87 91.68 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.606 2.204 . . . . 0.0 112.391 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.36 -20.53 39.74 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.771 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.517 ' CD1' ' CD2' ' A' ' 621' ' ' HIS . 21.1 m-85 -81.68 150.58 27.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.874 0.369 . . . . 0.0 110.895 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -137.33 145.93 43.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.724 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 31.7 t -55.95 125.49 11.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.235 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 652' ' ' ALA . . . . . . . . . . . . . . . -80.45 112.98 35.68 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.1 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.62 159.01 11.93 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.474 2.116 . . . . 0.0 112.315 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 -103.15 165.09 11.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.937 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 23.0 t -68.24 -28.6 67.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.979 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -57.37 142.25 44.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.989 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.94 135.38 50.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.92 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.175 -0.917 . . . . 0.0 110.937 179.96 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 31.1 t . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.868 0.366 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -161.88 164.04 28.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 2.1 ptm -59.59 -29.4 67.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 613' ' ' SER . . . . . . . . . . . . . 60.0 p -57.7 -23.01 49.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.099 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -101.6 -27.79 12.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.095 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 7.8 mt -68.25 155.46 92.27 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.937 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.67 150.69 35.68 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.646 2.231 . . . . 0.0 112.466 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 27.9 t -118.8 127.35 75.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.053 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.39 167.96 7.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.953 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 619' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 650' ' ' GLU . 5.2 m -159.24 161.45 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.003 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 12.8 tt -134.98 128.14 49.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.926 0.394 . . . . 0.0 111.528 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 621' ' ' HIS . . . . . 0.48 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 13.8 t-160 -80.51 137.93 36.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.33 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 20.8 t -85.18 -22.16 7.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.779 0.323 . . . . 0.0 111.482 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . 0.42 ' HB3' ' CE1' ' A' ' 621' ' ' HIS . 26.1 tt0 -68.46 -37.4 80.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.499 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 32.0 t -120.12 -23.39 6.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.705 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 86.69 10.41 73.02 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.754 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 7.3 tppt? -76.58 146.92 37.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.785 0.326 . . . . 0.0 110.754 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 3.4 mp -119.97 123.55 71.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.335 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 628' ' ' LEU . . . . . 0.448 ' CD1' ' CE1' ' A' ' 649' ' ' TYR . 15.0 mt -92.35 140.03 30.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.636 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.77 165.88 16.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.389 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . -56.04 -18.46 19.56 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.841 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 6.0 m -70.94 -43.7 67.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.648 0.261 . . . . 0.0 111.484 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.11 -24.22 15.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.797 0.332 . . . . 0.0 111.374 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.52 156.2 54.54 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.161 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.438 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 73.0 Cg_endo -74.75 163.77 35.03 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.689 2.259 . . . . 0.0 112.327 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 21.7 mttp -72.99 175.77 6.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.433 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -61.39 -48.97 78.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.774 0.321 . . . . 0.0 111.205 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.71 -36.26 48.64 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.832 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.94 -11.31 59.59 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.619 0.229 . . . . 0.0 111.619 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 639' ' ' LEU . . . . . . . . . . . . . 10.9 tp -55.98 -47.52 77.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.726 0.298 . . . . 0.0 111.211 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -54.85 -47.75 73.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.997 0.427 . . . . 0.0 111.105 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -67.89 -36.92 81.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.701 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 642' ' ' TRP . . . . . 0.438 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 39.7 t90 -66.59 -38.6 87.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.491 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 8.3 mt -66.26 -44.72 82.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.077 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -59.5 -40.03 85.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.201 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 2.7 ttm -79.26 -21.02 46.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.83 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 646' ' ' ASN . . . . . 0.425 ' HB2' ' CZ3' ' A' ' 642' ' ' TRP . 23.9 m-80 -133.4 65.67 72.78 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.842 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -59.65 149.79 80.44 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.57 2.18 . . . . 0.0 112.444 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.46 -13.55 51.05 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.852 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.48 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 13.2 m-85 -85.01 142.31 29.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 0.0 111.053 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 650' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 619' ' ' VAL . 1.4 mm-40 -130.74 146.18 52.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.509 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 27.2 t -54.36 123.83 5.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.835 0.35 . . . . 0.0 111.297 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 652' ' ' ALA . . . . . . . . . . . . . . . -64.15 112.6 7.91 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.102 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.51 159.0 54.33 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.416 2.077 . . . . 0.0 112.274 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 3.8 mpp_? -86.4 130.87 34.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 52.3 p -88.48 -5.41 58.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.358 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 60.92 163.5 0.07 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.859 0.362 . . . . 0.0 110.9 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.23 -58.37 3.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.889 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.816 0.341 . . . . 0.0 111.281 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -149.67 77.46 1.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.836 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 5.2 mtt -57.97 -30.99 66.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.032 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 613' ' ' SER . . . . . . . . . . . . . 16.9 t -59.97 -28.14 67.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.989 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.2 -27.84 18.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.077 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 71.2 mt -59.04 151.44 56.29 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.871 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.41 144.3 28.79 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.584 2.189 . . . . 0.0 112.309 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.81 115.66 48.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.145 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 618' ' ' LYS . . . . . 0.405 ' HG3' ' N ' ' A' ' 630' ' ' GLY . 0.3 OUTLIER -65.46 175.66 1.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.813 179.912 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 11.2 m -158.33 157.07 3.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.158 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . 0.402 ' CD1' ' CG1' ' A' ' 627' ' ' ILE . 5.6 tp -124.35 127.6 73.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.922 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 621' ' ' HIS . . . . . 0.505 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 7.1 t-160 -89.51 127.98 35.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.692 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.6 t -88.35 -38.03 11.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.071 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -68.52 -30.59 69.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.413 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 8.9 t -112.5 -23.36 10.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.543 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 79.27 1.88 86.55 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.746 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.67 156.79 32.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.825 0.345 . . . . 0.0 110.888 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 627' ' ' ILE . . . . . 0.402 ' CG1' ' CD1' ' A' ' 620' ' ' ILE . 1.9 mt -126.65 124.46 65.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.103 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 628' ' ' LEU . . . . . 0.451 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 19.1 mt -102.25 129.89 48.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.842 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.6 166.09 16.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.221 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 630' ' ' GLY . . . . . 0.405 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -50.2 -22.23 4.78 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.832 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 8.1 p -68.5 -43.79 76.09 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -98.43 -25.05 14.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.524 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.48 154.7 63.01 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.262 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.463 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 72.0 Cg_endo -75.44 161.72 37.07 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.625 2.216 . . . . 0.0 112.382 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -81.66 158.85 24.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.411 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -53.1 -27.09 18.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.787 0.327 . . . . 0.0 111.417 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.68 -36.34 48.57 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.831 -0.699 . . . . 0.0 113.397 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -111.96 11.63 20.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.875 0.337 . . . . 0.0 111.908 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 639' ' ' LEU . . . . . . . . . . . . . 10.4 tp -62.18 -52.19 64.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.799 0.333 . . . . 0.0 111.084 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -53.24 -42.34 66.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.125 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.98 -39.06 76.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.883 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 642' ' ' TRP . . . . . 0.463 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 34.7 t90 -64.59 -46.91 80.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.677 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 11.7 mt -63.83 -40.53 96.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.509 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -60.63 -41.01 94.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.568 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 1.2 ttt -78.03 -35.75 49.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.845 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 646' ' ' ASN . . . . . 0.417 ' HB2' ' CZ3' ' A' ' 642' ' ' TRP . 24.5 m-80 -109.88 81.32 1.99 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.79 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.45 147.85 71.98 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.563 2.176 . . . . 0.0 112.392 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.46 -14.15 50.8 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.738 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.505 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 17.1 m-85 -88.39 149.41 23.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.85 0.357 . . . . 0.0 111.009 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -136.22 145.76 46.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.641 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.2 t -58.22 128.3 18.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.234 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 652' ' ' ALA . . . . . . . . . . . . . . . -80.21 142.85 55.52 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.048 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.73 158.59 8.09 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.557 2.172 . . . . 0.0 112.215 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 59.35 174.77 0.08 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 47.9 m -109.17 -31.53 7.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.849 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.89 -173.46 4.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 18.0 m -136.21 -48.7 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.943 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.934 179.986 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 17.2 m . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.723 0.297 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 63.58 127.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.922 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 30.4 ttm -58.05 -30.38 66.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.941 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 613' ' ' SER . . . . . . . . . . . . . 2.8 p -64.73 -24.6 67.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.059 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -95.0 -27.89 15.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.013 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 80.1 mt -73.01 152.18 90.71 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.963 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.31 145.68 24.24 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.71 2.274 . . . . 0.0 112.402 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.3 t -118.84 119.88 62.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.086 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 618' ' ' LYS . . . . . 0.413 ' HG3' ' N ' ' A' ' 630' ' ' GLY . 0.0 OUTLIER -61.41 169.58 2.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.911 0.386 . . . . 0.0 110.985 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 619' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 650' ' ' GLU . 32.9 m -155.83 143.35 11.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.858 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.37 127.58 73.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.888 0.375 . . . . 0.0 111.132 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 621' ' ' HIS . . . . . 0.494 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 3.6 t-160 -86.69 131.09 34.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.62 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.6 t -86.43 -29.69 6.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.851 0.357 . . . . 0.0 111.054 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -68.55 -37.38 79.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.49 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 8.7 p -111.96 -23.48 10.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.456 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 87.21 -10.52 68.5 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.921 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.4 141.99 53.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.797 0.332 . . . . 0.0 110.89 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 1.9 mt -121.08 129.39 75.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.307 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 12.5 mt -95.68 139.64 31.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.777 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.84 165.91 16.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.497 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 630' ' ' GLY . . . . . 0.413 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -57.2 -18.38 27.77 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.92 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.63 -43.73 68.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.753 0.311 . . . . 0.0 111.446 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -98.19 -22.49 16.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.358 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.46 156.33 53.19 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.291 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.451 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 64.1 Cg_endo -72.42 163.82 37.45 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.735 2.29 . . . . 0.0 112.247 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -72.9 176.45 5.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.525 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -59.43 -48.49 81.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.46 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.47 -36.19 50.03 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.049 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -81.73 -9.85 59.53 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 639' ' ' LEU . . . . . . . . . . . . . 12.0 tp -62.18 -50.11 73.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.654 0.264 . . . . 0.0 111.077 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -52.41 -46.25 66.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.001 0.429 . . . . 0.0 111.17 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.48 -37.61 77.32 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.919 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 642' ' ' TRP . . . . . 0.451 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 44.2 t90 -65.31 -40.81 94.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.747 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 86.0 mt -67.59 -42.58 82.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.319 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.64 -40.45 87.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.414 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.22 -37.09 54.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.623 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -110.92 80.25 2.16 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.648 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.43 147.65 71.73 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.462 2.108 . . . . 0.0 112.454 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.45 -7.74 47.07 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.836 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.494 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 12.5 m-85 -93.47 157.55 16.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.897 0.379 . . . . 0.0 111.026 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 650' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' A' ' 619' ' ' VAL . 18.7 mm-40 -149.4 151.67 34.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.26 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 28.5 t -54.04 119.72 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.821 0.344 . . . . 0.0 111.259 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 652' ' ' ALA . . . . . . . . . . . . . . . -82.95 142.12 44.43 Favored Pre-proline 0 C--N 1.333 -0.145 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.199 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.06 156.34 38.33 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.526 2.151 . . . . 0.0 112.269 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.65 -19.93 12.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.095 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 8.1 t 65.43 31.85 10.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.865 0.364 . . . . 0.0 110.912 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -126.67 174.53 8.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.809 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 41.4 m -88.1 -65.43 1.02 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.95 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.81 -179.984 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.878 0.371 . . . . 0.0 111.278 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -149.98 41.66 0.84 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.856 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 72.9 mtp -61.44 -31.42 71.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.875 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 613' ' ' SER . . . . . . . . . . . . . 2.3 t -63.13 -30.74 71.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.996 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.15 -27.92 38.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.037 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 39.3 mt -62.4 148.79 89.34 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.93 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.05 155.99 47.45 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.604 2.203 . . . . 0.0 112.323 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 27.9 t -118.69 121.06 66.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.06 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.53 134.97 39.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.965 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 2.6 m -124.0 176.89 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.189 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 3.4 tt -143.0 133.12 22.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.509 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 621' ' ' HIS . . . . . 0.482 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 3.3 t-160 -84.65 136.89 33.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.055 179.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 27.0 t -84.65 -36.55 11.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.826 0.346 . . . . 0.0 111.21 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -68.56 -33.0 73.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.41 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.17 -23.24 12.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.55 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 77.36 4.55 84.4 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.683 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 9.0 tttt -76.57 148.38 37.06 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.76 0.314 . . . . 0.0 110.836 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 10.7 mt -122.28 105.54 16.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.363 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 628' ' ' LEU . . . . . 0.452 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 13.6 mt -80.1 130.99 35.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.322 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.53 166.03 16.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.384 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . -50.51 -22.59 5.59 Favored Glycine 0 CA--C 1.517 0.193 0 C-N-CA 120.81 -0.71 . . . . 0.0 113.005 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.16 -43.89 81.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.675 0.274 . . . . 0.0 111.586 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -98.18 -23.72 15.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.911 0.386 . . . . 0.0 111.489 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.62 156.41 54.22 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.302 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.46 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 71.7 Cg_endo -75.11 163.79 34.41 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.878 2.385 . . . . 0.0 112.222 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -72.97 174.73 7.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.495 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -60.99 -44.21 97.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.852 0.358 . . . . 0.0 111.461 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.67 -36.22 49.0 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.214 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 6.1 mm100 -87.19 -7.36 58.02 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 639' ' ' LEU . . . . . . . . . . . . . 14.3 tp -59.62 -49.6 77.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.759 0.314 . . . . 0.0 111.197 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -52.42 -50.39 62.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.943 0.402 . . . . 0.0 111.281 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -66.58 -34.53 78.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.096 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 642' ' ' TRP . . . . . 0.46 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 49.5 t90 -66.73 -46.12 76.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.875 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 35.9 mt -62.76 -43.8 97.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.479 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.17 -38.83 87.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.562 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 6.8 tmm? -78.88 -24.85 43.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.005 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -123.39 77.8 53.84 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.826 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -64.81 144.68 84.28 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.705 2.27 . . . . 0.0 112.395 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.48 -3.41 43.04 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.965 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.482 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 7.7 m-85 -96.25 152.53 18.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.894 0.378 . . . . 0.0 110.976 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -147.81 147.2 29.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.847 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.4 t -57.65 126.55 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.126 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 652' ' ' ALA . . . . . . . . . . . . . . . -64.16 148.1 95.96 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.186 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.18 156.5 55.34 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.558 2.172 . . . . 0.0 112.335 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.24 -28.64 38.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.004 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 10.2 p 59.9 29.64 19.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.006 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 2.1 t70 61.16 113.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.977 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 9.9 t 62.79 -80.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.048 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.878 179.948 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.811 0.338 . . . . 0.0 111.252 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -153.48 -56.38 0.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.85 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.33 -36.08 82.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.945 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 613' ' ' SER . . . . . . . . . . . . . 99.3 p -65.3 -21.98 66.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.135 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -94.42 17.9 12.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.284 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 28.5 mt -106.2 148.65 37.03 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.722 0.296 . . . . 0.0 110.879 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.19 136.87 20.57 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.548 2.166 . . . . 0.0 112.365 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.5 t -112.65 115.44 49.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.06 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 618' ' ' LYS . . . . . 0.411 ' HG3' ' N ' ' A' ' 630' ' ' GLY . 0.3 OUTLIER -60.76 173.2 0.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.967 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 5.7 m -157.81 159.31 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.237 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.72 127.71 72.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.696 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 621' ' ' HIS . . . . . 0.522 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 5.6 t-160 -88.77 127.59 35.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.746 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 26.9 t -88.36 -28.53 5.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.167 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . 0.421 ' HB3' ' CE1' ' A' ' 621' ' ' HIS . 2.4 tm-20 -68.52 -37.29 79.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.232 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 1.6 t -114.52 -23.38 9.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.542 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 90.57 -12.61 67.91 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.74 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.31 143.61 53.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.844 0.355 . . . . 0.0 110.922 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 2.0 mt -120.36 127.09 75.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.21 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 628' ' ' LEU . . . . . 0.463 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 5.6 mt -93.75 133.77 36.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.814 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.85 166.28 16.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.327 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 630' ' ' GLY . . . . . 0.411 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -50.08 -23.59 5.78 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.977 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 5.8 t -65.72 -43.4 89.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.703 0.287 . . . . 0.0 111.305 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.35 -20.58 17.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.359 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.53 150.7 80.17 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.318 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.442 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 72.9 Cg_endo -75.27 163.81 34.05 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.753 2.302 . . . . 0.0 112.353 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 35.5 mttp -73.03 172.0 11.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.425 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -62.39 -38.09 88.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.862 0.363 . . . . 0.0 111.425 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.7 -36.22 48.83 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.237 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -94.38 -3.34 50.47 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 639' ' ' LEU . . . . . . . . . . . . . 13.6 tp -59.64 -50.54 73.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.728 0.299 . . . . 0.0 111.194 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -52.9 -44.52 67.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.219 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.82 -36.81 75.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.003 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 642' ' ' TRP . . . . . 0.442 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 35.1 t90 -67.23 -41.27 85.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.789 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 16.4 mt -67.13 -43.56 82.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.479 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -60.78 -40.49 92.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.541 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.35 -37.28 57.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.797 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -107.84 81.76 1.26 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.818 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -68.39 147.43 71.48 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.616 2.211 . . . . 0.0 112.442 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.34 -20.59 39.63 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.578 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.522 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 23.8 m-85 -81.57 149.97 28.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.876 0.37 . . . . 0.0 111.115 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -142.49 155.62 45.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.62 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.4 t -54.57 127.74 13.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.18 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 652' ' ' ALA . . . . . . . . . . . . . . . -103.53 104.67 43.12 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.231 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.66 159.24 42.02 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.54 2.16 . . . . 0.0 112.182 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 37.2 mtt85 -65.18 109.84 2.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.904 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 2.1 p -123.22 34.07 5.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.987 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.18 -31.32 70.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.845 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 4.4 p -92.9 126.08 37.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.831 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.86 179.967 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 120.77 0.319 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 59.77 97.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.812 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.0 -29.85 68.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.079 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 613' ' ' SER . . . . . . . . . . . . . 1.4 m -73.43 -26.32 60.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.098 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.57 17.88 23.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.425 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 13.4 mt -68.83 161.83 68.68 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.675 0.274 . . . . 0.0 110.899 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.36 140.0 24.01 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.606 2.204 . . . . 0.0 112.32 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 26.2 t -116.45 115.41 48.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.055 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 618' ' ' LYS . . . . . 0.45 ' HG3' ' N ' ' A' ' 630' ' ' GLY . 0.0 OUTLIER -61.51 170.79 1.71 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.923 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 619' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 650' ' ' GLU . 27.7 m -157.42 146.06 10.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.995 179.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.43 127.63 73.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.943 0.402 . . . . 0.0 111.265 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 621' ' ' HIS . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 4.4 t-160 -83.96 131.79 34.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.675 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.5 t -87.8 -29.77 5.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.897 0.38 . . . . 0.0 111.051 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -68.43 -37.3 80.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.198 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 1.5 m -110.85 -23.48 10.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.405 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 85.58 -7.62 75.69 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.906 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -69.4 152.39 44.98 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.791 0.329 . . . . 0.0 110.824 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 2.0 mt -127.64 138.66 54.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.213 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 26.4 mt -105.46 139.2 40.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.768 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.83 165.96 16.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.483 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 630' ' ' GLY . . . . . 0.45 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -56.48 -18.94 24.52 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.005 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 10.0 t -71.17 -43.55 67.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.685 0.278 . . . . 0.0 111.554 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.2 -21.39 16.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.342 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.53 156.22 54.53 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.247 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.444 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 71.6 Cg_endo -73.88 163.79 36.15 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.631 2.221 . . . . 0.0 112.287 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 4.3 mtpp -73.04 176.4 5.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.595 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -60.7 -48.96 79.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.802 0.334 . . . . 0.0 111.286 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.72 -36.32 48.46 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.877 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.11 -11.84 59.72 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 639' ' ' LEU . . . . . . . . . . . . . 10.5 tp -57.71 -49.65 75.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.758 0.313 . . . . 0.0 111.143 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.73 -45.59 70.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.111 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.74 -37.72 76.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.872 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 642' ' ' TRP . . . . . 0.444 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 34.9 t90 -64.83 -42.67 94.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.682 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 65.6 mt -66.33 -42.4 88.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.417 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.17 -41.1 87.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.459 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 4.1 mmt -77.55 -35.17 53.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.645 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 646' ' ' ASN . . . . . 0.435 ' HB2' ' CZ3' ' A' ' 642' ' ' TRP . 23.5 m-80 -113.17 79.75 3.87 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.779 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.33 145.96 67.44 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.608 2.205 . . . . 0.0 112.404 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.44 -6.24 45.43 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.832 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.508 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 11.4 m-85 -95.51 149.5 21.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.911 0.386 . . . . 0.0 111.021 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 650' ' ' GLU . . . . . 0.533 ' O ' ' HA ' ' A' ' 619' ' ' VAL . 69.1 mt-10 -136.5 145.46 45.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.17 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 2.4 m -54.31 123.35 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.9 0.381 . . . . 0.0 111.491 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 652' ' ' ALA . . . . . . . . . . . . . . . -99.65 98.3 6.89 Favored Pre-proline 0 C--N 1.333 -0.152 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.243 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.91 156.41 66.01 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.386 2.057 . . . . 0.0 112.272 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -110.59 176.61 4.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.881 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.69 -43.01 1.89 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.084 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -75.63 81.49 2.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.937 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 3.5 m -127.42 -45.56 1.5 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.877 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.92 179.957 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.742 0.306 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -126.72 -54.45 1.42 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 7.0 mmm -59.3 -28.35 66.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.049 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 613' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.35 -27.24 64.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.06 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.21 -27.8 21.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.196 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 16.2 mt -71.17 146.25 92.17 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.971 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.31 142.62 21.46 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.698 2.265 . . . . 0.0 112.442 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.92 122.72 70.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.122 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 618' ' ' LYS . . . . . 0.4 ' HG3' ' N ' ' A' ' 630' ' ' GLY . 0.8 OUTLIER -65.11 171.17 3.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.759 179.883 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 619' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 650' ' ' GLU . 27.2 m -156.71 152.43 7.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.308 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . 0.406 ' CD1' ' CG1' ' A' ' 627' ' ' ILE . 3.6 tp -124.88 127.45 72.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.647 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 621' ' ' HIS . . . . . 0.529 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 4.1 t-160 -89.26 135.83 33.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.633 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 25.8 t -87.12 -35.77 8.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.819 0.343 . . . . 0.0 111.287 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . 0.432 ' HB2' ' CE1' ' A' ' 621' ' ' HIS . 30.2 mt-10 -68.59 -32.99 73.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.536 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 3.3 t -112.2 -23.36 10.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.592 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 78.97 0.29 81.55 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.906 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -76.68 150.56 36.32 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.757 0.313 . . . . 0.0 110.929 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 627' ' ' ILE . . . . . 0.406 ' CG1' ' CD1' ' A' ' 620' ' ' ILE . 6.2 mt -119.32 119.38 60.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.199 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 628' ' ' LEU . . . . . 0.415 HD12 ' CE2' ' A' ' 649' ' ' TYR . 37.2 mt -87.13 135.82 33.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.745 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.52 166.03 16.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.407 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 630' ' ' GLY . . . . . 0.4 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -56.37 -17.73 19.54 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.646 -0.788 . . . . 0.0 113.004 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.55 -43.6 59.5 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.75 0.275 . . . . 0.0 111.681 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.15 -24.08 15.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.702 0.287 . . . . 0.0 111.461 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.44 154.3 64.77 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.171 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.442 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 72.7 Cg_endo -75.26 156.83 41.87 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.598 2.199 . . . . 0.0 112.414 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? -73.22 165.59 24.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.42 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -62.79 -29.14 70.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.81 0.338 . . . . 0.0 111.302 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.57 -36.35 49.11 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.308 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -106.69 4.72 28.1 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 639' ' ' LEU . . . . . . . . . . . . . 13.5 tp -57.26 -50.13 73.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.749 0.309 . . . . 0.0 111.079 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -52.88 -42.12 65.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.987 0.422 . . . . 0.0 110.961 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.85 -39.7 76.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.775 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 642' ' ' TRP . . . . . 0.442 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 33.3 t90 -66.32 -36.53 83.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.554 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 46.7 mt -69.4 -41.76 76.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.296 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -61.24 -41.16 96.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.328 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 73.7 mtp -77.83 -32.06 51.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.623 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 646' ' ' ASN . . . . . 0.419 ' HB2' ' CZ3' ' A' ' 642' ' ' TRP . 28.2 m-80 -118.93 75.45 13.76 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.682 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.19 149.79 76.45 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.562 2.175 . . . . 0.0 112.442 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.39 -12.3 51.26 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.779 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.529 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 16.0 m-85 -87.8 159.3 18.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.89 0.376 . . . . 0.0 111.032 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 650' ' ' GLU . . . . . 0.52 ' O ' ' HA ' ' A' ' 619' ' ' VAL . 30.1 mt-10 -149.96 147.22 27.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.232 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 31.3 t -53.95 127.09 11.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.777 0.323 . . . . 0.0 111.272 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 652' ' ' ALA . . . . . . . . . . . . . . . -83.24 136.74 43.07 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.291 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.04 159.16 37.79 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.448 2.099 . . . . 0.0 112.219 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -80.74 132.69 35.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.809 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 48.2 t -57.22 -33.51 67.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.971 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -125.09 146.22 49.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.877 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 93.5 p -159.07 179.06 9.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.905 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.32 -0.848 . . . . 0.0 110.852 -179.951 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 120.864 0.364 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 12.9 mp0 60.58 106.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.93 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -59.9 -28.69 67.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 613' ' ' SER . . . . . . . . . . . . . 10.9 m -57.27 -26.59 61.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.134 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -91.98 -27.83 17.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.068 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 8.9 mt -77.6 144.35 69.39 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.957 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.29 149.48 27.94 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.612 2.208 . . . . 0.0 112.444 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.4 t -118.87 130.54 73.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.112 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 618' ' ' LYS . . . . . 0.406 ' HG3' ' N ' ' A' ' 630' ' ' GLY . 0.0 OUTLIER -67.43 164.83 17.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.992 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 619' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 650' ' ' GLU . 33.5 m -156.19 144.07 11.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.97 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.24 127.66 73.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.889 0.376 . . . . 0.0 111.285 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 621' ' ' HIS . . . . . 0.489 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 2.5 t-160 -85.46 133.52 34.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.601 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 20.5 t -86.62 -29.52 5.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.77 0.319 . . . . 0.0 111.133 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.53 -37.34 79.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.357 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 1.8 m -110.1 -23.36 11.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.355 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 82.5 5.83 89.16 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.006 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.63 151.99 36.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.755 0.312 . . . . 0.0 110.895 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 3.5 mt -127.4 114.47 36.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.221 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 628' ' ' LEU . . . . . 0.417 HD11 ' CE1' ' A' ' 649' ' ' TYR . 19.1 mt -86.76 134.46 33.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.808 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.81 166.09 16.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.496 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 630' ' ' GLY . . . . . 0.406 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -58.46 -15.36 24.18 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.176 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.51 -43.68 38.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.899 0.35 . . . . 0.0 111.742 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.94 -26.1 14.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.873 0.368 . . . . 0.0 111.371 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.51 156.03 55.54 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.215 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.437 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 52.2 Cg_endo -68.69 163.81 35.64 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.594 2.196 . . . . 0.0 112.195 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 26.9 mttp -72.85 171.47 12.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.473 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -62.63 -40.21 96.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.426 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.58 -36.25 49.34 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.099 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -91.21 -5.25 55.14 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 639' ' ' LEU . . . . . . . . . . . . . 15.3 tp -57.78 -50.76 72.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.714 0.292 . . . . 0.0 111.271 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.08 -44.0 61.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.913 0.387 . . . . 0.0 111.111 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -68.17 -39.16 82.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.977 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 642' ' ' TRP . . . . . 0.437 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 18.4 t90 -68.98 -34.0 74.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.851 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 17.4 mt -69.05 -47.5 65.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.481 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -61.31 -41.07 96.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.486 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 15.9 tpt -74.17 -33.87 63.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.583 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 646' ' ' ASN . . . . . 0.436 ' ND2' ' CD2' ' A' ' 642' ' ' TRP . 35.6 m-80 -114.47 74.23 3.02 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.647 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.81 147.09 89.41 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.613 2.208 . . . . 0.0 112.51 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.44 -4.12 43.61 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.893 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.489 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 8.9 m-85 -94.88 156.59 16.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.966 0.412 . . . . 0.0 111.109 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 650' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 619' ' ' VAL . 14.7 mm-40 -144.27 145.75 32.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.281 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 24.3 t -54.06 121.29 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.811 0.338 . . . . 0.0 111.32 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 652' ' ' ALA . . . . . . . . . . . . . . . -90.22 146.87 35.64 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.144 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.78 158.94 9.88 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.531 2.154 . . . . 0.0 112.227 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.07 179.63 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.851 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 38.4 t -60.47 -31.58 70.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.892 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.21 81.79 1.82 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.927 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 14.3 t -131.91 171.43 13.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.848 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.905 179.965 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.828 0.346 . . . . 0.0 111.17 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 60.25 32.95 20.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.863 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.35 -31.48 65.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.906 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 613' ' ' SER . . . . . . . . . . . . . 2.9 m -69.43 -21.45 63.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.163 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -92.82 17.88 9.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.396 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 62.3 mt -91.68 151.4 42.32 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.766 0.317 . . . . 0.0 110.878 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.82 149.08 53.39 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.562 2.175 . . . . 0.0 112.294 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.2 t -118.81 119.92 62.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.984 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 618' ' ' LYS . . . . . 0.409 ' HG3' ' N ' ' A' ' 630' ' ' GLY . 0.0 OUTLIER -55.41 172.01 0.16 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.924 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 12.1 m -158.13 160.02 2.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.248 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . 0.403 HD13 ' CG1' ' A' ' 627' ' ' ILE . 6.4 tp -124.41 127.67 73.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.784 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 621' ' ' HIS . . . . . 0.491 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 7.2 t-160 -92.31 128.63 38.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.723 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.4 t -87.74 -28.61 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.859 0.361 . . . . 0.0 111.256 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.57 -37.15 79.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.388 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 70.1 m -113.99 -23.35 9.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.615 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 84.8 4.95 86.89 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.748 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.58 156.84 32.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.863 0.363 . . . . 0.0 111.079 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 627' ' ' ILE . . . . . 0.403 ' CG1' HD13 ' A' ' 620' ' ' ILE . 2.4 mt -125.35 115.29 43.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.054 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 628' ' ' LEU . . . . . 0.451 ' CD1' ' CE1' ' A' ' 649' ' ' TYR . 28.4 mt -90.04 130.33 36.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.822 0.344 . . . . 0.0 110.875 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.78 166.22 16.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.12 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 630' ' ' GLY . . . . . 0.409 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -50.67 -21.25 4.65 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.87 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 4.3 m -69.85 -43.65 71.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.648 0.261 . . . . 0.0 111.658 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -98.34 -23.47 15.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.778 0.323 . . . . 0.0 111.528 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.44 156.24 53.59 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.244 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.427 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 73.0 Cg_endo -75.18 163.72 34.4 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.735 2.29 . . . . 0.0 112.325 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 26.9 mttt -73.01 176.37 5.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.535 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -61.55 -48.94 78.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.849 0.357 . . . . 0.0 111.234 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.69 -36.22 48.89 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.745 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.0 -12.49 59.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.563 0.22 . . . . 0.0 111.55 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 639' ' ' LEU . . . . . . . . . . . . . 11.6 tp -56.16 -47.85 77.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.786 0.327 . . . . 0.0 111.154 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -53.49 -51.32 63.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.978 0.418 . . . . 0.0 111.038 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -67.82 -34.52 76.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.012 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 642' ' ' TRP . . . . . 0.427 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 30.0 t90 -67.65 -38.56 84.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.744 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.46 -43.34 73.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.433 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -61.1 -39.49 90.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.521 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 2.4 ttp -78.73 -35.71 44.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.806 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -110.49 78.34 1.45 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.943 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.39 146.65 69.42 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.531 2.154 . . . . 0.0 112.355 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.34 -12.53 51.5 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.783 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.491 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 15.9 m-85 -88.37 161.71 16.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.899 0.381 . . . . 0.0 111.042 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -148.4 145.81 28.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.698 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.5 t -58.26 130.43 21.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.282 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 652' ' ' ALA . . . . . . . . . . . . . . . -87.14 139.24 32.35 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.971 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -73.39 156.52 50.29 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.405 2.07 . . . . 0.0 112.374 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 9.5 mmt85 -109.13 130.81 55.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 16.5 t -86.83 -33.08 19.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.941 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.08 137.12 35.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.83 -52.93 2.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.873 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.831 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 18.0 mt . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.676 0.274 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.77 150.81 39.9 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.586 2.191 . . . . 0.0 112.368 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 617' ' ' VAL . . . . . 0.439 ' O ' ' HB1' ' A' ' 633' ' ' ALA . 21.4 t -118.83 128.53 75.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.106 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 618' ' ' LYS . . . . . 0.463 ' O ' HG13 ' A' ' 619' ' ' VAL . 0.0 OUTLIER -66.35 170.47 5.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.857 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 619' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 618' ' ' LYS . 16.2 m -157.79 157.26 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.149 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.937 HD13 HG12 ' A' ' 627' ' ' ILE . 3.9 tp -124.59 127.64 73.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.724 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 621' ' ' HIS . . . . . 0.517 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 18.0 t-160 -91.01 132.91 35.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.552 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 622' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 648' ' ' GLY . 23.4 t -87.4 -34.07 7.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.811 0.339 . . . . 0.0 111.231 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -33.82 74.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.348 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 44.2 t -111.51 -23.45 10.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.521 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 80.45 -0.58 84.68 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.508 -0.854 . . . . 0.0 112.828 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 626' ' ' LYS . . . . . 0.578 ' O ' HD12 ' A' ' 620' ' ' ILE . 7.2 tptp -76.59 149.2 36.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.819 0.343 . . . . 0.0 111.026 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 627' ' ' ILE . . . . . 0.937 HG12 HD13 ' A' ' 620' ' ' ILE . 5.7 mt -116.87 114.87 47.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.977 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 628' ' ' LEU . . . . . 0.463 HD12 ' CE2' ' A' ' 649' ' ' TYR . 41.2 mt -84.71 128.39 34.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.808 0.337 . . . . 0.0 111.01 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.72 166.2 16.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.206 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 630' ' ' GLY . . . . . 0.429 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -50.63 -21.18 4.54 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.873 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 19.2 p -71.17 -43.66 67.05 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -98.3 -29.34 13.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.759 0.314 . . . . 0.0 111.56 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 633' ' ' ALA . . . . . 0.439 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.36 156.36 52.07 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.286 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.611 ' HG2' HD12 ' A' ' 639' ' ' LEU . 71.2 Cg_endo -73.37 163.6 37.35 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.727 2.285 . . . . 0.0 112.326 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -73.05 164.39 26.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.314 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -62.76 -31.57 72.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.85 0.357 . . . . 0.0 111.309 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.71 -36.23 48.75 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.371 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -104.01 3.33 33.27 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 639' ' ' LEU . . . . . 0.611 HD12 ' HG2' ' A' ' 634' ' ' PRO . 13.6 tp -58.36 -46.95 85.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.779 0.323 . . . . 0.0 111.121 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.17 -44.81 68.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.975 0.417 . . . . 0.0 111.132 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.79 -36.92 76.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.196 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 642' ' ' TRP . . . . . 0.454 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 47.6 t90 -66.67 -44.92 80.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 44.9 mt -65.91 -40.86 91.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.525 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.65 -40.87 96.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.647 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.1 -38.1 52.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.805 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -107.13 82.27 1.12 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.745 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.4 150.43 75.83 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.551 2.167 . . . . 0.0 112.447 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 648' ' ' GLY . . . . . 0.456 ' O ' HG23 ' A' ' 622' ' ' VAL . . . 104.45 -12.96 51.29 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.808 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.517 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 18.0 m-85 -90.03 160.94 16.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.829 0.347 . . . . 0.0 110.977 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -149.87 145.95 26.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.715 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.204 -179.897 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 16.1 mt . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.656 0.265 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -74.21 155.96 46.69 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.597 2.198 . . . . 0.0 112.25 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 617' ' ' VAL . . . . . 0.502 ' O ' ' HB1' ' A' ' 633' ' ' ALA . 21.4 t -117.47 133.33 64.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.131 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 618' ' ' LYS . . . . . 0.415 ' HG3' ' N ' ' A' ' 630' ' ' GLY . 0.0 OUTLIER -66.85 169.97 7.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.945 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 619' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 650' ' ' GLU . 26.8 m -157.14 162.88 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.82 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.21 128.04 12.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.987 0.422 . . . . 0.0 111.619 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 621' ' ' HIS . . . . . 0.494 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 3.6 t-160 -83.17 133.46 35.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.458 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.5 t -85.82 -23.67 6.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.754 0.311 . . . . 0.0 111.38 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -68.54 -37.41 79.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.494 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 49.0 m -117.17 -23.47 7.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.585 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 87.72 8.98 72.44 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.952 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.56 142.9 40.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.758 0.313 . . . . 0.0 110.807 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 1.9 mt -119.53 120.86 64.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.32 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 23.3 mt -90.43 138.18 31.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.752 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.61 165.89 16.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.554 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 630' ' ' GLY . . . . . 0.415 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -55.94 -18.63 19.33 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.766 -0.73 . . . . 0.0 113.068 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 2.5 m -71.75 -43.54 65.62 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.793 0.297 . . . . 0.0 111.524 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -98.18 -22.79 16.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.429 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 633' ' ' ALA . . . . . 0.502 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.55 156.26 54.46 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.169 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.584 ' HG2' HD12 ' A' ' 639' ' ' LEU . 71.7 Cg_endo -75.39 156.54 41.3 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.624 2.216 . . . . 0.0 112.313 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -73.95 168.02 20.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.487 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -62.86 -29.91 71.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.827 0.346 . . . . 0.0 111.249 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.64 -36.36 48.72 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.346 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.99 4.42 29.39 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 639' ' ' LEU . . . . . 0.584 HD12 ' HG2' ' A' ' 634' ' ' PRO . 16.4 tp -57.16 -52.32 65.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.697 0.284 . . . . 0.0 111.093 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -52.78 -43.7 66.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.969 0.414 . . . . 0.0 111.078 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.26 -36.25 76.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.924 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 642' ' ' TRP . . . . . 0.449 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 53.5 t90 -66.78 -49.64 65.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.68 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 82.1 mt -60.82 -42.11 97.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.488 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -61.06 -40.9 95.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.59 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.73 -25.68 49.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.993 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -121.87 78.98 40.82 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.773 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.1 144.12 86.3 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.717 2.278 . . . . 0.0 112.482 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.53 -7.58 46.58 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.841 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.494 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 12.2 m-85 -96.36 151.57 19.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.016 0.436 . . . . 0.0 111.105 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 650' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 619' ' ' VAL . 19.2 pt-20 -146.4 145.79 30.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.119 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 C--N 1.331 -0.237 0 CA-C-O 120.802 0.334 . . . . 0.0 111.487 -179.523 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 87.2 mt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.715 0.293 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.35 143.55 39.35 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.59 2.193 . . . . 0.0 112.446 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 617' ' ' VAL . . . . . 0.408 ' O ' ' HB1' ' A' ' 633' ' ' ALA . 21.6 t -118.89 115.32 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.007 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 618' ' ' LYS . . . . . 0.408 ' CB ' ' HA ' ' A' ' 629' ' ' THR . 0.0 OUTLIER -63.88 144.24 57.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.649 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 7.3 m -118.75 162.98 16.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.099 0.476 . . . . 0.0 111.544 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.429 ' CD1' HG12 ' A' ' 627' ' ' ILE . 4.9 tp -124.31 127.69 73.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.454 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 621' ' ' HIS . . . . . 0.498 ' HB2' ' CE1' ' A' ' 649' ' ' TYR . 6.3 t-160 -96.78 119.29 34.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.661 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.3 t -88.39 -33.62 6.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.281 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.42 -34.92 76.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.172 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 3.6 m -110.85 -23.39 11.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.336 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 85.76 -6.04 81.91 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.85 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.29 155.47 40.36 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.823 0.344 . . . . 0.0 110.788 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 627' ' ' ILE . . . . . 0.429 HG12 ' CD1' ' A' ' 620' ' ' ILE . 12.1 mt -126.75 121.27 58.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.293 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 628' ' ' LEU . . . . . 0.465 ' CD1' ' CE1' ' A' ' 649' ' ' TYR . 16.4 mt -103.06 124.93 49.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.425 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 629' ' ' THR . . . . . 0.408 ' HA ' ' CB ' ' A' ' 618' ' ' LYS . 0.4 OUTLIER -85.45 166.08 16.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.187 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . -46.84 -25.14 2.19 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.963 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 14.0 p -65.45 -43.96 88.76 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.616 0.246 . . . . 0.0 111.625 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -98.55 -24.24 15.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.874 0.369 . . . . 0.0 111.58 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 633' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.54 156.27 54.29 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.451 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.499 ' HG2' HD12 ' A' ' 639' ' ' LEU . 72.7 Cg_endo -75.25 163.95 33.82 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.82 2.347 . . . . 0.0 112.303 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -72.96 176.43 5.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.471 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -58.95 -48.92 79.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.405 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.67 -36.19 49.08 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.037 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -81.5 -9.8 59.62 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.645 0.239 . . . . 0.0 111.645 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 639' ' ' LEU . . . . . 0.499 HD12 ' HG2' ' A' ' 634' ' ' PRO . 13.1 tp -58.88 -53.35 59.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.713 0.292 . . . . 0.0 111.162 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -52.19 -49.33 64.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.944 0.402 . . . . 0.0 111.068 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -66.78 -35.88 81.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.891 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 642' ' ' TRP . . . . . 0.438 ' CZ3' ' HB2' ' A' ' 646' ' ' ASN . 27.9 t90 -66.85 -38.77 87.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.661 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 12.0 mt -68.33 -42.12 79.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.467 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.65 -41.01 96.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.469 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 3.3 tpp -77.73 -33.23 53.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.797 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 646' ' ' ASN . . . . . 0.438 ' HB2' ' CZ3' ' A' ' 642' ' ' TRP . 10.4 m-80 -115.28 79.28 6.59 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.755 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.46 148.59 73.48 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.569 2.179 . . . . 0.0 112.47 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.41 -8.77 48.55 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.789 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.498 ' CE1' ' HB2' ' A' ' 621' ' ' HIS . 17.7 m-85 -94.91 161.74 14.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.96 0.409 . . . . 0.0 111.168 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -149.86 168.09 24.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.753 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 29.2 t . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.975 179.955 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 5.6 mt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.719 0.295 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.18 140.92 31.65 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.525 2.15 . . . . 0.0 112.317 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.5 t -111.42 119.61 60.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.098 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 618' ' ' LYS . . . . . 0.468 ' O ' HG13 ' A' ' 619' ' ' VAL . 0.0 OUTLIER -58.85 174.49 0.34 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 619' ' ' VAL . . . . . 0.468 HG13 ' O ' ' A' ' 618' ' ' LYS . 16.2 m -157.87 155.85 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.135 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.942 HD13 HG12 ' A' ' 627' ' ' ILE . 4.9 tp -124.5 127.61 73.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.771 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 621' ' ' HIS . . . . . 0.51 ' CG ' ' CE1' ' A' ' 649' ' ' TYR . 1.6 t60 -89.91 133.28 34.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.723 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 622' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 648' ' ' GLY . 26.1 t -87.12 -29.45 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.366 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -68.46 -37.16 79.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.374 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.18 -23.32 10.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.427 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 82.45 3.31 90.58 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.697 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 626' ' ' LYS . . . . . 0.814 ' O ' HD12 ' A' ' 620' ' ' ILE . 3.5 mtmt -76.7 151.14 36.21 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.81 0.338 . . . . 0.0 111.027 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 627' ' ' ILE . . . . . 0.942 HG12 HD13 ' A' ' 620' ' ' ILE . 7.1 mt -117.08 111.05 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.019 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 628' ' ' LEU . . . . . 0.506 HD12 ' CE2' ' A' ' 649' ' ' TYR . 75.4 mt -81.41 133.59 35.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.848 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.74 166.05 16.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.196 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 630' ' ' GLY . . . . . 0.427 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -50.27 -21.34 4.16 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.771 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 1.1 m -69.79 -43.48 72.02 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.06 -30.73 12.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.819 0.342 . . . . 0.0 111.465 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.41 156.35 52.59 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.187 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.685 ' HG2' HD12 ' A' ' 639' ' ' LEU . 73.0 Cg_endo -75.18 162.92 35.91 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.713 2.275 . . . . 0.0 112.451 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 43.0 mttm -85.44 157.04 20.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.571 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -53.04 -26.87 17.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.499 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -73.97 -36.29 52.34 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.395 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -116.02 14.23 16.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.025 0.413 . . . . 0.0 111.872 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 639' ' ' LEU . . . . . 0.685 HD12 ' HG2' ' A' ' 634' ' ' PRO . 10.9 tp -59.59 -51.61 69.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.796 0.331 . . . . 0.0 111.108 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -52.98 -43.28 66.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.99 0.424 . . . . 0.0 111.106 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.94 -38.93 76.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.806 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 642' ' ' TRP . . . . . 0.439 ' CZ3' ' HB2' ' A' ' 646' ' ' ASN . 37.7 t90 -64.69 -42.46 95.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.699 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 90.4 mt -66.61 -40.97 89.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.35 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -60.11 -41.04 91.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.494 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 18.4 ttt -77.47 -36.25 53.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.562 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 646' ' ' ASN . . . . . 0.439 ' HB2' ' CZ3' ' A' ' 642' ' ' TRP . 20.9 m-80 -112.38 78.01 2.45 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.584 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.81 149.03 83.43 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.609 2.206 . . . . 0.0 112.451 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 648' ' ' GLY . . . . . 0.612 ' O ' HG23 ' A' ' 622' ' ' VAL . . . 104.46 -18.89 43.78 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.615 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.51 ' CE1' ' CG ' ' A' ' 621' ' ' HIS . 21.3 m-85 -83.41 157.97 22.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.837 0.351 . . . . 0.0 111.005 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -148.61 145.9 27.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.563 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 2.7 m . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.407 -179.838 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 10.8 mt . . . . . 0 CA--C 1.528 0.11 0 CA-C-O 120.726 0.298 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.26 153.13 31.33 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.597 2.198 . . . . 0.0 112.425 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.7 t -118.85 122.63 69.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.065 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 618' ' ' LYS . . . . . 0.537 ' O ' HG13 ' A' ' 619' ' ' VAL . 0.1 OUTLIER -63.63 176.42 0.88 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.874 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 619' ' ' VAL . . . . . 0.537 HG13 ' O ' ' A' ' 618' ' ' LYS . 5.9 m -159.23 158.02 2.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.246 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.819 HD13 HG12 ' A' ' 627' ' ' ILE . 5.0 tp -124.57 127.55 72.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.686 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 621' ' ' HIS . . . . . 0.517 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 7.6 t-160 -89.82 127.46 35.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.734 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.6 t -88.47 -39.27 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 0.0 111.05 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -68.5 -29.97 68.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.388 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 1.7 t -112.83 -23.44 10.13 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.573 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 79.4 -0.0 82.08 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.825 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -76.44 156.83 32.77 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.812 0.339 . . . . 0.0 110.887 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 627' ' ' ILE . . . . . 0.819 HG12 HD13 ' A' ' 620' ' ' ILE . 2.8 mt -128.39 126.58 65.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.238 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 628' ' ' LEU . . . . . 0.462 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 11.5 mt -103.45 130.71 50.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.654 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.69 166.08 16.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.254 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 630' ' ' GLY . . . . . 0.409 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -53.59 -19.05 8.58 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.031 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 23.0 m -71.78 -43.81 65.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.681 0.277 . . . . 0.0 111.693 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -98.26 -23.18 15.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.857 0.361 . . . . 0.0 111.518 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.41 156.36 52.56 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.353 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.512 ' HG2' HD12 ' A' ' 639' ' ' LEU . 61.0 Cg_endo -71.68 163.96 37.25 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.764 2.31 . . . . 0.0 112.188 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -72.88 176.45 5.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.448 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -59.79 -49.01 79.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.792 0.33 . . . . 0.0 111.383 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.72 -36.22 48.71 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.01 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -81.16 -10.52 59.62 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 639' ' ' LEU . . . . . 0.512 HD12 ' HG2' ' A' ' 634' ' ' PRO . 10.9 tp -59.24 -50.71 72.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.774 0.321 . . . . 0.0 111.181 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -53.1 -45.63 68.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.299 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.77 -37.19 76.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.921 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 642' ' ' TRP . . . . . 0.444 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 51.8 t90 -64.28 -54.6 30.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.794 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 67.7 mt -58.53 -43.09 89.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.615 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -59.57 -38.13 80.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.614 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.03 -25.55 37.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.955 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -122.15 78.08 42.83 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.93 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.56 151.7 78.32 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.711 2.274 . . . . 0.0 112.313 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.41 -17.1 47.77 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.823 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.517 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 23.6 m-85 -89.54 152.25 21.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.907 0.384 . . . . 0.0 111.049 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -144.04 153.49 42.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.636 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.251 -179.902 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 25.4 mt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.764 0.316 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 616' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 635' ' ' LYS . 70.3 Cg_endo -74.69 148.1 36.33 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.604 2.203 . . . . 0.0 112.627 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.4 t -118.97 115.29 47.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.811 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.66 143.36 57.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.953 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 2.5 m -127.05 165.72 25.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.336 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.55 HD13 ' C ' ' A' ' 620' ' ' ILE . 0.0 OUTLIER -127.26 127.46 69.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.669 179.582 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 621' ' ' HIS . . . . . 0.462 ' ND1' ' CE2' ' A' ' 649' ' ' TYR . 5.9 t-160 -91.87 125.87 36.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.941 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 26.1 t -86.82 -31.1 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.264 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 623' ' ' GLU . . . . . 0.4 ' HB2' ' NE2' ' A' ' 621' ' ' HIS . 36.2 mt-10 -68.12 -37.3 80.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.106 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 21.1 t -105.75 -23.58 12.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.219 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 88.21 -15.37 56.39 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.922 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 10.0 mtpp -70.25 156.83 38.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.687 0.279 . . . . 0.0 110.918 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 2.0 mp -128.55 115.39 37.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.061 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 628' ' ' LEU . . . . . 0.499 HD12 ' CE1' ' A' ' 649' ' ' TYR . 15.8 mt -85.06 130.18 34.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.906 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 629' ' ' THR . . . . . 0.445 ' OG1' HG23 ' A' ' 631' ' ' THR . 0.7 OUTLIER -85.7 166.05 16.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.184 179.646 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 630' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' A' ' 616' ' ' PRO . . . -48.49 -24.05 3.58 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.838 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 631' ' ' THR . . . . . 0.445 HG23 ' OG1' ' A' ' 629' ' ' THR . 8.5 p -65.34 -43.98 89.21 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.51 -34.11 10.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.902 0.382 . . . . 0.0 111.642 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.38 156.12 53.72 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.712 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.697 ' HG2' HD12 ' A' ' 639' ' ' LEU . 89.5 Cg_endo -75.32 163.76 34.04 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.957 2.438 . . . . 0.0 112.556 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 635' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 616' ' ' PRO . 0.0 OUTLIER -92.06 166.1 12.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.511 179.362 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -52.94 -26.89 16.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.588 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -67.17 -36.25 89.82 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.416 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.33 17.57 7.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 117.014 0.407 . . . . 0.0 111.854 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 639' ' ' LEU . . . . . 0.697 HD12 ' HG2' ' A' ' 634' ' ' PRO . 13.9 tp -64.71 -54.58 29.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.779 0.323 . . . . 0.0 111.23 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -52.26 -43.42 64.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.182 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -67.97 -37.53 81.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.848 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 642' ' ' TRP . . . . . 0.483 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 28.0 t90 -66.81 -48.79 67.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.864 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 36.1 mt -60.18 -41.19 92.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.591 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.15 -40.98 99.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.581 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 28.8 ttp -79.49 -18.74 51.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.175 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 646' ' ' ASN . . . . . 0.43 ' HB2' ' CZ3' ' A' ' 642' ' ' TRP . 27.7 m-80 -129.56 68.36 80.3 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.866 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -56.84 154.33 32.7 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.539 2.16 . . . . 0.0 112.328 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.29 -16.77 48.79 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.706 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.499 ' CE1' HD12 ' A' ' 628' ' ' LEU . 25.0 m-85 -88.13 161.17 17.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.819 0.343 . . . . 0.0 111.125 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -149.74 157.85 43.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.788 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.158 179.983 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 16.3 mt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.683 0.277 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.94 151.12 39.43 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.597 2.198 . . . . 0.0 112.374 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.93 119.13 60.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.155 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.92 146.04 54.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.762 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 4.1 m -122.68 164.51 19.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.392 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.667 HD13 HG12 ' A' ' 627' ' ' ILE . 5.9 tp -124.46 127.64 73.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.573 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 621' ' ' HIS . . . . . 0.491 ' HB2' ' CE1' ' A' ' 649' ' ' TYR . 2.1 t60 -95.5 118.82 32.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.78 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 19.2 t -89.18 -28.19 5.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.227 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -61.72 -37.37 83.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.108 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 61.3 m -119.17 -23.39 6.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.412 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 95.29 -3.29 66.25 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.837 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.33 147.07 51.61 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.811 0.339 . . . . 0.0 110.745 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 627' ' ' ILE . . . . . 0.667 HG12 HD13 ' A' ' 620' ' ' ILE . 1.6 mp -120.84 118.91 57.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.323 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 628' ' ' LEU . . . . . 0.516 HD12 ' CE1' ' A' ' 649' ' ' TYR . 27.2 mt -97.56 127.29 43.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.476 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.5 166.04 16.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.251 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . -49.2 -22.15 3.17 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.074 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 1.2 m -68.55 -43.98 75.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -98.42 -25.99 14.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.907 0.384 . . . . 0.0 111.47 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 633' ' ' ALA . . . . . 0.42 ' HB1' ' HD2' ' A' ' 634' ' ' PRO . . . -61.49 156.59 51.93 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.389 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.513 ' HG2' HD12 ' A' ' 639' ' ' LEU . 58.0 Cg_endo -69.45 163.85 36.45 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.884 2.389 . . . . 0.0 112.189 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 25.4 mttp -72.92 174.19 8.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.454 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -60.37 -48.94 79.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.381 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.83 -36.24 48.16 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.0 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -82.38 -9.62 59.38 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 639' ' ' LEU . . . . . 0.513 HD12 ' HG2' ' A' ' 634' ' ' PRO . 11.4 tp -57.35 -45.66 84.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.774 0.321 . . . . 0.0 111.197 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.27 -49.77 68.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.995 0.426 . . . . 0.0 111.309 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -68.92 -34.48 75.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.176 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 642' ' ' TRP . . . . . 0.427 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 49.7 t90 -67.03 -44.43 80.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.826 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 83.2 mt -65.47 -44.4 87.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.387 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -60.78 -37.19 81.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.523 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 6.3 mtt -80.97 -26.27 36.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.008 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -122.34 78.3 44.74 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.976 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -64.28 150.14 88.87 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.72 2.28 . . . . 0.0 112.388 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.38 -15.85 49.64 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.789 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.516 ' CE1' HD12 ' A' ' 628' ' ' LEU . 22.5 m-85 -88.55 161.77 16.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.918 0.39 . . . . 0.0 111.116 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -148.64 145.91 27.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.765 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.226 179.989 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 19.7 mt . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.775 0.321 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.53 152.4 65.28 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.609 2.206 . . . . 0.0 112.319 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 617' ' ' VAL . . . . . 0.442 ' O ' ' HB1' ' A' ' 633' ' ' ALA . 21.5 t -118.81 131.47 71.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.13 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 618' ' ' LYS . . . . . 0.53 ' O ' HG13 ' A' ' 619' ' ' VAL . 0.0 OUTLIER -70.16 172.8 7.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.88 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 619' ' ' VAL . . . . . 0.53 HG13 ' O ' ' A' ' 618' ' ' LYS . 6.2 m -159.17 162.97 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.171 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.893 HD13 ' CG1' ' A' ' 627' ' ' ILE . 4.7 tp -129.13 127.51 65.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.744 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 621' ' ' HIS . . . . . 0.504 ' CG ' ' CE1' ' A' ' 649' ' ' TYR . 8.1 t-160 -91.19 134.35 34.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.72 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 622' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 648' ' ' GLY . 25.5 t -87.39 -31.12 5.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.895 0.379 . . . . 0.0 111.108 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -68.6 -36.9 79.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.353 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 1.3 m -111.36 -23.27 10.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.645 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 81.43 1.69 90.19 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.817 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 626' ' ' LYS . . . . . 0.762 ' O ' HD12 ' A' ' 620' ' ' ILE . 0.0 OUTLIER -76.69 153.62 34.96 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.863 0.364 . . . . 0.0 110.958 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 627' ' ' ILE . . . . . 0.893 ' CG1' HD13 ' A' ' 620' ' ' ILE . 3.9 mt -120.67 109.26 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.096 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 628' ' ' LEU . . . . . 0.451 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 30.4 mt -78.33 129.86 35.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.817 0.341 . . . . 0.0 110.66 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.7 166.06 16.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.193 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . -52.38 -19.04 5.58 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.9 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 35.7 m -72.96 -43.61 62.08 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -98.03 -29.0 13.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.786 0.327 . . . . 0.0 111.604 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 633' ' ' ALA . . . . . 0.442 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.38 156.29 52.67 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.082 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.63 ' HG2' HD12 ' A' ' 639' ' ' LEU . 72.8 Cg_endo -75.28 157.85 41.38 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.672 2.248 . . . . 0.0 112.425 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 29.1 mttp -74.0 155.36 38.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.571 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -53.14 -26.98 18.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.503 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.37 -36.37 50.12 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.308 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -111.34 11.06 21.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.819 0.31 . . . . 0.0 111.733 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 639' ' ' LEU . . . . . 0.63 HD12 ' HG2' ' A' ' 634' ' ' PRO . 12.6 tp -63.63 -48.1 78.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.763 0.316 . . . . 0.0 111.103 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -52.83 -43.77 66.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.961 0.41 . . . . 0.0 111.095 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.87 -38.46 76.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.975 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 642' ' ' TRP . . . . . 0.444 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 30.5 t90 -67.68 -36.62 81.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.678 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 14.1 mt -69.3 -43.39 73.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.341 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.52 -40.96 96.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.456 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -75.68 -39.26 57.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.718 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -106.22 80.06 0.64 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.727 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.12 147.59 73.51 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.573 2.182 . . . . 0.0 112.448 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 648' ' ' GLY . . . . . 0.578 ' O ' HG23 ' A' ' 622' ' ' VAL . . . 104.43 -15.23 50.24 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.702 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.504 ' CE1' ' CG ' ' A' ' 621' ' ' HIS . 19.4 m-85 -86.66 153.08 22.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.806 0.336 . . . . 0.0 111.014 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -143.6 145.83 32.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.634 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 31.0 t . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.236 -179.983 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 10.0 mt . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.753 0.311 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.38 152.17 38.72 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.569 2.179 . . . . 0.0 112.365 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 617' ' ' VAL . . . . . 0.475 ' O ' ' HB1' ' A' ' 633' ' ' ALA . 26.5 t -118.87 129.36 75.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.025 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 618' ' ' LYS . . . . . 0.493 ' O ' HG13 ' A' ' 619' ' ' VAL . 0.0 OUTLIER -68.41 173.54 4.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 619' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 618' ' ' LYS . 12.0 m -158.58 160.67 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.21 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.862 HD13 HG12 ' A' ' 627' ' ' ILE . 5.5 tp -124.3 127.65 73.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.636 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 621' ' ' HIS . . . . . 0.508 ' CG ' ' CE1' ' A' ' 649' ' ' TYR . 1.5 t60 -93.23 127.97 39.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.79 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 622' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 648' ' ' GLY . 21.4 t -88.68 -27.32 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.309 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -68.35 -37.22 80.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.149 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 12.4 p -113.51 -23.21 9.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.398 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 87.51 -5.72 84.57 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.886 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 626' ' ' LYS . . . . . 0.519 ' O ' HD12 ' A' ' 620' ' ' ILE . 29.1 tttt -69.39 156.8 38.23 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.856 0.36 . . . . 0.0 110.966 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 627' ' ' ILE . . . . . 0.862 HG12 HD13 ' A' ' 620' ' ' ILE . 2.6 mt -124.35 114.54 41.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.972 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 628' ' ' LEU . . . . . 0.502 HD12 ' CE2' ' A' ' 649' ' ' TYR . 45.1 mt -87.13 127.91 35.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.825 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.66 166.22 16.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.133 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 630' ' ' GLY . . . . . 0.416 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -49.58 -21.74 3.47 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.864 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 29.0 p -70.08 -43.69 70.62 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -98.38 -27.59 14.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.827 0.346 . . . . 0.0 111.628 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 633' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.41 156.36 52.61 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.298 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.513 ' HG2' HD12 ' A' ' 639' ' ' LEU . 71.5 Cg_endo -72.9 163.82 37.31 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.767 2.312 . . . . 0.0 112.314 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -73.04 172.54 10.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.4 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -61.01 -43.94 98.14 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.796 0.331 . . . . 0.0 111.433 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.54 -36.32 49.36 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.841 -0.695 . . . . 0.0 113.114 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -88.02 -6.05 58.18 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 639' ' ' LEU . . . . . 0.513 HD12 ' HG2' ' A' ' 634' ' ' PRO . 16.3 tp -58.49 -51.28 70.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.665 0.269 . . . . 0.0 111.229 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -50.67 -50.51 54.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.005 0.431 . . . . 0.0 111.122 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -66.55 -35.41 80.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.986 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 642' ' ' TRP . . . . . 0.442 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 36.4 t90 -67.63 -37.75 82.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.679 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.88 -46.03 72.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.291 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.27 -36.78 80.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.423 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 3.6 ttm -80.83 -24.33 38.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.894 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -125.8 75.46 70.84 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.872 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.84 149.59 90.34 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.682 2.254 . . . . 0.0 112.401 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 648' ' ' GLY . . . . . 0.402 ' O ' HG23 ' A' ' 622' ' ' VAL . . . 104.51 -18.29 44.89 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.735 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.508 ' CE1' ' CG ' ' A' ' 621' ' ' HIS . 20.7 m-85 -83.39 161.63 21.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.872 0.368 . . . . 0.0 111.075 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -149.64 145.98 27.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.75 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.159 -179.916 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 50.9 mt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.745 0.307 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.79 151.35 57.25 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.632 2.221 . . . . 0.0 112.324 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 617' ' ' VAL . . . . . 0.406 ' O ' ' HB1' ' A' ' 633' ' ' ALA . 21.3 t -118.83 128.92 75.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.143 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 618' ' ' LYS . . . . . 0.515 ' O ' HG13 ' A' ' 619' ' ' VAL . 0.0 OUTLIER -66.39 176.72 1.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.813 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 619' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 618' ' ' LYS . 10.1 m -158.95 158.84 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.257 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.749 HD13 HG12 ' A' ' 627' ' ' ILE . 5.3 tp -124.36 127.55 73.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.533 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 621' ' ' HIS . . . . . 0.484 ' CG ' ' CE1' ' A' ' 649' ' ' TYR . 7.8 t-160 -93.12 128.79 39.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.659 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.4 t -88.24 -34.65 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.216 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -68.46 -33.97 75.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.334 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 1.7 m -111.5 -23.4 10.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.558 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 82.39 -4.0 79.38 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.826 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.56 156.89 36.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.839 0.352 . . . . 0.0 110.935 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 627' ' ' ILE . . . . . 0.749 HG12 HD13 ' A' ' 620' ' ' ILE . 1.6 mt -125.85 119.13 53.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.102 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 628' ' ' LEU . . . . . 0.458 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 17.6 mt -90.36 130.36 36.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.877 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.69 165.98 16.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.181 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 630' ' ' GLY . . . . . 0.401 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -50.73 -21.26 4.74 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.966 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 22.1 p -69.83 -43.63 71.59 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -98.31 -30.18 12.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.785 0.326 . . . . 0.0 111.516 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 633' ' ' ALA . . . . . 0.406 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.36 156.25 52.79 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.182 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.686 ' HG2' HD12 ' A' ' 639' ' ' LEU . 72.4 Cg_endo -75.26 163.64 34.38 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.755 2.304 . . . . 0.0 112.444 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -80.52 157.08 26.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.546 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -53.08 -26.96 17.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.501 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.49 -36.3 49.68 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.81 -0.709 . . . . 0.0 113.39 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -113.51 12.6 18.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.964 0.382 . . . . 0.0 111.806 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 639' ' ' LEU . . . . . 0.686 HD12 ' HG2' ' A' ' 634' ' ' PRO . 11.9 tp -62.99 -49.69 73.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.775 0.321 . . . . 0.0 111.089 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -53.34 -41.73 66.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.211 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.74 -38.75 76.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.893 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 642' ' ' TRP . . . . . 0.443 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 47.3 t90 -66.14 -46.37 77.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.706 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 643' ' ' LEU . . . . . 0.431 HD12 ' HG ' ' A' ' 639' ' ' LEU . 15.3 mt -61.92 -44.34 96.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.589 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.65 -39.62 89.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.547 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.2 -24.53 47.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.982 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -124.05 77.12 59.26 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.939 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -61.88 149.9 88.28 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.577 2.184 . . . . 0.0 112.224 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.43 -13.31 51.26 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.816 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.484 ' CE1' ' CG ' ' A' ' 621' ' ' HIS . 24.5 m-85 -94.05 156.15 16.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.861 0.363 . . . . 0.0 111.014 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -149.98 151.82 33.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.783 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.08 -179.926 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 73.2 mt . . . . . 0 CA--C 1.527 0.078 0 CA-C-O 120.782 0.325 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.75 148.72 36.9 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.532 2.154 . . . . 0.0 112.364 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 617' ' ' VAL . . . . . 0.462 ' O ' ' HB1' ' A' ' 633' ' ' ALA . 21.8 t -118.83 115.38 47.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.963 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 618' ' ' LYS . . . . . 0.541 ' O ' HG13 ' A' ' 619' ' ' VAL . 0.0 OUTLIER -62.47 174.85 0.87 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.951 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 619' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 618' ' ' LYS . 4.6 m -159.15 157.62 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.199 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.496 HD13 ' C ' ' A' ' 620' ' ' ILE . 0.0 OUTLIER -124.37 127.64 73.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.805 179.785 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 621' ' ' HIS . . . . . 0.517 ' CD2' ' CD1' ' A' ' 649' ' ' TYR . 5.4 t-160 -87.59 124.73 33.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.794 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 622' ' ' VAL . . . . . 0.408 HG21 ' OE1' ' A' ' 650' ' ' GLU . 25.8 t -88.28 -29.48 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.311 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 623' ' ' GLU . . . . . 0.438 ' HB3' ' CE1' ' A' ' 621' ' ' HIS . 7.2 tp10 -68.38 -37.27 80.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.245 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 3.4 t -112.24 -23.33 10.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.281 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 89.26 -10.85 71.6 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.791 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -69.25 145.47 53.1 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.874 0.368 . . . . 0.0 110.854 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 10.1 mt -120.91 131.09 73.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.046 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 628' ' ' LEU . . . . . 0.455 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 11.1 mt -103.36 136.02 43.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.857 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.72 166.09 16.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.32 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 630' ' ' GLY . . . . . 0.405 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -51.39 -22.81 7.94 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.78 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 19.8 p -65.91 -43.84 86.99 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.719 0.295 . . . . 0.0 111.459 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -98.36 -21.56 16.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.341 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 633' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.48 156.24 53.92 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.352 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.505 ' HG2' HD12 ' A' ' 639' ' ' LEU . 73.3 Cg_endo -74.29 163.86 35.45 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.696 2.264 . . . . 0.0 112.174 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 31.5 mttt -72.98 175.62 6.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.475 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -60.54 -48.73 80.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.43 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.52 -36.25 49.63 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.943 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.07 -10.11 59.32 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 639' ' ' LEU . . . . . 0.514 ' HG ' HD12 ' A' ' 643' ' ' LEU . 10.6 tp -56.34 -50.62 70.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.73 0.3 . . . . 0.0 111.218 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -54.12 -47.63 71.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.989 0.423 . . . . 0.0 111.186 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -67.89 -36.59 80.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.754 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 642' ' ' TRP . . . . . 0.437 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 42.2 t90 -65.49 -43.77 89.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.723 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 643' ' ' LEU . . . . . 0.514 HD12 ' HG ' ' A' ' 639' ' ' LEU . 2.6 mt -63.55 -45.11 92.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.319 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -60.2 -37.44 80.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.378 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.14 -23.3 41.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.951 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -127.34 73.11 77.54 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.928 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -61.17 148.87 91.68 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.606 2.204 . . . . 0.0 112.391 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.36 -20.53 39.74 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.771 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.517 ' CD1' ' CD2' ' A' ' 621' ' ' HIS . 21.1 m-85 -81.68 150.58 27.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.874 0.369 . . . . 0.0 110.895 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 650' ' ' GLU . . . . . 0.408 ' OE1' HG21 ' A' ' 622' ' ' VAL . 26.2 mt-10 -137.33 145.93 43.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.724 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.235 -179.95 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 7.8 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.76 0.314 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.67 150.69 35.68 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.646 2.231 . . . . 0.0 112.466 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 617' ' ' VAL . . . . . 0.456 ' O ' ' HB1' ' A' ' 633' ' ' ALA . 27.9 t -118.8 127.35 75.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.053 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 618' ' ' LYS . . . . . 0.549 ' O ' HG13 ' A' ' 619' ' ' VAL . 0.0 OUTLIER -65.39 167.96 7.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.953 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 619' ' ' VAL . . . . . 0.549 HG13 ' O ' ' A' ' 618' ' ' LYS . 5.2 m -159.24 161.45 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.003 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 12.8 tt -134.98 128.14 49.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.926 0.394 . . . . 0.0 111.528 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 621' ' ' HIS . . . . . 0.491 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 1.1 t60 -80.51 137.93 36.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.33 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 622' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 648' ' ' GLY . 20.8 t -85.18 -22.16 7.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.779 0.323 . . . . 0.0 111.482 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -68.46 -37.4 80.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.499 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 32.0 t -120.12 -23.39 6.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.705 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 86.69 10.41 73.02 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.754 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 7.3 tppt? -76.58 146.92 37.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.785 0.326 . . . . 0.0 110.754 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 3.4 mp -119.97 123.55 71.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.335 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 628' ' ' LEU . . . . . 0.448 ' CD1' ' CE1' ' A' ' 649' ' ' TYR . 15.0 mt -92.35 140.03 30.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.636 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.77 165.88 16.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.389 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . -56.04 -18.46 19.56 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.841 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 6.0 m -70.94 -43.7 67.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.648 0.261 . . . . 0.0 111.484 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.11 -24.22 15.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.797 0.332 . . . . 0.0 111.374 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 633' ' ' ALA . . . . . 0.456 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.52 156.2 54.54 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.161 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.455 ' HG2' HD12 ' A' ' 639' ' ' LEU . 73.0 Cg_endo -74.75 163.77 35.03 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.689 2.259 . . . . 0.0 112.327 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 21.7 mttp -72.99 175.77 6.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.433 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -61.39 -48.97 78.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.774 0.321 . . . . 0.0 111.205 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.71 -36.26 48.64 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.832 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.94 -11.31 59.59 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.619 0.229 . . . . 0.0 111.619 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 639' ' ' LEU . . . . . 0.455 HD12 ' HG2' ' A' ' 634' ' ' PRO . 10.9 tp -55.98 -47.52 77.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.726 0.298 . . . . 0.0 111.211 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -54.85 -47.75 73.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.997 0.427 . . . . 0.0 111.105 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -67.89 -36.92 81.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.701 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 642' ' ' TRP . . . . . 0.44 ' CZ3' ' HB2' ' A' ' 646' ' ' ASN . 39.7 t90 -66.59 -38.6 87.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.491 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 8.3 mt -66.26 -44.72 82.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.077 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -59.5 -40.03 85.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.201 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 2.7 ttm -79.26 -21.02 46.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.83 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 646' ' ' ASN . . . . . 0.44 ' HB2' ' CZ3' ' A' ' 642' ' ' TRP . 23.9 m-80 -133.4 65.67 72.78 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.842 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -59.65 149.79 80.44 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.57 2.18 . . . . 0.0 112.444 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 648' ' ' GLY . . . . . 0.67 ' O ' HG23 ' A' ' 622' ' ' VAL . . . 104.46 -13.55 51.05 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.852 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.491 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 13.2 m-85 -85.01 142.31 29.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 0.0 111.053 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 650' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 619' ' ' VAL . 1.4 mm-40 -130.74 146.18 52.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.509 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 27.2 t . . . . . 0 C--N 1.33 -0.258 0 CA-C-O 120.835 0.35 . . . . 0.0 111.297 -179.794 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 71.2 mt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.755 0.312 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.41 144.3 28.79 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.584 2.189 . . . . 0.0 112.309 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 617' ' ' VAL . . . . . 0.457 ' CG1' HG13 ' A' ' 651' ' ' VAL . 21.6 t -118.81 115.66 48.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.145 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 618' ' ' LYS . . . . . 0.491 ' O ' HG13 ' A' ' 619' ' ' VAL . 0.3 OUTLIER -65.46 175.66 1.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.813 179.912 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 619' ' ' VAL . . . . . 0.491 HG13 ' O ' ' A' ' 618' ' ' LYS . 11.2 m -158.33 157.07 3.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.158 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.799 HD13 HG12 ' A' ' 627' ' ' ILE . 5.6 tp -124.35 127.6 73.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.922 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 621' ' ' HIS . . . . . 0.502 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 7.1 t-160 -89.51 127.98 35.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.692 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.6 t -88.35 -38.03 11.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.071 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -68.52 -30.59 69.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.413 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 8.9 t -112.5 -23.36 10.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.543 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 79.27 1.88 86.55 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.746 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 626' ' ' LYS . . . . . 0.59 ' O ' HD12 ' A' ' 620' ' ' ILE . 0.4 OUTLIER -76.67 156.79 32.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.825 0.345 . . . . 0.0 110.888 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 627' ' ' ILE . . . . . 0.799 HG12 HD13 ' A' ' 620' ' ' ILE . 1.9 mt -126.65 124.46 65.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.103 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 628' ' ' LEU . . . . . 0.451 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 19.1 mt -102.25 129.89 48.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.842 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.6 166.09 16.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.221 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 630' ' ' GLY . . . . . 0.43 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -50.2 -22.23 4.78 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.832 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 8.1 p -68.5 -43.79 76.09 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -98.43 -25.05 14.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.524 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 633' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.48 154.7 63.01 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.262 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.556 ' HG2' HD12 ' A' ' 639' ' ' LEU . 72.0 Cg_endo -75.44 161.72 37.07 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.625 2.216 . . . . 0.0 112.382 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -81.66 158.85 24.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.411 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -53.1 -27.09 18.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.787 0.327 . . . . 0.0 111.417 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.68 -36.34 48.57 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.831 -0.699 . . . . 0.0 113.397 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -111.96 11.63 20.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.875 0.337 . . . . 0.0 111.908 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 639' ' ' LEU . . . . . 0.556 HD12 ' HG2' ' A' ' 634' ' ' PRO . 10.4 tp -62.18 -52.19 64.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.799 0.333 . . . . 0.0 111.084 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -53.24 -42.34 66.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.125 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.98 -39.06 76.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.883 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 642' ' ' TRP . . . . . 0.451 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 34.7 t90 -64.59 -46.91 80.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.677 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 643' ' ' LEU . . . . . 0.464 HD23 ' HA ' ' A' ' 643' ' ' LEU . 11.7 mt -63.83 -40.53 96.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.509 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -60.63 -41.01 94.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.568 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 1.2 ttt -78.03 -35.75 49.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.845 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 646' ' ' ASN . . . . . 0.43 ' HB2' ' CZ3' ' A' ' 642' ' ' TRP . 24.5 m-80 -109.88 81.32 1.99 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.79 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.45 147.85 71.98 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.563 2.176 . . . . 0.0 112.392 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.46 -14.15 50.8 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.738 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.502 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 17.1 m-85 -88.39 149.41 23.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.85 0.357 . . . . 0.0 111.009 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -136.22 145.76 46.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.641 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 651' ' ' VAL . . . . . 0.457 HG13 ' CG1' ' A' ' 617' ' ' VAL . 21.2 t . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.234 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 80.1 mt . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.842 0.353 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.31 145.68 24.24 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.71 2.274 . . . . 0.0 112.402 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 617' ' ' VAL . . . . . 0.51 ' CG1' HG13 ' A' ' 651' ' ' VAL . 21.3 t -118.84 119.88 62.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.086 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 618' ' ' LYS . . . . . 0.422 ' HG3' ' N ' ' A' ' 630' ' ' GLY . 0.0 OUTLIER -61.41 169.58 2.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.911 0.386 . . . . 0.0 110.985 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 619' ' ' VAL . . . . . 0.517 HG23 ' CD1' ' A' ' 649' ' ' TYR . 32.9 m -155.83 143.35 11.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.858 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.493 HD13 ' C ' ' A' ' 620' ' ' ILE . 0.0 OUTLIER -124.37 127.58 73.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.888 0.375 . . . . 0.0 111.132 -179.768 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 621' ' ' HIS . . . . . 0.492 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 3.6 t-160 -86.69 131.09 34.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.62 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.6 t -86.43 -29.69 6.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.851 0.357 . . . . 0.0 111.054 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -68.55 -37.38 79.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.49 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 8.7 p -111.96 -23.48 10.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.456 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 87.21 -10.52 68.5 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.921 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.4 141.99 53.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.797 0.332 . . . . 0.0 110.89 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 1.9 mt -121.08 129.39 75.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.307 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 628' ' ' LEU . . . . . 0.46 HD12 ' CG2' ' A' ' 619' ' ' VAL . 12.5 mt -95.68 139.64 31.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.777 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.84 165.91 16.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.497 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 630' ' ' GLY . . . . . 0.422 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -57.2 -18.38 27.77 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.92 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.63 -43.73 68.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.753 0.311 . . . . 0.0 111.446 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -98.19 -22.49 16.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.358 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.46 156.33 53.19 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.291 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.461 ' HG2' HD12 ' A' ' 639' ' ' LEU . 64.1 Cg_endo -72.42 163.82 37.45 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.735 2.29 . . . . 0.0 112.247 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -72.9 176.45 5.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.525 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -59.43 -48.49 81.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.46 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.47 -36.19 50.03 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.049 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -81.73 -9.85 59.53 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 639' ' ' LEU . . . . . 0.461 HD12 ' HG2' ' A' ' 634' ' ' PRO . 12.0 tp -62.18 -50.11 73.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.654 0.264 . . . . 0.0 111.077 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -52.41 -46.25 66.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.001 0.429 . . . . 0.0 111.17 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.48 -37.61 77.32 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.919 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 642' ' ' TRP . . . . . 0.442 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 44.2 t90 -65.31 -40.81 94.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.747 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 86.0 mt -67.59 -42.58 82.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.319 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.64 -40.45 87.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.414 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.22 -37.09 54.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.623 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -110.92 80.25 2.16 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.648 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.43 147.65 71.73 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.462 2.108 . . . . 0.0 112.454 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.45 -7.74 47.07 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.836 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.517 ' CD1' HG23 ' A' ' 619' ' ' VAL . 12.5 m-85 -93.47 157.55 16.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.897 0.379 . . . . 0.0 111.026 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 650' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 619' ' ' VAL . 18.7 mm-40 -149.4 151.67 34.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.26 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 651' ' ' VAL . . . . . 0.51 HG13 ' CG1' ' A' ' 617' ' ' VAL . 28.5 t . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 120.821 0.344 . . . . 0.0 111.259 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 39.3 mt . . . . . 0 CA--C 1.527 0.094 0 CA-C-O 120.67 0.272 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.05 155.99 47.45 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.604 2.203 . . . . 0.0 112.323 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 617' ' ' VAL . . . . . 0.612 ' CG1' HG13 ' A' ' 651' ' ' VAL . 27.9 t -118.69 121.06 66.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.06 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.53 134.97 39.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.965 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 619' ' ' VAL . . . . . 0.596 HG12 ' HA ' ' A' ' 651' ' ' VAL . 2.6 m -124.0 176.89 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.189 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 3.4 tt -143.0 133.12 22.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.509 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 621' ' ' HIS . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 3.3 t-160 -84.65 136.89 33.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.055 179.073 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 622' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 648' ' ' GLY . 27.0 t -84.65 -36.55 11.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.826 0.346 . . . . 0.0 111.21 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -68.56 -33.0 73.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.41 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.17 -23.24 12.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.55 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 77.36 4.55 84.4 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.683 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 9.0 tttt -76.57 148.38 37.06 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.76 0.314 . . . . 0.0 110.836 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 10.7 mt -122.28 105.54 16.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.363 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 628' ' ' LEU . . . . . 0.452 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 13.6 mt -80.1 130.99 35.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.322 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.53 166.03 16.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.384 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . -50.51 -22.59 5.59 Favored Glycine 0 CA--C 1.517 0.193 0 C-N-CA 120.81 -0.71 . . . . 0.0 113.005 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.16 -43.89 81.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.675 0.274 . . . . 0.0 111.586 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -98.18 -23.72 15.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.911 0.386 . . . . 0.0 111.489 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 633' ' ' ALA . . . . . 0.442 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.62 156.41 54.22 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.302 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.451 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 71.7 Cg_endo -75.11 163.79 34.41 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.878 2.385 . . . . 0.0 112.222 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -72.97 174.73 7.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.495 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -60.99 -44.21 97.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.852 0.358 . . . . 0.0 111.461 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.67 -36.22 49.0 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.214 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 6.1 mm100 -87.19 -7.36 58.02 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 639' ' ' LEU . . . . . 0.446 HD12 ' HG2' ' A' ' 634' ' ' PRO . 14.3 tp -59.62 -49.6 77.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.759 0.314 . . . . 0.0 111.197 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -52.42 -50.39 62.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.943 0.402 . . . . 0.0 111.281 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -66.58 -34.53 78.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.096 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 642' ' ' TRP . . . . . 0.451 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 49.5 t90 -66.73 -46.12 76.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.875 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 35.9 mt -62.76 -43.8 97.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.479 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.17 -38.83 87.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.562 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 6.8 tmm? -78.88 -24.85 43.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.005 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -123.39 77.8 53.84 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.826 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -64.81 144.68 84.28 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.705 2.27 . . . . 0.0 112.395 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 648' ' ' GLY . . . . . 0.456 ' O ' HG23 ' A' ' 622' ' ' VAL . . . 104.48 -3.41 43.04 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.965 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.479 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 7.7 m-85 -96.25 152.53 18.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.894 0.378 . . . . 0.0 110.976 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -147.81 147.2 29.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.847 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 651' ' ' VAL . . . . . 0.612 HG13 ' CG1' ' A' ' 617' ' ' VAL . 21.4 t . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.126 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 28.5 mt . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.722 0.296 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.19 136.87 20.57 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.548 2.166 . . . . 0.0 112.365 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 617' ' ' VAL . . . . . 0.49 ' O ' ' HB1' ' A' ' 633' ' ' ALA . 21.5 t -112.65 115.44 49.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.06 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 618' ' ' LYS . . . . . 0.49 ' O ' HG13 ' A' ' 619' ' ' VAL . 0.3 OUTLIER -60.76 173.2 0.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.967 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 619' ' ' VAL . . . . . 0.589 ' O ' HG23 ' A' ' 627' ' ' ILE . 5.7 m -157.81 159.31 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.237 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.403 HG12 ' CG1' ' A' ' 627' ' ' ILE . 0.0 OUTLIER -124.72 127.71 72.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.696 179.652 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 621' ' ' HIS . . . . . 0.519 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 3.6 t60 -88.77 127.59 35.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.746 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 26.9 t -88.36 -28.53 5.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.167 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -68.52 -37.29 79.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.232 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 1.6 t -114.52 -23.38 9.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.542 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 90.57 -12.61 67.91 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.74 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.31 143.61 53.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.844 0.355 . . . . 0.0 110.922 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 627' ' ' ILE . . . . . 0.589 HG23 ' O ' ' A' ' 619' ' ' VAL . 2.0 mt -120.36 127.09 75.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.21 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 628' ' ' LEU . . . . . 0.463 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 5.6 mt -93.75 133.77 36.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.814 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 629' ' ' THR . . . . . 0.608 ' OG1' HG22 ' A' ' 631' ' ' THR . 0.3 OUTLIER -85.85 166.28 16.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.327 179.758 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 630' ' ' GLY . . . . . 0.439 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -50.08 -23.59 5.78 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.977 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 631' ' ' THR . . . . . 0.608 HG22 ' OG1' ' A' ' 629' ' ' THR . 5.8 t -65.72 -43.4 89.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.703 0.287 . . . . 0.0 111.305 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.35 -20.58 17.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.359 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 633' ' ' ALA . . . . . 0.49 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.53 150.7 80.17 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.318 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.478 ' HG2' HD12 ' A' ' 639' ' ' LEU . 72.9 Cg_endo -75.27 163.81 34.05 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.753 2.302 . . . . 0.0 112.353 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 35.5 mttp -73.03 172.0 11.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.425 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -62.39 -38.09 88.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.862 0.363 . . . . 0.0 111.425 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.7 -36.22 48.83 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.237 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -94.38 -3.34 50.47 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 639' ' ' LEU . . . . . 0.478 HD12 ' HG2' ' A' ' 634' ' ' PRO . 13.6 tp -59.64 -50.54 73.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.728 0.299 . . . . 0.0 111.194 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -52.9 -44.52 67.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.219 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.82 -36.81 75.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.003 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 642' ' ' TRP . . . . . 0.434 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 35.1 t90 -67.23 -41.27 85.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.789 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 643' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 643' ' ' LEU . 16.4 mt -67.13 -43.56 82.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.479 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -60.78 -40.49 92.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.541 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.35 -37.28 57.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.797 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -107.84 81.76 1.26 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.818 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -68.39 147.43 71.48 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.616 2.211 . . . . 0.0 112.442 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.34 -20.59 39.63 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.578 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.519 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 23.8 m-85 -81.57 149.97 28.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.876 0.37 . . . . 0.0 111.115 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -142.49 155.62 45.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.62 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.18 179.998 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 615' ' ' LEU . . . . . 0.469 HD22 ' HD2' ' A' ' 616' ' ' PRO . 13.4 mt . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.675 0.274 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 616' ' ' PRO . . . . . 0.469 ' HD2' HD22 ' A' ' 615' ' ' LEU . 74.3 Cg_endo -75.36 140.0 24.01 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.606 2.204 . . . . 0.0 112.32 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 617' ' ' VAL . . . . . 0.473 ' O ' ' HB1' ' A' ' 633' ' ' ALA . 26.2 t -116.45 115.41 48.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.055 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 618' ' ' LYS . . . . . 0.471 ' HG3' ' N ' ' A' ' 630' ' ' GLY . 0.0 OUTLIER -61.51 170.79 1.71 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.923 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 619' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 650' ' ' GLU . 27.7 m -157.42 146.06 10.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.995 179.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.404 HG12 HG13 ' A' ' 627' ' ' ILE . 0.0 OUTLIER -124.43 127.63 73.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.943 0.402 . . . . 0.0 111.265 -179.754 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 621' ' ' HIS . . . . . 0.51 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 4.4 t-160 -83.96 131.79 34.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.675 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.5 t -87.8 -29.77 5.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.897 0.38 . . . . 0.0 111.051 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -68.43 -37.3 80.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.198 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 1.5 m -110.85 -23.48 10.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.405 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 85.58 -7.62 75.69 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.906 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -69.4 152.39 44.98 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.791 0.329 . . . . 0.0 110.824 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 627' ' ' ILE . . . . . 0.404 HG13 HG12 ' A' ' 620' ' ' ILE . 2.0 mt -127.64 138.66 54.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.213 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 26.4 mt -105.46 139.2 40.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.768 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.83 165.96 16.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.483 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 630' ' ' GLY . . . . . 0.471 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -56.48 -18.94 24.52 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.005 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 10.0 t -71.17 -43.55 67.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.685 0.278 . . . . 0.0 111.554 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.2 -21.39 16.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.342 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 633' ' ' ALA . . . . . 0.473 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.53 156.22 54.53 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.247 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.45 ' HG2' HD12 ' A' ' 639' ' ' LEU . 71.6 Cg_endo -73.88 163.79 36.15 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.631 2.221 . . . . 0.0 112.287 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 4.3 mtpp -73.04 176.4 5.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.595 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -60.7 -48.96 79.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.802 0.334 . . . . 0.0 111.286 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.72 -36.32 48.46 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.877 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.11 -11.84 59.72 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 639' ' ' LEU . . . . . 0.45 HD12 ' HG2' ' A' ' 634' ' ' PRO . 10.5 tp -57.71 -49.65 75.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.758 0.313 . . . . 0.0 111.143 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.73 -45.59 70.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.111 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.74 -37.72 76.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.872 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 642' ' ' TRP . . . . . 0.45 ' CZ3' ' HB2' ' A' ' 646' ' ' ASN . 34.9 t90 -64.83 -42.67 94.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.682 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 65.6 mt -66.33 -42.4 88.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.417 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.17 -41.1 87.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.459 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 4.1 mmt -77.55 -35.17 53.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.645 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 646' ' ' ASN . . . . . 0.45 ' HB2' ' CZ3' ' A' ' 642' ' ' TRP . 23.5 m-80 -113.17 79.75 3.87 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.779 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.33 145.96 67.44 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.608 2.205 . . . . 0.0 112.404 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.44 -6.24 45.43 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.832 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.526 ' CD1' HG23 ' A' ' 619' ' ' VAL . 11.4 m-85 -95.51 149.5 21.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.911 0.386 . . . . 0.0 111.021 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 650' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 619' ' ' VAL . 69.1 mt-10 -136.5 145.46 45.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.17 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 2.4 m . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 120.9 0.381 . . . . 0.0 111.491 -179.594 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 16.2 mt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.707 0.289 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.31 142.62 21.46 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.698 2.265 . . . . 0.0 112.442 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 617' ' ' VAL . . . . . 0.743 ' CG1' HG13 ' A' ' 651' ' ' VAL . 21.5 t -118.92 122.72 70.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.122 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 618' ' ' LYS . . . . . 0.412 ' HG3' ' N ' ' A' ' 630' ' ' GLY . 0.8 OUTLIER -65.11 171.17 3.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.759 179.883 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 619' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 650' ' ' GLU . 27.2 m -156.71 152.43 7.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.308 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.92 HD13 ' CG1' ' A' ' 627' ' ' ILE . 3.6 tp -124.88 127.45 72.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.647 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 621' ' ' HIS . . . . . 0.527 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 2.1 t60 -89.26 135.83 33.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.633 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 622' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 648' ' ' GLY . 25.8 t -87.12 -35.77 8.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.819 0.343 . . . . 0.0 111.287 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -68.59 -32.99 73.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.536 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 3.3 t -112.2 -23.36 10.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.592 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 78.97 0.29 81.55 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.906 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 626' ' ' LYS . . . . . 0.647 ' O ' HD12 ' A' ' 620' ' ' ILE . 5.6 ttmt -76.68 150.56 36.32 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.757 0.313 . . . . 0.0 110.929 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 627' ' ' ILE . . . . . 0.92 ' CG1' HD13 ' A' ' 620' ' ' ILE . 6.2 mt -119.32 119.38 60.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.199 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 628' ' ' LEU . . . . . 0.485 ' HB2' HG22 ' A' ' 619' ' ' VAL . 37.2 mt -87.13 135.82 33.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.745 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.52 166.03 16.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.407 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 630' ' ' GLY . . . . . 0.412 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -56.37 -17.73 19.54 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.646 -0.788 . . . . 0.0 113.004 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.55 -43.6 59.5 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.75 0.275 . . . . 0.0 111.681 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.15 -24.08 15.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.702 0.287 . . . . 0.0 111.461 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 633' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.44 154.3 64.77 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.171 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.609 ' HG2' HD12 ' A' ' 639' ' ' LEU . 72.7 Cg_endo -75.26 156.83 41.87 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.598 2.199 . . . . 0.0 112.414 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? -73.22 165.59 24.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.42 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -62.79 -29.14 70.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.81 0.338 . . . . 0.0 111.302 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.57 -36.35 49.11 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.308 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -106.69 4.72 28.1 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 639' ' ' LEU . . . . . 0.609 HD12 ' HG2' ' A' ' 634' ' ' PRO . 13.5 tp -57.26 -50.13 73.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.749 0.309 . . . . 0.0 111.079 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -52.88 -42.12 65.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.987 0.422 . . . . 0.0 110.961 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.85 -39.7 76.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.775 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 642' ' ' TRP . . . . . 0.433 ' CZ3' ' HB2' ' A' ' 646' ' ' ASN . 33.3 t90 -66.32 -36.53 83.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.554 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 46.7 mt -69.4 -41.76 76.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.296 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -61.24 -41.16 96.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.328 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 73.7 mtp -77.83 -32.06 51.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.623 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 646' ' ' ASN . . . . . 0.433 ' HB2' ' CZ3' ' A' ' 642' ' ' TRP . 28.2 m-80 -118.93 75.45 13.76 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.682 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.19 149.79 76.45 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.562 2.175 . . . . 0.0 112.442 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 648' ' ' GLY . . . . . 0.578 ' O ' HG23 ' A' ' 622' ' ' VAL . . . 104.39 -12.3 51.26 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.779 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.527 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 16.0 m-85 -87.8 159.3 18.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.89 0.376 . . . . 0.0 111.032 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 650' ' ' GLU . . . . . 0.514 ' O ' ' HA ' ' A' ' 619' ' ' VAL . 30.1 mt-10 -149.96 147.22 27.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.232 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 651' ' ' VAL . . . . . 0.743 HG13 ' CG1' ' A' ' 617' ' ' VAL . 31.3 t . . . . . 0 C--N 1.33 -0.273 0 CA-C-O 120.777 0.323 . . . . 0.0 111.272 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 8.9 mt . . . . . 0 CA--C 1.529 0.161 0 CA-C-O 120.613 0.244 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.29 149.48 27.94 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.612 2.208 . . . . 0.0 112.444 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 617' ' ' VAL . . . . . 0.526 ' CG1' HG13 ' A' ' 651' ' ' VAL . 21.4 t -118.87 130.54 73.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.112 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 618' ' ' LYS . . . . . 0.418 ' HG3' ' N ' ' A' ' 630' ' ' GLY . 0.0 OUTLIER -67.43 164.83 17.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.992 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 619' ' ' VAL . . . . . 0.613 HG23 ' CD1' ' A' ' 649' ' ' TYR . 33.5 m -156.19 144.07 11.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.97 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 649' ' ' TYR . 0.0 OUTLIER -124.24 127.66 73.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.889 0.376 . . . . 0.0 111.285 -179.813 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 621' ' ' HIS . . . . . 0.488 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 2.5 t-160 -85.46 133.52 34.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.601 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 20.5 t -86.62 -29.52 5.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.77 0.319 . . . . 0.0 111.133 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.53 -37.34 79.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.357 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 1.8 m -110.1 -23.36 11.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.355 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 82.5 5.83 89.16 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.006 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.63 151.99 36.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.755 0.312 . . . . 0.0 110.895 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 3.5 mt -127.4 114.47 36.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.221 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 628' ' ' LEU . . . . . 0.516 HD12 ' CG2' ' A' ' 619' ' ' VAL . 19.1 mt -86.76 134.46 33.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.808 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.81 166.09 16.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.496 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 630' ' ' GLY . . . . . 0.418 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -58.46 -15.36 24.18 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.176 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.51 -43.68 38.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.899 0.35 . . . . 0.0 111.742 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.94 -26.1 14.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.873 0.368 . . . . 0.0 111.371 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.51 156.03 55.54 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.215 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.431 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 52.2 Cg_endo -68.69 163.81 35.64 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.594 2.196 . . . . 0.0 112.195 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 26.9 mttp -72.85 171.47 12.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.473 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -62.63 -40.21 96.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.426 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.58 -36.25 49.34 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.099 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -91.21 -5.25 55.14 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 639' ' ' LEU . . . . . 0.423 HD12 ' HG2' ' A' ' 634' ' ' PRO . 15.3 tp -57.78 -50.76 72.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.714 0.292 . . . . 0.0 111.271 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.08 -44.0 61.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.913 0.387 . . . . 0.0 111.111 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -68.17 -39.16 82.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.977 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 642' ' ' TRP . . . . . 0.436 ' CD2' ' ND2' ' A' ' 646' ' ' ASN . 18.4 t90 -68.98 -34.0 74.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.851 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 17.4 mt -69.05 -47.5 65.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.481 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -61.31 -41.07 96.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.486 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 15.9 tpt -74.17 -33.87 63.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.583 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 646' ' ' ASN . . . . . 0.436 ' ND2' ' CD2' ' A' ' 642' ' ' TRP . 35.6 m-80 -114.47 74.23 3.02 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.647 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.81 147.09 89.41 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.613 2.208 . . . . 0.0 112.51 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.44 -4.12 43.61 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.893 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.613 ' CD1' HG23 ' A' ' 619' ' ' VAL . 8.9 m-85 -94.88 156.59 16.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.966 0.412 . . . . 0.0 111.109 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 650' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 619' ' ' VAL . 14.7 mm-40 -144.27 145.75 32.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.281 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 651' ' ' VAL . . . . . 0.526 HG13 ' CG1' ' A' ' 617' ' ' VAL . 24.3 t . . . . . 0 C--N 1.33 -0.262 0 CA-C-O 120.811 0.338 . . . . 0.0 111.32 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 62.3 mt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.766 0.317 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.82 149.08 53.39 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.562 2.175 . . . . 0.0 112.294 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 617' ' ' VAL . . . . . 0.417 ' O ' ' HB1' ' A' ' 633' ' ' ALA . 21.2 t -118.81 119.92 62.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.984 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 618' ' ' LYS . . . . . 0.486 ' O ' HG13 ' A' ' 619' ' ' VAL . 0.0 OUTLIER -55.41 172.01 0.16 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.924 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 619' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 618' ' ' LYS . 12.1 m -158.13 160.02 2.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.248 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.792 HD13 HG12 ' A' ' 627' ' ' ILE . 6.4 tp -124.41 127.67 73.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.784 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 621' ' ' HIS . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 7.2 t-160 -92.31 128.63 38.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.723 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.4 t -87.74 -28.61 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.859 0.361 . . . . 0.0 111.256 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.57 -37.15 79.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.388 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 70.1 m -113.99 -23.35 9.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.615 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 84.8 4.95 86.89 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.748 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 626' ' ' LYS . . . . . 0.653 ' O ' HD12 ' A' ' 620' ' ' ILE . 0.1 OUTLIER -76.58 156.84 32.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.863 0.363 . . . . 0.0 111.079 -179.937 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 627' ' ' ILE . . . . . 0.792 HG12 HD13 ' A' ' 620' ' ' ILE . 2.4 mt -125.35 115.29 43.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.054 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 628' ' ' LEU . . . . . 0.451 ' CD1' ' CE1' ' A' ' 649' ' ' TYR . 28.4 mt -90.04 130.33 36.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.822 0.344 . . . . 0.0 110.875 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.78 166.22 16.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.12 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 630' ' ' GLY . . . . . 0.435 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -50.67 -21.25 4.65 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.87 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 4.3 m -69.85 -43.65 71.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.648 0.261 . . . . 0.0 111.658 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -98.34 -23.47 15.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.778 0.323 . . . . 0.0 111.528 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 633' ' ' ALA . . . . . 0.417 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.44 156.24 53.59 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.244 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.437 ' HB3' ' CD1' ' A' ' 642' ' ' TRP . 73.0 Cg_endo -75.18 163.72 34.4 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.735 2.29 . . . . 0.0 112.325 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 26.9 mttt -73.01 176.37 5.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.535 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -61.55 -48.94 78.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.849 0.357 . . . . 0.0 111.234 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.69 -36.22 48.89 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.745 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -80.0 -12.49 59.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.563 0.22 . . . . 0.0 111.55 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 639' ' ' LEU . . . . . . . . . . . . . 11.6 tp -56.16 -47.85 77.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.786 0.327 . . . . 0.0 111.154 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -53.49 -51.32 63.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.978 0.418 . . . . 0.0 111.038 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -67.82 -34.52 76.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.012 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 642' ' ' TRP . . . . . 0.437 ' CD1' ' HB3' ' A' ' 634' ' ' PRO . 30.0 t90 -67.65 -38.56 84.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.744 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.46 -43.34 73.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.433 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -61.1 -39.49 90.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.521 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 2.4 ttp -78.73 -35.71 44.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.806 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -110.49 78.34 1.45 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.943 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.39 146.65 69.42 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.531 2.154 . . . . 0.0 112.355 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.34 -12.53 51.5 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.783 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 15.9 m-85 -88.37 161.71 16.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.899 0.381 . . . . 0.0 111.042 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -148.4 145.81 28.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.698 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.282 -179.945 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.8 0.333 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -103.42 159.13 15.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.869 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 3.5 mtt -57.99 -30.9 66.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.034 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 613' ' ' SER . . . . . 0.459 ' HA ' ' HB3' ' A' ' 636' ' ' ALA . 1.4 m -63.31 -24.65 67.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.986 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.22 -27.83 19.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.088 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 18.0 mt -81.45 147.09 58.98 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.966 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.77 150.81 39.9 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.586 2.191 . . . . 0.0 112.368 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 617' ' ' VAL . . . . . 0.439 ' O ' ' HB1' ' A' ' 633' ' ' ALA . 21.4 t -118.83 128.53 75.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.106 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 618' ' ' LYS . . . . . 0.671 ' HB2' ' HB3' ' A' ' 652' ' ' ALA . 0.0 OUTLIER -66.35 170.47 5.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.857 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 619' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 618' ' ' LYS . 16.2 m -157.79 157.26 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.149 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.937 HD13 HG12 ' A' ' 627' ' ' ILE . 3.9 tp -124.59 127.64 73.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.724 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 621' ' ' HIS . . . . . 0.517 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 18.0 t-160 -91.01 132.91 35.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.552 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 622' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 648' ' ' GLY . 23.4 t -87.4 -34.07 7.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.811 0.339 . . . . 0.0 111.231 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -33.82 74.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.348 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 44.2 t -111.51 -23.45 10.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.521 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 80.45 -0.58 84.68 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.508 -0.854 . . . . 0.0 112.828 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 626' ' ' LYS . . . . . 0.578 ' O ' HD12 ' A' ' 620' ' ' ILE . 7.2 tptp -76.59 149.2 36.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.819 0.343 . . . . 0.0 111.026 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 627' ' ' ILE . . . . . 0.937 HG12 HD13 ' A' ' 620' ' ' ILE . 5.7 mt -116.87 114.87 47.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.977 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 628' ' ' LEU . . . . . 0.463 HD12 ' CE2' ' A' ' 649' ' ' TYR . 41.2 mt -84.71 128.39 34.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.808 0.337 . . . . 0.0 111.01 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.72 166.2 16.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.206 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 630' ' ' GLY . . . . . 0.429 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -50.63 -21.18 4.54 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.873 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 19.2 p -71.17 -43.66 67.05 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -98.3 -29.34 13.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.759 0.314 . . . . 0.0 111.56 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 633' ' ' ALA . . . . . 0.439 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.36 156.36 52.07 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.286 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.611 ' HG2' HD12 ' A' ' 639' ' ' LEU . 71.2 Cg_endo -73.37 163.6 37.35 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.727 2.285 . . . . 0.0 112.326 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -73.05 164.39 26.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.314 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 636' ' ' ALA . . . . . 0.459 ' HB3' ' HA ' ' A' ' 613' ' ' SER . . . -62.76 -31.57 72.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.85 0.357 . . . . 0.0 111.309 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.71 -36.23 48.75 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.371 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -104.01 3.33 33.27 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 639' ' ' LEU . . . . . 0.611 HD12 ' HG2' ' A' ' 634' ' ' PRO . 13.6 tp -58.36 -46.95 85.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.779 0.323 . . . . 0.0 111.121 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.17 -44.81 68.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.975 0.417 . . . . 0.0 111.132 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.79 -36.92 76.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.196 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 642' ' ' TRP . . . . . 0.454 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 47.6 t90 -66.67 -44.92 80.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 44.9 mt -65.91 -40.86 91.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.525 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.65 -40.87 96.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.647 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.1 -38.1 52.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.805 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -107.13 82.27 1.12 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.745 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.4 150.43 75.83 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.551 2.167 . . . . 0.0 112.447 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 648' ' ' GLY . . . . . 0.456 ' O ' HG23 ' A' ' 622' ' ' VAL . . . 104.45 -12.96 51.29 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.808 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.517 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 18.0 m-85 -90.03 160.94 16.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.829 0.347 . . . . 0.0 110.977 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -149.87 145.95 26.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.715 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.4 t -56.2 126.91 14.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.204 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 652' ' ' ALA . . . . . 0.671 ' HB3' ' HB2' ' A' ' 618' ' ' LYS . . . -86.86 156.88 55.22 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.1 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 653' ' ' PRO . . . . . 0.406 ' HD2' ' HB1' ' A' ' 652' ' ' ALA . 52.3 Cg_endo -69.41 157.41 61.18 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.536 2.157 . . . . 0.0 112.37 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -83.8 -173.26 4.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.924 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 1.1 m -118.53 31.8 6.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.921 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -80.66 -72.36 0.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.909 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 74.7 m 60.39 167.59 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.904 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.787 0.327 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -103.84 121.44 43.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 16.5 ptm -69.22 -41.47 77.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.924 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 613' ' ' SER . . . . . . . . . . . . . 91.0 p -58.46 -25.17 61.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.997 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.99 -27.91 43.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.014 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 16.1 mt -71.46 146.32 91.48 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.945 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -74.21 155.96 46.69 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.597 2.198 . . . . 0.0 112.25 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 617' ' ' VAL . . . . . 0.502 ' O ' ' HB1' ' A' ' 633' ' ' ALA . 21.4 t -117.47 133.33 64.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.131 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 618' ' ' LYS . . . . . 0.601 ' CB ' ' HB3' ' A' ' 652' ' ' ALA . 0.0 OUTLIER -66.85 169.97 7.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.945 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 619' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 650' ' ' GLU . 26.8 m -157.14 162.88 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.82 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.21 128.04 12.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.987 0.422 . . . . 0.0 111.619 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 621' ' ' HIS . . . . . 0.494 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 3.6 t-160 -83.17 133.46 35.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.458 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.5 t -85.82 -23.67 6.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.754 0.311 . . . . 0.0 111.38 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -68.54 -37.41 79.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.494 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 49.0 m -117.17 -23.47 7.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.585 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 87.72 8.98 72.44 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.952 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.56 142.9 40.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.758 0.313 . . . . 0.0 110.807 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 1.9 mt -119.53 120.86 64.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.32 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 23.3 mt -90.43 138.18 31.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.752 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.61 165.89 16.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.554 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 630' ' ' GLY . . . . . 0.415 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -55.94 -18.63 19.33 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.766 -0.73 . . . . 0.0 113.068 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 2.5 m -71.75 -43.54 65.62 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.793 0.297 . . . . 0.0 111.524 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -98.18 -22.79 16.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.429 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 633' ' ' ALA . . . . . 0.502 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.55 156.26 54.46 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.169 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.584 ' HG2' HD12 ' A' ' 639' ' ' LEU . 71.7 Cg_endo -75.39 156.54 41.3 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.624 2.216 . . . . 0.0 112.313 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -73.95 168.02 20.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.487 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -62.86 -29.91 71.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.827 0.346 . . . . 0.0 111.249 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.64 -36.36 48.72 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.346 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.99 4.42 29.39 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 639' ' ' LEU . . . . . 0.584 HD12 ' HG2' ' A' ' 634' ' ' PRO . 16.4 tp -57.16 -52.32 65.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.697 0.284 . . . . 0.0 111.093 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -52.78 -43.7 66.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.969 0.414 . . . . 0.0 111.078 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.26 -36.25 76.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.924 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 642' ' ' TRP . . . . . 0.449 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 53.5 t90 -66.78 -49.64 65.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.68 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 82.1 mt -60.82 -42.11 97.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.488 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -61.06 -40.9 95.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.59 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.73 -25.68 49.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.993 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -121.87 78.98 40.82 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.773 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.1 144.12 86.3 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.717 2.278 . . . . 0.0 112.482 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.53 -7.58 46.58 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.841 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.494 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 12.2 m-85 -96.36 151.57 19.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.016 0.436 . . . . 0.0 111.105 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 650' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 619' ' ' VAL . 19.2 pt-20 -146.4 145.79 30.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.119 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 2.8 m -54.34 130.84 16.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.802 0.334 . . . . 0.0 111.487 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 652' ' ' ALA . . . . . 0.601 ' HB3' ' CB ' ' A' ' 618' ' ' LYS . . . -93.11 104.65 12.52 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.1 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -68.88 158.97 55.75 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.468 2.112 . . . . 0.0 112.3 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -134.26 138.9 45.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.86 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 4.9 m -100.79 34.9 2.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.916 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -136.09 142.83 44.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.932 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 45.6 m -153.59 -51.55 0.1 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.867 179.977 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 3.7 t . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.793 0.33 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -72.69 -45.51 58.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.87 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -84.94 -26.73 27.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.07 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 613' ' ' SER . . . . . . . . . . . . . 64.7 m -56.29 -27.15 54.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.195 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.05 17.9 11.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.2 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 87.2 mt -105.42 153.23 39.88 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.868 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.35 143.55 39.35 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.59 2.193 . . . . 0.0 112.446 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 617' ' ' VAL . . . . . 0.408 ' O ' ' HB1' ' A' ' 633' ' ' ALA . 21.6 t -118.89 115.32 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.007 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 618' ' ' LYS . . . . . 0.695 ' HG2' ' HB3' ' A' ' 652' ' ' ALA . 0.0 OUTLIER -63.88 144.24 57.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.649 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 7.3 m -118.75 162.98 16.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.099 0.476 . . . . 0.0 111.544 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.429 ' CD1' HG12 ' A' ' 627' ' ' ILE . 4.9 tp -124.31 127.69 73.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.454 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 621' ' ' HIS . . . . . 0.498 ' HB2' ' CE1' ' A' ' 649' ' ' TYR . 6.3 t-160 -96.78 119.29 34.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.661 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.3 t -88.39 -33.62 6.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.281 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.42 -34.92 76.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.172 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 3.6 m -110.85 -23.39 11.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.336 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 85.76 -6.04 81.91 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.85 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.29 155.47 40.36 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.823 0.344 . . . . 0.0 110.788 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 627' ' ' ILE . . . . . 0.429 HG12 ' CD1' ' A' ' 620' ' ' ILE . 12.1 mt -126.75 121.27 58.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.293 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 628' ' ' LEU . . . . . 0.465 ' CD1' ' CE1' ' A' ' 649' ' ' TYR . 16.4 mt -103.06 124.93 49.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.425 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 629' ' ' THR . . . . . 0.408 ' HA ' ' CB ' ' A' ' 618' ' ' LYS . 0.4 OUTLIER -85.45 166.08 16.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.187 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . -46.84 -25.14 2.19 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.963 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 14.0 p -65.45 -43.96 88.76 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.616 0.246 . . . . 0.0 111.625 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -98.55 -24.24 15.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.874 0.369 . . . . 0.0 111.58 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 633' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.54 156.27 54.29 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.451 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.499 ' HG2' HD12 ' A' ' 639' ' ' LEU . 72.7 Cg_endo -75.25 163.95 33.82 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.82 2.347 . . . . 0.0 112.303 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -72.96 176.43 5.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.471 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -58.95 -48.92 79.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.405 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.67 -36.19 49.08 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.037 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -81.5 -9.8 59.62 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.645 0.239 . . . . 0.0 111.645 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 639' ' ' LEU . . . . . 0.499 HD12 ' HG2' ' A' ' 634' ' ' PRO . 13.1 tp -58.88 -53.35 59.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.713 0.292 . . . . 0.0 111.162 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -52.19 -49.33 64.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.944 0.402 . . . . 0.0 111.068 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -66.78 -35.88 81.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.891 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 642' ' ' TRP . . . . . 0.438 ' CZ3' ' HB2' ' A' ' 646' ' ' ASN . 27.9 t90 -66.85 -38.77 87.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.661 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 12.0 mt -68.33 -42.12 79.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.467 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.65 -41.01 96.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.469 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 3.3 tpp -77.73 -33.23 53.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.797 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 646' ' ' ASN . . . . . 0.438 ' HB2' ' CZ3' ' A' ' 642' ' ' TRP . 10.4 m-80 -115.28 79.28 6.59 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.755 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.46 148.59 73.48 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.569 2.179 . . . . 0.0 112.47 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.41 -8.77 48.55 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.789 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.498 ' CE1' ' HB2' ' A' ' 621' ' ' HIS . 17.7 m-85 -94.91 161.74 14.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.96 0.409 . . . . 0.0 111.168 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -149.86 168.09 24.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.753 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 29.2 t -74.53 118.21 19.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.975 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 652' ' ' ALA . . . . . 0.695 ' HB3' ' HG2' ' A' ' 618' ' ' LYS . . . -81.53 139.72 47.86 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.086 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.66 159.01 39.38 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.548 2.165 . . . . 0.0 112.353 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -63.13 129.44 40.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.837 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.03 -32.39 10.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.933 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.59 -31.46 26.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.855 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 20.9 m -75.91 129.03 36.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.886 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.883 -179.988 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.839 0.352 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -163.33 164.69 24.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.897 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 612' ' ' MET . . . . . 0.68 ' HA ' HD12 ' A' ' 615' ' ' LEU . 22.4 mtt -82.25 -31.65 30.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.922 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 613' ' ' SER . . . . . 0.449 ' O ' ' HB3' ' A' ' 636' ' ' ALA . 1.3 m -67.97 -27.24 66.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.012 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.94 -27.85 55.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.097 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 615' ' ' LEU . . . . . 0.68 HD12 ' HA ' ' A' ' 612' ' ' MET . 5.6 mt -79.62 148.15 68.89 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.897 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.18 140.92 31.65 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.525 2.15 . . . . 0.0 112.317 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.5 t -111.42 119.61 60.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.098 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 618' ' ' LYS . . . . . 0.762 ' HB2' ' HB3' ' A' ' 652' ' ' ALA . 0.0 OUTLIER -58.85 174.49 0.34 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 619' ' ' VAL . . . . . 0.468 HG13 ' O ' ' A' ' 618' ' ' LYS . 16.2 m -157.87 155.85 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.135 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.942 HD13 HG12 ' A' ' 627' ' ' ILE . 4.9 tp -124.5 127.61 73.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.771 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 621' ' ' HIS . . . . . 0.51 ' CG ' ' CE1' ' A' ' 649' ' ' TYR . 1.6 t60 -89.91 133.28 34.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.723 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 622' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 648' ' ' GLY . 26.1 t -87.12 -29.45 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.366 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -68.46 -37.16 79.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.374 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.18 -23.32 10.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.427 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 82.45 3.31 90.58 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.697 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 626' ' ' LYS . . . . . 0.814 ' O ' HD12 ' A' ' 620' ' ' ILE . 3.5 mtmt -76.7 151.14 36.21 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.81 0.338 . . . . 0.0 111.027 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 627' ' ' ILE . . . . . 0.942 HG12 HD13 ' A' ' 620' ' ' ILE . 7.1 mt -117.08 111.05 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.019 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 628' ' ' LEU . . . . . 0.506 HD12 ' CE2' ' A' ' 649' ' ' TYR . 75.4 mt -81.41 133.59 35.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.848 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.74 166.05 16.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.196 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 630' ' ' GLY . . . . . 0.427 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -50.27 -21.34 4.16 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.771 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 1.1 m -69.79 -43.48 72.02 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.06 -30.73 12.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.819 0.342 . . . . 0.0 111.465 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.41 156.35 52.59 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.187 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.685 ' HG2' HD12 ' A' ' 639' ' ' LEU . 73.0 Cg_endo -75.18 162.92 35.91 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.713 2.275 . . . . 0.0 112.451 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 43.0 mttm -85.44 157.04 20.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.571 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 636' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 613' ' ' SER . . . -53.04 -26.87 17.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.499 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -73.97 -36.29 52.34 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.395 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -116.02 14.23 16.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.025 0.413 . . . . 0.0 111.872 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 639' ' ' LEU . . . . . 0.685 HD12 ' HG2' ' A' ' 634' ' ' PRO . 10.9 tp -59.59 -51.61 69.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.796 0.331 . . . . 0.0 111.108 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -52.98 -43.28 66.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.99 0.424 . . . . 0.0 111.106 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.94 -38.93 76.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.806 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 642' ' ' TRP . . . . . 0.439 ' CZ3' ' HB2' ' A' ' 646' ' ' ASN . 37.7 t90 -64.69 -42.46 95.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.699 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 90.4 mt -66.61 -40.97 89.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.35 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -60.11 -41.04 91.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.494 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 18.4 ttt -77.47 -36.25 53.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.562 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 646' ' ' ASN . . . . . 0.439 ' HB2' ' CZ3' ' A' ' 642' ' ' TRP . 20.9 m-80 -112.38 78.01 2.45 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.584 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.81 149.03 83.43 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.609 2.206 . . . . 0.0 112.451 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 648' ' ' GLY . . . . . 0.612 ' O ' HG23 ' A' ' 622' ' ' VAL . . . 104.46 -18.89 43.78 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.615 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.51 ' CE1' ' CG ' ' A' ' 621' ' ' HIS . 21.3 m-85 -83.41 157.97 22.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.837 0.351 . . . . 0.0 111.005 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -148.61 145.9 27.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.563 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 2.7 m -54.51 126.66 11.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.407 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 652' ' ' ALA . . . . . 0.762 ' HB3' ' HB2' ' A' ' 618' ' ' LYS . . . -77.34 155.51 81.79 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.094 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.42 158.93 52.99 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.556 2.171 . . . . 0.0 112.309 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -83.53 171.92 12.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.924 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 10.3 t -99.15 31.58 3.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.917 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 13.2 p30 -114.73 -178.3 3.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.903 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.09 124.89 0.53 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.873 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.822 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 59.2 p . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.796 0.331 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -74.22 133.4 42.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.803 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.97 -32.96 39.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.969 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 613' ' ' SER . . . . . . . . . . . . . 13.2 m -59.88 -27.68 66.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.034 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -77.01 -26.97 54.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.065 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 10.8 mt -73.72 144.99 83.85 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.935 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.26 153.13 31.33 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.597 2.198 . . . . 0.0 112.425 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.7 t -118.85 122.63 69.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.065 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 618' ' ' LYS . . . . . 0.691 ' HB2' ' HB3' ' A' ' 652' ' ' ALA . 0.1 OUTLIER -63.63 176.42 0.88 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.874 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 619' ' ' VAL . . . . . 0.537 HG13 ' O ' ' A' ' 618' ' ' LYS . 5.9 m -159.23 158.02 2.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.246 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.819 HD13 HG12 ' A' ' 627' ' ' ILE . 5.0 tp -124.57 127.55 72.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.686 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 621' ' ' HIS . . . . . 0.517 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 7.6 t-160 -89.82 127.46 35.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.734 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.6 t -88.47 -39.27 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 0.0 111.05 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -68.5 -29.97 68.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.388 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 1.7 t -112.83 -23.44 10.13 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.573 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 79.4 -0.0 82.08 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.825 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -76.44 156.83 32.77 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.812 0.339 . . . . 0.0 110.887 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 627' ' ' ILE . . . . . 0.819 HG12 HD13 ' A' ' 620' ' ' ILE . 2.8 mt -128.39 126.58 65.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.238 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 628' ' ' LEU . . . . . 0.462 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 11.5 mt -103.45 130.71 50.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.654 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.69 166.08 16.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.254 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 630' ' ' GLY . . . . . 0.409 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -53.59 -19.05 8.58 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.031 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 23.0 m -71.78 -43.81 65.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.681 0.277 . . . . 0.0 111.693 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -98.26 -23.18 15.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.857 0.361 . . . . 0.0 111.518 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.41 156.36 52.56 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.353 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.512 ' HG2' HD12 ' A' ' 639' ' ' LEU . 61.0 Cg_endo -71.68 163.96 37.25 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.764 2.31 . . . . 0.0 112.188 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -72.88 176.45 5.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.448 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -59.79 -49.01 79.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.792 0.33 . . . . 0.0 111.383 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.72 -36.22 48.71 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.01 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -81.16 -10.52 59.62 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 639' ' ' LEU . . . . . 0.512 HD12 ' HG2' ' A' ' 634' ' ' PRO . 10.9 tp -59.24 -50.71 72.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.774 0.321 . . . . 0.0 111.181 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -53.1 -45.63 68.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.299 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.77 -37.19 76.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.921 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 642' ' ' TRP . . . . . 0.444 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 51.8 t90 -64.28 -54.6 30.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.794 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 67.7 mt -58.53 -43.09 89.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.615 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -59.57 -38.13 80.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.614 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.03 -25.55 37.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.955 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -122.15 78.08 42.83 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.93 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.56 151.7 78.32 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.711 2.274 . . . . 0.0 112.313 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.41 -17.1 47.77 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.823 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.517 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 23.6 m-85 -89.54 152.25 21.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.907 0.384 . . . . 0.0 111.049 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -144.04 153.49 42.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.636 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.6 t -54.57 125.93 10.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.251 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 652' ' ' ALA . . . . . 0.691 ' HB3' ' HB2' ' A' ' 618' ' ' LYS . . . -75.99 118.59 72.26 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.182 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.81 159.02 7.56 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.425 2.083 . . . . 0.0 112.263 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 -91.69 137.18 32.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.851 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 47.7 m -98.46 31.32 2.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.905 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -152.68 -175.0 5.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.51 -50.8 0.37 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.871 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.952 179.965 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.849 0.357 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -157.32 30.58 0.29 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -77.38 -38.36 50.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.956 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 613' ' ' SER . . . . . 0.759 ' O ' ' HB3' ' A' ' 636' ' ' ALA . 92.8 p -64.38 -21.53 66.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.001 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -86.0 -27.91 24.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.016 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 25.4 mt -79.31 156.05 76.43 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.949 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 616' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 635' ' ' LYS . 70.3 Cg_endo -74.69 148.1 36.33 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.604 2.203 . . . . 0.0 112.627 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.4 t -118.97 115.29 47.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.811 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 618' ' ' LYS . . . . . 0.432 ' HG2' ' HB3' ' A' ' 652' ' ' ALA . 0.0 OUTLIER -64.66 143.36 57.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.953 -179.891 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 2.5 m -127.05 165.72 25.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.336 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.55 HD13 ' C ' ' A' ' 620' ' ' ILE . 0.0 OUTLIER -127.26 127.46 69.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.669 179.582 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 621' ' ' HIS . . . . . 0.462 ' ND1' ' CE2' ' A' ' 649' ' ' TYR . 5.9 t-160 -91.87 125.87 36.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.941 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 26.1 t -86.82 -31.1 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.264 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 623' ' ' GLU . . . . . 0.4 ' HB2' ' NE2' ' A' ' 621' ' ' HIS . 36.2 mt-10 -68.12 -37.3 80.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.106 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 21.1 t -105.75 -23.58 12.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.219 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 88.21 -15.37 56.39 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.922 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 10.0 mtpp -70.25 156.83 38.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.687 0.279 . . . . 0.0 110.918 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 2.0 mp -128.55 115.39 37.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.061 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 628' ' ' LEU . . . . . 0.499 HD12 ' CE1' ' A' ' 649' ' ' TYR . 15.8 mt -85.06 130.18 34.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.906 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 629' ' ' THR . . . . . 0.445 ' OG1' HG23 ' A' ' 631' ' ' THR . 0.7 OUTLIER -85.7 166.05 16.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.184 179.646 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 630' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' A' ' 616' ' ' PRO . . . -48.49 -24.05 3.58 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.838 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 631' ' ' THR . . . . . 0.445 HG23 ' OG1' ' A' ' 629' ' ' THR . 8.5 p -65.34 -43.98 89.21 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.51 -34.11 10.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.902 0.382 . . . . 0.0 111.642 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.38 156.12 53.72 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.712 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.697 ' HG2' HD12 ' A' ' 639' ' ' LEU . 89.5 Cg_endo -75.32 163.76 34.04 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.957 2.438 . . . . 0.0 112.556 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 635' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 616' ' ' PRO . 0.0 OUTLIER -92.06 166.1 12.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.511 179.362 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 636' ' ' ALA . . . . . 0.759 ' HB3' ' O ' ' A' ' 613' ' ' SER . . . -52.94 -26.89 16.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.588 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -67.17 -36.25 89.82 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.416 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.33 17.57 7.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 117.014 0.407 . . . . 0.0 111.854 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 639' ' ' LEU . . . . . 0.697 HD12 ' HG2' ' A' ' 634' ' ' PRO . 13.9 tp -64.71 -54.58 29.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.779 0.323 . . . . 0.0 111.23 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -52.26 -43.42 64.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.182 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -67.97 -37.53 81.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.848 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 642' ' ' TRP . . . . . 0.483 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 28.0 t90 -66.81 -48.79 67.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.864 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 36.1 mt -60.18 -41.19 92.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.591 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.15 -40.98 99.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.581 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 28.8 ttp -79.49 -18.74 51.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.175 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 646' ' ' ASN . . . . . 0.43 ' HB2' ' CZ3' ' A' ' 642' ' ' TRP . 27.7 m-80 -129.56 68.36 80.3 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.866 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -56.84 154.33 32.7 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.539 2.16 . . . . 0.0 112.328 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.29 -16.77 48.79 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.706 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.499 ' CE1' HD12 ' A' ' 628' ' ' LEU . 25.0 m-85 -88.13 161.17 17.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.819 0.343 . . . . 0.0 111.125 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -149.74 157.85 43.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.788 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.4 t -59.47 123.07 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.158 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 652' ' ' ALA . . . . . 0.432 ' HB3' ' HG2' ' A' ' 618' ' ' LYS . . . -96.89 116.17 65.97 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.0 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.59 158.97 54.31 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.432 2.088 . . . . 0.0 112.3 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.17 133.53 48.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.934 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.08 -33.55 17.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.814 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.78 86.8 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.978 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.98 -65.14 0.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.909 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.916 179.995 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.805 0.335 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.81 136.74 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.922 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -60.22 -24.85 65.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.075 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 613' ' ' SER . . . . . 0.627 ' O ' ' HB3' ' A' ' 636' ' ' ALA . 17.3 p -54.91 -26.41 35.79 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.158 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -93.33 -27.89 16.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.997 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 16.3 mt -76.61 146.44 76.84 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.895 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.94 151.12 39.43 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.597 2.198 . . . . 0.0 112.374 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.93 119.13 60.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.155 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 618' ' ' LYS . . . . . 0.539 ' HG2' ' HB3' ' A' ' 652' ' ' ALA . 0.0 OUTLIER -63.92 146.04 54.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.762 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 4.1 m -122.68 164.51 19.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.392 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.667 HD13 HG12 ' A' ' 627' ' ' ILE . 5.9 tp -124.46 127.64 73.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.573 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 621' ' ' HIS . . . . . 0.491 ' HB2' ' CE1' ' A' ' 649' ' ' TYR . 2.1 t60 -95.5 118.82 32.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.78 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 19.2 t -89.18 -28.19 5.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.227 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -61.72 -37.37 83.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.108 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 61.3 m -119.17 -23.39 6.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.412 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 95.29 -3.29 66.25 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.837 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.33 147.07 51.61 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.811 0.339 . . . . 0.0 110.745 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 627' ' ' ILE . . . . . 0.667 HG12 HD13 ' A' ' 620' ' ' ILE . 1.6 mp -120.84 118.91 57.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.323 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 628' ' ' LEU . . . . . 0.516 HD12 ' CE1' ' A' ' 649' ' ' TYR . 27.2 mt -97.56 127.29 43.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.476 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.5 166.04 16.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.251 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . -49.2 -22.15 3.17 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.074 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 1.2 m -68.55 -43.98 75.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -98.42 -25.99 14.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.907 0.384 . . . . 0.0 111.47 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 633' ' ' ALA . . . . . 0.42 ' HB1' ' HD2' ' A' ' 634' ' ' PRO . . . -61.49 156.59 51.93 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.389 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.513 ' HG2' HD12 ' A' ' 639' ' ' LEU . 58.0 Cg_endo -69.45 163.85 36.45 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.884 2.389 . . . . 0.0 112.189 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 25.4 mttp -72.92 174.19 8.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.454 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 636' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 613' ' ' SER . . . -60.37 -48.94 79.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.381 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.83 -36.24 48.16 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.0 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -82.38 -9.62 59.38 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 639' ' ' LEU . . . . . 0.513 HD12 ' HG2' ' A' ' 634' ' ' PRO . 11.4 tp -57.35 -45.66 84.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.774 0.321 . . . . 0.0 111.197 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.27 -49.77 68.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.995 0.426 . . . . 0.0 111.309 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -68.92 -34.48 75.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.176 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 642' ' ' TRP . . . . . 0.427 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 49.7 t90 -67.03 -44.43 80.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.826 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 83.2 mt -65.47 -44.4 87.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.387 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -60.78 -37.19 81.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.523 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 6.3 mtt -80.97 -26.27 36.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.008 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -122.34 78.3 44.74 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.976 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -64.28 150.14 88.87 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.72 2.28 . . . . 0.0 112.388 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.38 -15.85 49.64 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.789 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.516 ' CE1' HD12 ' A' ' 628' ' ' LEU . 22.5 m-85 -88.55 161.77 16.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.918 0.39 . . . . 0.0 111.116 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -148.64 145.91 27.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.765 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.4 t -60.17 124.06 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.226 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 652' ' ' ALA . . . . . 0.539 ' HB3' ' HG2' ' A' ' 618' ' ' LYS . . . -98.83 114.23 65.24 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.009 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -51.98 158.52 4.76 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.47 2.113 . . . . 0.0 112.305 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.01 -179.44 0.74 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.964 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 24.3 m -107.6 -32.77 7.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.979 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -134.7 109.69 8.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.882 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 37.8 t -137.17 177.01 8.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.915 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.852 179.984 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 62.8 m . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.833 0.349 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -157.38 31.77 0.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 2.8 mtt -73.73 -40.34 63.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.935 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 613' ' ' SER . . . . . 0.436 ' O ' ' HB3' ' A' ' 636' ' ' ALA . 8.6 t -64.26 -29.19 70.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.957 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.49 -27.88 41.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.043 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 19.7 mt -88.83 152.68 49.07 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.005 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.53 152.4 65.28 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.609 2.206 . . . . 0.0 112.319 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 617' ' ' VAL . . . . . 0.442 ' O ' ' HB1' ' A' ' 633' ' ' ALA . 21.5 t -118.81 131.47 71.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.13 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 618' ' ' LYS . . . . . 0.669 ' HB2' ' HB3' ' A' ' 652' ' ' ALA . 0.0 OUTLIER -70.16 172.8 7.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.88 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 619' ' ' VAL . . . . . 0.53 HG13 ' O ' ' A' ' 618' ' ' LYS . 6.2 m -159.17 162.97 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.171 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.893 HD13 ' CG1' ' A' ' 627' ' ' ILE . 4.7 tp -129.13 127.51 65.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.744 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 621' ' ' HIS . . . . . 0.504 ' CG ' ' CE1' ' A' ' 649' ' ' TYR . 8.1 t-160 -91.19 134.35 34.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.72 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 622' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 648' ' ' GLY . 25.5 t -87.39 -31.12 5.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.895 0.379 . . . . 0.0 111.108 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -68.6 -36.9 79.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.353 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 1.3 m -111.36 -23.27 10.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.645 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 81.43 1.69 90.19 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.817 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 626' ' ' LYS . . . . . 0.762 ' O ' HD12 ' A' ' 620' ' ' ILE . 0.0 OUTLIER -76.69 153.62 34.96 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.863 0.364 . . . . 0.0 110.958 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 627' ' ' ILE . . . . . 0.893 ' CG1' HD13 ' A' ' 620' ' ' ILE . 3.9 mt -120.67 109.26 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.096 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 628' ' ' LEU . . . . . 0.451 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 30.4 mt -78.33 129.86 35.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.817 0.341 . . . . 0.0 110.66 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.7 166.06 16.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.193 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . -52.38 -19.04 5.58 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.9 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 35.7 m -72.96 -43.61 62.08 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -98.03 -29.0 13.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.786 0.327 . . . . 0.0 111.604 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 633' ' ' ALA . . . . . 0.442 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.38 156.29 52.67 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.082 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.63 ' HG2' HD12 ' A' ' 639' ' ' LEU . 72.8 Cg_endo -75.28 157.85 41.38 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.672 2.248 . . . . 0.0 112.425 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 29.1 mttp -74.0 155.36 38.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.571 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 636' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 613' ' ' SER . . . -53.14 -26.98 18.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.503 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.37 -36.37 50.12 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.308 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -111.34 11.06 21.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.819 0.31 . . . . 0.0 111.733 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 639' ' ' LEU . . . . . 0.63 HD12 ' HG2' ' A' ' 634' ' ' PRO . 12.6 tp -63.63 -48.1 78.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.763 0.316 . . . . 0.0 111.103 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -52.83 -43.77 66.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.961 0.41 . . . . 0.0 111.095 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.87 -38.46 76.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.975 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 642' ' ' TRP . . . . . 0.444 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 30.5 t90 -67.68 -36.62 81.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.678 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 14.1 mt -69.3 -43.39 73.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.341 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.52 -40.96 96.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.456 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -75.68 -39.26 57.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.718 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -106.22 80.06 0.64 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.727 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.12 147.59 73.51 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.573 2.182 . . . . 0.0 112.448 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 648' ' ' GLY . . . . . 0.578 ' O ' HG23 ' A' ' 622' ' ' VAL . . . 104.43 -15.23 50.24 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.702 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.504 ' CE1' ' CG ' ' A' ' 621' ' ' HIS . 19.4 m-85 -86.66 153.08 22.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.806 0.336 . . . . 0.0 111.014 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -143.6 145.83 32.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.634 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 31.0 t -55.12 128.7 15.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.236 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 652' ' ' ALA . . . . . 0.669 ' HB3' ' HB2' ' A' ' 618' ' ' LYS . . . -77.55 129.34 77.38 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.099 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.94 158.71 8.37 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.461 2.108 . . . . 0.0 112.281 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 52.6 mmm-85 58.89 105.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.944 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 6.4 m -114.79 31.5 6.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -124.15 -44.35 2.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.67 163.64 32.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.854 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.97 179.956 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 28.6 t . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.84 0.352 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -124.69 140.9 52.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.812 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 6.0 ttt -59.39 -29.52 67.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.956 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 613' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.76 -28.01 69.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.001 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.79 -27.88 26.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.1 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 10.0 mt -84.48 146.17 46.67 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.899 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.38 152.17 38.72 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.569 2.179 . . . . 0.0 112.365 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 617' ' ' VAL . . . . . 0.475 ' O ' ' HB1' ' A' ' 633' ' ' ALA . 26.5 t -118.87 129.36 75.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.025 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 618' ' ' LYS . . . . . 0.686 ' HB2' ' HB3' ' A' ' 652' ' ' ALA . 0.0 OUTLIER -68.41 173.54 4.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 619' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 618' ' ' LYS . 12.0 m -158.58 160.67 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.21 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.862 HD13 HG12 ' A' ' 627' ' ' ILE . 5.5 tp -124.3 127.65 73.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.636 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 621' ' ' HIS . . . . . 0.508 ' CG ' ' CE1' ' A' ' 649' ' ' TYR . 1.5 t60 -93.23 127.97 39.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.79 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 622' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 648' ' ' GLY . 21.4 t -88.68 -27.32 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.309 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -68.35 -37.22 80.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.149 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 12.4 p -113.51 -23.21 9.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.398 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 87.51 -5.72 84.57 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.886 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 626' ' ' LYS . . . . . 0.519 ' O ' HD12 ' A' ' 620' ' ' ILE . 29.1 tttt -69.39 156.8 38.23 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.856 0.36 . . . . 0.0 110.966 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 627' ' ' ILE . . . . . 0.862 HG12 HD13 ' A' ' 620' ' ' ILE . 2.6 mt -124.35 114.54 41.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.972 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 628' ' ' LEU . . . . . 0.502 HD12 ' CE2' ' A' ' 649' ' ' TYR . 45.1 mt -87.13 127.91 35.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.825 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.66 166.22 16.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.133 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 630' ' ' GLY . . . . . 0.416 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -49.58 -21.74 3.47 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.864 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 29.0 p -70.08 -43.69 70.62 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -98.38 -27.59 14.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.827 0.346 . . . . 0.0 111.628 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 633' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.41 156.36 52.61 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.298 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.513 ' HG2' HD12 ' A' ' 639' ' ' LEU . 71.5 Cg_endo -72.9 163.82 37.31 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.767 2.312 . . . . 0.0 112.314 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -73.04 172.54 10.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.4 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -61.01 -43.94 98.14 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.796 0.331 . . . . 0.0 111.433 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.54 -36.32 49.36 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.841 -0.695 . . . . 0.0 113.114 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -88.02 -6.05 58.18 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 639' ' ' LEU . . . . . 0.513 HD12 ' HG2' ' A' ' 634' ' ' PRO . 16.3 tp -58.49 -51.28 70.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.665 0.269 . . . . 0.0 111.229 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -50.67 -50.51 54.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.005 0.431 . . . . 0.0 111.122 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -66.55 -35.41 80.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.986 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 642' ' ' TRP . . . . . 0.442 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 36.4 t90 -67.63 -37.75 82.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.679 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.88 -46.03 72.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.291 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.27 -36.78 80.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.423 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 3.6 ttm -80.83 -24.33 38.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.894 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -125.8 75.46 70.84 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.872 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.84 149.59 90.34 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.682 2.254 . . . . 0.0 112.401 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 648' ' ' GLY . . . . . 0.402 ' O ' HG23 ' A' ' 622' ' ' VAL . . . 104.51 -18.29 44.89 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.735 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.508 ' CE1' ' CG ' ' A' ' 621' ' ' HIS . 20.7 m-85 -83.39 161.63 21.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.872 0.368 . . . . 0.0 111.075 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -149.64 145.98 27.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.75 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.3 t -56.31 128.88 17.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.159 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 652' ' ' ALA . . . . . 0.686 ' HB3' ' HB2' ' A' ' 618' ' ' LYS . . . -81.86 132.13 55.19 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.096 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -73.28 158.8 48.13 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.468 2.112 . . . . 0.0 112.324 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.15 148.42 51.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.935 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 1.5 p -137.44 58.73 1.69 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.858 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.5 -67.37 0.28 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.868 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 1.3 m -94.0 -55.12 3.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.808 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.872 179.98 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 72.1 p . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.825 0.345 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -77.23 90.31 3.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.93 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 6.1 ptt? -70.07 -44.99 67.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.87 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 613' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.36 -25.45 62.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.005 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.15 -24.78 51.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.04 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 50.9 mt -58.63 149.78 60.65 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.889 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.79 151.35 57.25 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.632 2.221 . . . . 0.0 112.324 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 617' ' ' VAL . . . . . 0.406 ' O ' ' HB1' ' A' ' 633' ' ' ALA . 21.3 t -118.83 128.92 75.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.143 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 618' ' ' LYS . . . . . 0.56 ' HB2' ' HB3' ' A' ' 652' ' ' ALA . 0.0 OUTLIER -66.39 176.72 1.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.813 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 619' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 618' ' ' LYS . 10.1 m -158.95 158.84 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.257 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.749 HD13 HG12 ' A' ' 627' ' ' ILE . 5.3 tp -124.36 127.55 73.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.533 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 621' ' ' HIS . . . . . 0.484 ' CG ' ' CE1' ' A' ' 649' ' ' TYR . 7.8 t-160 -93.12 128.79 39.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.659 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.4 t -88.24 -34.65 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.216 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -68.46 -33.97 75.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.334 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 1.7 m -111.5 -23.4 10.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.558 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 82.39 -4.0 79.38 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.826 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.56 156.89 36.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.839 0.352 . . . . 0.0 110.935 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 627' ' ' ILE . . . . . 0.749 HG12 HD13 ' A' ' 620' ' ' ILE . 1.6 mt -125.85 119.13 53.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.102 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 628' ' ' LEU . . . . . 0.458 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 17.6 mt -90.36 130.36 36.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.877 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.69 165.98 16.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.181 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 630' ' ' GLY . . . . . 0.401 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -50.73 -21.26 4.74 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.966 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 22.1 p -69.83 -43.63 71.59 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -98.31 -30.18 12.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.785 0.326 . . . . 0.0 111.516 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 633' ' ' ALA . . . . . 0.406 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.36 156.25 52.79 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.182 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.686 ' HG2' HD12 ' A' ' 639' ' ' LEU . 72.4 Cg_endo -75.26 163.64 34.38 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.755 2.304 . . . . 0.0 112.444 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -80.52 157.08 26.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.546 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -53.08 -26.96 17.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.501 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.49 -36.3 49.68 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.81 -0.709 . . . . 0.0 113.39 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -113.51 12.6 18.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.964 0.382 . . . . 0.0 111.806 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 639' ' ' LEU . . . . . 0.686 HD12 ' HG2' ' A' ' 634' ' ' PRO . 11.9 tp -62.99 -49.69 73.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.775 0.321 . . . . 0.0 111.089 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -53.34 -41.73 66.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.211 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.74 -38.75 76.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.893 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 642' ' ' TRP . . . . . 0.443 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 47.3 t90 -66.14 -46.37 77.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.706 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 643' ' ' LEU . . . . . 0.431 HD12 ' HG ' ' A' ' 639' ' ' LEU . 15.3 mt -61.92 -44.34 96.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.589 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.65 -39.62 89.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.547 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.2 -24.53 47.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.982 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -124.05 77.12 59.26 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.939 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -61.88 149.9 88.28 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.577 2.184 . . . . 0.0 112.224 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.43 -13.31 51.26 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.816 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.484 ' CE1' ' CG ' ' A' ' 621' ' ' HIS . 24.5 m-85 -94.05 156.15 16.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.861 0.363 . . . . 0.0 111.014 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -149.98 151.82 33.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.783 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.6 t -54.6 125.6 9.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.08 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 652' ' ' ALA . . . . . 0.56 ' HB3' ' HB2' ' A' ' 618' ' ' LYS . . . -87.23 138.21 32.47 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.174 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.99 159.12 10.04 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.47 2.113 . . . . 0.0 112.302 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 61.64 154.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.98 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.2 -31.72 11.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.92 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -113.45 160.27 18.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.9 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.62 -68.31 0.9 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.92 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.864 179.98 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.728 0.299 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -115.58 -56.0 2.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.955 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 612' ' ' MET . . . . . 0.613 ' HA ' HD12 ' A' ' 615' ' ' LEU . 54.8 mtt -59.76 -28.75 67.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.94 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 613' ' ' SER . . . . . . . . . . . . . 5.9 m -57.71 -24.91 59.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.147 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -100.15 -27.96 13.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.017 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 615' ' ' LEU . . . . . 0.613 HD12 ' HA ' ' A' ' 612' ' ' MET . 73.2 mt -64.12 154.81 81.28 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.95 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.75 148.72 36.9 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.532 2.154 . . . . 0.0 112.364 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 617' ' ' VAL . . . . . 0.462 ' O ' ' HB1' ' A' ' 633' ' ' ALA . 21.8 t -118.83 115.38 47.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.963 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 618' ' ' LYS . . . . . 0.674 ' HB2' ' HB3' ' A' ' 652' ' ' ALA . 0.0 OUTLIER -62.47 174.85 0.87 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.951 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 619' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 618' ' ' LYS . 4.6 m -159.15 157.62 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.199 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.496 HD13 ' C ' ' A' ' 620' ' ' ILE . 0.0 OUTLIER -124.37 127.64 73.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.805 179.785 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 621' ' ' HIS . . . . . 0.517 ' CD2' ' CD1' ' A' ' 649' ' ' TYR . 5.4 t-160 -87.59 124.73 33.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.794 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 622' ' ' VAL . . . . . 0.408 HG21 ' OE1' ' A' ' 650' ' ' GLU . 25.8 t -88.28 -29.48 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.311 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 623' ' ' GLU . . . . . 0.438 ' HB3' ' CE1' ' A' ' 621' ' ' HIS . 7.2 tp10 -68.38 -37.27 80.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.245 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 3.4 t -112.24 -23.33 10.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.281 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 89.26 -10.85 71.6 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.791 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -69.25 145.47 53.1 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.874 0.368 . . . . 0.0 110.854 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 10.1 mt -120.91 131.09 73.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.046 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 628' ' ' LEU . . . . . 0.455 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 11.1 mt -103.36 136.02 43.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.857 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.72 166.09 16.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.32 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 630' ' ' GLY . . . . . 0.405 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -51.39 -22.81 7.94 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.78 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 19.8 p -65.91 -43.84 86.99 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.719 0.295 . . . . 0.0 111.459 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -98.36 -21.56 16.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.341 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 633' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.48 156.24 53.92 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.352 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.505 ' HG2' HD12 ' A' ' 639' ' ' LEU . 73.3 Cg_endo -74.29 163.86 35.45 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.696 2.264 . . . . 0.0 112.174 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 31.5 mttt -72.98 175.62 6.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.475 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -60.54 -48.73 80.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.43 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.52 -36.25 49.63 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.943 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.07 -10.11 59.32 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 639' ' ' LEU . . . . . 0.514 ' HG ' HD12 ' A' ' 643' ' ' LEU . 10.6 tp -56.34 -50.62 70.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.73 0.3 . . . . 0.0 111.218 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -54.12 -47.63 71.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.989 0.423 . . . . 0.0 111.186 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -67.89 -36.59 80.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.754 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 642' ' ' TRP . . . . . 0.437 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 42.2 t90 -65.49 -43.77 89.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.723 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 643' ' ' LEU . . . . . 0.514 HD12 ' HG ' ' A' ' 639' ' ' LEU . 2.6 mt -63.55 -45.11 92.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.319 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -60.2 -37.44 80.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.378 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.14 -23.3 41.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.951 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -127.34 73.11 77.54 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.928 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -61.17 148.87 91.68 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.606 2.204 . . . . 0.0 112.391 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.36 -20.53 39.74 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.771 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.517 ' CD1' ' CD2' ' A' ' 621' ' ' HIS . 21.1 m-85 -81.68 150.58 27.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.874 0.369 . . . . 0.0 110.895 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 650' ' ' GLU . . . . . 0.408 ' OE1' HG21 ' A' ' 622' ' ' VAL . 26.2 mt-10 -137.33 145.93 43.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.724 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 31.7 t -55.95 125.49 11.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.235 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 652' ' ' ALA . . . . . 0.674 ' HB3' ' HB2' ' A' ' 618' ' ' LYS . . . -80.45 112.98 35.68 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.1 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.62 159.01 11.93 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.474 2.116 . . . . 0.0 112.315 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 -103.15 165.09 11.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.937 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 23.0 t -68.24 -28.6 67.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.979 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -57.37 142.25 44.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.989 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.94 135.38 50.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.92 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.175 -0.917 . . . . 0.0 110.937 179.96 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 31.1 t . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.868 0.366 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -161.88 164.04 28.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 612' ' ' MET . . . . . 0.826 ' HA ' HD12 ' A' ' 615' ' ' LEU . 2.1 ptm -59.59 -29.4 67.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 613' ' ' SER . . . . . 0.51 ' O ' ' HB3' ' A' ' 636' ' ' ALA . 60.0 p -57.7 -23.01 49.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.099 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -101.6 -27.79 12.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.095 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 615' ' ' LEU . . . . . 0.826 HD12 ' HA ' ' A' ' 612' ' ' MET . 7.8 mt -68.25 155.46 92.27 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.937 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.67 150.69 35.68 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.646 2.231 . . . . 0.0 112.466 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 617' ' ' VAL . . . . . 0.456 ' O ' ' HB1' ' A' ' 633' ' ' ALA . 27.9 t -118.8 127.35 75.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.053 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 618' ' ' LYS . . . . . 0.561 ' HB2' ' HB3' ' A' ' 652' ' ' ALA . 0.0 OUTLIER -65.39 167.96 7.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.953 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 619' ' ' VAL . . . . . 0.549 HG13 ' O ' ' A' ' 618' ' ' LYS . 5.2 m -159.24 161.45 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.003 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 12.8 tt -134.98 128.14 49.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.926 0.394 . . . . 0.0 111.528 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 621' ' ' HIS . . . . . 0.491 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 1.1 t60 -80.51 137.93 36.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.33 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 622' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 648' ' ' GLY . 20.8 t -85.18 -22.16 7.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.779 0.323 . . . . 0.0 111.482 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -68.46 -37.4 80.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.499 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 32.0 t -120.12 -23.39 6.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.705 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 86.69 10.41 73.02 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.754 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 7.3 tppt? -76.58 146.92 37.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.785 0.326 . . . . 0.0 110.754 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 3.4 mp -119.97 123.55 71.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.335 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 628' ' ' LEU . . . . . 0.448 ' CD1' ' CE1' ' A' ' 649' ' ' TYR . 15.0 mt -92.35 140.03 30.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.636 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.77 165.88 16.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.389 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . -56.04 -18.46 19.56 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.841 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 6.0 m -70.94 -43.7 67.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.648 0.261 . . . . 0.0 111.484 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.11 -24.22 15.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.797 0.332 . . . . 0.0 111.374 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 633' ' ' ALA . . . . . 0.456 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.52 156.2 54.54 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.161 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.455 ' HG2' HD12 ' A' ' 639' ' ' LEU . 73.0 Cg_endo -74.75 163.77 35.03 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.689 2.259 . . . . 0.0 112.327 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 21.7 mttp -72.99 175.77 6.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.433 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 636' ' ' ALA . . . . . 0.51 ' HB3' ' O ' ' A' ' 613' ' ' SER . . . -61.39 -48.97 78.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.774 0.321 . . . . 0.0 111.205 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.71 -36.26 48.64 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.832 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.94 -11.31 59.59 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.619 0.229 . . . . 0.0 111.619 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 639' ' ' LEU . . . . . 0.455 HD12 ' HG2' ' A' ' 634' ' ' PRO . 10.9 tp -55.98 -47.52 77.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.726 0.298 . . . . 0.0 111.211 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -54.85 -47.75 73.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.997 0.427 . . . . 0.0 111.105 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -67.89 -36.92 81.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.701 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 642' ' ' TRP . . . . . 0.44 ' CZ3' ' HB2' ' A' ' 646' ' ' ASN . 39.7 t90 -66.59 -38.6 87.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.491 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 8.3 mt -66.26 -44.72 82.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.077 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -59.5 -40.03 85.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.201 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 2.7 ttm -79.26 -21.02 46.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.83 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 646' ' ' ASN . . . . . 0.44 ' HB2' ' CZ3' ' A' ' 642' ' ' TRP . 23.9 m-80 -133.4 65.67 72.78 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.842 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -59.65 149.79 80.44 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.57 2.18 . . . . 0.0 112.444 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 648' ' ' GLY . . . . . 0.67 ' O ' HG23 ' A' ' 622' ' ' VAL . . . 104.46 -13.55 51.05 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.852 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.491 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 13.2 m-85 -85.01 142.31 29.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 0.0 111.053 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 650' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 619' ' ' VAL . 1.4 mm-40 -130.74 146.18 52.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.509 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 27.2 t -54.36 123.83 5.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.835 0.35 . . . . 0.0 111.297 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 652' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 618' ' ' LYS . . . -64.15 112.6 7.91 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.102 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.51 159.0 54.33 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.416 2.077 . . . . 0.0 112.274 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 3.8 mpp_? -86.4 130.87 34.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 52.3 p -88.48 -5.41 58.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.358 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 60.92 163.5 0.07 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.859 0.362 . . . . 0.0 110.9 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.23 -58.37 3.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.889 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.816 0.341 . . . . 0.0 111.281 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -149.67 77.46 1.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.836 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 612' ' ' MET . . . . . 0.425 ' HA ' HD12 ' A' ' 615' ' ' LEU . 5.2 mtt -57.97 -30.99 66.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.032 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 613' ' ' SER . . . . . 0.547 ' O ' ' HB3' ' A' ' 636' ' ' ALA . 16.9 t -59.97 -28.14 67.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.989 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.2 -27.84 18.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.077 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 615' ' ' LEU . . . . . 0.425 HD12 ' HA ' ' A' ' 612' ' ' MET . 71.2 mt -59.04 151.44 56.29 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.871 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.41 144.3 28.79 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.584 2.189 . . . . 0.0 112.309 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 617' ' ' VAL . . . . . 0.457 ' CG1' HG13 ' A' ' 651' ' ' VAL . 21.6 t -118.81 115.66 48.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.145 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 618' ' ' LYS . . . . . 0.715 ' HB2' ' HB3' ' A' ' 652' ' ' ALA . 0.3 OUTLIER -65.46 175.66 1.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.813 179.912 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 619' ' ' VAL . . . . . 0.491 HG13 ' O ' ' A' ' 618' ' ' LYS . 11.2 m -158.33 157.07 3.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.158 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.799 HD13 HG12 ' A' ' 627' ' ' ILE . 5.6 tp -124.35 127.6 73.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.922 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 621' ' ' HIS . . . . . 0.502 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 7.1 t-160 -89.51 127.98 35.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.692 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.6 t -88.35 -38.03 11.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.071 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -68.52 -30.59 69.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.413 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 8.9 t -112.5 -23.36 10.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.543 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 79.27 1.88 86.55 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.746 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 626' ' ' LYS . . . . . 0.59 ' O ' HD12 ' A' ' 620' ' ' ILE . 0.4 OUTLIER -76.67 156.79 32.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.825 0.345 . . . . 0.0 110.888 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 627' ' ' ILE . . . . . 0.799 HG12 HD13 ' A' ' 620' ' ' ILE . 1.9 mt -126.65 124.46 65.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.103 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 628' ' ' LEU . . . . . 0.451 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 19.1 mt -102.25 129.89 48.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.842 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.6 166.09 16.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.221 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 630' ' ' GLY . . . . . 0.43 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -50.2 -22.23 4.78 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.832 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 8.1 p -68.5 -43.79 76.09 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -98.43 -25.05 14.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.524 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 633' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.48 154.7 63.01 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.262 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.556 ' HG2' HD12 ' A' ' 639' ' ' LEU . 72.0 Cg_endo -75.44 161.72 37.07 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.625 2.216 . . . . 0.0 112.382 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -81.66 158.85 24.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.411 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 636' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 613' ' ' SER . . . -53.1 -27.09 18.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.787 0.327 . . . . 0.0 111.417 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.68 -36.34 48.57 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.831 -0.699 . . . . 0.0 113.397 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -111.96 11.63 20.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.875 0.337 . . . . 0.0 111.908 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 639' ' ' LEU . . . . . 0.556 HD12 ' HG2' ' A' ' 634' ' ' PRO . 10.4 tp -62.18 -52.19 64.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.799 0.333 . . . . 0.0 111.084 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -53.24 -42.34 66.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.125 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.98 -39.06 76.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.883 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 642' ' ' TRP . . . . . 0.451 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 34.7 t90 -64.59 -46.91 80.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.677 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 643' ' ' LEU . . . . . 0.464 HD23 ' HA ' ' A' ' 643' ' ' LEU . 11.7 mt -63.83 -40.53 96.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.509 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -60.63 -41.01 94.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.568 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 1.2 ttt -78.03 -35.75 49.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.845 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 646' ' ' ASN . . . . . 0.43 ' HB2' ' CZ3' ' A' ' 642' ' ' TRP . 24.5 m-80 -109.88 81.32 1.99 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.79 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.45 147.85 71.98 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.563 2.176 . . . . 0.0 112.392 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.46 -14.15 50.8 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.738 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.502 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 17.1 m-85 -88.39 149.41 23.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.85 0.357 . . . . 0.0 111.009 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -136.22 145.76 46.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.641 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 651' ' ' VAL . . . . . 0.457 HG13 ' CG1' ' A' ' 617' ' ' VAL . 21.2 t -58.22 128.3 18.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.234 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 652' ' ' ALA . . . . . 0.715 ' HB3' ' HB2' ' A' ' 618' ' ' LYS . . . -80.21 142.85 55.52 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.048 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.73 158.59 8.09 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.557 2.172 . . . . 0.0 112.215 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 59.35 174.77 0.08 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 47.9 m -109.17 -31.53 7.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.849 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.89 -173.46 4.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 18.0 m -136.21 -48.7 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.943 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.934 179.986 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 17.2 m . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.723 0.297 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 63.58 127.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.922 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 30.4 ttm -58.05 -30.38 66.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.941 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 613' ' ' SER . . . . . 0.6 ' O ' ' HB3' ' A' ' 636' ' ' ALA . 2.8 p -64.73 -24.6 67.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.059 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -95.0 -27.89 15.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.013 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 80.1 mt -73.01 152.18 90.71 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.963 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.31 145.68 24.24 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.71 2.274 . . . . 0.0 112.402 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 617' ' ' VAL . . . . . 0.51 ' CG1' HG13 ' A' ' 651' ' ' VAL . 21.3 t -118.84 119.88 62.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.086 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 618' ' ' LYS . . . . . 0.802 ' CB ' ' HB3' ' A' ' 652' ' ' ALA . 0.0 OUTLIER -61.41 169.58 2.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.911 0.386 . . . . 0.0 110.985 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 619' ' ' VAL . . . . . 0.517 HG23 ' CD1' ' A' ' 649' ' ' TYR . 32.9 m -155.83 143.35 11.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.858 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.493 HD13 ' C ' ' A' ' 620' ' ' ILE . 0.0 OUTLIER -124.37 127.58 73.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.888 0.375 . . . . 0.0 111.132 -179.768 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 621' ' ' HIS . . . . . 0.492 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 3.6 t-160 -86.69 131.09 34.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.62 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.6 t -86.43 -29.69 6.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.851 0.357 . . . . 0.0 111.054 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -68.55 -37.38 79.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.49 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 8.7 p -111.96 -23.48 10.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.456 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 87.21 -10.52 68.5 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.921 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.4 141.99 53.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.797 0.332 . . . . 0.0 110.89 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 1.9 mt -121.08 129.39 75.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.307 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 628' ' ' LEU . . . . . 0.46 HD12 ' CG2' ' A' ' 619' ' ' VAL . 12.5 mt -95.68 139.64 31.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.777 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.84 165.91 16.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.497 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 630' ' ' GLY . . . . . 0.422 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -57.2 -18.38 27.77 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.92 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.63 -43.73 68.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.753 0.311 . . . . 0.0 111.446 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -98.19 -22.49 16.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.358 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.46 156.33 53.19 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.291 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.461 ' HG2' HD12 ' A' ' 639' ' ' LEU . 64.1 Cg_endo -72.42 163.82 37.45 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.735 2.29 . . . . 0.0 112.247 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -72.9 176.45 5.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.525 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 636' ' ' ALA . . . . . 0.6 ' HB3' ' O ' ' A' ' 613' ' ' SER . . . -59.43 -48.49 81.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.46 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.47 -36.19 50.03 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.049 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -81.73 -9.85 59.53 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 639' ' ' LEU . . . . . 0.461 HD12 ' HG2' ' A' ' 634' ' ' PRO . 12.0 tp -62.18 -50.11 73.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.654 0.264 . . . . 0.0 111.077 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -52.41 -46.25 66.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.001 0.429 . . . . 0.0 111.17 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.48 -37.61 77.32 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.919 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 642' ' ' TRP . . . . . 0.442 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 44.2 t90 -65.31 -40.81 94.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.747 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 86.0 mt -67.59 -42.58 82.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.319 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.64 -40.45 87.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.414 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.22 -37.09 54.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.623 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -110.92 80.25 2.16 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.648 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.43 147.65 71.73 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.462 2.108 . . . . 0.0 112.454 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.45 -7.74 47.07 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.836 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.517 ' CD1' HG23 ' A' ' 619' ' ' VAL . 12.5 m-85 -93.47 157.55 16.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.897 0.379 . . . . 0.0 111.026 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 650' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 619' ' ' VAL . 18.7 mm-40 -149.4 151.67 34.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.26 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 651' ' ' VAL . . . . . 0.51 HG13 ' CG1' ' A' ' 617' ' ' VAL . 28.5 t -54.04 119.72 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.821 0.344 . . . . 0.0 111.259 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 652' ' ' ALA . . . . . 0.802 ' HB3' ' CB ' ' A' ' 618' ' ' LYS . . . -82.95 142.12 44.43 Favored Pre-proline 0 C--N 1.333 -0.145 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.199 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.06 156.34 38.33 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.526 2.151 . . . . 0.0 112.269 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.65 -19.93 12.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.095 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 8.1 t 65.43 31.85 10.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.865 0.364 . . . . 0.0 110.912 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -126.67 174.53 8.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.809 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 41.4 m -88.1 -65.43 1.02 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.95 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.81 -179.984 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.878 0.371 . . . . 0.0 111.278 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -149.98 41.66 0.84 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.856 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 72.9 mtp -61.44 -31.42 71.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.875 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 613' ' ' SER . . . . . . . . . . . . . 2.3 t -63.13 -30.74 71.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.996 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.15 -27.92 38.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.037 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 39.3 mt -62.4 148.79 89.34 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.93 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.05 155.99 47.45 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.604 2.203 . . . . 0.0 112.323 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 617' ' ' VAL . . . . . 0.612 ' CG1' HG13 ' A' ' 651' ' ' VAL . 27.9 t -118.69 121.06 66.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.06 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 618' ' ' LYS . . . . . 0.689 ' HG2' ' HB3' ' A' ' 652' ' ' ALA . 0.0 OUTLIER -76.53 134.97 39.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.965 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 619' ' ' VAL . . . . . 0.596 HG12 ' HA ' ' A' ' 651' ' ' VAL . 2.6 m -124.0 176.89 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.189 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 3.4 tt -143.0 133.12 22.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.509 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 621' ' ' HIS . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 3.3 t-160 -84.65 136.89 33.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.055 179.073 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 622' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 648' ' ' GLY . 27.0 t -84.65 -36.55 11.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.826 0.346 . . . . 0.0 111.21 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -68.56 -33.0 73.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.41 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.17 -23.24 12.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.55 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 77.36 4.55 84.4 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.683 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 9.0 tttt -76.57 148.38 37.06 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.76 0.314 . . . . 0.0 110.836 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 10.7 mt -122.28 105.54 16.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.363 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 628' ' ' LEU . . . . . 0.452 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 13.6 mt -80.1 130.99 35.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.322 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.53 166.03 16.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.384 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . -50.51 -22.59 5.59 Favored Glycine 0 CA--C 1.517 0.193 0 C-N-CA 120.81 -0.71 . . . . 0.0 113.005 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.16 -43.89 81.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.675 0.274 . . . . 0.0 111.586 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -98.18 -23.72 15.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.911 0.386 . . . . 0.0 111.489 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 633' ' ' ALA . . . . . 0.442 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.62 156.41 54.22 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.302 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.451 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 71.7 Cg_endo -75.11 163.79 34.41 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.878 2.385 . . . . 0.0 112.222 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -72.97 174.73 7.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.495 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -60.99 -44.21 97.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.852 0.358 . . . . 0.0 111.461 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.67 -36.22 49.0 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.214 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 6.1 mm100 -87.19 -7.36 58.02 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 639' ' ' LEU . . . . . 0.446 HD12 ' HG2' ' A' ' 634' ' ' PRO . 14.3 tp -59.62 -49.6 77.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.759 0.314 . . . . 0.0 111.197 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -52.42 -50.39 62.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.943 0.402 . . . . 0.0 111.281 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -66.58 -34.53 78.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.096 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 642' ' ' TRP . . . . . 0.451 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 49.5 t90 -66.73 -46.12 76.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.875 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 35.9 mt -62.76 -43.8 97.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.479 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.17 -38.83 87.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.562 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 6.8 tmm? -78.88 -24.85 43.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.005 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -123.39 77.8 53.84 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.826 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -64.81 144.68 84.28 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.705 2.27 . . . . 0.0 112.395 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 648' ' ' GLY . . . . . 0.456 ' O ' HG23 ' A' ' 622' ' ' VAL . . . 104.48 -3.41 43.04 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.965 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.479 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 7.7 m-85 -96.25 152.53 18.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.894 0.378 . . . . 0.0 110.976 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -147.81 147.2 29.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.847 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 651' ' ' VAL . . . . . 0.612 HG13 ' CG1' ' A' ' 617' ' ' VAL . 21.4 t -57.65 126.55 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.126 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 652' ' ' ALA . . . . . 0.689 ' HB3' ' HG2' ' A' ' 618' ' ' LYS . . . -64.16 148.1 95.96 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.186 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.18 156.5 55.34 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.558 2.172 . . . . 0.0 112.335 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.24 -28.64 38.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.004 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 10.2 p 59.9 29.64 19.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.006 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 2.1 t70 61.16 113.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.977 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 9.9 t 62.79 -80.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.048 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.878 179.948 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.811 0.338 . . . . 0.0 111.252 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -153.48 -56.38 0.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.85 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.33 -36.08 82.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.945 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 613' ' ' SER . . . . . 0.474 ' O ' ' HB3' ' A' ' 636' ' ' ALA . 99.3 p -65.3 -21.98 66.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.135 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -94.42 17.9 12.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.284 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 28.5 mt -106.2 148.65 37.03 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.722 0.296 . . . . 0.0 110.879 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.19 136.87 20.57 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.548 2.166 . . . . 0.0 112.365 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 617' ' ' VAL . . . . . 0.49 ' O ' ' HB1' ' A' ' 633' ' ' ALA . 21.5 t -112.65 115.44 49.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.06 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 618' ' ' LYS . . . . . 0.49 ' O ' HG13 ' A' ' 619' ' ' VAL . 0.3 OUTLIER -60.76 173.2 0.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.967 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 619' ' ' VAL . . . . . 0.589 ' O ' HG23 ' A' ' 627' ' ' ILE . 5.7 m -157.81 159.31 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.237 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.403 HG12 ' CG1' ' A' ' 627' ' ' ILE . 0.0 OUTLIER -124.72 127.71 72.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.696 179.652 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 621' ' ' HIS . . . . . 0.519 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 3.6 t60 -88.77 127.59 35.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.746 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 26.9 t -88.36 -28.53 5.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.167 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -68.52 -37.29 79.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.232 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 1.6 t -114.52 -23.38 9.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.542 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 90.57 -12.61 67.91 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.74 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.31 143.61 53.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.844 0.355 . . . . 0.0 110.922 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 627' ' ' ILE . . . . . 0.589 HG23 ' O ' ' A' ' 619' ' ' VAL . 2.0 mt -120.36 127.09 75.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.21 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 628' ' ' LEU . . . . . 0.463 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 5.6 mt -93.75 133.77 36.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.814 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 629' ' ' THR . . . . . 0.608 ' OG1' HG22 ' A' ' 631' ' ' THR . 0.3 OUTLIER -85.85 166.28 16.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.327 179.758 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 630' ' ' GLY . . . . . 0.439 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -50.08 -23.59 5.78 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.977 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 631' ' ' THR . . . . . 0.608 HG22 ' OG1' ' A' ' 629' ' ' THR . 5.8 t -65.72 -43.4 89.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.703 0.287 . . . . 0.0 111.305 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.35 -20.58 17.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.359 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 633' ' ' ALA . . . . . 0.49 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.53 150.7 80.17 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.318 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.478 ' HG2' HD12 ' A' ' 639' ' ' LEU . 72.9 Cg_endo -75.27 163.81 34.05 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.753 2.302 . . . . 0.0 112.353 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 35.5 mttp -73.03 172.0 11.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.425 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 636' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 613' ' ' SER . . . -62.39 -38.09 88.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.862 0.363 . . . . 0.0 111.425 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.7 -36.22 48.83 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.237 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -94.38 -3.34 50.47 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 639' ' ' LEU . . . . . 0.478 HD12 ' HG2' ' A' ' 634' ' ' PRO . 13.6 tp -59.64 -50.54 73.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.728 0.299 . . . . 0.0 111.194 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -52.9 -44.52 67.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.219 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.82 -36.81 75.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.003 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 642' ' ' TRP . . . . . 0.434 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 35.1 t90 -67.23 -41.27 85.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.789 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 643' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 643' ' ' LEU . 16.4 mt -67.13 -43.56 82.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.479 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -60.78 -40.49 92.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.541 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.35 -37.28 57.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.797 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -107.84 81.76 1.26 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.818 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -68.39 147.43 71.48 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.616 2.211 . . . . 0.0 112.442 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.34 -20.59 39.63 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.578 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.519 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 23.8 m-85 -81.57 149.97 28.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.876 0.37 . . . . 0.0 111.115 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -142.49 155.62 45.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.62 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.4 t -54.57 127.74 13.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.18 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 652' ' ' ALA . . . . . . . . . . . . . . . -103.53 104.67 43.12 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.231 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.66 159.24 42.02 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.54 2.16 . . . . 0.0 112.182 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 37.2 mtt85 -65.18 109.84 2.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.904 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 2.1 p -123.22 34.07 5.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.987 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.18 -31.32 70.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.845 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 4.4 p -92.9 126.08 37.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.831 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.86 179.967 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 120.77 0.319 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 59.77 97.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.812 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 612' ' ' MET . . . . . 0.407 ' HA ' ' CD1' ' A' ' 615' ' ' LEU . 0.0 OUTLIER -69.0 -29.85 68.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.079 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 613' ' ' SER . . . . . . . . . . . . . 1.4 m -73.43 -26.32 60.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.098 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.57 17.88 23.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.425 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 615' ' ' LEU . . . . . 0.469 HD22 ' HD2' ' A' ' 616' ' ' PRO . 13.4 mt -68.83 161.83 68.68 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.675 0.274 . . . . 0.0 110.899 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 616' ' ' PRO . . . . . 0.469 ' HD2' HD22 ' A' ' 615' ' ' LEU . 74.3 Cg_endo -75.36 140.0 24.01 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.606 2.204 . . . . 0.0 112.32 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 617' ' ' VAL . . . . . 0.473 ' O ' ' HB1' ' A' ' 633' ' ' ALA . 26.2 t -116.45 115.41 48.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.055 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 618' ' ' LYS . . . . . 0.555 ' CB ' ' HB3' ' A' ' 652' ' ' ALA . 0.0 OUTLIER -61.51 170.79 1.71 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.923 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 619' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 650' ' ' GLU . 27.7 m -157.42 146.06 10.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.995 179.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.404 HG12 HG13 ' A' ' 627' ' ' ILE . 0.0 OUTLIER -124.43 127.63 73.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.943 0.402 . . . . 0.0 111.265 -179.754 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 621' ' ' HIS . . . . . 0.51 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 4.4 t-160 -83.96 131.79 34.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.675 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.5 t -87.8 -29.77 5.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.897 0.38 . . . . 0.0 111.051 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -68.43 -37.3 80.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.198 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 1.5 m -110.85 -23.48 10.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.405 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 85.58 -7.62 75.69 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.906 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -69.4 152.39 44.98 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.791 0.329 . . . . 0.0 110.824 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 627' ' ' ILE . . . . . 0.404 HG13 HG12 ' A' ' 620' ' ' ILE . 2.0 mt -127.64 138.66 54.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.213 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 26.4 mt -105.46 139.2 40.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.768 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.83 165.96 16.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.483 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 630' ' ' GLY . . . . . 0.471 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -56.48 -18.94 24.52 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.005 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 10.0 t -71.17 -43.55 67.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.685 0.278 . . . . 0.0 111.554 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.2 -21.39 16.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.342 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 633' ' ' ALA . . . . . 0.473 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.53 156.22 54.53 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.247 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.45 ' HG2' HD12 ' A' ' 639' ' ' LEU . 71.6 Cg_endo -73.88 163.79 36.15 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.631 2.221 . . . . 0.0 112.287 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 4.3 mtpp -73.04 176.4 5.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.595 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -60.7 -48.96 79.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.802 0.334 . . . . 0.0 111.286 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.72 -36.32 48.46 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.877 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.11 -11.84 59.72 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 639' ' ' LEU . . . . . 0.45 HD12 ' HG2' ' A' ' 634' ' ' PRO . 10.5 tp -57.71 -49.65 75.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.758 0.313 . . . . 0.0 111.143 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.73 -45.59 70.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.111 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.74 -37.72 76.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.872 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 642' ' ' TRP . . . . . 0.45 ' CZ3' ' HB2' ' A' ' 646' ' ' ASN . 34.9 t90 -64.83 -42.67 94.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.682 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 65.6 mt -66.33 -42.4 88.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.417 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.17 -41.1 87.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.459 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 4.1 mmt -77.55 -35.17 53.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.645 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 646' ' ' ASN . . . . . 0.45 ' HB2' ' CZ3' ' A' ' 642' ' ' TRP . 23.5 m-80 -113.17 79.75 3.87 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.779 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.33 145.96 67.44 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.608 2.205 . . . . 0.0 112.404 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.44 -6.24 45.43 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.832 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.526 ' CD1' HG23 ' A' ' 619' ' ' VAL . 11.4 m-85 -95.51 149.5 21.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.911 0.386 . . . . 0.0 111.021 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 650' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 619' ' ' VAL . 69.1 mt-10 -136.5 145.46 45.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.17 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 2.4 m -54.31 123.35 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.9 0.381 . . . . 0.0 111.491 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 652' ' ' ALA . . . . . 0.555 ' HB3' ' CB ' ' A' ' 618' ' ' LYS . . . -99.65 98.3 6.89 Favored Pre-proline 0 C--N 1.333 -0.152 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.243 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.91 156.41 66.01 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.386 2.057 . . . . 0.0 112.272 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -110.59 176.61 4.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.881 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.69 -43.01 1.89 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.084 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -75.63 81.49 2.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.937 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 3.5 m -127.42 -45.56 1.5 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.877 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.92 179.957 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 610' ' ' SER . . . . . 0.449 ' N ' ' HG ' ' A' ' 613' ' ' SER . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.742 0.306 . . . . 0.0 111.165 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -126.72 -54.45 1.42 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 7.0 mmm -59.3 -28.35 66.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.049 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 613' ' ' SER . . . . . 0.608 ' HA ' ' HB3' ' A' ' 636' ' ' ALA . 0.9 OUTLIER -58.35 -27.24 64.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.06 -179.873 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.21 -27.8 21.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.196 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 16.2 mt -71.17 146.25 92.17 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.971 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.31 142.62 21.46 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.698 2.265 . . . . 0.0 112.442 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 617' ' ' VAL . . . . . 0.743 ' CG1' HG13 ' A' ' 651' ' ' VAL . 21.5 t -118.92 122.72 70.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.122 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 618' ' ' LYS . . . . . 0.731 ' CB ' ' HB3' ' A' ' 652' ' ' ALA . 0.8 OUTLIER -65.11 171.17 3.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.759 179.883 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 619' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 650' ' ' GLU . 27.2 m -156.71 152.43 7.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.308 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.92 HD13 ' CG1' ' A' ' 627' ' ' ILE . 3.6 tp -124.88 127.45 72.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.647 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 621' ' ' HIS . . . . . 0.527 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 2.1 t60 -89.26 135.83 33.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.633 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 622' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 648' ' ' GLY . 25.8 t -87.12 -35.77 8.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.819 0.343 . . . . 0.0 111.287 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -68.59 -32.99 73.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.536 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 3.3 t -112.2 -23.36 10.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.592 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 78.97 0.29 81.55 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.906 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 626' ' ' LYS . . . . . 0.647 ' O ' HD12 ' A' ' 620' ' ' ILE . 5.6 ttmt -76.68 150.56 36.32 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.757 0.313 . . . . 0.0 110.929 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 627' ' ' ILE . . . . . 0.92 ' CG1' HD13 ' A' ' 620' ' ' ILE . 6.2 mt -119.32 119.38 60.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.199 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 628' ' ' LEU . . . . . 0.485 ' HB2' HG22 ' A' ' 619' ' ' VAL . 37.2 mt -87.13 135.82 33.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.745 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.52 166.03 16.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.407 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 630' ' ' GLY . . . . . 0.412 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -56.37 -17.73 19.54 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.646 -0.788 . . . . 0.0 113.004 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.55 -43.6 59.5 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.75 0.275 . . . . 0.0 111.681 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.15 -24.08 15.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.702 0.287 . . . . 0.0 111.461 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 633' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.44 154.3 64.77 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.171 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.609 ' HG2' HD12 ' A' ' 639' ' ' LEU . 72.7 Cg_endo -75.26 156.83 41.87 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.598 2.199 . . . . 0.0 112.414 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? -73.22 165.59 24.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.42 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 636' ' ' ALA . . . . . 0.608 ' HB3' ' HA ' ' A' ' 613' ' ' SER . . . -62.79 -29.14 70.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.81 0.338 . . . . 0.0 111.302 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.57 -36.35 49.11 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.308 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -106.69 4.72 28.1 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 639' ' ' LEU . . . . . 0.609 HD12 ' HG2' ' A' ' 634' ' ' PRO . 13.5 tp -57.26 -50.13 73.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.749 0.309 . . . . 0.0 111.079 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -52.88 -42.12 65.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.987 0.422 . . . . 0.0 110.961 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.85 -39.7 76.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.775 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 642' ' ' TRP . . . . . 0.433 ' CZ3' ' HB2' ' A' ' 646' ' ' ASN . 33.3 t90 -66.32 -36.53 83.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.554 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 46.7 mt -69.4 -41.76 76.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.296 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -61.24 -41.16 96.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.328 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 73.7 mtp -77.83 -32.06 51.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.623 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 646' ' ' ASN . . . . . 0.433 ' HB2' ' CZ3' ' A' ' 642' ' ' TRP . 28.2 m-80 -118.93 75.45 13.76 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.682 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.19 149.79 76.45 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.562 2.175 . . . . 0.0 112.442 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 648' ' ' GLY . . . . . 0.578 ' O ' HG23 ' A' ' 622' ' ' VAL . . . 104.39 -12.3 51.26 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.779 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.527 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 16.0 m-85 -87.8 159.3 18.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.89 0.376 . . . . 0.0 111.032 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 650' ' ' GLU . . . . . 0.514 ' O ' ' HA ' ' A' ' 619' ' ' VAL . 30.1 mt-10 -149.96 147.22 27.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.232 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 651' ' ' VAL . . . . . 0.743 HG13 ' CG1' ' A' ' 617' ' ' VAL . 31.3 t -53.95 127.09 11.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.777 0.323 . . . . 0.0 111.272 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 652' ' ' ALA . . . . . 0.731 ' HB3' ' CB ' ' A' ' 618' ' ' LYS . . . -83.24 136.74 43.07 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.291 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.04 159.16 37.79 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.448 2.099 . . . . 0.0 112.219 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -80.74 132.69 35.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.809 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 48.2 t -57.22 -33.51 67.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.971 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -125.09 146.22 49.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.877 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 93.5 p -159.07 179.06 9.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.905 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.32 -0.848 . . . . 0.0 110.852 -179.951 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 120.864 0.364 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 12.9 mp0 60.58 106.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.93 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -59.9 -28.69 67.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 613' ' ' SER . . . . . 0.477 ' HA ' ' HB3' ' A' ' 636' ' ' ALA . 10.9 m -57.27 -26.59 61.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.134 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -91.98 -27.83 17.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.068 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 8.9 mt -77.6 144.35 69.39 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.957 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.29 149.48 27.94 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.612 2.208 . . . . 0.0 112.444 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 617' ' ' VAL . . . . . 0.526 ' CG1' HG13 ' A' ' 651' ' ' VAL . 21.4 t -118.87 130.54 73.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.112 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 618' ' ' LYS . . . . . 0.799 ' HB3' ' HB3' ' A' ' 652' ' ' ALA . 0.0 OUTLIER -67.43 164.83 17.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.992 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 619' ' ' VAL . . . . . 0.613 HG23 ' CD1' ' A' ' 649' ' ' TYR . 33.5 m -156.19 144.07 11.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.97 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 649' ' ' TYR . 0.0 OUTLIER -124.24 127.66 73.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.889 0.376 . . . . 0.0 111.285 -179.813 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 621' ' ' HIS . . . . . 0.488 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 2.5 t-160 -85.46 133.52 34.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.601 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 20.5 t -86.62 -29.52 5.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.77 0.319 . . . . 0.0 111.133 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.53 -37.34 79.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.357 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 1.8 m -110.1 -23.36 11.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.355 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 82.5 5.83 89.16 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.006 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.63 151.99 36.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.755 0.312 . . . . 0.0 110.895 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 3.5 mt -127.4 114.47 36.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.221 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 628' ' ' LEU . . . . . 0.516 HD12 ' CG2' ' A' ' 619' ' ' VAL . 19.1 mt -86.76 134.46 33.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.808 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.81 166.09 16.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.496 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 630' ' ' GLY . . . . . 0.418 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -58.46 -15.36 24.18 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.176 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.51 -43.68 38.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.899 0.35 . . . . 0.0 111.742 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.94 -26.1 14.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.873 0.368 . . . . 0.0 111.371 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.51 156.03 55.54 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.215 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.431 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 52.2 Cg_endo -68.69 163.81 35.64 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.594 2.196 . . . . 0.0 112.195 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 26.9 mttp -72.85 171.47 12.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.473 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 636' ' ' ALA . . . . . 0.477 ' HB3' ' HA ' ' A' ' 613' ' ' SER . . . -62.63 -40.21 96.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.426 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.58 -36.25 49.34 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.099 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -91.21 -5.25 55.14 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 639' ' ' LEU . . . . . 0.423 HD12 ' HG2' ' A' ' 634' ' ' PRO . 15.3 tp -57.78 -50.76 72.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.714 0.292 . . . . 0.0 111.271 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.08 -44.0 61.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.913 0.387 . . . . 0.0 111.111 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -68.17 -39.16 82.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.977 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 642' ' ' TRP . . . . . 0.436 ' CD2' ' ND2' ' A' ' 646' ' ' ASN . 18.4 t90 -68.98 -34.0 74.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.851 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 17.4 mt -69.05 -47.5 65.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.481 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -61.31 -41.07 96.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.486 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 15.9 tpt -74.17 -33.87 63.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.583 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 646' ' ' ASN . . . . . 0.436 ' ND2' ' CD2' ' A' ' 642' ' ' TRP . 35.6 m-80 -114.47 74.23 3.02 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.647 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.81 147.09 89.41 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.613 2.208 . . . . 0.0 112.51 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.44 -4.12 43.61 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.893 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.613 ' CD1' HG23 ' A' ' 619' ' ' VAL . 8.9 m-85 -94.88 156.59 16.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.966 0.412 . . . . 0.0 111.109 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 650' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 619' ' ' VAL . 14.7 mm-40 -144.27 145.75 32.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.281 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 651' ' ' VAL . . . . . 0.526 HG13 ' CG1' ' A' ' 617' ' ' VAL . 24.3 t -54.06 121.29 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.811 0.338 . . . . 0.0 111.32 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 652' ' ' ALA . . . . . 0.799 ' HB3' ' HB3' ' A' ' 618' ' ' LYS . . . -90.22 146.87 35.64 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.144 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.78 158.94 9.88 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.531 2.154 . . . . 0.0 112.227 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.07 179.63 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.851 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 38.4 t -60.47 -31.58 70.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.892 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.21 81.79 1.82 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.927 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 14.3 t -131.91 171.43 13.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.848 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.905 179.965 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.828 0.346 . . . . 0.0 111.17 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 60.25 32.95 20.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.863 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.35 -31.48 65.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.906 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 613' ' ' SER . . . . . . . . . . . . . 2.9 m -69.43 -21.45 63.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.163 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -92.82 17.88 9.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.396 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 62.3 mt -91.68 151.4 42.32 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.766 0.317 . . . . 0.0 110.878 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.82 149.08 53.39 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.562 2.175 . . . . 0.0 112.294 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 617' ' ' VAL . . . . . 0.417 ' O ' ' HB1' ' A' ' 633' ' ' ALA . 21.2 t -118.81 119.92 62.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.984 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 618' ' ' LYS . . . . . 0.675 ' HB2' ' HB3' ' A' ' 652' ' ' ALA . 0.0 OUTLIER -55.41 172.01 0.16 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.924 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 619' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 618' ' ' LYS . 12.1 m -158.13 160.02 2.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.248 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.792 HD13 HG12 ' A' ' 627' ' ' ILE . 6.4 tp -124.41 127.67 73.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.784 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 621' ' ' HIS . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 7.2 t-160 -92.31 128.63 38.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.723 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.4 t -87.74 -28.61 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.859 0.361 . . . . 0.0 111.256 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.57 -37.15 79.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.388 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 70.1 m -113.99 -23.35 9.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.615 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 84.8 4.95 86.89 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.748 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 626' ' ' LYS . . . . . 0.653 ' O ' HD12 ' A' ' 620' ' ' ILE . 0.1 OUTLIER -76.58 156.84 32.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.863 0.363 . . . . 0.0 111.079 -179.937 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 627' ' ' ILE . . . . . 0.792 HG12 HD13 ' A' ' 620' ' ' ILE . 2.4 mt -125.35 115.29 43.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.054 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 628' ' ' LEU . . . . . 0.451 ' CD1' ' CE1' ' A' ' 649' ' ' TYR . 28.4 mt -90.04 130.33 36.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.822 0.344 . . . . 0.0 110.875 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.78 166.22 16.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.12 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 630' ' ' GLY . . . . . 0.435 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -50.67 -21.25 4.65 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.87 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 4.3 m -69.85 -43.65 71.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.648 0.261 . . . . 0.0 111.658 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -98.34 -23.47 15.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.778 0.323 . . . . 0.0 111.528 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 633' ' ' ALA . . . . . 0.417 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.44 156.24 53.59 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.244 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.437 ' HB3' ' CD1' ' A' ' 642' ' ' TRP . 73.0 Cg_endo -75.18 163.72 34.4 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.735 2.29 . . . . 0.0 112.325 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 26.9 mttt -73.01 176.37 5.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.535 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -61.55 -48.94 78.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.849 0.357 . . . . 0.0 111.234 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.69 -36.22 48.89 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.745 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -80.0 -12.49 59.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.563 0.22 . . . . 0.0 111.55 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 639' ' ' LEU . . . . . . . . . . . . . 11.6 tp -56.16 -47.85 77.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.786 0.327 . . . . 0.0 111.154 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -53.49 -51.32 63.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.978 0.418 . . . . 0.0 111.038 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -67.82 -34.52 76.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.012 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 642' ' ' TRP . . . . . 0.437 ' CD1' ' HB3' ' A' ' 634' ' ' PRO . 30.0 t90 -67.65 -38.56 84.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.744 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.46 -43.34 73.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.433 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -61.1 -39.49 90.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.521 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 2.4 ttp -78.73 -35.71 44.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.806 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -110.49 78.34 1.45 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.943 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.39 146.65 69.42 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.531 2.154 . . . . 0.0 112.355 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.34 -12.53 51.5 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.783 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 15.9 m-85 -88.37 161.71 16.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.899 0.381 . . . . 0.0 111.042 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -148.4 145.81 28.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.698 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.5 t -58.26 130.43 21.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.282 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 652' ' ' ALA . . . . . 0.675 ' HB3' ' HB2' ' A' ' 618' ' ' LYS . . . -87.14 139.24 32.35 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.971 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -73.39 156.52 50.29 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.405 2.07 . . . . 0.0 112.374 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 9.5 mmt85 -109.13 130.81 55.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 16.5 t -86.83 -33.08 19.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.941 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.08 137.12 35.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.83 -52.93 2.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.873 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.831 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 18.0 mt . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.676 0.274 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.77 150.81 39.9 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.586 2.191 . . . . 0.0 112.368 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 617' ' ' VAL . . . . . 0.439 ' O ' ' HB1' ' A' ' 633' ' ' ALA . 21.4 t -118.83 128.53 75.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.106 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 618' ' ' LYS . . . . . 0.463 ' O ' HG13 ' A' ' 619' ' ' VAL . 0.0 OUTLIER -66.35 170.47 5.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.857 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 619' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 618' ' ' LYS . 16.2 m -157.79 157.26 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.149 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.937 HD13 HG12 ' A' ' 627' ' ' ILE . 3.9 tp -124.59 127.64 73.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.724 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 621' ' ' HIS . . . . . 0.517 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 18.0 t-160 -91.01 132.91 35.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.552 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 622' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 648' ' ' GLY . 23.4 t -87.4 -34.07 7.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.811 0.339 . . . . 0.0 111.231 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -33.82 74.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.348 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 44.2 t -111.51 -23.45 10.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.521 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 80.45 -0.58 84.68 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.508 -0.854 . . . . 0.0 112.828 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 626' ' ' LYS . . . . . 0.578 ' O ' HD12 ' A' ' 620' ' ' ILE . 7.2 tptp -76.59 149.2 36.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.819 0.343 . . . . 0.0 111.026 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 627' ' ' ILE . . . . . 0.937 HG12 HD13 ' A' ' 620' ' ' ILE . 5.7 mt -116.87 114.87 47.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.977 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 628' ' ' LEU . . . . . 0.463 HD12 ' CE2' ' A' ' 649' ' ' TYR . 41.2 mt -84.71 128.39 34.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.808 0.337 . . . . 0.0 111.01 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.72 166.2 16.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.206 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 630' ' ' GLY . . . . . 0.429 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -50.63 -21.18 4.54 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.873 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 19.2 p -71.17 -43.66 67.05 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -98.3 -29.34 13.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.759 0.314 . . . . 0.0 111.56 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 633' ' ' ALA . . . . . 0.439 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.36 156.36 52.07 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.286 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.611 ' HG2' HD12 ' A' ' 639' ' ' LEU . 71.2 Cg_endo -73.37 163.6 37.35 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.727 2.285 . . . . 0.0 112.326 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -73.05 164.39 26.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.314 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -62.76 -31.57 72.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.85 0.357 . . . . 0.0 111.309 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.71 -36.23 48.75 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.371 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -104.01 3.33 33.27 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 639' ' ' LEU . . . . . 0.611 HD12 ' HG2' ' A' ' 634' ' ' PRO . 13.6 tp -58.36 -46.95 85.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.779 0.323 . . . . 0.0 111.121 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.17 -44.81 68.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.975 0.417 . . . . 0.0 111.132 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.79 -36.92 76.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.196 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 642' ' ' TRP . . . . . 0.454 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 47.6 t90 -66.67 -44.92 80.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 44.9 mt -65.91 -40.86 91.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.525 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.65 -40.87 96.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.647 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.1 -38.1 52.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.805 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -107.13 82.27 1.12 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.745 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.4 150.43 75.83 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.551 2.167 . . . . 0.0 112.447 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 648' ' ' GLY . . . . . 0.456 ' O ' HG23 ' A' ' 622' ' ' VAL . . . 104.45 -12.96 51.29 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.808 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.517 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 18.0 m-85 -90.03 160.94 16.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.829 0.347 . . . . 0.0 110.977 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -149.87 145.95 26.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.715 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.204 -179.897 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 16.1 mt . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.656 0.265 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -74.21 155.96 46.69 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.597 2.198 . . . . 0.0 112.25 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 617' ' ' VAL . . . . . 0.502 ' O ' ' HB1' ' A' ' 633' ' ' ALA . 21.4 t -117.47 133.33 64.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.131 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 618' ' ' LYS . . . . . 0.415 ' HG3' ' N ' ' A' ' 630' ' ' GLY . 0.0 OUTLIER -66.85 169.97 7.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.945 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 619' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 650' ' ' GLU . 26.8 m -157.14 162.88 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.82 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.21 128.04 12.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.987 0.422 . . . . 0.0 111.619 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 621' ' ' HIS . . . . . 0.494 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 3.6 t-160 -83.17 133.46 35.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.458 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.5 t -85.82 -23.67 6.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.754 0.311 . . . . 0.0 111.38 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -68.54 -37.41 79.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.494 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 49.0 m -117.17 -23.47 7.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.585 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 87.72 8.98 72.44 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.952 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.56 142.9 40.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.758 0.313 . . . . 0.0 110.807 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 1.9 mt -119.53 120.86 64.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.32 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 23.3 mt -90.43 138.18 31.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.752 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.61 165.89 16.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.554 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 630' ' ' GLY . . . . . 0.415 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -55.94 -18.63 19.33 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.766 -0.73 . . . . 0.0 113.068 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 2.5 m -71.75 -43.54 65.62 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.793 0.297 . . . . 0.0 111.524 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -98.18 -22.79 16.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.429 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 633' ' ' ALA . . . . . 0.502 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.55 156.26 54.46 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.169 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.584 ' HG2' HD12 ' A' ' 639' ' ' LEU . 71.7 Cg_endo -75.39 156.54 41.3 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.624 2.216 . . . . 0.0 112.313 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -73.95 168.02 20.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.487 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -62.86 -29.91 71.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.827 0.346 . . . . 0.0 111.249 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.64 -36.36 48.72 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.346 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.99 4.42 29.39 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 639' ' ' LEU . . . . . 0.584 HD12 ' HG2' ' A' ' 634' ' ' PRO . 16.4 tp -57.16 -52.32 65.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.697 0.284 . . . . 0.0 111.093 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -52.78 -43.7 66.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.969 0.414 . . . . 0.0 111.078 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.26 -36.25 76.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.924 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 642' ' ' TRP . . . . . 0.449 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 53.5 t90 -66.78 -49.64 65.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.68 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 82.1 mt -60.82 -42.11 97.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.488 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -61.06 -40.9 95.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.59 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.73 -25.68 49.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.993 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -121.87 78.98 40.82 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.773 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.1 144.12 86.3 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.717 2.278 . . . . 0.0 112.482 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.53 -7.58 46.58 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.841 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.494 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 12.2 m-85 -96.36 151.57 19.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.016 0.436 . . . . 0.0 111.105 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 650' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 619' ' ' VAL . 19.2 pt-20 -146.4 145.79 30.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.119 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 C--N 1.331 -0.237 0 CA-C-O 120.802 0.334 . . . . 0.0 111.487 -179.523 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 87.2 mt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.715 0.293 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.35 143.55 39.35 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.59 2.193 . . . . 0.0 112.446 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 617' ' ' VAL . . . . . 0.408 ' O ' ' HB1' ' A' ' 633' ' ' ALA . 21.6 t -118.89 115.32 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.007 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 618' ' ' LYS . . . . . 0.408 ' CB ' ' HA ' ' A' ' 629' ' ' THR . 0.0 OUTLIER -63.88 144.24 57.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.649 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 7.3 m -118.75 162.98 16.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.099 0.476 . . . . 0.0 111.544 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.429 ' CD1' HG12 ' A' ' 627' ' ' ILE . 4.9 tp -124.31 127.69 73.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.454 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 621' ' ' HIS . . . . . 0.498 ' HB2' ' CE1' ' A' ' 649' ' ' TYR . 6.3 t-160 -96.78 119.29 34.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.661 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.3 t -88.39 -33.62 6.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.281 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.42 -34.92 76.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.172 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 3.6 m -110.85 -23.39 11.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.336 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 85.76 -6.04 81.91 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.85 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.29 155.47 40.36 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.823 0.344 . . . . 0.0 110.788 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 627' ' ' ILE . . . . . 0.429 HG12 ' CD1' ' A' ' 620' ' ' ILE . 12.1 mt -126.75 121.27 58.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.293 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 628' ' ' LEU . . . . . 0.465 ' CD1' ' CE1' ' A' ' 649' ' ' TYR . 16.4 mt -103.06 124.93 49.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.425 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 629' ' ' THR . . . . . 0.408 ' HA ' ' CB ' ' A' ' 618' ' ' LYS . 0.4 OUTLIER -85.45 166.08 16.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.187 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . -46.84 -25.14 2.19 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.963 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 14.0 p -65.45 -43.96 88.76 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.616 0.246 . . . . 0.0 111.625 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -98.55 -24.24 15.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.874 0.369 . . . . 0.0 111.58 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 633' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.54 156.27 54.29 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.451 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.499 ' HG2' HD12 ' A' ' 639' ' ' LEU . 72.7 Cg_endo -75.25 163.95 33.82 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.82 2.347 . . . . 0.0 112.303 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -72.96 176.43 5.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.471 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -58.95 -48.92 79.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.405 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.67 -36.19 49.08 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.037 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -81.5 -9.8 59.62 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.645 0.239 . . . . 0.0 111.645 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 639' ' ' LEU . . . . . 0.499 HD12 ' HG2' ' A' ' 634' ' ' PRO . 13.1 tp -58.88 -53.35 59.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.713 0.292 . . . . 0.0 111.162 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -52.19 -49.33 64.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.944 0.402 . . . . 0.0 111.068 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -66.78 -35.88 81.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.891 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 642' ' ' TRP . . . . . 0.438 ' CZ3' ' HB2' ' A' ' 646' ' ' ASN . 27.9 t90 -66.85 -38.77 87.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.661 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 12.0 mt -68.33 -42.12 79.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.467 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.65 -41.01 96.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.469 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 3.3 tpp -77.73 -33.23 53.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.797 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 646' ' ' ASN . . . . . 0.438 ' HB2' ' CZ3' ' A' ' 642' ' ' TRP . 10.4 m-80 -115.28 79.28 6.59 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.755 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.46 148.59 73.48 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.569 2.179 . . . . 0.0 112.47 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.41 -8.77 48.55 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.789 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.498 ' CE1' ' HB2' ' A' ' 621' ' ' HIS . 17.7 m-85 -94.91 161.74 14.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.96 0.409 . . . . 0.0 111.168 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -149.86 168.09 24.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.753 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 29.2 t . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.975 179.955 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 5.6 mt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.719 0.295 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.18 140.92 31.65 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.525 2.15 . . . . 0.0 112.317 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.5 t -111.42 119.61 60.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.098 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 618' ' ' LYS . . . . . 0.468 ' O ' HG13 ' A' ' 619' ' ' VAL . 0.0 OUTLIER -58.85 174.49 0.34 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 619' ' ' VAL . . . . . 0.468 HG13 ' O ' ' A' ' 618' ' ' LYS . 16.2 m -157.87 155.85 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.135 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.942 HD13 HG12 ' A' ' 627' ' ' ILE . 4.9 tp -124.5 127.61 73.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.771 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 621' ' ' HIS . . . . . 0.51 ' CG ' ' CE1' ' A' ' 649' ' ' TYR . 6.4 t-160 -89.91 133.28 34.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.723 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 622' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 648' ' ' GLY . 26.1 t -87.12 -29.45 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.366 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 623' ' ' GLU . . . . . 0.455 ' HB3' ' CE1' ' A' ' 621' ' ' HIS . 32.4 tt0 -68.46 -37.16 79.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.374 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.18 -23.32 10.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.427 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 82.45 3.31 90.58 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.697 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 626' ' ' LYS . . . . . 0.814 ' O ' HD12 ' A' ' 620' ' ' ILE . 3.5 mtmt -76.7 151.14 36.21 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.81 0.338 . . . . 0.0 111.027 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 627' ' ' ILE . . . . . 0.942 HG12 HD13 ' A' ' 620' ' ' ILE . 7.1 mt -117.08 111.05 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.019 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 628' ' ' LEU . . . . . 0.506 HD12 ' CE2' ' A' ' 649' ' ' TYR . 75.4 mt -81.41 133.59 35.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.848 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.74 166.05 16.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.196 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 630' ' ' GLY . . . . . 0.427 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -50.27 -21.34 4.16 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.771 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 1.1 m -69.79 -43.48 72.02 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.06 -30.73 12.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.819 0.342 . . . . 0.0 111.465 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.41 156.35 52.59 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.187 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.685 ' HG2' HD12 ' A' ' 639' ' ' LEU . 73.0 Cg_endo -75.18 162.92 35.91 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.713 2.275 . . . . 0.0 112.451 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 43.0 mttm -85.44 157.04 20.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.571 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -53.04 -26.87 17.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.499 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -73.97 -36.29 52.34 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.395 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -116.02 14.23 16.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.025 0.413 . . . . 0.0 111.872 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 639' ' ' LEU . . . . . 0.685 HD12 ' HG2' ' A' ' 634' ' ' PRO . 10.9 tp -59.59 -51.61 69.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.796 0.331 . . . . 0.0 111.108 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -52.98 -43.28 66.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.99 0.424 . . . . 0.0 111.106 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.94 -38.93 76.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.806 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 642' ' ' TRP . . . . . 0.439 ' CZ3' ' HB2' ' A' ' 646' ' ' ASN . 37.7 t90 -64.69 -42.46 95.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.699 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 90.4 mt -66.61 -40.97 89.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.35 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -60.11 -41.04 91.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.494 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 18.4 ttt -77.47 -36.25 53.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.562 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 646' ' ' ASN . . . . . 0.439 ' HB2' ' CZ3' ' A' ' 642' ' ' TRP . 20.9 m-80 -112.38 78.01 2.45 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.584 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.81 149.03 83.43 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.609 2.206 . . . . 0.0 112.451 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 648' ' ' GLY . . . . . 0.612 ' O ' HG23 ' A' ' 622' ' ' VAL . . . 104.46 -18.89 43.78 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.615 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.51 ' CE1' ' CG ' ' A' ' 621' ' ' HIS . 21.3 m-85 -83.41 157.97 22.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.837 0.351 . . . . 0.0 111.005 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -148.61 145.9 27.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.563 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 2.7 m . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.407 -179.838 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 10.8 mt . . . . . 0 CA--C 1.528 0.11 0 CA-C-O 120.726 0.298 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.26 153.13 31.33 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.597 2.198 . . . . 0.0 112.425 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.7 t -118.85 122.63 69.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.065 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 618' ' ' LYS . . . . . 0.537 ' O ' HG13 ' A' ' 619' ' ' VAL . 0.1 OUTLIER -63.63 176.42 0.88 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.874 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 619' ' ' VAL . . . . . 0.537 HG13 ' O ' ' A' ' 618' ' ' LYS . 5.9 m -159.23 158.02 2.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.246 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.819 HD13 HG12 ' A' ' 627' ' ' ILE . 5.0 tp -124.57 127.55 72.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.686 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 621' ' ' HIS . . . . . 0.517 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 7.6 t-160 -89.82 127.46 35.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.734 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.6 t -88.47 -39.27 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 0.0 111.05 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -68.5 -29.97 68.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.388 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 1.7 t -112.83 -23.44 10.13 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.573 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 79.4 -0.0 82.08 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.825 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -76.44 156.83 32.77 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.812 0.339 . . . . 0.0 110.887 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 627' ' ' ILE . . . . . 0.819 HG12 HD13 ' A' ' 620' ' ' ILE . 2.8 mt -128.39 126.58 65.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.238 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 628' ' ' LEU . . . . . 0.462 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 11.5 mt -103.45 130.71 50.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.654 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.69 166.08 16.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.254 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 630' ' ' GLY . . . . . 0.409 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -53.59 -19.05 8.58 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.031 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 23.0 m -71.78 -43.81 65.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.681 0.277 . . . . 0.0 111.693 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -98.26 -23.18 15.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.857 0.361 . . . . 0.0 111.518 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.41 156.36 52.56 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.353 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.512 ' HG2' HD12 ' A' ' 639' ' ' LEU . 61.0 Cg_endo -71.68 163.96 37.25 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.764 2.31 . . . . 0.0 112.188 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -72.88 176.45 5.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.448 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -59.79 -49.01 79.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.792 0.33 . . . . 0.0 111.383 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.72 -36.22 48.71 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.01 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -81.16 -10.52 59.62 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 639' ' ' LEU . . . . . 0.512 HD12 ' HG2' ' A' ' 634' ' ' PRO . 10.9 tp -59.24 -50.71 72.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.774 0.321 . . . . 0.0 111.181 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -53.1 -45.63 68.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.299 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.77 -37.19 76.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.921 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 642' ' ' TRP . . . . . 0.444 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 51.8 t90 -64.28 -54.6 30.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.794 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 67.7 mt -58.53 -43.09 89.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.615 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -59.57 -38.13 80.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.614 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.03 -25.55 37.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.955 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -122.15 78.08 42.83 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.93 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.56 151.7 78.32 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.711 2.274 . . . . 0.0 112.313 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.41 -17.1 47.77 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.823 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.517 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 23.6 m-85 -89.54 152.25 21.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.907 0.384 . . . . 0.0 111.049 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -144.04 153.49 42.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.636 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.251 -179.902 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 25.4 mt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.764 0.316 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 616' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 635' ' ' LYS . 70.3 Cg_endo -74.69 148.1 36.33 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.604 2.203 . . . . 0.0 112.627 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.4 t -118.97 115.29 47.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.811 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.66 143.36 57.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.953 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 2.5 m -127.05 165.72 25.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.336 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.55 HD13 ' C ' ' A' ' 620' ' ' ILE . 0.0 OUTLIER -127.26 127.46 69.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.669 179.582 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 621' ' ' HIS . . . . . 0.462 ' ND1' ' CE2' ' A' ' 649' ' ' TYR . 5.9 t-160 -91.87 125.87 36.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.941 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 26.1 t -86.82 -31.1 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.264 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 623' ' ' GLU . . . . . 0.4 ' HB2' ' NE2' ' A' ' 621' ' ' HIS . 36.2 mt-10 -68.12 -37.3 80.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.106 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 21.1 t -105.75 -23.58 12.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.219 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 88.21 -15.37 56.39 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.922 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 10.0 mtpp -70.25 156.83 38.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.687 0.279 . . . . 0.0 110.918 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 2.0 mp -128.55 115.39 37.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.061 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 628' ' ' LEU . . . . . 0.499 HD12 ' CE1' ' A' ' 649' ' ' TYR . 15.8 mt -85.06 130.18 34.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.906 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 629' ' ' THR . . . . . 0.445 ' OG1' HG23 ' A' ' 631' ' ' THR . 0.7 OUTLIER -85.7 166.05 16.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.184 179.646 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 630' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' A' ' 616' ' ' PRO . . . -48.49 -24.05 3.58 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.838 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 631' ' ' THR . . . . . 0.445 HG23 ' OG1' ' A' ' 629' ' ' THR . 8.5 p -65.34 -43.98 89.21 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.51 -34.11 10.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.902 0.382 . . . . 0.0 111.642 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.38 156.12 53.72 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.712 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.697 ' HG2' HD12 ' A' ' 639' ' ' LEU . 89.5 Cg_endo -75.32 163.76 34.04 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.957 2.438 . . . . 0.0 112.556 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 635' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 616' ' ' PRO . 0.0 OUTLIER -92.06 166.1 12.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.511 179.362 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -52.94 -26.89 16.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.588 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -67.17 -36.25 89.82 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.416 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.33 17.57 7.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 117.014 0.407 . . . . 0.0 111.854 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 639' ' ' LEU . . . . . 0.697 HD12 ' HG2' ' A' ' 634' ' ' PRO . 13.9 tp -64.71 -54.58 29.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.779 0.323 . . . . 0.0 111.23 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -52.26 -43.42 64.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.182 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -67.97 -37.53 81.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.848 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 642' ' ' TRP . . . . . 0.483 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 28.0 t90 -66.81 -48.79 67.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.864 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 36.1 mt -60.18 -41.19 92.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.591 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.15 -40.98 99.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.581 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 28.8 ttp -79.49 -18.74 51.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.175 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 646' ' ' ASN . . . . . 0.43 ' HB2' ' CZ3' ' A' ' 642' ' ' TRP . 27.7 m-80 -129.56 68.36 80.3 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.866 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -56.84 154.33 32.7 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.539 2.16 . . . . 0.0 112.328 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.29 -16.77 48.79 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.706 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.499 ' CE1' HD12 ' A' ' 628' ' ' LEU . 25.0 m-85 -88.13 161.17 17.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.819 0.343 . . . . 0.0 111.125 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -149.74 157.85 43.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.788 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.158 179.983 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 16.3 mt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.683 0.277 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.94 151.12 39.43 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.597 2.198 . . . . 0.0 112.374 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.93 119.13 60.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.155 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.92 146.04 54.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.762 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 4.1 m -122.68 164.51 19.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.392 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.667 HD13 HG12 ' A' ' 627' ' ' ILE . 5.9 tp -124.46 127.64 73.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.573 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 621' ' ' HIS . . . . . 0.499 ' CD2' ' CD2' ' A' ' 649' ' ' TYR . 5.5 t-160 -95.5 118.82 32.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.78 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 19.2 t -89.18 -28.19 5.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.227 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -61.72 -37.37 83.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.108 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 61.3 m -119.17 -23.39 6.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.412 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 95.29 -3.29 66.25 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.837 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.33 147.07 51.61 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.811 0.339 . . . . 0.0 110.745 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 627' ' ' ILE . . . . . 0.667 HG12 HD13 ' A' ' 620' ' ' ILE . 1.6 mp -120.84 118.91 57.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.323 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 628' ' ' LEU . . . . . 0.516 HD12 ' CE1' ' A' ' 649' ' ' TYR . 27.2 mt -97.56 127.29 43.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.476 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.5 166.04 16.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.251 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . -49.2 -22.15 3.17 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.074 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 1.2 m -68.55 -43.98 75.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -98.42 -25.99 14.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.907 0.384 . . . . 0.0 111.47 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 633' ' ' ALA . . . . . 0.42 ' HB1' ' HD2' ' A' ' 634' ' ' PRO . . . -61.49 156.59 51.93 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.389 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.513 ' HG2' HD12 ' A' ' 639' ' ' LEU . 58.0 Cg_endo -69.45 163.85 36.45 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.884 2.389 . . . . 0.0 112.189 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 25.4 mttp -72.92 174.19 8.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.454 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -60.37 -48.94 79.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.381 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.83 -36.24 48.16 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.0 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -82.38 -9.62 59.38 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 639' ' ' LEU . . . . . 0.513 HD12 ' HG2' ' A' ' 634' ' ' PRO . 11.4 tp -57.35 -45.66 84.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.774 0.321 . . . . 0.0 111.197 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.27 -49.77 68.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.995 0.426 . . . . 0.0 111.309 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -68.92 -34.48 75.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.176 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 642' ' ' TRP . . . . . 0.427 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 49.7 t90 -67.03 -44.43 80.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.826 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 83.2 mt -65.47 -44.4 87.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.387 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -60.78 -37.19 81.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.523 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 6.3 mtt -80.97 -26.27 36.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.008 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -122.34 78.3 44.74 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.976 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -64.28 150.14 88.87 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.72 2.28 . . . . 0.0 112.388 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.38 -15.85 49.64 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.789 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.516 ' CE1' HD12 ' A' ' 628' ' ' LEU . 22.5 m-85 -88.55 161.77 16.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.918 0.39 . . . . 0.0 111.116 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -148.64 145.91 27.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.765 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.226 179.989 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 19.7 mt . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.775 0.321 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.53 152.4 65.28 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.609 2.206 . . . . 0.0 112.319 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 617' ' ' VAL . . . . . 0.442 ' O ' ' HB1' ' A' ' 633' ' ' ALA . 21.5 t -118.81 131.47 71.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.13 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 618' ' ' LYS . . . . . 0.53 ' O ' HG13 ' A' ' 619' ' ' VAL . 0.0 OUTLIER -70.16 172.8 7.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.88 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 619' ' ' VAL . . . . . 0.53 HG13 ' O ' ' A' ' 618' ' ' LYS . 6.2 m -159.17 162.97 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.171 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.893 HD13 ' CG1' ' A' ' 627' ' ' ILE . 4.7 tp -129.13 127.51 65.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.744 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 621' ' ' HIS . . . . . 0.504 ' CG ' ' CE1' ' A' ' 649' ' ' TYR . 8.1 t-160 -91.19 134.35 34.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.72 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 622' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 648' ' ' GLY . 25.5 t -87.39 -31.12 5.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.895 0.379 . . . . 0.0 111.108 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -68.6 -36.9 79.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.353 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 1.3 m -111.36 -23.27 10.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.645 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 81.43 1.69 90.19 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.817 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 626' ' ' LYS . . . . . 0.762 ' O ' HD12 ' A' ' 620' ' ' ILE . 0.0 OUTLIER -76.69 153.62 34.96 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.863 0.364 . . . . 0.0 110.958 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 627' ' ' ILE . . . . . 0.893 ' CG1' HD13 ' A' ' 620' ' ' ILE . 3.9 mt -120.67 109.26 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.096 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 628' ' ' LEU . . . . . 0.451 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 30.4 mt -78.33 129.86 35.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.817 0.341 . . . . 0.0 110.66 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.7 166.06 16.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.193 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . -52.38 -19.04 5.58 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.9 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 35.7 m -72.96 -43.61 62.08 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -98.03 -29.0 13.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.786 0.327 . . . . 0.0 111.604 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 633' ' ' ALA . . . . . 0.442 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.38 156.29 52.67 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.082 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.63 ' HG2' HD12 ' A' ' 639' ' ' LEU . 72.8 Cg_endo -75.28 157.85 41.38 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.672 2.248 . . . . 0.0 112.425 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 29.1 mttp -74.0 155.36 38.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.571 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -53.14 -26.98 18.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.503 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.37 -36.37 50.12 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.308 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -111.34 11.06 21.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.819 0.31 . . . . 0.0 111.733 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 639' ' ' LEU . . . . . 0.63 HD12 ' HG2' ' A' ' 634' ' ' PRO . 12.6 tp -63.63 -48.1 78.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.763 0.316 . . . . 0.0 111.103 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -52.83 -43.77 66.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.961 0.41 . . . . 0.0 111.095 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.87 -38.46 76.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.975 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 642' ' ' TRP . . . . . 0.444 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 30.5 t90 -67.68 -36.62 81.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.678 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 14.1 mt -69.3 -43.39 73.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.341 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.52 -40.96 96.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.456 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -75.68 -39.26 57.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.718 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -106.22 80.06 0.64 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.727 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.12 147.59 73.51 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.573 2.182 . . . . 0.0 112.448 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 648' ' ' GLY . . . . . 0.578 ' O ' HG23 ' A' ' 622' ' ' VAL . . . 104.43 -15.23 50.24 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.702 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.504 ' CE1' ' CG ' ' A' ' 621' ' ' HIS . 19.4 m-85 -86.66 153.08 22.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.806 0.336 . . . . 0.0 111.014 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -143.6 145.83 32.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.634 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 31.0 t . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.236 -179.983 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 10.0 mt . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.753 0.311 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.38 152.17 38.72 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.569 2.179 . . . . 0.0 112.365 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 617' ' ' VAL . . . . . 0.475 ' O ' ' HB1' ' A' ' 633' ' ' ALA . 26.5 t -118.87 129.36 75.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.025 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 618' ' ' LYS . . . . . 0.493 ' O ' HG13 ' A' ' 619' ' ' VAL . 0.0 OUTLIER -68.41 173.54 4.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 619' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 618' ' ' LYS . 12.0 m -158.58 160.67 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.21 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.862 HD13 HG12 ' A' ' 627' ' ' ILE . 5.5 tp -124.3 127.65 73.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.636 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 621' ' ' HIS . . . . . 0.508 ' CG ' ' CE1' ' A' ' 649' ' ' TYR . 7.3 t-160 -93.23 127.97 39.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.79 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 622' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 648' ' ' GLY . 21.4 t -88.68 -27.32 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.309 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 623' ' ' GLU . . . . . 0.429 ' HB3' ' CE1' ' A' ' 621' ' ' HIS . 13.2 tt0 -68.35 -37.22 80.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.149 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 12.4 p -113.51 -23.21 9.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.398 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 87.51 -5.72 84.57 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.886 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 626' ' ' LYS . . . . . 0.519 ' O ' HD12 ' A' ' 620' ' ' ILE . 29.1 tttt -69.39 156.8 38.23 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.856 0.36 . . . . 0.0 110.966 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 627' ' ' ILE . . . . . 0.862 HG12 HD13 ' A' ' 620' ' ' ILE . 2.6 mt -124.35 114.54 41.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.972 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 628' ' ' LEU . . . . . 0.502 HD12 ' CE2' ' A' ' 649' ' ' TYR . 45.1 mt -87.13 127.91 35.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.825 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.66 166.22 16.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.133 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 630' ' ' GLY . . . . . 0.416 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -49.58 -21.74 3.47 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.864 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 29.0 p -70.08 -43.69 70.62 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -98.38 -27.59 14.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.827 0.346 . . . . 0.0 111.628 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 633' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.41 156.36 52.61 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.298 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.513 ' HG2' HD12 ' A' ' 639' ' ' LEU . 71.5 Cg_endo -72.9 163.82 37.31 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.767 2.312 . . . . 0.0 112.314 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -73.04 172.54 10.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.4 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -61.01 -43.94 98.14 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.796 0.331 . . . . 0.0 111.433 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.54 -36.32 49.36 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.841 -0.695 . . . . 0.0 113.114 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -88.02 -6.05 58.18 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 639' ' ' LEU . . . . . 0.513 HD12 ' HG2' ' A' ' 634' ' ' PRO . 16.3 tp -58.49 -51.28 70.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.665 0.269 . . . . 0.0 111.229 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -50.67 -50.51 54.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.005 0.431 . . . . 0.0 111.122 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -66.55 -35.41 80.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.986 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 642' ' ' TRP . . . . . 0.442 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 36.4 t90 -67.63 -37.75 82.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.679 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.88 -46.03 72.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.291 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.27 -36.78 80.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.423 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 3.6 ttm -80.83 -24.33 38.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.894 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -125.8 75.46 70.84 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.872 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.84 149.59 90.34 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.682 2.254 . . . . 0.0 112.401 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 648' ' ' GLY . . . . . 0.402 ' O ' HG23 ' A' ' 622' ' ' VAL . . . 104.51 -18.29 44.89 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.735 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.508 ' CE1' ' CG ' ' A' ' 621' ' ' HIS . 20.7 m-85 -83.39 161.63 21.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.872 0.368 . . . . 0.0 111.075 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -149.64 145.98 27.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.75 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.159 -179.916 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 50.9 mt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.745 0.307 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.79 151.35 57.25 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.632 2.221 . . . . 0.0 112.324 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 617' ' ' VAL . . . . . 0.406 ' O ' ' HB1' ' A' ' 633' ' ' ALA . 21.3 t -118.83 128.92 75.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.143 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 618' ' ' LYS . . . . . 0.515 ' O ' HG13 ' A' ' 619' ' ' VAL . 0.0 OUTLIER -66.39 176.72 1.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.813 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 619' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 618' ' ' LYS . 10.1 m -158.95 158.84 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.257 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.749 HD13 HG12 ' A' ' 627' ' ' ILE . 5.3 tp -124.36 127.55 73.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.533 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 621' ' ' HIS . . . . . 0.484 ' CG ' ' CE1' ' A' ' 649' ' ' TYR . 7.8 t-160 -93.12 128.79 39.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.659 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.4 t -88.24 -34.65 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.216 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -68.46 -33.97 75.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.334 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 1.7 m -111.5 -23.4 10.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.558 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 82.39 -4.0 79.38 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.826 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.56 156.89 36.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.839 0.352 . . . . 0.0 110.935 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 627' ' ' ILE . . . . . 0.749 HG12 HD13 ' A' ' 620' ' ' ILE . 1.6 mt -125.85 119.13 53.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.102 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 628' ' ' LEU . . . . . 0.458 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 17.6 mt -90.36 130.36 36.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.877 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.69 165.98 16.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.181 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 630' ' ' GLY . . . . . 0.401 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -50.73 -21.26 4.74 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.966 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 22.1 p -69.83 -43.63 71.59 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -98.31 -30.18 12.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.785 0.326 . . . . 0.0 111.516 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 633' ' ' ALA . . . . . 0.406 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.36 156.25 52.79 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.182 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.686 ' HG2' HD12 ' A' ' 639' ' ' LEU . 72.4 Cg_endo -75.26 163.64 34.38 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.755 2.304 . . . . 0.0 112.444 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -80.52 157.08 26.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.546 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -53.08 -26.96 17.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.501 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.49 -36.3 49.68 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.81 -0.709 . . . . 0.0 113.39 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -113.51 12.6 18.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.964 0.382 . . . . 0.0 111.806 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 639' ' ' LEU . . . . . 0.686 HD12 ' HG2' ' A' ' 634' ' ' PRO . 11.9 tp -62.99 -49.69 73.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.775 0.321 . . . . 0.0 111.089 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -53.34 -41.73 66.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.211 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.74 -38.75 76.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.893 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 642' ' ' TRP . . . . . 0.443 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 47.3 t90 -66.14 -46.37 77.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.706 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 643' ' ' LEU . . . . . 0.431 HD12 ' HG ' ' A' ' 639' ' ' LEU . 15.3 mt -61.92 -44.34 96.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.589 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.65 -39.62 89.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.547 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.2 -24.53 47.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.982 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -124.05 77.12 59.26 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.939 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -61.88 149.9 88.28 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.577 2.184 . . . . 0.0 112.224 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.43 -13.31 51.26 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.816 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.484 ' CE1' ' CG ' ' A' ' 621' ' ' HIS . 24.5 m-85 -94.05 156.15 16.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.861 0.363 . . . . 0.0 111.014 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -149.98 151.82 33.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.783 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.08 -179.926 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 73.2 mt . . . . . 0 CA--C 1.527 0.078 0 CA-C-O 120.782 0.325 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.75 148.72 36.9 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.532 2.154 . . . . 0.0 112.364 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 617' ' ' VAL . . . . . 0.462 ' O ' ' HB1' ' A' ' 633' ' ' ALA . 21.8 t -118.83 115.38 47.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.963 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 618' ' ' LYS . . . . . 0.541 ' O ' HG13 ' A' ' 619' ' ' VAL . 0.0 OUTLIER -62.47 174.85 0.87 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.951 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 619' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 618' ' ' LYS . 4.6 m -159.15 157.62 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.199 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.496 HD13 ' C ' ' A' ' 620' ' ' ILE . 0.0 OUTLIER -124.37 127.64 73.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.805 179.785 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 621' ' ' HIS . . . . . 0.517 ' CD2' ' CD1' ' A' ' 649' ' ' TYR . 5.4 t-160 -87.59 124.73 33.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.794 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 622' ' ' VAL . . . . . 0.408 HG21 ' OE1' ' A' ' 650' ' ' GLU . 25.8 t -88.28 -29.48 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.311 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 623' ' ' GLU . . . . . 0.438 ' HB3' ' CE1' ' A' ' 621' ' ' HIS . 7.2 tp10 -68.38 -37.27 80.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.245 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 3.4 t -112.24 -23.33 10.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.281 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 89.26 -10.85 71.6 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.791 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -69.25 145.47 53.1 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.874 0.368 . . . . 0.0 110.854 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 10.1 mt -120.91 131.09 73.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.046 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 628' ' ' LEU . . . . . 0.455 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 11.1 mt -103.36 136.02 43.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.857 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.72 166.09 16.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.32 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 630' ' ' GLY . . . . . 0.405 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -51.39 -22.81 7.94 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.78 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 19.8 p -65.91 -43.84 86.99 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.719 0.295 . . . . 0.0 111.459 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -98.36 -21.56 16.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.341 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 633' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.48 156.24 53.92 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.352 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.505 ' HG2' HD12 ' A' ' 639' ' ' LEU . 73.3 Cg_endo -74.29 163.86 35.45 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.696 2.264 . . . . 0.0 112.174 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 31.5 mttt -72.98 175.62 6.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.475 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -60.54 -48.73 80.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.43 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.52 -36.25 49.63 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.943 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.07 -10.11 59.32 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 639' ' ' LEU . . . . . 0.514 ' HG ' HD12 ' A' ' 643' ' ' LEU . 10.6 tp -56.34 -50.62 70.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.73 0.3 . . . . 0.0 111.218 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -54.12 -47.63 71.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.989 0.423 . . . . 0.0 111.186 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -67.89 -36.59 80.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.754 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 642' ' ' TRP . . . . . 0.437 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 42.2 t90 -65.49 -43.77 89.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.723 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 643' ' ' LEU . . . . . 0.514 HD12 ' HG ' ' A' ' 639' ' ' LEU . 2.6 mt -63.55 -45.11 92.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.319 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -60.2 -37.44 80.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.378 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.14 -23.3 41.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.951 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -127.34 73.11 77.54 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.928 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -61.17 148.87 91.68 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.606 2.204 . . . . 0.0 112.391 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.36 -20.53 39.74 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.771 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.517 ' CD1' ' CD2' ' A' ' 621' ' ' HIS . 21.1 m-85 -81.68 150.58 27.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.874 0.369 . . . . 0.0 110.895 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 650' ' ' GLU . . . . . 0.408 ' OE1' HG21 ' A' ' 622' ' ' VAL . 26.2 mt-10 -137.33 145.93 43.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.724 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 31.7 t . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.235 -179.95 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 7.8 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.76 0.314 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.67 150.69 35.68 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.646 2.231 . . . . 0.0 112.466 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 617' ' ' VAL . . . . . 0.456 ' O ' ' HB1' ' A' ' 633' ' ' ALA . 27.9 t -118.8 127.35 75.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.053 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 618' ' ' LYS . . . . . 0.549 ' O ' HG13 ' A' ' 619' ' ' VAL . 0.0 OUTLIER -65.39 167.96 7.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.953 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 619' ' ' VAL . . . . . 0.549 HG13 ' O ' ' A' ' 618' ' ' LYS . 5.2 m -159.24 161.45 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.003 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 12.8 tt -134.98 128.14 49.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.926 0.394 . . . . 0.0 111.528 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 621' ' ' HIS . . . . . 0.491 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 13.8 t-160 -80.51 137.93 36.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.33 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 622' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 648' ' ' GLY . 20.8 t -85.18 -22.16 7.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.779 0.323 . . . . 0.0 111.482 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 623' ' ' GLU . . . . . 0.44 ' HB3' ' CE1' ' A' ' 621' ' ' HIS . 26.1 tt0 -68.46 -37.4 80.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.499 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 32.0 t -120.12 -23.39 6.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.705 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 86.69 10.41 73.02 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.754 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 7.3 tppt? -76.58 146.92 37.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.785 0.326 . . . . 0.0 110.754 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 3.4 mp -119.97 123.55 71.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.335 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 628' ' ' LEU . . . . . 0.448 ' CD1' ' CE1' ' A' ' 649' ' ' TYR . 15.0 mt -92.35 140.03 30.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.636 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.77 165.88 16.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.389 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . -56.04 -18.46 19.56 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.841 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 6.0 m -70.94 -43.7 67.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.648 0.261 . . . . 0.0 111.484 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.11 -24.22 15.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.797 0.332 . . . . 0.0 111.374 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 633' ' ' ALA . . . . . 0.456 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.52 156.2 54.54 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.161 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.455 ' HG2' HD12 ' A' ' 639' ' ' LEU . 73.0 Cg_endo -74.75 163.77 35.03 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.689 2.259 . . . . 0.0 112.327 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 21.7 mttp -72.99 175.77 6.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.433 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -61.39 -48.97 78.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.774 0.321 . . . . 0.0 111.205 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.71 -36.26 48.64 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.832 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.94 -11.31 59.59 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.619 0.229 . . . . 0.0 111.619 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 639' ' ' LEU . . . . . 0.455 HD12 ' HG2' ' A' ' 634' ' ' PRO . 10.9 tp -55.98 -47.52 77.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.726 0.298 . . . . 0.0 111.211 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -54.85 -47.75 73.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.997 0.427 . . . . 0.0 111.105 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -67.89 -36.92 81.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.701 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 642' ' ' TRP . . . . . 0.44 ' CZ3' ' HB2' ' A' ' 646' ' ' ASN . 39.7 t90 -66.59 -38.6 87.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.491 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 8.3 mt -66.26 -44.72 82.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.077 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -59.5 -40.03 85.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.201 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 2.7 ttm -79.26 -21.02 46.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.83 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 646' ' ' ASN . . . . . 0.44 ' HB2' ' CZ3' ' A' ' 642' ' ' TRP . 23.9 m-80 -133.4 65.67 72.78 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.842 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -59.65 149.79 80.44 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.57 2.18 . . . . 0.0 112.444 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 648' ' ' GLY . . . . . 0.67 ' O ' HG23 ' A' ' 622' ' ' VAL . . . 104.46 -13.55 51.05 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.852 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.491 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 13.2 m-85 -85.01 142.31 29.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 0.0 111.053 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 650' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 619' ' ' VAL . 1.4 mm-40 -130.74 146.18 52.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.509 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 27.2 t . . . . . 0 C--N 1.33 -0.258 0 CA-C-O 120.835 0.35 . . . . 0.0 111.297 -179.794 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 71.2 mt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.755 0.312 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.41 144.3 28.79 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.584 2.189 . . . . 0.0 112.309 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 617' ' ' VAL . . . . . 0.457 ' CG1' HG13 ' A' ' 651' ' ' VAL . 21.6 t -118.81 115.66 48.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.145 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 618' ' ' LYS . . . . . 0.491 ' O ' HG13 ' A' ' 619' ' ' VAL . 0.3 OUTLIER -65.46 175.66 1.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.813 179.912 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 619' ' ' VAL . . . . . 0.491 HG13 ' O ' ' A' ' 618' ' ' LYS . 11.2 m -158.33 157.07 3.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.158 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.799 HD13 HG12 ' A' ' 627' ' ' ILE . 5.6 tp -124.35 127.6 73.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.922 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 621' ' ' HIS . . . . . 0.502 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 7.1 t-160 -89.51 127.98 35.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.692 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.6 t -88.35 -38.03 11.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.071 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -68.52 -30.59 69.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.413 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 8.9 t -112.5 -23.36 10.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.543 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 79.27 1.88 86.55 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.746 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 626' ' ' LYS . . . . . 0.59 ' O ' HD12 ' A' ' 620' ' ' ILE . 0.4 OUTLIER -76.67 156.79 32.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.825 0.345 . . . . 0.0 110.888 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 627' ' ' ILE . . . . . 0.799 HG12 HD13 ' A' ' 620' ' ' ILE . 1.9 mt -126.65 124.46 65.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.103 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 628' ' ' LEU . . . . . 0.451 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 19.1 mt -102.25 129.89 48.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.842 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.6 166.09 16.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.221 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 630' ' ' GLY . . . . . 0.43 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -50.2 -22.23 4.78 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.832 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 8.1 p -68.5 -43.79 76.09 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -98.43 -25.05 14.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.524 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 633' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.48 154.7 63.01 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.262 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.556 ' HG2' HD12 ' A' ' 639' ' ' LEU . 72.0 Cg_endo -75.44 161.72 37.07 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.625 2.216 . . . . 0.0 112.382 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -81.66 158.85 24.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.411 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -53.1 -27.09 18.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.787 0.327 . . . . 0.0 111.417 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.68 -36.34 48.57 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.831 -0.699 . . . . 0.0 113.397 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -111.96 11.63 20.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.875 0.337 . . . . 0.0 111.908 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 639' ' ' LEU . . . . . 0.556 HD12 ' HG2' ' A' ' 634' ' ' PRO . 10.4 tp -62.18 -52.19 64.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.799 0.333 . . . . 0.0 111.084 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -53.24 -42.34 66.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.125 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.98 -39.06 76.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.883 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 642' ' ' TRP . . . . . 0.451 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 34.7 t90 -64.59 -46.91 80.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.677 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 643' ' ' LEU . . . . . 0.464 HD23 ' HA ' ' A' ' 643' ' ' LEU . 11.7 mt -63.83 -40.53 96.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.509 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -60.63 -41.01 94.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.568 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 1.2 ttt -78.03 -35.75 49.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.845 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 646' ' ' ASN . . . . . 0.43 ' HB2' ' CZ3' ' A' ' 642' ' ' TRP . 24.5 m-80 -109.88 81.32 1.99 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.79 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.45 147.85 71.98 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.563 2.176 . . . . 0.0 112.392 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.46 -14.15 50.8 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.738 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.502 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 17.1 m-85 -88.39 149.41 23.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.85 0.357 . . . . 0.0 111.009 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -136.22 145.76 46.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.641 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 651' ' ' VAL . . . . . 0.457 HG13 ' CG1' ' A' ' 617' ' ' VAL . 21.2 t . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.234 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 80.1 mt . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.842 0.353 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.31 145.68 24.24 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.71 2.274 . . . . 0.0 112.402 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 617' ' ' VAL . . . . . 0.51 ' CG1' HG13 ' A' ' 651' ' ' VAL . 21.3 t -118.84 119.88 62.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.086 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 618' ' ' LYS . . . . . 0.422 ' HG3' ' N ' ' A' ' 630' ' ' GLY . 0.0 OUTLIER -61.41 169.58 2.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.911 0.386 . . . . 0.0 110.985 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 619' ' ' VAL . . . . . 0.517 HG23 ' CD1' ' A' ' 649' ' ' TYR . 32.9 m -155.83 143.35 11.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.858 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.493 HD13 ' C ' ' A' ' 620' ' ' ILE . 0.0 OUTLIER -124.37 127.58 73.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.888 0.375 . . . . 0.0 111.132 -179.768 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 621' ' ' HIS . . . . . 0.492 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 3.6 t-160 -86.69 131.09 34.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.62 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.6 t -86.43 -29.69 6.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.851 0.357 . . . . 0.0 111.054 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -68.55 -37.38 79.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.49 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 8.7 p -111.96 -23.48 10.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.456 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 87.21 -10.52 68.5 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.921 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.4 141.99 53.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.797 0.332 . . . . 0.0 110.89 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 1.9 mt -121.08 129.39 75.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.307 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 628' ' ' LEU . . . . . 0.46 HD12 ' CG2' ' A' ' 619' ' ' VAL . 12.5 mt -95.68 139.64 31.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.777 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.84 165.91 16.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.497 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 630' ' ' GLY . . . . . 0.422 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -57.2 -18.38 27.77 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.92 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.63 -43.73 68.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.753 0.311 . . . . 0.0 111.446 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -98.19 -22.49 16.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.358 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.46 156.33 53.19 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.291 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.461 ' HG2' HD12 ' A' ' 639' ' ' LEU . 64.1 Cg_endo -72.42 163.82 37.45 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.735 2.29 . . . . 0.0 112.247 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -72.9 176.45 5.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.525 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -59.43 -48.49 81.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.46 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.47 -36.19 50.03 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.049 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -81.73 -9.85 59.53 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 639' ' ' LEU . . . . . 0.461 HD12 ' HG2' ' A' ' 634' ' ' PRO . 12.0 tp -62.18 -50.11 73.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.654 0.264 . . . . 0.0 111.077 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -52.41 -46.25 66.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.001 0.429 . . . . 0.0 111.17 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.48 -37.61 77.32 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.919 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 642' ' ' TRP . . . . . 0.442 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 44.2 t90 -65.31 -40.81 94.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.747 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 86.0 mt -67.59 -42.58 82.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.319 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.64 -40.45 87.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.414 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.22 -37.09 54.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.623 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -110.92 80.25 2.16 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.648 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.43 147.65 71.73 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.462 2.108 . . . . 0.0 112.454 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.45 -7.74 47.07 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.836 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.517 ' CD1' HG23 ' A' ' 619' ' ' VAL . 12.5 m-85 -93.47 157.55 16.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.897 0.379 . . . . 0.0 111.026 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 650' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 619' ' ' VAL . 18.7 mm-40 -149.4 151.67 34.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.26 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 651' ' ' VAL . . . . . 0.51 HG13 ' CG1' ' A' ' 617' ' ' VAL . 28.5 t . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 120.821 0.344 . . . . 0.0 111.259 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 39.3 mt . . . . . 0 CA--C 1.527 0.094 0 CA-C-O 120.67 0.272 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.05 155.99 47.45 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.604 2.203 . . . . 0.0 112.323 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 617' ' ' VAL . . . . . 0.612 ' CG1' HG13 ' A' ' 651' ' ' VAL . 27.9 t -118.69 121.06 66.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.06 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.53 134.97 39.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.965 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 619' ' ' VAL . . . . . 0.596 HG12 ' HA ' ' A' ' 651' ' ' VAL . 2.6 m -124.0 176.89 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.189 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 3.4 tt -143.0 133.12 22.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.509 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 621' ' ' HIS . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 3.3 t-160 -84.65 136.89 33.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.055 179.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 622' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 648' ' ' GLY . 27.0 t -84.65 -36.55 11.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.826 0.346 . . . . 0.0 111.21 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -68.56 -33.0 73.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.41 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.17 -23.24 12.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.55 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 77.36 4.55 84.4 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.683 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 9.0 tttt -76.57 148.38 37.06 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.76 0.314 . . . . 0.0 110.836 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 10.7 mt -122.28 105.54 16.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.363 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 628' ' ' LEU . . . . . 0.452 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 13.6 mt -80.1 130.99 35.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.322 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.53 166.03 16.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.384 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . -50.51 -22.59 5.59 Favored Glycine 0 CA--C 1.517 0.193 0 C-N-CA 120.81 -0.71 . . . . 0.0 113.005 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.16 -43.89 81.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.675 0.274 . . . . 0.0 111.586 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -98.18 -23.72 15.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.911 0.386 . . . . 0.0 111.489 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 633' ' ' ALA . . . . . 0.442 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.62 156.41 54.22 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.302 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.451 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 71.7 Cg_endo -75.11 163.79 34.41 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.878 2.385 . . . . 0.0 112.222 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -72.97 174.73 7.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.495 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -60.99 -44.21 97.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.852 0.358 . . . . 0.0 111.461 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.67 -36.22 49.0 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.214 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 6.1 mm100 -87.19 -7.36 58.02 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 639' ' ' LEU . . . . . 0.446 HD12 ' HG2' ' A' ' 634' ' ' PRO . 14.3 tp -59.62 -49.6 77.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.759 0.314 . . . . 0.0 111.197 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -52.42 -50.39 62.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.943 0.402 . . . . 0.0 111.281 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -66.58 -34.53 78.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.096 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 642' ' ' TRP . . . . . 0.451 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 49.5 t90 -66.73 -46.12 76.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.875 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 35.9 mt -62.76 -43.8 97.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.479 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.17 -38.83 87.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.562 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 6.8 tmm? -78.88 -24.85 43.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.005 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -123.39 77.8 53.84 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.826 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -64.81 144.68 84.28 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.705 2.27 . . . . 0.0 112.395 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 648' ' ' GLY . . . . . 0.456 ' O ' HG23 ' A' ' 622' ' ' VAL . . . 104.48 -3.41 43.04 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.965 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.479 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 7.7 m-85 -96.25 152.53 18.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.894 0.378 . . . . 0.0 110.976 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -147.81 147.2 29.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.847 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 651' ' ' VAL . . . . . 0.612 HG13 ' CG1' ' A' ' 617' ' ' VAL . 21.4 t . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.126 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 28.5 mt . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.722 0.296 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.19 136.87 20.57 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.548 2.166 . . . . 0.0 112.365 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 617' ' ' VAL . . . . . 0.49 ' O ' ' HB1' ' A' ' 633' ' ' ALA . 21.5 t -112.65 115.44 49.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.06 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 618' ' ' LYS . . . . . 0.49 ' O ' HG13 ' A' ' 619' ' ' VAL . 0.3 OUTLIER -60.76 173.2 0.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.967 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 619' ' ' VAL . . . . . 0.589 ' O ' HG23 ' A' ' 627' ' ' ILE . 5.7 m -157.81 159.31 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.237 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.403 HG12 ' CG1' ' A' ' 627' ' ' ILE . 0.0 OUTLIER -124.72 127.71 72.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.696 179.652 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 621' ' ' HIS . . . . . 0.519 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 5.6 t-160 -88.77 127.59 35.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.746 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 26.9 t -88.36 -28.53 5.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.167 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 623' ' ' GLU . . . . . 0.441 ' HB3' ' CE1' ' A' ' 621' ' ' HIS . 2.4 tm-20 -68.52 -37.29 79.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.232 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 1.6 t -114.52 -23.38 9.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.542 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 90.57 -12.61 67.91 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.74 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.31 143.61 53.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.844 0.355 . . . . 0.0 110.922 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 627' ' ' ILE . . . . . 0.589 HG23 ' O ' ' A' ' 619' ' ' VAL . 2.0 mt -120.36 127.09 75.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.21 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 628' ' ' LEU . . . . . 0.463 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 5.6 mt -93.75 133.77 36.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.814 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 629' ' ' THR . . . . . 0.608 ' OG1' HG22 ' A' ' 631' ' ' THR . 0.3 OUTLIER -85.85 166.28 16.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.327 179.758 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 630' ' ' GLY . . . . . 0.439 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -50.08 -23.59 5.78 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.977 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 631' ' ' THR . . . . . 0.608 HG22 ' OG1' ' A' ' 629' ' ' THR . 5.8 t -65.72 -43.4 89.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.703 0.287 . . . . 0.0 111.305 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.35 -20.58 17.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.359 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 633' ' ' ALA . . . . . 0.49 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.53 150.7 80.17 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.318 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.478 ' HG2' HD12 ' A' ' 639' ' ' LEU . 72.9 Cg_endo -75.27 163.81 34.05 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.753 2.302 . . . . 0.0 112.353 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 35.5 mttp -73.03 172.0 11.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.425 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -62.39 -38.09 88.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.862 0.363 . . . . 0.0 111.425 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.7 -36.22 48.83 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.237 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -94.38 -3.34 50.47 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 639' ' ' LEU . . . . . 0.478 HD12 ' HG2' ' A' ' 634' ' ' PRO . 13.6 tp -59.64 -50.54 73.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.728 0.299 . . . . 0.0 111.194 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -52.9 -44.52 67.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.219 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.82 -36.81 75.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.003 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 642' ' ' TRP . . . . . 0.434 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 35.1 t90 -67.23 -41.27 85.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.789 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 643' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 643' ' ' LEU . 16.4 mt -67.13 -43.56 82.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.479 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -60.78 -40.49 92.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.541 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.35 -37.28 57.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.797 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -107.84 81.76 1.26 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.818 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -68.39 147.43 71.48 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.616 2.211 . . . . 0.0 112.442 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.34 -20.59 39.63 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.578 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.519 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 23.8 m-85 -81.57 149.97 28.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.876 0.37 . . . . 0.0 111.115 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -142.49 155.62 45.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.62 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.18 179.998 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 615' ' ' LEU . . . . . 0.469 HD22 ' HD2' ' A' ' 616' ' ' PRO . 13.4 mt . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.675 0.274 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 616' ' ' PRO . . . . . 0.469 ' HD2' HD22 ' A' ' 615' ' ' LEU . 74.3 Cg_endo -75.36 140.0 24.01 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.606 2.204 . . . . 0.0 112.32 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 617' ' ' VAL . . . . . 0.473 ' O ' ' HB1' ' A' ' 633' ' ' ALA . 26.2 t -116.45 115.41 48.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.055 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 618' ' ' LYS . . . . . 0.471 ' HG3' ' N ' ' A' ' 630' ' ' GLY . 0.0 OUTLIER -61.51 170.79 1.71 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.923 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 619' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 650' ' ' GLU . 27.7 m -157.42 146.06 10.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.995 179.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.404 HG12 HG13 ' A' ' 627' ' ' ILE . 0.0 OUTLIER -124.43 127.63 73.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.943 0.402 . . . . 0.0 111.265 -179.754 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 621' ' ' HIS . . . . . 0.51 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 4.4 t-160 -83.96 131.79 34.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.675 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.5 t -87.8 -29.77 5.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.897 0.38 . . . . 0.0 111.051 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -68.43 -37.3 80.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.198 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 1.5 m -110.85 -23.48 10.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.405 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 85.58 -7.62 75.69 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.906 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -69.4 152.39 44.98 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.791 0.329 . . . . 0.0 110.824 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 627' ' ' ILE . . . . . 0.404 HG13 HG12 ' A' ' 620' ' ' ILE . 2.0 mt -127.64 138.66 54.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.213 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 26.4 mt -105.46 139.2 40.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.768 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.83 165.96 16.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.483 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 630' ' ' GLY . . . . . 0.471 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -56.48 -18.94 24.52 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.005 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 10.0 t -71.17 -43.55 67.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.685 0.278 . . . . 0.0 111.554 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.2 -21.39 16.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.342 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 633' ' ' ALA . . . . . 0.473 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.53 156.22 54.53 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.247 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.45 ' HG2' HD12 ' A' ' 639' ' ' LEU . 71.6 Cg_endo -73.88 163.79 36.15 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.631 2.221 . . . . 0.0 112.287 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 4.3 mtpp -73.04 176.4 5.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.595 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -60.7 -48.96 79.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.802 0.334 . . . . 0.0 111.286 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.72 -36.32 48.46 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.877 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.11 -11.84 59.72 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 639' ' ' LEU . . . . . 0.45 HD12 ' HG2' ' A' ' 634' ' ' PRO . 10.5 tp -57.71 -49.65 75.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.758 0.313 . . . . 0.0 111.143 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.73 -45.59 70.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.111 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.74 -37.72 76.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.872 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 642' ' ' TRP . . . . . 0.45 ' CZ3' ' HB2' ' A' ' 646' ' ' ASN . 34.9 t90 -64.83 -42.67 94.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.682 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 65.6 mt -66.33 -42.4 88.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.417 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.17 -41.1 87.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.459 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 4.1 mmt -77.55 -35.17 53.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.645 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 646' ' ' ASN . . . . . 0.45 ' HB2' ' CZ3' ' A' ' 642' ' ' TRP . 23.5 m-80 -113.17 79.75 3.87 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.779 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.33 145.96 67.44 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.608 2.205 . . . . 0.0 112.404 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.44 -6.24 45.43 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.832 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.526 ' CD1' HG23 ' A' ' 619' ' ' VAL . 11.4 m-85 -95.51 149.5 21.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.911 0.386 . . . . 0.0 111.021 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 650' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 619' ' ' VAL . 69.1 mt-10 -136.5 145.46 45.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.17 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 2.4 m . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 120.9 0.381 . . . . 0.0 111.491 -179.594 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 16.2 mt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.707 0.289 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.31 142.62 21.46 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.698 2.265 . . . . 0.0 112.442 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 617' ' ' VAL . . . . . 0.743 ' CG1' HG13 ' A' ' 651' ' ' VAL . 21.5 t -118.92 122.72 70.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.122 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 618' ' ' LYS . . . . . 0.412 ' HG3' ' N ' ' A' ' 630' ' ' GLY . 0.8 OUTLIER -65.11 171.17 3.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.759 179.883 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 619' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 650' ' ' GLU . 27.2 m -156.71 152.43 7.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.308 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.92 HD13 ' CG1' ' A' ' 627' ' ' ILE . 3.6 tp -124.88 127.45 72.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.647 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 621' ' ' HIS . . . . . 0.527 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 4.1 t-160 -89.26 135.83 33.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.633 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 622' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 648' ' ' GLY . 25.8 t -87.12 -35.77 8.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.819 0.343 . . . . 0.0 111.287 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 623' ' ' GLU . . . . . 0.439 ' HB2' ' CE1' ' A' ' 621' ' ' HIS . 30.2 mt-10 -68.59 -32.99 73.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.536 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 3.3 t -112.2 -23.36 10.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.592 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 78.97 0.29 81.55 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.906 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 626' ' ' LYS . . . . . 0.647 ' O ' HD12 ' A' ' 620' ' ' ILE . 5.6 ttmt -76.68 150.56 36.32 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.757 0.313 . . . . 0.0 110.929 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 627' ' ' ILE . . . . . 0.92 ' CG1' HD13 ' A' ' 620' ' ' ILE . 6.2 mt -119.32 119.38 60.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.199 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 628' ' ' LEU . . . . . 0.485 ' HB2' HG22 ' A' ' 619' ' ' VAL . 37.2 mt -87.13 135.82 33.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.745 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.52 166.03 16.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.407 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 630' ' ' GLY . . . . . 0.412 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -56.37 -17.73 19.54 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.646 -0.788 . . . . 0.0 113.004 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.55 -43.6 59.5 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.75 0.275 . . . . 0.0 111.681 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.15 -24.08 15.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.702 0.287 . . . . 0.0 111.461 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 633' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.44 154.3 64.77 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.171 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.609 ' HG2' HD12 ' A' ' 639' ' ' LEU . 72.7 Cg_endo -75.26 156.83 41.87 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.598 2.199 . . . . 0.0 112.414 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? -73.22 165.59 24.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.42 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -62.79 -29.14 70.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.81 0.338 . . . . 0.0 111.302 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.57 -36.35 49.11 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.308 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -106.69 4.72 28.1 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 639' ' ' LEU . . . . . 0.609 HD12 ' HG2' ' A' ' 634' ' ' PRO . 13.5 tp -57.26 -50.13 73.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.749 0.309 . . . . 0.0 111.079 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -52.88 -42.12 65.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.987 0.422 . . . . 0.0 110.961 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.85 -39.7 76.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.775 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 642' ' ' TRP . . . . . 0.433 ' CZ3' ' HB2' ' A' ' 646' ' ' ASN . 33.3 t90 -66.32 -36.53 83.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.554 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 46.7 mt -69.4 -41.76 76.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.296 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -61.24 -41.16 96.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.328 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 73.7 mtp -77.83 -32.06 51.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.623 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 646' ' ' ASN . . . . . 0.433 ' HB2' ' CZ3' ' A' ' 642' ' ' TRP . 28.2 m-80 -118.93 75.45 13.76 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.682 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.19 149.79 76.45 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.562 2.175 . . . . 0.0 112.442 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 648' ' ' GLY . . . . . 0.578 ' O ' HG23 ' A' ' 622' ' ' VAL . . . 104.39 -12.3 51.26 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.779 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.527 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 16.0 m-85 -87.8 159.3 18.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.89 0.376 . . . . 0.0 111.032 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 650' ' ' GLU . . . . . 0.514 ' O ' ' HA ' ' A' ' 619' ' ' VAL . 30.1 mt-10 -149.96 147.22 27.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.232 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 651' ' ' VAL . . . . . 0.743 HG13 ' CG1' ' A' ' 617' ' ' VAL . 31.3 t . . . . . 0 C--N 1.33 -0.273 0 CA-C-O 120.777 0.323 . . . . 0.0 111.272 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 8.9 mt . . . . . 0 CA--C 1.529 0.161 0 CA-C-O 120.613 0.244 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.29 149.48 27.94 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.612 2.208 . . . . 0.0 112.444 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 617' ' ' VAL . . . . . 0.526 ' CG1' HG13 ' A' ' 651' ' ' VAL . 21.4 t -118.87 130.54 73.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.112 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 618' ' ' LYS . . . . . 0.418 ' HG3' ' N ' ' A' ' 630' ' ' GLY . 0.0 OUTLIER -67.43 164.83 17.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.992 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 619' ' ' VAL . . . . . 0.613 HG23 ' CD1' ' A' ' 649' ' ' TYR . 33.5 m -156.19 144.07 11.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.97 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 649' ' ' TYR . 0.0 OUTLIER -124.24 127.66 73.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.889 0.376 . . . . 0.0 111.285 -179.813 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 621' ' ' HIS . . . . . 0.488 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 2.5 t-160 -85.46 133.52 34.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.601 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 20.5 t -86.62 -29.52 5.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.77 0.319 . . . . 0.0 111.133 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.53 -37.34 79.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.357 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 1.8 m -110.1 -23.36 11.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.355 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 82.5 5.83 89.16 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.006 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.63 151.99 36.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.755 0.312 . . . . 0.0 110.895 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 3.5 mt -127.4 114.47 36.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.221 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 628' ' ' LEU . . . . . 0.516 HD12 ' CG2' ' A' ' 619' ' ' VAL . 19.1 mt -86.76 134.46 33.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.808 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.81 166.09 16.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.496 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 630' ' ' GLY . . . . . 0.418 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -58.46 -15.36 24.18 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.176 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.51 -43.68 38.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.899 0.35 . . . . 0.0 111.742 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.94 -26.1 14.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.873 0.368 . . . . 0.0 111.371 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.51 156.03 55.54 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.215 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.431 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 52.2 Cg_endo -68.69 163.81 35.64 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.594 2.196 . . . . 0.0 112.195 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 26.9 mttp -72.85 171.47 12.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.473 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -62.63 -40.21 96.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.426 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.58 -36.25 49.34 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.099 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -91.21 -5.25 55.14 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 639' ' ' LEU . . . . . 0.423 HD12 ' HG2' ' A' ' 634' ' ' PRO . 15.3 tp -57.78 -50.76 72.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.714 0.292 . . . . 0.0 111.271 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.08 -44.0 61.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.913 0.387 . . . . 0.0 111.111 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -68.17 -39.16 82.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.977 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 642' ' ' TRP . . . . . 0.436 ' CD2' ' ND2' ' A' ' 646' ' ' ASN . 18.4 t90 -68.98 -34.0 74.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.851 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 17.4 mt -69.05 -47.5 65.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.481 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -61.31 -41.07 96.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.486 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 15.9 tpt -74.17 -33.87 63.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.583 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 646' ' ' ASN . . . . . 0.436 ' ND2' ' CD2' ' A' ' 642' ' ' TRP . 35.6 m-80 -114.47 74.23 3.02 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.647 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.81 147.09 89.41 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.613 2.208 . . . . 0.0 112.51 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.44 -4.12 43.61 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.893 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.613 ' CD1' HG23 ' A' ' 619' ' ' VAL . 8.9 m-85 -94.88 156.59 16.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.966 0.412 . . . . 0.0 111.109 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 650' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 619' ' ' VAL . 14.7 mm-40 -144.27 145.75 32.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.281 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 651' ' ' VAL . . . . . 0.526 HG13 ' CG1' ' A' ' 617' ' ' VAL . 24.3 t . . . . . 0 C--N 1.33 -0.262 0 CA-C-O 120.811 0.338 . . . . 0.0 111.32 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 62.3 mt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.766 0.317 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.82 149.08 53.39 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.562 2.175 . . . . 0.0 112.294 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 617' ' ' VAL . . . . . 0.417 ' O ' ' HB1' ' A' ' 633' ' ' ALA . 21.2 t -118.81 119.92 62.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.984 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 618' ' ' LYS . . . . . 0.486 ' O ' HG13 ' A' ' 619' ' ' VAL . 0.0 OUTLIER -55.41 172.01 0.16 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.924 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 619' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 618' ' ' LYS . 12.1 m -158.13 160.02 2.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.248 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.792 HD13 HG12 ' A' ' 627' ' ' ILE . 6.4 tp -124.41 127.67 73.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.784 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 621' ' ' HIS . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 7.2 t-160 -92.31 128.63 38.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.723 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.4 t -87.74 -28.61 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.859 0.361 . . . . 0.0 111.256 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.57 -37.15 79.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.388 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 70.1 m -113.99 -23.35 9.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.615 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 84.8 4.95 86.89 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.748 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 626' ' ' LYS . . . . . 0.653 ' O ' HD12 ' A' ' 620' ' ' ILE . 0.1 OUTLIER -76.58 156.84 32.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.863 0.363 . . . . 0.0 111.079 -179.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 627' ' ' ILE . . . . . 0.792 HG12 HD13 ' A' ' 620' ' ' ILE . 2.4 mt -125.35 115.29 43.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.054 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 628' ' ' LEU . . . . . 0.451 ' CD1' ' CE1' ' A' ' 649' ' ' TYR . 28.4 mt -90.04 130.33 36.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.822 0.344 . . . . 0.0 110.875 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.78 166.22 16.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.12 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 630' ' ' GLY . . . . . 0.435 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -50.67 -21.25 4.65 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.87 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 4.3 m -69.85 -43.65 71.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.648 0.261 . . . . 0.0 111.658 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -98.34 -23.47 15.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.778 0.323 . . . . 0.0 111.528 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 633' ' ' ALA . . . . . 0.417 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.44 156.24 53.59 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.244 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.437 ' HB3' ' CD1' ' A' ' 642' ' ' TRP . 73.0 Cg_endo -75.18 163.72 34.4 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.735 2.29 . . . . 0.0 112.325 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 26.9 mttt -73.01 176.37 5.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.535 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -61.55 -48.94 78.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.849 0.357 . . . . 0.0 111.234 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.69 -36.22 48.89 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.745 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.0 -12.49 59.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.563 0.22 . . . . 0.0 111.55 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 639' ' ' LEU . . . . . . . . . . . . . 11.6 tp -56.16 -47.85 77.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.786 0.327 . . . . 0.0 111.154 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -53.49 -51.32 63.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.978 0.418 . . . . 0.0 111.038 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -67.82 -34.52 76.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.012 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 642' ' ' TRP . . . . . 0.437 ' CD1' ' HB3' ' A' ' 634' ' ' PRO . 30.0 t90 -67.65 -38.56 84.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.744 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.46 -43.34 73.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.433 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -61.1 -39.49 90.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.521 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 2.4 ttp -78.73 -35.71 44.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.806 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -110.49 78.34 1.45 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.943 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.39 146.65 69.42 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.531 2.154 . . . . 0.0 112.355 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.34 -12.53 51.5 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.783 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 15.9 m-85 -88.37 161.71 16.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.899 0.381 . . . . 0.0 111.042 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -148.4 145.81 28.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.698 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.282 -179.945 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.8 0.333 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -103.42 159.13 15.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.869 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 3.5 mtt -57.99 -30.9 66.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.034 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 613' ' ' SER . . . . . 0.459 ' HA ' ' HB3' ' A' ' 636' ' ' ALA . 1.4 m -63.31 -24.65 67.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.986 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.22 -27.83 19.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.088 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 18.0 mt -81.45 147.09 58.98 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.966 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.77 150.81 39.9 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.586 2.191 . . . . 0.0 112.368 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 617' ' ' VAL . . . . . 0.439 ' O ' ' HB1' ' A' ' 633' ' ' ALA . 21.4 t -118.83 128.53 75.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.106 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 618' ' ' LYS . . . . . 0.671 ' HB2' ' HB3' ' A' ' 652' ' ' ALA . 0.0 OUTLIER -66.35 170.47 5.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.857 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 619' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 618' ' ' LYS . 16.2 m -157.79 157.26 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.149 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.937 HD13 HG12 ' A' ' 627' ' ' ILE . 3.9 tp -124.59 127.64 73.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.724 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 621' ' ' HIS . . . . . 0.517 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 18.0 t-160 -91.01 132.91 35.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.552 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 622' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 648' ' ' GLY . 23.4 t -87.4 -34.07 7.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.811 0.339 . . . . 0.0 111.231 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -33.82 74.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.348 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 44.2 t -111.51 -23.45 10.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.521 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 80.45 -0.58 84.68 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.508 -0.854 . . . . 0.0 112.828 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 626' ' ' LYS . . . . . 0.578 ' O ' HD12 ' A' ' 620' ' ' ILE . 7.2 tptp -76.59 149.2 36.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.819 0.343 . . . . 0.0 111.026 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 627' ' ' ILE . . . . . 0.937 HG12 HD13 ' A' ' 620' ' ' ILE . 5.7 mt -116.87 114.87 47.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.977 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 628' ' ' LEU . . . . . 0.463 HD12 ' CE2' ' A' ' 649' ' ' TYR . 41.2 mt -84.71 128.39 34.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.808 0.337 . . . . 0.0 111.01 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.72 166.2 16.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.206 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 630' ' ' GLY . . . . . 0.429 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -50.63 -21.18 4.54 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.873 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 19.2 p -71.17 -43.66 67.05 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -98.3 -29.34 13.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.759 0.314 . . . . 0.0 111.56 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 633' ' ' ALA . . . . . 0.439 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.36 156.36 52.07 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.286 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.611 ' HG2' HD12 ' A' ' 639' ' ' LEU . 71.2 Cg_endo -73.37 163.6 37.35 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.727 2.285 . . . . 0.0 112.326 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -73.05 164.39 26.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.314 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 636' ' ' ALA . . . . . 0.459 ' HB3' ' HA ' ' A' ' 613' ' ' SER . . . -62.76 -31.57 72.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.85 0.357 . . . . 0.0 111.309 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.71 -36.23 48.75 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.371 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -104.01 3.33 33.27 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 639' ' ' LEU . . . . . 0.611 HD12 ' HG2' ' A' ' 634' ' ' PRO . 13.6 tp -58.36 -46.95 85.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.779 0.323 . . . . 0.0 111.121 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.17 -44.81 68.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.975 0.417 . . . . 0.0 111.132 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.79 -36.92 76.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.196 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 642' ' ' TRP . . . . . 0.454 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 47.6 t90 -66.67 -44.92 80.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 44.9 mt -65.91 -40.86 91.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.525 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.65 -40.87 96.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.647 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.1 -38.1 52.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.805 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -107.13 82.27 1.12 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.745 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.4 150.43 75.83 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.551 2.167 . . . . 0.0 112.447 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 648' ' ' GLY . . . . . 0.456 ' O ' HG23 ' A' ' 622' ' ' VAL . . . 104.45 -12.96 51.29 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.808 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.517 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 18.0 m-85 -90.03 160.94 16.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.829 0.347 . . . . 0.0 110.977 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -149.87 145.95 26.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.715 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.4 t -56.2 126.91 14.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.204 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 652' ' ' ALA . . . . . 0.671 ' HB3' ' HB2' ' A' ' 618' ' ' LYS . . . -86.86 156.88 55.22 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.1 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . 0.406 ' HD2' ' HB1' ' A' ' 652' ' ' ALA . 52.3 Cg_endo -69.41 157.41 61.18 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.536 2.157 . . . . 0.0 112.37 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -83.8 -173.26 4.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.924 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 1.1 m -118.53 31.8 6.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.921 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -80.66 -72.36 0.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.909 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 74.7 m 60.39 167.59 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.904 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.787 0.327 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -103.84 121.44 43.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 16.5 ptm -69.22 -41.47 77.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.924 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 613' ' ' SER . . . . . . . . . . . . . 91.0 p -58.46 -25.17 61.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.997 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.99 -27.91 43.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.014 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 16.1 mt -71.46 146.32 91.48 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.945 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -74.21 155.96 46.69 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.597 2.198 . . . . 0.0 112.25 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 617' ' ' VAL . . . . . 0.502 ' O ' ' HB1' ' A' ' 633' ' ' ALA . 21.4 t -117.47 133.33 64.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.131 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 618' ' ' LYS . . . . . 0.601 ' CB ' ' HB3' ' A' ' 652' ' ' ALA . 0.0 OUTLIER -66.85 169.97 7.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.945 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 619' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 650' ' ' GLU . 26.8 m -157.14 162.88 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.82 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.21 128.04 12.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.987 0.422 . . . . 0.0 111.619 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 621' ' ' HIS . . . . . 0.494 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 3.6 t-160 -83.17 133.46 35.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.458 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.5 t -85.82 -23.67 6.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.754 0.311 . . . . 0.0 111.38 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -68.54 -37.41 79.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.494 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 49.0 m -117.17 -23.47 7.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.585 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 87.72 8.98 72.44 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.952 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.56 142.9 40.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.758 0.313 . . . . 0.0 110.807 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 1.9 mt -119.53 120.86 64.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.32 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 23.3 mt -90.43 138.18 31.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.752 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.61 165.89 16.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.554 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 630' ' ' GLY . . . . . 0.415 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -55.94 -18.63 19.33 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.766 -0.73 . . . . 0.0 113.068 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 2.5 m -71.75 -43.54 65.62 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.793 0.297 . . . . 0.0 111.524 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -98.18 -22.79 16.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.429 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 633' ' ' ALA . . . . . 0.502 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.55 156.26 54.46 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.169 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.584 ' HG2' HD12 ' A' ' 639' ' ' LEU . 71.7 Cg_endo -75.39 156.54 41.3 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.624 2.216 . . . . 0.0 112.313 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -73.95 168.02 20.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.487 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -62.86 -29.91 71.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.827 0.346 . . . . 0.0 111.249 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.64 -36.36 48.72 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.346 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.99 4.42 29.39 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 639' ' ' LEU . . . . . 0.584 HD12 ' HG2' ' A' ' 634' ' ' PRO . 16.4 tp -57.16 -52.32 65.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.697 0.284 . . . . 0.0 111.093 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -52.78 -43.7 66.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.969 0.414 . . . . 0.0 111.078 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.26 -36.25 76.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.924 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 642' ' ' TRP . . . . . 0.449 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 53.5 t90 -66.78 -49.64 65.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.68 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 82.1 mt -60.82 -42.11 97.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.488 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -61.06 -40.9 95.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.59 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.73 -25.68 49.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.993 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -121.87 78.98 40.82 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.773 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.1 144.12 86.3 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.717 2.278 . . . . 0.0 112.482 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.53 -7.58 46.58 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.841 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.494 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 12.2 m-85 -96.36 151.57 19.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.016 0.436 . . . . 0.0 111.105 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 650' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 619' ' ' VAL . 19.2 pt-20 -146.4 145.79 30.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.119 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 2.8 m -54.34 130.84 16.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.802 0.334 . . . . 0.0 111.487 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 652' ' ' ALA . . . . . 0.601 ' HB3' ' CB ' ' A' ' 618' ' ' LYS . . . -93.11 104.65 12.52 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.1 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -68.88 158.97 55.75 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.468 2.112 . . . . 0.0 112.3 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -134.26 138.9 45.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.86 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 4.9 m -100.79 34.9 2.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.916 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -136.09 142.83 44.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.932 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 45.6 m -153.59 -51.55 0.1 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.867 179.977 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 3.7 t . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.793 0.33 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -72.69 -45.51 58.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.87 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -84.94 -26.73 27.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.07 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 613' ' ' SER . . . . . . . . . . . . . 64.7 m -56.29 -27.15 54.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.195 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.05 17.9 11.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.2 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 87.2 mt -105.42 153.23 39.88 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.868 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.35 143.55 39.35 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.59 2.193 . . . . 0.0 112.446 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 617' ' ' VAL . . . . . 0.408 ' O ' ' HB1' ' A' ' 633' ' ' ALA . 21.6 t -118.89 115.32 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.007 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 618' ' ' LYS . . . . . 0.695 ' HG2' ' HB3' ' A' ' 652' ' ' ALA . 0.0 OUTLIER -63.88 144.24 57.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.649 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 7.3 m -118.75 162.98 16.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.099 0.476 . . . . 0.0 111.544 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.429 ' CD1' HG12 ' A' ' 627' ' ' ILE . 4.9 tp -124.31 127.69 73.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.454 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 621' ' ' HIS . . . . . 0.498 ' HB2' ' CE1' ' A' ' 649' ' ' TYR . 6.3 t-160 -96.78 119.29 34.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.661 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.3 t -88.39 -33.62 6.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.281 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.42 -34.92 76.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.172 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 3.6 m -110.85 -23.39 11.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.336 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 85.76 -6.04 81.91 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.85 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.29 155.47 40.36 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.823 0.344 . . . . 0.0 110.788 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 627' ' ' ILE . . . . . 0.429 HG12 ' CD1' ' A' ' 620' ' ' ILE . 12.1 mt -126.75 121.27 58.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.293 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 628' ' ' LEU . . . . . 0.465 ' CD1' ' CE1' ' A' ' 649' ' ' TYR . 16.4 mt -103.06 124.93 49.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.425 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 629' ' ' THR . . . . . 0.408 ' HA ' ' CB ' ' A' ' 618' ' ' LYS . 0.4 OUTLIER -85.45 166.08 16.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.187 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . -46.84 -25.14 2.19 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.963 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 14.0 p -65.45 -43.96 88.76 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.616 0.246 . . . . 0.0 111.625 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -98.55 -24.24 15.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.874 0.369 . . . . 0.0 111.58 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 633' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.54 156.27 54.29 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.451 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.499 ' HG2' HD12 ' A' ' 639' ' ' LEU . 72.7 Cg_endo -75.25 163.95 33.82 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.82 2.347 . . . . 0.0 112.303 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -72.96 176.43 5.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.471 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -58.95 -48.92 79.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.405 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.67 -36.19 49.08 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.037 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -81.5 -9.8 59.62 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.645 0.239 . . . . 0.0 111.645 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 639' ' ' LEU . . . . . 0.499 HD12 ' HG2' ' A' ' 634' ' ' PRO . 13.1 tp -58.88 -53.35 59.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.713 0.292 . . . . 0.0 111.162 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -52.19 -49.33 64.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.944 0.402 . . . . 0.0 111.068 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -66.78 -35.88 81.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.891 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 642' ' ' TRP . . . . . 0.438 ' CZ3' ' HB2' ' A' ' 646' ' ' ASN . 27.9 t90 -66.85 -38.77 87.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.661 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 12.0 mt -68.33 -42.12 79.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.467 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.65 -41.01 96.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.469 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 3.3 tpp -77.73 -33.23 53.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.797 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 646' ' ' ASN . . . . . 0.438 ' HB2' ' CZ3' ' A' ' 642' ' ' TRP . 10.4 m-80 -115.28 79.28 6.59 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.755 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.46 148.59 73.48 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.569 2.179 . . . . 0.0 112.47 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.41 -8.77 48.55 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.789 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.498 ' CE1' ' HB2' ' A' ' 621' ' ' HIS . 17.7 m-85 -94.91 161.74 14.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.96 0.409 . . . . 0.0 111.168 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -149.86 168.09 24.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.753 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 29.2 t -74.53 118.21 19.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.975 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 652' ' ' ALA . . . . . 0.695 ' HB3' ' HG2' ' A' ' 618' ' ' LYS . . . -81.53 139.72 47.86 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.086 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.66 159.01 39.38 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.548 2.165 . . . . 0.0 112.353 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -63.13 129.44 40.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.837 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.03 -32.39 10.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.933 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.59 -31.46 26.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.855 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 20.9 m -75.91 129.03 36.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.886 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.883 -179.988 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.839 0.352 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -163.33 164.69 24.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.897 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 612' ' ' MET . . . . . 0.68 ' HA ' HD12 ' A' ' 615' ' ' LEU . 22.4 mtt -82.25 -31.65 30.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.922 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 613' ' ' SER . . . . . 0.449 ' O ' ' HB3' ' A' ' 636' ' ' ALA . 1.3 m -67.97 -27.24 66.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.012 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.94 -27.85 55.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.097 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 615' ' ' LEU . . . . . 0.68 HD12 ' HA ' ' A' ' 612' ' ' MET . 5.6 mt -79.62 148.15 68.89 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.897 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.18 140.92 31.65 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.525 2.15 . . . . 0.0 112.317 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.5 t -111.42 119.61 60.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.098 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 618' ' ' LYS . . . . . 0.762 ' HB2' ' HB3' ' A' ' 652' ' ' ALA . 0.0 OUTLIER -58.85 174.49 0.34 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 619' ' ' VAL . . . . . 0.468 HG13 ' O ' ' A' ' 618' ' ' LYS . 16.2 m -157.87 155.85 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.135 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.942 HD13 HG12 ' A' ' 627' ' ' ILE . 4.9 tp -124.5 127.61 73.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.771 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 621' ' ' HIS . . . . . 0.51 ' CG ' ' CE1' ' A' ' 649' ' ' TYR . 6.4 t-160 -89.91 133.28 34.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.723 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 622' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 648' ' ' GLY . 26.1 t -87.12 -29.45 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.366 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . 0.455 ' HB3' ' CE1' ' A' ' 621' ' ' HIS . 32.4 tt0 -68.46 -37.16 79.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.374 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.18 -23.32 10.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.427 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 82.45 3.31 90.58 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.697 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 626' ' ' LYS . . . . . 0.814 ' O ' HD12 ' A' ' 620' ' ' ILE . 3.5 mtmt -76.7 151.14 36.21 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.81 0.338 . . . . 0.0 111.027 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 627' ' ' ILE . . . . . 0.942 HG12 HD13 ' A' ' 620' ' ' ILE . 7.1 mt -117.08 111.05 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.019 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 628' ' ' LEU . . . . . 0.506 HD12 ' CE2' ' A' ' 649' ' ' TYR . 75.4 mt -81.41 133.59 35.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.848 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.74 166.05 16.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.196 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 630' ' ' GLY . . . . . 0.427 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -50.27 -21.34 4.16 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.771 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 1.1 m -69.79 -43.48 72.02 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.06 -30.73 12.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.819 0.342 . . . . 0.0 111.465 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.41 156.35 52.59 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.187 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.685 ' HG2' HD12 ' A' ' 639' ' ' LEU . 73.0 Cg_endo -75.18 162.92 35.91 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.713 2.275 . . . . 0.0 112.451 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 43.0 mttm -85.44 157.04 20.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.571 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 636' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 613' ' ' SER . . . -53.04 -26.87 17.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.499 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -73.97 -36.29 52.34 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.395 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -116.02 14.23 16.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.025 0.413 . . . . 0.0 111.872 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 639' ' ' LEU . . . . . 0.685 HD12 ' HG2' ' A' ' 634' ' ' PRO . 10.9 tp -59.59 -51.61 69.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.796 0.331 . . . . 0.0 111.108 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -52.98 -43.28 66.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.99 0.424 . . . . 0.0 111.106 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.94 -38.93 76.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.806 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 642' ' ' TRP . . . . . 0.439 ' CZ3' ' HB2' ' A' ' 646' ' ' ASN . 37.7 t90 -64.69 -42.46 95.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.699 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 90.4 mt -66.61 -40.97 89.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.35 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -60.11 -41.04 91.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.494 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 18.4 ttt -77.47 -36.25 53.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.562 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 646' ' ' ASN . . . . . 0.439 ' HB2' ' CZ3' ' A' ' 642' ' ' TRP . 20.9 m-80 -112.38 78.01 2.45 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.584 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.81 149.03 83.43 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.609 2.206 . . . . 0.0 112.451 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 648' ' ' GLY . . . . . 0.612 ' O ' HG23 ' A' ' 622' ' ' VAL . . . 104.46 -18.89 43.78 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.615 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.51 ' CE1' ' CG ' ' A' ' 621' ' ' HIS . 21.3 m-85 -83.41 157.97 22.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.837 0.351 . . . . 0.0 111.005 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -148.61 145.9 27.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.563 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 2.7 m -54.51 126.66 11.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.407 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 652' ' ' ALA . . . . . 0.762 ' HB3' ' HB2' ' A' ' 618' ' ' LYS . . . -77.34 155.51 81.79 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.094 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.42 158.93 52.99 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.556 2.171 . . . . 0.0 112.309 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -83.53 171.92 12.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.924 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 10.3 t -99.15 31.58 3.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.917 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 13.2 p30 -114.73 -178.3 3.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.903 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.09 124.89 0.53 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.873 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.822 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 59.2 p . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.796 0.331 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -74.22 133.4 42.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.803 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.97 -32.96 39.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.969 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 613' ' ' SER . . . . . . . . . . . . . 13.2 m -59.88 -27.68 66.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.034 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -77.01 -26.97 54.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.065 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 10.8 mt -73.72 144.99 83.85 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.935 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.26 153.13 31.33 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.597 2.198 . . . . 0.0 112.425 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.7 t -118.85 122.63 69.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.065 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 618' ' ' LYS . . . . . 0.691 ' HB2' ' HB3' ' A' ' 652' ' ' ALA . 0.1 OUTLIER -63.63 176.42 0.88 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.874 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 619' ' ' VAL . . . . . 0.537 HG13 ' O ' ' A' ' 618' ' ' LYS . 5.9 m -159.23 158.02 2.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.246 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.819 HD13 HG12 ' A' ' 627' ' ' ILE . 5.0 tp -124.57 127.55 72.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.686 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 621' ' ' HIS . . . . . 0.517 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 7.6 t-160 -89.82 127.46 35.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.734 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.6 t -88.47 -39.27 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 0.0 111.05 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -68.5 -29.97 68.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.388 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 1.7 t -112.83 -23.44 10.13 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.573 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 79.4 -0.0 82.08 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.825 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -76.44 156.83 32.77 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.812 0.339 . . . . 0.0 110.887 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 627' ' ' ILE . . . . . 0.819 HG12 HD13 ' A' ' 620' ' ' ILE . 2.8 mt -128.39 126.58 65.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.238 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 628' ' ' LEU . . . . . 0.462 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 11.5 mt -103.45 130.71 50.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.654 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.69 166.08 16.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.254 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 630' ' ' GLY . . . . . 0.409 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -53.59 -19.05 8.58 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.031 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 23.0 m -71.78 -43.81 65.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.681 0.277 . . . . 0.0 111.693 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -98.26 -23.18 15.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.857 0.361 . . . . 0.0 111.518 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.41 156.36 52.56 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.353 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.512 ' HG2' HD12 ' A' ' 639' ' ' LEU . 61.0 Cg_endo -71.68 163.96 37.25 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.764 2.31 . . . . 0.0 112.188 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -72.88 176.45 5.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.448 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -59.79 -49.01 79.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.792 0.33 . . . . 0.0 111.383 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.72 -36.22 48.71 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.01 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -81.16 -10.52 59.62 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 639' ' ' LEU . . . . . 0.512 HD12 ' HG2' ' A' ' 634' ' ' PRO . 10.9 tp -59.24 -50.71 72.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.774 0.321 . . . . 0.0 111.181 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -53.1 -45.63 68.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.299 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.77 -37.19 76.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.921 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 642' ' ' TRP . . . . . 0.444 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 51.8 t90 -64.28 -54.6 30.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.794 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 67.7 mt -58.53 -43.09 89.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.615 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -59.57 -38.13 80.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.614 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.03 -25.55 37.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.955 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -122.15 78.08 42.83 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.93 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.56 151.7 78.32 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.711 2.274 . . . . 0.0 112.313 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.41 -17.1 47.77 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.823 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.517 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 23.6 m-85 -89.54 152.25 21.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.907 0.384 . . . . 0.0 111.049 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -144.04 153.49 42.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.636 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.6 t -54.57 125.93 10.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.251 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 652' ' ' ALA . . . . . 0.691 ' HB3' ' HB2' ' A' ' 618' ' ' LYS . . . -75.99 118.59 72.26 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.182 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.81 159.02 7.56 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.425 2.083 . . . . 0.0 112.263 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 -91.69 137.18 32.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.851 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 47.7 m -98.46 31.32 2.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.905 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -152.68 -175.0 5.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.51 -50.8 0.37 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.871 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.952 179.965 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.849 0.357 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -157.32 30.58 0.29 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -77.38 -38.36 50.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.956 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 613' ' ' SER . . . . . 0.759 ' O ' ' HB3' ' A' ' 636' ' ' ALA . 92.8 p -64.38 -21.53 66.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.001 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -86.0 -27.91 24.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.016 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 25.4 mt -79.31 156.05 76.43 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.949 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 635' ' ' LYS . 70.3 Cg_endo -74.69 148.1 36.33 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.604 2.203 . . . . 0.0 112.627 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.4 t -118.97 115.29 47.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.811 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 618' ' ' LYS . . . . . 0.432 ' HG2' ' HB3' ' A' ' 652' ' ' ALA . 0.0 OUTLIER -64.66 143.36 57.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.953 -179.891 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 2.5 m -127.05 165.72 25.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.336 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.55 HD13 ' C ' ' A' ' 620' ' ' ILE . 0.0 OUTLIER -127.26 127.46 69.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.669 179.582 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 621' ' ' HIS . . . . . 0.462 ' ND1' ' CE2' ' A' ' 649' ' ' TYR . 5.9 t-160 -91.87 125.87 36.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.941 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 26.1 t -86.82 -31.1 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.264 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . 0.4 ' HB2' ' NE2' ' A' ' 621' ' ' HIS . 36.2 mt-10 -68.12 -37.3 80.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.106 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 21.1 t -105.75 -23.58 12.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.219 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 88.21 -15.37 56.39 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.922 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 10.0 mtpp -70.25 156.83 38.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.687 0.279 . . . . 0.0 110.918 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 2.0 mp -128.55 115.39 37.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.061 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 628' ' ' LEU . . . . . 0.499 HD12 ' CE1' ' A' ' 649' ' ' TYR . 15.8 mt -85.06 130.18 34.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.906 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 629' ' ' THR . . . . . 0.445 ' OG1' HG23 ' A' ' 631' ' ' THR . 0.7 OUTLIER -85.7 166.05 16.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.184 179.646 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 630' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' A' ' 616' ' ' PRO . . . -48.49 -24.05 3.58 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.838 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 631' ' ' THR . . . . . 0.445 HG23 ' OG1' ' A' ' 629' ' ' THR . 8.5 p -65.34 -43.98 89.21 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.51 -34.11 10.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.902 0.382 . . . . 0.0 111.642 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.38 156.12 53.72 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.712 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.697 ' HG2' HD12 ' A' ' 639' ' ' LEU . 89.5 Cg_endo -75.32 163.76 34.04 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.957 2.438 . . . . 0.0 112.556 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 635' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 616' ' ' PRO . 0.0 OUTLIER -92.06 166.1 12.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.511 179.362 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 636' ' ' ALA . . . . . 0.759 ' HB3' ' O ' ' A' ' 613' ' ' SER . . . -52.94 -26.89 16.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.588 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -67.17 -36.25 89.82 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.416 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.33 17.57 7.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 117.014 0.407 . . . . 0.0 111.854 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 639' ' ' LEU . . . . . 0.697 HD12 ' HG2' ' A' ' 634' ' ' PRO . 13.9 tp -64.71 -54.58 29.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.779 0.323 . . . . 0.0 111.23 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -52.26 -43.42 64.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.182 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -67.97 -37.53 81.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.848 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 642' ' ' TRP . . . . . 0.483 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 28.0 t90 -66.81 -48.79 67.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.864 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 36.1 mt -60.18 -41.19 92.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.591 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.15 -40.98 99.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.581 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 28.8 ttp -79.49 -18.74 51.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.175 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 646' ' ' ASN . . . . . 0.43 ' HB2' ' CZ3' ' A' ' 642' ' ' TRP . 27.7 m-80 -129.56 68.36 80.3 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.866 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -56.84 154.33 32.7 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.539 2.16 . . . . 0.0 112.328 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.29 -16.77 48.79 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.706 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.499 ' CE1' HD12 ' A' ' 628' ' ' LEU . 25.0 m-85 -88.13 161.17 17.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.819 0.343 . . . . 0.0 111.125 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -149.74 157.85 43.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.788 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.4 t -59.47 123.07 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.158 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 652' ' ' ALA . . . . . 0.432 ' HB3' ' HG2' ' A' ' 618' ' ' LYS . . . -96.89 116.17 65.97 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.0 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.59 158.97 54.31 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.432 2.088 . . . . 0.0 112.3 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.17 133.53 48.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.934 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.08 -33.55 17.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.814 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.78 86.8 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.978 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.98 -65.14 0.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.909 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.916 179.995 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.805 0.335 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.81 136.74 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.922 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -60.22 -24.85 65.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.075 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 613' ' ' SER . . . . . 0.627 ' O ' ' HB3' ' A' ' 636' ' ' ALA . 17.3 p -54.91 -26.41 35.79 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.158 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -93.33 -27.89 16.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.997 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 16.3 mt -76.61 146.44 76.84 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.895 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.94 151.12 39.43 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.597 2.198 . . . . 0.0 112.374 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.93 119.13 60.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.155 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 618' ' ' LYS . . . . . 0.539 ' HG2' ' HB3' ' A' ' 652' ' ' ALA . 0.0 OUTLIER -63.92 146.04 54.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.762 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 4.1 m -122.68 164.51 19.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.392 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.667 HD13 HG12 ' A' ' 627' ' ' ILE . 5.9 tp -124.46 127.64 73.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.573 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 621' ' ' HIS . . . . . 0.499 ' CD2' ' CD2' ' A' ' 649' ' ' TYR . 5.5 t-160 -95.5 118.82 32.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.78 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 19.2 t -89.18 -28.19 5.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.227 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -61.72 -37.37 83.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.108 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 61.3 m -119.17 -23.39 6.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.412 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 95.29 -3.29 66.25 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.837 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.33 147.07 51.61 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.811 0.339 . . . . 0.0 110.745 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 627' ' ' ILE . . . . . 0.667 HG12 HD13 ' A' ' 620' ' ' ILE . 1.6 mp -120.84 118.91 57.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.323 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 628' ' ' LEU . . . . . 0.516 HD12 ' CE1' ' A' ' 649' ' ' TYR . 27.2 mt -97.56 127.29 43.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.476 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.5 166.04 16.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.251 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . -49.2 -22.15 3.17 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.074 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 1.2 m -68.55 -43.98 75.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -98.42 -25.99 14.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.907 0.384 . . . . 0.0 111.47 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 633' ' ' ALA . . . . . 0.42 ' HB1' ' HD2' ' A' ' 634' ' ' PRO . . . -61.49 156.59 51.93 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.389 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.513 ' HG2' HD12 ' A' ' 639' ' ' LEU . 58.0 Cg_endo -69.45 163.85 36.45 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.884 2.389 . . . . 0.0 112.189 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 25.4 mttp -72.92 174.19 8.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.454 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 636' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 613' ' ' SER . . . -60.37 -48.94 79.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.381 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.83 -36.24 48.16 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.0 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -82.38 -9.62 59.38 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 639' ' ' LEU . . . . . 0.513 HD12 ' HG2' ' A' ' 634' ' ' PRO . 11.4 tp -57.35 -45.66 84.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.774 0.321 . . . . 0.0 111.197 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.27 -49.77 68.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.995 0.426 . . . . 0.0 111.309 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -68.92 -34.48 75.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.176 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 642' ' ' TRP . . . . . 0.427 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 49.7 t90 -67.03 -44.43 80.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.826 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 83.2 mt -65.47 -44.4 87.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.387 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -60.78 -37.19 81.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.523 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 6.3 mtt -80.97 -26.27 36.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.008 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -122.34 78.3 44.74 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.976 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -64.28 150.14 88.87 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.72 2.28 . . . . 0.0 112.388 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.38 -15.85 49.64 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.789 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.516 ' CE1' HD12 ' A' ' 628' ' ' LEU . 22.5 m-85 -88.55 161.77 16.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.918 0.39 . . . . 0.0 111.116 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -148.64 145.91 27.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.765 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.4 t -60.17 124.06 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.226 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 652' ' ' ALA . . . . . 0.539 ' HB3' ' HG2' ' A' ' 618' ' ' LYS . . . -98.83 114.23 65.24 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.009 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -51.98 158.52 4.76 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.47 2.113 . . . . 0.0 112.305 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.01 -179.44 0.74 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.964 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 24.3 m -107.6 -32.77 7.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.979 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -134.7 109.69 8.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.882 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 37.8 t -137.17 177.01 8.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.915 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.852 179.984 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 62.8 m . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.833 0.349 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -157.38 31.77 0.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 2.8 mtt -73.73 -40.34 63.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.935 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 613' ' ' SER . . . . . 0.436 ' O ' ' HB3' ' A' ' 636' ' ' ALA . 8.6 t -64.26 -29.19 70.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.957 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.49 -27.88 41.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.043 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 19.7 mt -88.83 152.68 49.07 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.005 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.53 152.4 65.28 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.609 2.206 . . . . 0.0 112.319 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 617' ' ' VAL . . . . . 0.442 ' O ' ' HB1' ' A' ' 633' ' ' ALA . 21.5 t -118.81 131.47 71.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.13 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 618' ' ' LYS . . . . . 0.669 ' HB2' ' HB3' ' A' ' 652' ' ' ALA . 0.0 OUTLIER -70.16 172.8 7.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.88 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 619' ' ' VAL . . . . . 0.53 HG13 ' O ' ' A' ' 618' ' ' LYS . 6.2 m -159.17 162.97 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.171 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.893 HD13 ' CG1' ' A' ' 627' ' ' ILE . 4.7 tp -129.13 127.51 65.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.744 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 621' ' ' HIS . . . . . 0.504 ' CG ' ' CE1' ' A' ' 649' ' ' TYR . 8.1 t-160 -91.19 134.35 34.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.72 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 622' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 648' ' ' GLY . 25.5 t -87.39 -31.12 5.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.895 0.379 . . . . 0.0 111.108 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -68.6 -36.9 79.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.353 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 1.3 m -111.36 -23.27 10.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.645 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 81.43 1.69 90.19 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.817 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 626' ' ' LYS . . . . . 0.762 ' O ' HD12 ' A' ' 620' ' ' ILE . 0.0 OUTLIER -76.69 153.62 34.96 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.863 0.364 . . . . 0.0 110.958 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 627' ' ' ILE . . . . . 0.893 ' CG1' HD13 ' A' ' 620' ' ' ILE . 3.9 mt -120.67 109.26 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.096 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 628' ' ' LEU . . . . . 0.451 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 30.4 mt -78.33 129.86 35.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.817 0.341 . . . . 0.0 110.66 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.7 166.06 16.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.193 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . -52.38 -19.04 5.58 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.9 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 35.7 m -72.96 -43.61 62.08 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -98.03 -29.0 13.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.786 0.327 . . . . 0.0 111.604 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 633' ' ' ALA . . . . . 0.442 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.38 156.29 52.67 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.082 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.63 ' HG2' HD12 ' A' ' 639' ' ' LEU . 72.8 Cg_endo -75.28 157.85 41.38 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.672 2.248 . . . . 0.0 112.425 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 29.1 mttp -74.0 155.36 38.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.571 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 636' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 613' ' ' SER . . . -53.14 -26.98 18.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.503 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.37 -36.37 50.12 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.308 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -111.34 11.06 21.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.819 0.31 . . . . 0.0 111.733 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 639' ' ' LEU . . . . . 0.63 HD12 ' HG2' ' A' ' 634' ' ' PRO . 12.6 tp -63.63 -48.1 78.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.763 0.316 . . . . 0.0 111.103 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -52.83 -43.77 66.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.961 0.41 . . . . 0.0 111.095 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.87 -38.46 76.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.975 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 642' ' ' TRP . . . . . 0.444 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 30.5 t90 -67.68 -36.62 81.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.678 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 14.1 mt -69.3 -43.39 73.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.341 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.52 -40.96 96.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.456 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -75.68 -39.26 57.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.718 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -106.22 80.06 0.64 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.727 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.12 147.59 73.51 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.573 2.182 . . . . 0.0 112.448 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 648' ' ' GLY . . . . . 0.578 ' O ' HG23 ' A' ' 622' ' ' VAL . . . 104.43 -15.23 50.24 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.702 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.504 ' CE1' ' CG ' ' A' ' 621' ' ' HIS . 19.4 m-85 -86.66 153.08 22.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.806 0.336 . . . . 0.0 111.014 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -143.6 145.83 32.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.634 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 31.0 t -55.12 128.7 15.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.236 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 652' ' ' ALA . . . . . 0.669 ' HB3' ' HB2' ' A' ' 618' ' ' LYS . . . -77.55 129.34 77.38 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.099 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.94 158.71 8.37 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.461 2.108 . . . . 0.0 112.281 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 52.6 mmm-85 58.89 105.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.944 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 6.4 m -114.79 31.5 6.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -124.15 -44.35 2.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.67 163.64 32.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.854 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.97 179.956 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 28.6 t . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.84 0.352 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -124.69 140.9 52.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.812 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 6.0 ttt -59.39 -29.52 67.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.956 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 613' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.76 -28.01 69.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.001 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.79 -27.88 26.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.1 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 10.0 mt -84.48 146.17 46.67 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.899 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.38 152.17 38.72 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.569 2.179 . . . . 0.0 112.365 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 617' ' ' VAL . . . . . 0.475 ' O ' ' HB1' ' A' ' 633' ' ' ALA . 26.5 t -118.87 129.36 75.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.025 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 618' ' ' LYS . . . . . 0.686 ' HB2' ' HB3' ' A' ' 652' ' ' ALA . 0.0 OUTLIER -68.41 173.54 4.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 619' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 618' ' ' LYS . 12.0 m -158.58 160.67 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.21 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.862 HD13 HG12 ' A' ' 627' ' ' ILE . 5.5 tp -124.3 127.65 73.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.636 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 621' ' ' HIS . . . . . 0.508 ' CG ' ' CE1' ' A' ' 649' ' ' TYR . 7.3 t-160 -93.23 127.97 39.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.79 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 622' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 648' ' ' GLY . 21.4 t -88.68 -27.32 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.309 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . 0.429 ' HB3' ' CE1' ' A' ' 621' ' ' HIS . 13.2 tt0 -68.35 -37.22 80.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.149 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 12.4 p -113.51 -23.21 9.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.398 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 87.51 -5.72 84.57 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.886 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 626' ' ' LYS . . . . . 0.519 ' O ' HD12 ' A' ' 620' ' ' ILE . 29.1 tttt -69.39 156.8 38.23 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.856 0.36 . . . . 0.0 110.966 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 627' ' ' ILE . . . . . 0.862 HG12 HD13 ' A' ' 620' ' ' ILE . 2.6 mt -124.35 114.54 41.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.972 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 628' ' ' LEU . . . . . 0.502 HD12 ' CE2' ' A' ' 649' ' ' TYR . 45.1 mt -87.13 127.91 35.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.825 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.66 166.22 16.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.133 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 630' ' ' GLY . . . . . 0.416 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -49.58 -21.74 3.47 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.864 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 29.0 p -70.08 -43.69 70.62 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -98.38 -27.59 14.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.827 0.346 . . . . 0.0 111.628 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 633' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.41 156.36 52.61 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.298 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.513 ' HG2' HD12 ' A' ' 639' ' ' LEU . 71.5 Cg_endo -72.9 163.82 37.31 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.767 2.312 . . . . 0.0 112.314 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -73.04 172.54 10.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.4 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -61.01 -43.94 98.14 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.796 0.331 . . . . 0.0 111.433 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.54 -36.32 49.36 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.841 -0.695 . . . . 0.0 113.114 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -88.02 -6.05 58.18 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 639' ' ' LEU . . . . . 0.513 HD12 ' HG2' ' A' ' 634' ' ' PRO . 16.3 tp -58.49 -51.28 70.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.665 0.269 . . . . 0.0 111.229 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -50.67 -50.51 54.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.005 0.431 . . . . 0.0 111.122 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -66.55 -35.41 80.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.986 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 642' ' ' TRP . . . . . 0.442 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 36.4 t90 -67.63 -37.75 82.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.679 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.88 -46.03 72.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.291 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.27 -36.78 80.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.423 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 3.6 ttm -80.83 -24.33 38.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.894 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -125.8 75.46 70.84 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.872 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.84 149.59 90.34 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.682 2.254 . . . . 0.0 112.401 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 648' ' ' GLY . . . . . 0.402 ' O ' HG23 ' A' ' 622' ' ' VAL . . . 104.51 -18.29 44.89 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.735 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.508 ' CE1' ' CG ' ' A' ' 621' ' ' HIS . 20.7 m-85 -83.39 161.63 21.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.872 0.368 . . . . 0.0 111.075 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -149.64 145.98 27.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.75 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.3 t -56.31 128.88 17.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.159 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 652' ' ' ALA . . . . . 0.686 ' HB3' ' HB2' ' A' ' 618' ' ' LYS . . . -81.86 132.13 55.19 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.096 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -73.28 158.8 48.13 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.468 2.112 . . . . 0.0 112.324 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.15 148.42 51.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.935 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 1.5 p -137.44 58.73 1.69 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.858 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.5 -67.37 0.28 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.868 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 1.3 m -94.0 -55.12 3.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.808 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.872 179.98 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 72.1 p . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.825 0.345 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -77.23 90.31 3.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.93 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 6.1 ptt? -70.07 -44.99 67.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.87 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 613' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.36 -25.45 62.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.005 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.15 -24.78 51.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.04 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 50.9 mt -58.63 149.78 60.65 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.889 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.79 151.35 57.25 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.632 2.221 . . . . 0.0 112.324 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 617' ' ' VAL . . . . . 0.406 ' O ' ' HB1' ' A' ' 633' ' ' ALA . 21.3 t -118.83 128.92 75.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.143 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 618' ' ' LYS . . . . . 0.56 ' HB2' ' HB3' ' A' ' 652' ' ' ALA . 0.0 OUTLIER -66.39 176.72 1.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.813 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 619' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 618' ' ' LYS . 10.1 m -158.95 158.84 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.257 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.749 HD13 HG12 ' A' ' 627' ' ' ILE . 5.3 tp -124.36 127.55 73.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.533 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 621' ' ' HIS . . . . . 0.484 ' CG ' ' CE1' ' A' ' 649' ' ' TYR . 7.8 t-160 -93.12 128.79 39.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.659 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.4 t -88.24 -34.65 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.216 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -68.46 -33.97 75.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.334 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 1.7 m -111.5 -23.4 10.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.558 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 82.39 -4.0 79.38 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.826 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.56 156.89 36.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.839 0.352 . . . . 0.0 110.935 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 627' ' ' ILE . . . . . 0.749 HG12 HD13 ' A' ' 620' ' ' ILE . 1.6 mt -125.85 119.13 53.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.102 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 628' ' ' LEU . . . . . 0.458 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 17.6 mt -90.36 130.36 36.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.877 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.69 165.98 16.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.181 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 630' ' ' GLY . . . . . 0.401 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -50.73 -21.26 4.74 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.966 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 22.1 p -69.83 -43.63 71.59 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -98.31 -30.18 12.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.785 0.326 . . . . 0.0 111.516 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 633' ' ' ALA . . . . . 0.406 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.36 156.25 52.79 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.182 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.686 ' HG2' HD12 ' A' ' 639' ' ' LEU . 72.4 Cg_endo -75.26 163.64 34.38 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.755 2.304 . . . . 0.0 112.444 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -80.52 157.08 26.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.546 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -53.08 -26.96 17.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.501 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.49 -36.3 49.68 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.81 -0.709 . . . . 0.0 113.39 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -113.51 12.6 18.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.964 0.382 . . . . 0.0 111.806 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 639' ' ' LEU . . . . . 0.686 HD12 ' HG2' ' A' ' 634' ' ' PRO . 11.9 tp -62.99 -49.69 73.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.775 0.321 . . . . 0.0 111.089 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -53.34 -41.73 66.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.211 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.74 -38.75 76.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.893 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 642' ' ' TRP . . . . . 0.443 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 47.3 t90 -66.14 -46.37 77.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.706 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 643' ' ' LEU . . . . . 0.431 HD12 ' HG ' ' A' ' 639' ' ' LEU . 15.3 mt -61.92 -44.34 96.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.589 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.65 -39.62 89.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.547 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.2 -24.53 47.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.982 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -124.05 77.12 59.26 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.939 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -61.88 149.9 88.28 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.577 2.184 . . . . 0.0 112.224 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.43 -13.31 51.26 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.816 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.484 ' CE1' ' CG ' ' A' ' 621' ' ' HIS . 24.5 m-85 -94.05 156.15 16.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.861 0.363 . . . . 0.0 111.014 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -149.98 151.82 33.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.783 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.6 t -54.6 125.6 9.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.08 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 652' ' ' ALA . . . . . 0.56 ' HB3' ' HB2' ' A' ' 618' ' ' LYS . . . -87.23 138.21 32.47 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.174 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.99 159.12 10.04 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.47 2.113 . . . . 0.0 112.302 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 61.64 154.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.98 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.2 -31.72 11.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.92 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -113.45 160.27 18.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.9 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.62 -68.31 0.9 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.92 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.864 179.98 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.728 0.299 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -115.58 -56.0 2.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.955 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 612' ' ' MET . . . . . 0.613 ' HA ' HD12 ' A' ' 615' ' ' LEU . 54.8 mtt -59.76 -28.75 67.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.94 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 613' ' ' SER . . . . . . . . . . . . . 5.9 m -57.71 -24.91 59.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.147 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -100.15 -27.96 13.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.017 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 615' ' ' LEU . . . . . 0.613 HD12 ' HA ' ' A' ' 612' ' ' MET . 73.2 mt -64.12 154.81 81.28 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.95 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.75 148.72 36.9 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.532 2.154 . . . . 0.0 112.364 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 617' ' ' VAL . . . . . 0.462 ' O ' ' HB1' ' A' ' 633' ' ' ALA . 21.8 t -118.83 115.38 47.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.963 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 618' ' ' LYS . . . . . 0.674 ' HB2' ' HB3' ' A' ' 652' ' ' ALA . 0.0 OUTLIER -62.47 174.85 0.87 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.951 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 619' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 618' ' ' LYS . 4.6 m -159.15 157.62 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.199 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.496 HD13 ' C ' ' A' ' 620' ' ' ILE . 0.0 OUTLIER -124.37 127.64 73.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.805 179.785 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 621' ' ' HIS . . . . . 0.517 ' CD2' ' CD1' ' A' ' 649' ' ' TYR . 5.4 t-160 -87.59 124.73 33.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.794 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 622' ' ' VAL . . . . . 0.408 HG21 ' OE1' ' A' ' 650' ' ' GLU . 25.8 t -88.28 -29.48 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.311 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . 0.438 ' HB3' ' CE1' ' A' ' 621' ' ' HIS . 7.2 tp10 -68.38 -37.27 80.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.245 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 3.4 t -112.24 -23.33 10.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.281 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 89.26 -10.85 71.6 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.791 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -69.25 145.47 53.1 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.874 0.368 . . . . 0.0 110.854 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 10.1 mt -120.91 131.09 73.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.046 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 628' ' ' LEU . . . . . 0.455 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 11.1 mt -103.36 136.02 43.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.857 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.72 166.09 16.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.32 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 630' ' ' GLY . . . . . 0.405 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -51.39 -22.81 7.94 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.78 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 19.8 p -65.91 -43.84 86.99 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.719 0.295 . . . . 0.0 111.459 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -98.36 -21.56 16.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.341 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 633' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.48 156.24 53.92 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.352 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.505 ' HG2' HD12 ' A' ' 639' ' ' LEU . 73.3 Cg_endo -74.29 163.86 35.45 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.696 2.264 . . . . 0.0 112.174 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 31.5 mttt -72.98 175.62 6.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.475 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -60.54 -48.73 80.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.43 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.52 -36.25 49.63 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.943 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.07 -10.11 59.32 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 639' ' ' LEU . . . . . 0.514 ' HG ' HD12 ' A' ' 643' ' ' LEU . 10.6 tp -56.34 -50.62 70.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.73 0.3 . . . . 0.0 111.218 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -54.12 -47.63 71.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.989 0.423 . . . . 0.0 111.186 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -67.89 -36.59 80.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.754 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 642' ' ' TRP . . . . . 0.437 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 42.2 t90 -65.49 -43.77 89.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.723 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 643' ' ' LEU . . . . . 0.514 HD12 ' HG ' ' A' ' 639' ' ' LEU . 2.6 mt -63.55 -45.11 92.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.319 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -60.2 -37.44 80.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.378 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.14 -23.3 41.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.951 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -127.34 73.11 77.54 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.928 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -61.17 148.87 91.68 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.606 2.204 . . . . 0.0 112.391 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.36 -20.53 39.74 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.771 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.517 ' CD1' ' CD2' ' A' ' 621' ' ' HIS . 21.1 m-85 -81.68 150.58 27.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.874 0.369 . . . . 0.0 110.895 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 650' ' ' GLU . . . . . 0.408 ' OE1' HG21 ' A' ' 622' ' ' VAL . 26.2 mt-10 -137.33 145.93 43.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.724 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 31.7 t -55.95 125.49 11.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.235 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 652' ' ' ALA . . . . . 0.674 ' HB3' ' HB2' ' A' ' 618' ' ' LYS . . . -80.45 112.98 35.68 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.1 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.62 159.01 11.93 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.474 2.116 . . . . 0.0 112.315 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 -103.15 165.09 11.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.937 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 23.0 t -68.24 -28.6 67.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.979 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -57.37 142.25 44.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.989 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.94 135.38 50.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.92 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.175 -0.917 . . . . 0.0 110.937 179.96 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 31.1 t . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.868 0.366 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -161.88 164.04 28.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 612' ' ' MET . . . . . 0.826 ' HA ' HD12 ' A' ' 615' ' ' LEU . 2.1 ptm -59.59 -29.4 67.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 613' ' ' SER . . . . . 0.51 ' O ' ' HB3' ' A' ' 636' ' ' ALA . 60.0 p -57.7 -23.01 49.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.099 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -101.6 -27.79 12.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.095 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 615' ' ' LEU . . . . . 0.826 HD12 ' HA ' ' A' ' 612' ' ' MET . 7.8 mt -68.25 155.46 92.27 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.937 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.67 150.69 35.68 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.646 2.231 . . . . 0.0 112.466 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 617' ' ' VAL . . . . . 0.456 ' O ' ' HB1' ' A' ' 633' ' ' ALA . 27.9 t -118.8 127.35 75.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.053 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 618' ' ' LYS . . . . . 0.561 ' HB2' ' HB3' ' A' ' 652' ' ' ALA . 0.0 OUTLIER -65.39 167.96 7.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.953 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 619' ' ' VAL . . . . . 0.549 HG13 ' O ' ' A' ' 618' ' ' LYS . 5.2 m -159.24 161.45 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.003 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 12.8 tt -134.98 128.14 49.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.926 0.394 . . . . 0.0 111.528 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 621' ' ' HIS . . . . . 0.491 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 13.8 t-160 -80.51 137.93 36.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.33 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 622' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 648' ' ' GLY . 20.8 t -85.18 -22.16 7.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.779 0.323 . . . . 0.0 111.482 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . 0.44 ' HB3' ' CE1' ' A' ' 621' ' ' HIS . 26.1 tt0 -68.46 -37.4 80.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.499 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 32.0 t -120.12 -23.39 6.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.705 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 86.69 10.41 73.02 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.754 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 7.3 tppt? -76.58 146.92 37.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.785 0.326 . . . . 0.0 110.754 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 3.4 mp -119.97 123.55 71.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.335 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 628' ' ' LEU . . . . . 0.448 ' CD1' ' CE1' ' A' ' 649' ' ' TYR . 15.0 mt -92.35 140.03 30.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.636 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.77 165.88 16.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.389 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . -56.04 -18.46 19.56 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.841 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 6.0 m -70.94 -43.7 67.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.648 0.261 . . . . 0.0 111.484 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.11 -24.22 15.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.797 0.332 . . . . 0.0 111.374 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 633' ' ' ALA . . . . . 0.456 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.52 156.2 54.54 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.161 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.455 ' HG2' HD12 ' A' ' 639' ' ' LEU . 73.0 Cg_endo -74.75 163.77 35.03 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.689 2.259 . . . . 0.0 112.327 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 21.7 mttp -72.99 175.77 6.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.433 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 636' ' ' ALA . . . . . 0.51 ' HB3' ' O ' ' A' ' 613' ' ' SER . . . -61.39 -48.97 78.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.774 0.321 . . . . 0.0 111.205 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.71 -36.26 48.64 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.832 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.94 -11.31 59.59 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.619 0.229 . . . . 0.0 111.619 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 639' ' ' LEU . . . . . 0.455 HD12 ' HG2' ' A' ' 634' ' ' PRO . 10.9 tp -55.98 -47.52 77.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.726 0.298 . . . . 0.0 111.211 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -54.85 -47.75 73.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.997 0.427 . . . . 0.0 111.105 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -67.89 -36.92 81.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.701 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 642' ' ' TRP . . . . . 0.44 ' CZ3' ' HB2' ' A' ' 646' ' ' ASN . 39.7 t90 -66.59 -38.6 87.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.491 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 8.3 mt -66.26 -44.72 82.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.077 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -59.5 -40.03 85.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.201 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 2.7 ttm -79.26 -21.02 46.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.83 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 646' ' ' ASN . . . . . 0.44 ' HB2' ' CZ3' ' A' ' 642' ' ' TRP . 23.9 m-80 -133.4 65.67 72.78 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.842 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -59.65 149.79 80.44 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.57 2.18 . . . . 0.0 112.444 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 648' ' ' GLY . . . . . 0.67 ' O ' HG23 ' A' ' 622' ' ' VAL . . . 104.46 -13.55 51.05 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.852 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.491 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 13.2 m-85 -85.01 142.31 29.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 0.0 111.053 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 650' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 619' ' ' VAL . 1.4 mm-40 -130.74 146.18 52.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.509 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 27.2 t -54.36 123.83 5.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.835 0.35 . . . . 0.0 111.297 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 652' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 618' ' ' LYS . . . -64.15 112.6 7.91 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.102 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.51 159.0 54.33 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.416 2.077 . . . . 0.0 112.274 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 3.8 mpp_? -86.4 130.87 34.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 52.3 p -88.48 -5.41 58.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.358 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 60.92 163.5 0.07 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.859 0.362 . . . . 0.0 110.9 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.23 -58.37 3.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.889 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.816 0.341 . . . . 0.0 111.281 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -149.67 77.46 1.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.836 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 612' ' ' MET . . . . . 0.425 ' HA ' HD12 ' A' ' 615' ' ' LEU . 5.2 mtt -57.97 -30.99 66.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.032 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 613' ' ' SER . . . . . 0.547 ' O ' ' HB3' ' A' ' 636' ' ' ALA . 16.9 t -59.97 -28.14 67.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.989 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.2 -27.84 18.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.077 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 615' ' ' LEU . . . . . 0.425 HD12 ' HA ' ' A' ' 612' ' ' MET . 71.2 mt -59.04 151.44 56.29 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.871 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.41 144.3 28.79 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.584 2.189 . . . . 0.0 112.309 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 617' ' ' VAL . . . . . 0.457 ' CG1' HG13 ' A' ' 651' ' ' VAL . 21.6 t -118.81 115.66 48.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.145 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 618' ' ' LYS . . . . . 0.715 ' HB2' ' HB3' ' A' ' 652' ' ' ALA . 0.3 OUTLIER -65.46 175.66 1.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.813 179.912 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 619' ' ' VAL . . . . . 0.491 HG13 ' O ' ' A' ' 618' ' ' LYS . 11.2 m -158.33 157.07 3.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.158 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.799 HD13 HG12 ' A' ' 627' ' ' ILE . 5.6 tp -124.35 127.6 73.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.922 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 621' ' ' HIS . . . . . 0.502 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 7.1 t-160 -89.51 127.98 35.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.692 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.6 t -88.35 -38.03 11.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.071 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -68.52 -30.59 69.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.413 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 8.9 t -112.5 -23.36 10.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.543 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 79.27 1.88 86.55 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.746 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 626' ' ' LYS . . . . . 0.59 ' O ' HD12 ' A' ' 620' ' ' ILE . 0.4 OUTLIER -76.67 156.79 32.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.825 0.345 . . . . 0.0 110.888 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 627' ' ' ILE . . . . . 0.799 HG12 HD13 ' A' ' 620' ' ' ILE . 1.9 mt -126.65 124.46 65.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.103 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 628' ' ' LEU . . . . . 0.451 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 19.1 mt -102.25 129.89 48.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.842 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.6 166.09 16.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.221 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 630' ' ' GLY . . . . . 0.43 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -50.2 -22.23 4.78 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.832 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 8.1 p -68.5 -43.79 76.09 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -98.43 -25.05 14.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.524 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 633' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.48 154.7 63.01 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.262 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.556 ' HG2' HD12 ' A' ' 639' ' ' LEU . 72.0 Cg_endo -75.44 161.72 37.07 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.625 2.216 . . . . 0.0 112.382 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -81.66 158.85 24.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.411 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 636' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 613' ' ' SER . . . -53.1 -27.09 18.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.787 0.327 . . . . 0.0 111.417 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.68 -36.34 48.57 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.831 -0.699 . . . . 0.0 113.397 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -111.96 11.63 20.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.875 0.337 . . . . 0.0 111.908 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 639' ' ' LEU . . . . . 0.556 HD12 ' HG2' ' A' ' 634' ' ' PRO . 10.4 tp -62.18 -52.19 64.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.799 0.333 . . . . 0.0 111.084 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -53.24 -42.34 66.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.125 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.98 -39.06 76.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.883 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 642' ' ' TRP . . . . . 0.451 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 34.7 t90 -64.59 -46.91 80.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.677 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 643' ' ' LEU . . . . . 0.464 HD23 ' HA ' ' A' ' 643' ' ' LEU . 11.7 mt -63.83 -40.53 96.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.509 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -60.63 -41.01 94.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.568 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 1.2 ttt -78.03 -35.75 49.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.845 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 646' ' ' ASN . . . . . 0.43 ' HB2' ' CZ3' ' A' ' 642' ' ' TRP . 24.5 m-80 -109.88 81.32 1.99 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.79 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.45 147.85 71.98 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.563 2.176 . . . . 0.0 112.392 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.46 -14.15 50.8 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.738 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.502 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 17.1 m-85 -88.39 149.41 23.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.85 0.357 . . . . 0.0 111.009 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -136.22 145.76 46.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.641 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 651' ' ' VAL . . . . . 0.457 HG13 ' CG1' ' A' ' 617' ' ' VAL . 21.2 t -58.22 128.3 18.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.234 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 652' ' ' ALA . . . . . 0.715 ' HB3' ' HB2' ' A' ' 618' ' ' LYS . . . -80.21 142.85 55.52 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.048 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.73 158.59 8.09 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.557 2.172 . . . . 0.0 112.215 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 59.35 174.77 0.08 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 47.9 m -109.17 -31.53 7.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.849 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.89 -173.46 4.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 18.0 m -136.21 -48.7 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.943 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.934 179.986 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 17.2 m . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.723 0.297 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 63.58 127.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.922 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 30.4 ttm -58.05 -30.38 66.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.941 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 613' ' ' SER . . . . . 0.6 ' O ' ' HB3' ' A' ' 636' ' ' ALA . 2.8 p -64.73 -24.6 67.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.059 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -95.0 -27.89 15.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.013 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 80.1 mt -73.01 152.18 90.71 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.963 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.31 145.68 24.24 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.71 2.274 . . . . 0.0 112.402 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 617' ' ' VAL . . . . . 0.51 ' CG1' HG13 ' A' ' 651' ' ' VAL . 21.3 t -118.84 119.88 62.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.086 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 618' ' ' LYS . . . . . 0.802 ' CB ' ' HB3' ' A' ' 652' ' ' ALA . 0.0 OUTLIER -61.41 169.58 2.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.911 0.386 . . . . 0.0 110.985 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 619' ' ' VAL . . . . . 0.517 HG23 ' CD1' ' A' ' 649' ' ' TYR . 32.9 m -155.83 143.35 11.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.858 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.493 HD13 ' C ' ' A' ' 620' ' ' ILE . 0.0 OUTLIER -124.37 127.58 73.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.888 0.375 . . . . 0.0 111.132 -179.768 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 621' ' ' HIS . . . . . 0.492 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 3.6 t-160 -86.69 131.09 34.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.62 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.6 t -86.43 -29.69 6.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.851 0.357 . . . . 0.0 111.054 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -68.55 -37.38 79.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.49 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 8.7 p -111.96 -23.48 10.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.456 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 87.21 -10.52 68.5 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.921 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.4 141.99 53.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.797 0.332 . . . . 0.0 110.89 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 1.9 mt -121.08 129.39 75.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.307 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 628' ' ' LEU . . . . . 0.46 HD12 ' CG2' ' A' ' 619' ' ' VAL . 12.5 mt -95.68 139.64 31.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.777 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.84 165.91 16.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.497 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 630' ' ' GLY . . . . . 0.422 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -57.2 -18.38 27.77 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.92 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.63 -43.73 68.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.753 0.311 . . . . 0.0 111.446 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -98.19 -22.49 16.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.358 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.46 156.33 53.19 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.291 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.461 ' HG2' HD12 ' A' ' 639' ' ' LEU . 64.1 Cg_endo -72.42 163.82 37.45 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.735 2.29 . . . . 0.0 112.247 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -72.9 176.45 5.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.525 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 636' ' ' ALA . . . . . 0.6 ' HB3' ' O ' ' A' ' 613' ' ' SER . . . -59.43 -48.49 81.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.46 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.47 -36.19 50.03 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.049 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -81.73 -9.85 59.53 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 639' ' ' LEU . . . . . 0.461 HD12 ' HG2' ' A' ' 634' ' ' PRO . 12.0 tp -62.18 -50.11 73.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.654 0.264 . . . . 0.0 111.077 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -52.41 -46.25 66.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.001 0.429 . . . . 0.0 111.17 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.48 -37.61 77.32 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.919 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 642' ' ' TRP . . . . . 0.442 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 44.2 t90 -65.31 -40.81 94.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.747 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 86.0 mt -67.59 -42.58 82.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.319 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.64 -40.45 87.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.414 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.22 -37.09 54.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.623 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -110.92 80.25 2.16 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.648 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.43 147.65 71.73 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.462 2.108 . . . . 0.0 112.454 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.45 -7.74 47.07 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.836 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.517 ' CD1' HG23 ' A' ' 619' ' ' VAL . 12.5 m-85 -93.47 157.55 16.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.897 0.379 . . . . 0.0 111.026 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 650' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 619' ' ' VAL . 18.7 mm-40 -149.4 151.67 34.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.26 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 651' ' ' VAL . . . . . 0.51 HG13 ' CG1' ' A' ' 617' ' ' VAL . 28.5 t -54.04 119.72 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.821 0.344 . . . . 0.0 111.259 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 652' ' ' ALA . . . . . 0.802 ' HB3' ' CB ' ' A' ' 618' ' ' LYS . . . -82.95 142.12 44.43 Favored Pre-proline 0 C--N 1.333 -0.145 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.199 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.06 156.34 38.33 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.526 2.151 . . . . 0.0 112.269 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.65 -19.93 12.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.095 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 8.1 t 65.43 31.85 10.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.865 0.364 . . . . 0.0 110.912 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -126.67 174.53 8.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.809 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 41.4 m -88.1 -65.43 1.02 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.95 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.81 -179.984 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.878 0.371 . . . . 0.0 111.278 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -149.98 41.66 0.84 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.856 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 72.9 mtp -61.44 -31.42 71.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.875 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 613' ' ' SER . . . . . . . . . . . . . 2.3 t -63.13 -30.74 71.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.996 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.15 -27.92 38.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.037 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 39.3 mt -62.4 148.79 89.34 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.93 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.05 155.99 47.45 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.604 2.203 . . . . 0.0 112.323 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 617' ' ' VAL . . . . . 0.612 ' CG1' HG13 ' A' ' 651' ' ' VAL . 27.9 t -118.69 121.06 66.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.06 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 618' ' ' LYS . . . . . 0.689 ' HG2' ' HB3' ' A' ' 652' ' ' ALA . 0.0 OUTLIER -76.53 134.97 39.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.965 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 619' ' ' VAL . . . . . 0.596 HG12 ' HA ' ' A' ' 651' ' ' VAL . 2.6 m -124.0 176.89 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.189 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 3.4 tt -143.0 133.12 22.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.509 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 621' ' ' HIS . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 3.3 t-160 -84.65 136.89 33.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.055 179.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 622' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 648' ' ' GLY . 27.0 t -84.65 -36.55 11.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.826 0.346 . . . . 0.0 111.21 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -68.56 -33.0 73.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.41 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.17 -23.24 12.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.55 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 77.36 4.55 84.4 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.683 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 9.0 tttt -76.57 148.38 37.06 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.76 0.314 . . . . 0.0 110.836 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 10.7 mt -122.28 105.54 16.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.363 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 628' ' ' LEU . . . . . 0.452 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 13.6 mt -80.1 130.99 35.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.322 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.53 166.03 16.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.384 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 630' ' ' GLY . . . . . . . . . . . . . . . -50.51 -22.59 5.59 Favored Glycine 0 CA--C 1.517 0.193 0 C-N-CA 120.81 -0.71 . . . . 0.0 113.005 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.16 -43.89 81.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.675 0.274 . . . . 0.0 111.586 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -98.18 -23.72 15.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.911 0.386 . . . . 0.0 111.489 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 633' ' ' ALA . . . . . 0.442 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.62 156.41 54.22 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.302 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.451 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 71.7 Cg_endo -75.11 163.79 34.41 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.878 2.385 . . . . 0.0 112.222 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -72.97 174.73 7.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.495 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -60.99 -44.21 97.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.852 0.358 . . . . 0.0 111.461 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.67 -36.22 49.0 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.214 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 6.1 mm100 -87.19 -7.36 58.02 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 639' ' ' LEU . . . . . 0.446 HD12 ' HG2' ' A' ' 634' ' ' PRO . 14.3 tp -59.62 -49.6 77.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.759 0.314 . . . . 0.0 111.197 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -52.42 -50.39 62.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.943 0.402 . . . . 0.0 111.281 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -66.58 -34.53 78.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.096 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 642' ' ' TRP . . . . . 0.451 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 49.5 t90 -66.73 -46.12 76.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.875 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 35.9 mt -62.76 -43.8 97.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.479 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.17 -38.83 87.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.562 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 6.8 tmm? -78.88 -24.85 43.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.005 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -123.39 77.8 53.84 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.826 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -64.81 144.68 84.28 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.705 2.27 . . . . 0.0 112.395 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 648' ' ' GLY . . . . . 0.456 ' O ' HG23 ' A' ' 622' ' ' VAL . . . 104.48 -3.41 43.04 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.965 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.479 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 7.7 m-85 -96.25 152.53 18.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.894 0.378 . . . . 0.0 110.976 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -147.81 147.2 29.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.847 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 651' ' ' VAL . . . . . 0.612 HG13 ' CG1' ' A' ' 617' ' ' VAL . 21.4 t -57.65 126.55 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.126 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 652' ' ' ALA . . . . . 0.689 ' HB3' ' HG2' ' A' ' 618' ' ' LYS . . . -64.16 148.1 95.96 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.186 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.18 156.5 55.34 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.558 2.172 . . . . 0.0 112.335 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.24 -28.64 38.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.004 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 10.2 p 59.9 29.64 19.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.006 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 2.1 t70 61.16 113.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.977 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 9.9 t 62.79 -80.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.048 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.878 179.948 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.811 0.338 . . . . 0.0 111.252 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -153.48 -56.38 0.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.85 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.33 -36.08 82.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.945 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 613' ' ' SER . . . . . 0.474 ' O ' ' HB3' ' A' ' 636' ' ' ALA . 99.3 p -65.3 -21.98 66.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.135 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -94.42 17.9 12.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.284 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 28.5 mt -106.2 148.65 37.03 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.722 0.296 . . . . 0.0 110.879 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.19 136.87 20.57 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.548 2.166 . . . . 0.0 112.365 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 617' ' ' VAL . . . . . 0.49 ' O ' ' HB1' ' A' ' 633' ' ' ALA . 21.5 t -112.65 115.44 49.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.06 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 618' ' ' LYS . . . . . 0.49 ' O ' HG13 ' A' ' 619' ' ' VAL . 0.3 OUTLIER -60.76 173.2 0.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.967 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 619' ' ' VAL . . . . . 0.589 ' O ' HG23 ' A' ' 627' ' ' ILE . 5.7 m -157.81 159.31 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.237 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.403 HG12 ' CG1' ' A' ' 627' ' ' ILE . 0.0 OUTLIER -124.72 127.71 72.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.696 179.652 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 621' ' ' HIS . . . . . 0.519 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 5.6 t-160 -88.77 127.59 35.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.746 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 26.9 t -88.36 -28.53 5.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.167 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . 0.441 ' HB3' ' CE1' ' A' ' 621' ' ' HIS . 2.4 tm-20 -68.52 -37.29 79.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.232 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 1.6 t -114.52 -23.38 9.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.542 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 90.57 -12.61 67.91 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.74 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.31 143.61 53.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.844 0.355 . . . . 0.0 110.922 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 627' ' ' ILE . . . . . 0.589 HG23 ' O ' ' A' ' 619' ' ' VAL . 2.0 mt -120.36 127.09 75.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.21 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 628' ' ' LEU . . . . . 0.463 ' CD1' ' CE2' ' A' ' 649' ' ' TYR . 5.6 mt -93.75 133.77 36.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.814 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 629' ' ' THR . . . . . 0.608 ' OG1' HG22 ' A' ' 631' ' ' THR . 0.3 OUTLIER -85.85 166.28 16.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.327 179.758 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 630' ' ' GLY . . . . . 0.439 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -50.08 -23.59 5.78 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.977 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 631' ' ' THR . . . . . 0.608 HG22 ' OG1' ' A' ' 629' ' ' THR . 5.8 t -65.72 -43.4 89.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.703 0.287 . . . . 0.0 111.305 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.35 -20.58 17.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.359 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 633' ' ' ALA . . . . . 0.49 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.53 150.7 80.17 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.318 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.478 ' HG2' HD12 ' A' ' 639' ' ' LEU . 72.9 Cg_endo -75.27 163.81 34.05 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.753 2.302 . . . . 0.0 112.353 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 35.5 mttp -73.03 172.0 11.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.425 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 636' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 613' ' ' SER . . . -62.39 -38.09 88.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.862 0.363 . . . . 0.0 111.425 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.7 -36.22 48.83 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.237 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -94.38 -3.34 50.47 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 639' ' ' LEU . . . . . 0.478 HD12 ' HG2' ' A' ' 634' ' ' PRO . 13.6 tp -59.64 -50.54 73.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.728 0.299 . . . . 0.0 111.194 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -52.9 -44.52 67.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.219 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.82 -36.81 75.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.003 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 642' ' ' TRP . . . . . 0.434 ' CG ' ' HG3' ' A' ' 634' ' ' PRO . 35.1 t90 -67.23 -41.27 85.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.789 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 643' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 643' ' ' LEU . 16.4 mt -67.13 -43.56 82.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.479 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -60.78 -40.49 92.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.541 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.35 -37.28 57.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.797 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -107.84 81.76 1.26 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.818 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -68.39 147.43 71.48 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.616 2.211 . . . . 0.0 112.442 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.34 -20.59 39.63 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.578 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.519 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 23.8 m-85 -81.57 149.97 28.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.876 0.37 . . . . 0.0 111.115 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -142.49 155.62 45.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.62 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.4 t -54.57 127.74 13.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.18 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 652' ' ' ALA . . . . . . . . . . . . . . . -103.53 104.67 43.12 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.231 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.66 159.24 42.02 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.54 2.16 . . . . 0.0 112.182 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 37.2 mtt85 -65.18 109.84 2.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.904 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 2.1 p -123.22 34.07 5.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.987 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.18 -31.32 70.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.845 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 4.4 p -92.9 126.08 37.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.831 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.86 179.967 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 120.77 0.319 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 59.77 97.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.812 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 612' ' ' MET . . . . . 0.407 ' HA ' ' CD1' ' A' ' 615' ' ' LEU . 0.0 OUTLIER -69.0 -29.85 68.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.079 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 613' ' ' SER . . . . . . . . . . . . . 1.4 m -73.43 -26.32 60.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.098 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.57 17.88 23.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.425 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 615' ' ' LEU . . . . . 0.469 HD22 ' HD2' ' A' ' 616' ' ' PRO . 13.4 mt -68.83 161.83 68.68 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.675 0.274 . . . . 0.0 110.899 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . 0.469 ' HD2' HD22 ' A' ' 615' ' ' LEU . 74.3 Cg_endo -75.36 140.0 24.01 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.606 2.204 . . . . 0.0 112.32 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 617' ' ' VAL . . . . . 0.473 ' O ' ' HB1' ' A' ' 633' ' ' ALA . 26.2 t -116.45 115.41 48.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.055 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 618' ' ' LYS . . . . . 0.555 ' CB ' ' HB3' ' A' ' 652' ' ' ALA . 0.0 OUTLIER -61.51 170.79 1.71 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.923 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 619' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 650' ' ' GLU . 27.7 m -157.42 146.06 10.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.995 179.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.404 HG12 HG13 ' A' ' 627' ' ' ILE . 0.0 OUTLIER -124.43 127.63 73.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.943 0.402 . . . . 0.0 111.265 -179.754 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 621' ' ' HIS . . . . . 0.51 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 4.4 t-160 -83.96 131.79 34.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.675 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.5 t -87.8 -29.77 5.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.897 0.38 . . . . 0.0 111.051 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -68.43 -37.3 80.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.198 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 1.5 m -110.85 -23.48 10.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.405 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 85.58 -7.62 75.69 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.906 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -69.4 152.39 44.98 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.791 0.329 . . . . 0.0 110.824 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 627' ' ' ILE . . . . . 0.404 HG13 HG12 ' A' ' 620' ' ' ILE . 2.0 mt -127.64 138.66 54.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.213 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 26.4 mt -105.46 139.2 40.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.768 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.83 165.96 16.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.483 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 630' ' ' GLY . . . . . 0.471 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -56.48 -18.94 24.52 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.005 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 10.0 t -71.17 -43.55 67.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.685 0.278 . . . . 0.0 111.554 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.2 -21.39 16.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.342 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 633' ' ' ALA . . . . . 0.473 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.53 156.22 54.53 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.247 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.45 ' HG2' HD12 ' A' ' 639' ' ' LEU . 71.6 Cg_endo -73.88 163.79 36.15 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.631 2.221 . . . . 0.0 112.287 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 4.3 mtpp -73.04 176.4 5.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.595 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -60.7 -48.96 79.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.802 0.334 . . . . 0.0 111.286 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.72 -36.32 48.46 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.877 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.11 -11.84 59.72 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 639' ' ' LEU . . . . . 0.45 HD12 ' HG2' ' A' ' 634' ' ' PRO . 10.5 tp -57.71 -49.65 75.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.758 0.313 . . . . 0.0 111.143 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.73 -45.59 70.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.111 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.74 -37.72 76.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.872 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 642' ' ' TRP . . . . . 0.45 ' CZ3' ' HB2' ' A' ' 646' ' ' ASN . 34.9 t90 -64.83 -42.67 94.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.682 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 65.6 mt -66.33 -42.4 88.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.417 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.17 -41.1 87.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.459 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 4.1 mmt -77.55 -35.17 53.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.645 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 646' ' ' ASN . . . . . 0.45 ' HB2' ' CZ3' ' A' ' 642' ' ' TRP . 23.5 m-80 -113.17 79.75 3.87 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.779 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.33 145.96 67.44 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.608 2.205 . . . . 0.0 112.404 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.44 -6.24 45.43 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.832 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.526 ' CD1' HG23 ' A' ' 619' ' ' VAL . 11.4 m-85 -95.51 149.5 21.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.911 0.386 . . . . 0.0 111.021 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 650' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 619' ' ' VAL . 69.1 mt-10 -136.5 145.46 45.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.17 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 2.4 m -54.31 123.35 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.9 0.381 . . . . 0.0 111.491 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 652' ' ' ALA . . . . . 0.555 ' HB3' ' CB ' ' A' ' 618' ' ' LYS . . . -99.65 98.3 6.89 Favored Pre-proline 0 C--N 1.333 -0.152 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.243 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.91 156.41 66.01 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.386 2.057 . . . . 0.0 112.272 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -110.59 176.61 4.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.881 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.69 -43.01 1.89 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.084 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -75.63 81.49 2.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.937 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 3.5 m -127.42 -45.56 1.5 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.877 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.92 179.957 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 610' ' ' SER . . . . . 0.449 ' N ' ' HG ' ' A' ' 613' ' ' SER . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.742 0.306 . . . . 0.0 111.165 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -126.72 -54.45 1.42 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 7.0 mmm -59.3 -28.35 66.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.049 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 613' ' ' SER . . . . . 0.608 ' HA ' ' HB3' ' A' ' 636' ' ' ALA . 0.9 OUTLIER -58.35 -27.24 64.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.06 -179.873 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.21 -27.8 21.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.196 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 16.2 mt -71.17 146.25 92.17 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.971 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.31 142.62 21.46 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.698 2.265 . . . . 0.0 112.442 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 617' ' ' VAL . . . . . 0.743 ' CG1' HG13 ' A' ' 651' ' ' VAL . 21.5 t -118.92 122.72 70.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.122 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 618' ' ' LYS . . . . . 0.731 ' CB ' ' HB3' ' A' ' 652' ' ' ALA . 0.8 OUTLIER -65.11 171.17 3.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.759 179.883 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 619' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 650' ' ' GLU . 27.2 m -156.71 152.43 7.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.308 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.92 HD13 ' CG1' ' A' ' 627' ' ' ILE . 3.6 tp -124.88 127.45 72.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.647 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 621' ' ' HIS . . . . . 0.527 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 4.1 t-160 -89.26 135.83 33.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.633 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 622' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 648' ' ' GLY . 25.8 t -87.12 -35.77 8.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.819 0.343 . . . . 0.0 111.287 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . 0.439 ' HB2' ' CE1' ' A' ' 621' ' ' HIS . 30.2 mt-10 -68.59 -32.99 73.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.536 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 3.3 t -112.2 -23.36 10.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.592 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 78.97 0.29 81.55 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.906 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 626' ' ' LYS . . . . . 0.647 ' O ' HD12 ' A' ' 620' ' ' ILE . 5.6 ttmt -76.68 150.56 36.32 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.757 0.313 . . . . 0.0 110.929 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 627' ' ' ILE . . . . . 0.92 ' CG1' HD13 ' A' ' 620' ' ' ILE . 6.2 mt -119.32 119.38 60.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.199 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 628' ' ' LEU . . . . . 0.485 ' HB2' HG22 ' A' ' 619' ' ' VAL . 37.2 mt -87.13 135.82 33.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.745 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.52 166.03 16.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.407 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 630' ' ' GLY . . . . . 0.412 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -56.37 -17.73 19.54 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.646 -0.788 . . . . 0.0 113.004 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.55 -43.6 59.5 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.75 0.275 . . . . 0.0 111.681 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.15 -24.08 15.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.702 0.287 . . . . 0.0 111.461 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 633' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.44 154.3 64.77 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.171 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.609 ' HG2' HD12 ' A' ' 639' ' ' LEU . 72.7 Cg_endo -75.26 156.83 41.87 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.598 2.199 . . . . 0.0 112.414 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? -73.22 165.59 24.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.42 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 636' ' ' ALA . . . . . 0.608 ' HB3' ' HA ' ' A' ' 613' ' ' SER . . . -62.79 -29.14 70.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.81 0.338 . . . . 0.0 111.302 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.57 -36.35 49.11 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.308 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -106.69 4.72 28.1 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 639' ' ' LEU . . . . . 0.609 HD12 ' HG2' ' A' ' 634' ' ' PRO . 13.5 tp -57.26 -50.13 73.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.749 0.309 . . . . 0.0 111.079 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -52.88 -42.12 65.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.987 0.422 . . . . 0.0 110.961 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -69.85 -39.7 76.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.775 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 642' ' ' TRP . . . . . 0.433 ' CZ3' ' HB2' ' A' ' 646' ' ' ASN . 33.3 t90 -66.32 -36.53 83.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.554 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 46.7 mt -69.4 -41.76 76.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.296 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -61.24 -41.16 96.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.328 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 73.7 mtp -77.83 -32.06 51.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.623 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 646' ' ' ASN . . . . . 0.433 ' HB2' ' CZ3' ' A' ' 642' ' ' TRP . 28.2 m-80 -118.93 75.45 13.76 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.682 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.19 149.79 76.45 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.562 2.175 . . . . 0.0 112.442 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 648' ' ' GLY . . . . . 0.578 ' O ' HG23 ' A' ' 622' ' ' VAL . . . 104.39 -12.3 51.26 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.779 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.527 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 16.0 m-85 -87.8 159.3 18.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.89 0.376 . . . . 0.0 111.032 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 650' ' ' GLU . . . . . 0.514 ' O ' ' HA ' ' A' ' 619' ' ' VAL . 30.1 mt-10 -149.96 147.22 27.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.232 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 651' ' ' VAL . . . . . 0.743 HG13 ' CG1' ' A' ' 617' ' ' VAL . 31.3 t -53.95 127.09 11.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.777 0.323 . . . . 0.0 111.272 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 652' ' ' ALA . . . . . 0.731 ' HB3' ' CB ' ' A' ' 618' ' ' LYS . . . -83.24 136.74 43.07 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.291 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.04 159.16 37.79 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.448 2.099 . . . . 0.0 112.219 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -80.74 132.69 35.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.809 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 48.2 t -57.22 -33.51 67.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.971 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -125.09 146.22 49.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.877 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 93.5 p -159.07 179.06 9.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.905 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.32 -0.848 . . . . 0.0 110.852 -179.951 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 120.864 0.364 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 12.9 mp0 60.58 106.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.93 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -59.9 -28.69 67.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 613' ' ' SER . . . . . 0.477 ' HA ' ' HB3' ' A' ' 636' ' ' ALA . 10.9 m -57.27 -26.59 61.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.134 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -91.98 -27.83 17.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.068 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 8.9 mt -77.6 144.35 69.39 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.957 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.29 149.48 27.94 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.612 2.208 . . . . 0.0 112.444 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 617' ' ' VAL . . . . . 0.526 ' CG1' HG13 ' A' ' 651' ' ' VAL . 21.4 t -118.87 130.54 73.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.112 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 618' ' ' LYS . . . . . 0.799 ' HB3' ' HB3' ' A' ' 652' ' ' ALA . 0.0 OUTLIER -67.43 164.83 17.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.992 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 619' ' ' VAL . . . . . 0.613 HG23 ' CD1' ' A' ' 649' ' ' TYR . 33.5 m -156.19 144.07 11.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.97 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 649' ' ' TYR . 0.0 OUTLIER -124.24 127.66 73.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.889 0.376 . . . . 0.0 111.285 -179.813 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 621' ' ' HIS . . . . . 0.488 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 2.5 t-160 -85.46 133.52 34.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.601 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 20.5 t -86.62 -29.52 5.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.77 0.319 . . . . 0.0 111.133 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.53 -37.34 79.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.357 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 1.8 m -110.1 -23.36 11.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.355 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 82.5 5.83 89.16 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.006 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 626' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.63 151.99 36.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.755 0.312 . . . . 0.0 110.895 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 3.5 mt -127.4 114.47 36.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.221 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 628' ' ' LEU . . . . . 0.516 HD12 ' CG2' ' A' ' 619' ' ' VAL . 19.1 mt -86.76 134.46 33.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.808 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.81 166.09 16.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.496 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 630' ' ' GLY . . . . . 0.418 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -58.46 -15.36 24.18 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.176 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.51 -43.68 38.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.899 0.35 . . . . 0.0 111.742 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.94 -26.1 14.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.873 0.368 . . . . 0.0 111.371 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 633' ' ' ALA . . . . . . . . . . . . . . . -61.51 156.03 55.54 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.215 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.431 ' HG3' ' CG ' ' A' ' 642' ' ' TRP . 52.2 Cg_endo -68.69 163.81 35.64 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.594 2.196 . . . . 0.0 112.195 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 26.9 mttp -72.85 171.47 12.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.473 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 636' ' ' ALA . . . . . 0.477 ' HB3' ' HA ' ' A' ' 613' ' ' SER . . . -62.63 -40.21 96.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.426 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.58 -36.25 49.34 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.099 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -91.21 -5.25 55.14 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 639' ' ' LEU . . . . . 0.423 HD12 ' HG2' ' A' ' 634' ' ' PRO . 15.3 tp -57.78 -50.76 72.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.714 0.292 . . . . 0.0 111.271 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.08 -44.0 61.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.913 0.387 . . . . 0.0 111.111 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -68.17 -39.16 82.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.977 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 642' ' ' TRP . . . . . 0.436 ' CD2' ' ND2' ' A' ' 646' ' ' ASN . 18.4 t90 -68.98 -34.0 74.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.851 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 17.4 mt -69.05 -47.5 65.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.481 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -61.31 -41.07 96.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.486 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 15.9 tpt -74.17 -33.87 63.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.583 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 646' ' ' ASN . . . . . 0.436 ' ND2' ' CD2' ' A' ' 642' ' ' TRP . 35.6 m-80 -114.47 74.23 3.02 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.647 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.81 147.09 89.41 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.613 2.208 . . . . 0.0 112.51 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.44 -4.12 43.61 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.893 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.613 ' CD1' HG23 ' A' ' 619' ' ' VAL . 8.9 m-85 -94.88 156.59 16.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.966 0.412 . . . . 0.0 111.109 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 650' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 619' ' ' VAL . 14.7 mm-40 -144.27 145.75 32.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.281 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 651' ' ' VAL . . . . . 0.526 HG13 ' CG1' ' A' ' 617' ' ' VAL . 24.3 t -54.06 121.29 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.811 0.338 . . . . 0.0 111.32 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 652' ' ' ALA . . . . . 0.799 ' HB3' ' HB3' ' A' ' 618' ' ' LYS . . . -90.22 146.87 35.64 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.144 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.78 158.94 9.88 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.531 2.154 . . . . 0.0 112.227 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.07 179.63 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.851 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 38.4 t -60.47 -31.58 70.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.892 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.21 81.79 1.82 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.927 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 14.3 t -131.91 171.43 13.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.848 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.905 179.965 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 610' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.828 0.346 . . . . 0.0 111.17 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 60.25 32.95 20.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.863 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 612' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.35 -31.48 65.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.906 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 613' ' ' SER . . . . . . . . . . . . . 2.9 m -69.43 -21.45 63.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.163 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -92.82 17.88 9.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.396 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 615' ' ' LEU . . . . . . . . . . . . . 62.3 mt -91.68 151.4 42.32 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.766 0.317 . . . . 0.0 110.878 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.82 149.08 53.39 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.562 2.175 . . . . 0.0 112.294 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 617' ' ' VAL . . . . . 0.417 ' O ' ' HB1' ' A' ' 633' ' ' ALA . 21.2 t -118.81 119.92 62.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.984 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 618' ' ' LYS . . . . . 0.675 ' HB2' ' HB3' ' A' ' 652' ' ' ALA . 0.0 OUTLIER -55.41 172.01 0.16 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.924 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 619' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 618' ' ' LYS . 12.1 m -158.13 160.02 2.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.248 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.792 HD13 HG12 ' A' ' 627' ' ' ILE . 6.4 tp -124.41 127.67 73.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.784 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 621' ' ' HIS . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 649' ' ' TYR . 7.2 t-160 -92.31 128.63 38.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.723 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 622' ' ' VAL . . . . . . . . . . . . . 21.4 t -87.74 -28.61 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.859 0.361 . . . . 0.0 111.256 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.57 -37.15 79.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.388 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 624' ' ' SER . . . . . . . . . . . . . 70.1 m -113.99 -23.35 9.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.615 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . 84.8 4.95 86.89 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.748 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 626' ' ' LYS . . . . . 0.653 ' O ' HD12 ' A' ' 620' ' ' ILE . 0.1 OUTLIER -76.58 156.84 32.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.863 0.363 . . . . 0.0 111.079 -179.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 627' ' ' ILE . . . . . 0.792 HG12 HD13 ' A' ' 620' ' ' ILE . 2.4 mt -125.35 115.29 43.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.054 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 628' ' ' LEU . . . . . 0.451 ' CD1' ' CE1' ' A' ' 649' ' ' TYR . 28.4 mt -90.04 130.33 36.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.822 0.344 . . . . 0.0 110.875 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.78 166.22 16.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.12 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 630' ' ' GLY . . . . . 0.435 ' N ' ' HG3' ' A' ' 618' ' ' LYS . . . -50.67 -21.25 4.65 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.87 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 631' ' ' THR . . . . . . . . . . . . . 4.3 m -69.85 -43.65 71.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.648 0.261 . . . . 0.0 111.658 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 632' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -98.34 -23.47 15.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.778 0.323 . . . . 0.0 111.528 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 633' ' ' ALA . . . . . 0.417 ' HB1' ' O ' ' A' ' 617' ' ' VAL . . . -61.44 156.24 53.59 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.244 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.437 ' HB3' ' CD1' ' A' ' 642' ' ' TRP . 73.0 Cg_endo -75.18 163.72 34.4 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.735 2.29 . . . . 0.0 112.325 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 26.9 mttt -73.01 176.37 5.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.535 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -61.55 -48.94 78.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.849 0.357 . . . . 0.0 111.234 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -74.69 -36.22 48.89 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.745 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 638' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.0 -12.49 59.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.563 0.22 . . . . 0.0 111.55 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 639' ' ' LEU . . . . . . . . . . . . . 11.6 tp -56.16 -47.85 77.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.786 0.327 . . . . 0.0 111.154 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -53.49 -51.32 63.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.978 0.418 . . . . 0.0 111.038 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -67.82 -34.52 76.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.012 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 642' ' ' TRP . . . . . 0.437 ' CD1' ' HB3' ' A' ' 634' ' ' PRO . 30.0 t90 -67.65 -38.56 84.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.744 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.46 -43.34 73.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.433 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 644' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -61.1 -39.49 90.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.521 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 645' ' ' MET . . . . . . . . . . . . . 2.4 ttp -78.73 -35.71 44.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.806 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 646' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -110.49 78.34 1.45 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.943 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 647' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.39 146.65 69.42 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.531 2.154 . . . . 0.0 112.355 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 648' ' ' GLY . . . . . . . . . . . . . . . 104.34 -12.53 51.5 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.783 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 621' ' ' HIS . 15.9 m-85 -88.37 161.71 16.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.899 0.381 . . . . 0.0 111.042 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -148.4 145.81 28.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.698 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 651' ' ' VAL . . . . . . . . . . . . . 21.5 t -58.26 130.43 21.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.282 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 652' ' ' ALA . . . . . 0.675 ' HB3' ' HB2' ' A' ' 618' ' ' LYS . . . -87.14 139.24 32.35 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.971 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 653' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -73.39 156.52 50.29 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.405 2.07 . . . . 0.0 112.374 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 654' ' ' ARG . . . . . . . . . . . . . 9.5 mmt85 -109.13 130.81 55.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 655' ' ' SER . . . . . . . . . . . . . 16.5 t -86.83 -33.08 19.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.941 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.08 137.12 35.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.83 -52.93 2.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.873 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 658' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.831 -179.965 . . . . . . . . 1 1 . 1 stop_ save_